<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Face Facility</title>

    <script async src="https://www.googletagmanager.com/gtag/js?id=G-2F6NE7JWTR"></script>
<script>
  window.dataLayer = window.dataLayer || [];
  function gtag(){dataLayer.push(arguments);}
  gtag('js', new Date());

  gtag('config', 'G-2F6NE7JWTR');
</script>
    <style>
        body { 
            font-family: Arial, sans-serif; 
            margin: 40px;
            line-height: 1.6;
            color: #333;
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
        }
        h1 { 
            color: #2c3e50;
            border-bottom: 2px solid #eee;
            padding-bottom: 10px;
        }
        h2 { 
            color: #34495e;
            margin-top: 30px;
            border-bottom: 1px solid #eee;
            padding-bottom: 5px;
        }
        .section { 
            margin: 20px 0;
            border: 1px solid #eee;
            border-radius: 5px;
            background-color: #fff;
            box-shadow: 0 1px 3px rgba(0,0,0,0.1);
        }
        .section-execute-plan-hidden {
            display: none;
        }
        table { 
            border-collapse: collapse;
            width: 100%;
            margin: 20px 0;
            font-size: 14px;
        }
        th, td { 
            border: 1px solid #ddd;
            padding: 12px 8px;
            text-align: left;
        }
        th { 
            background-color: #f5f5f5;
            font-weight: bold;
        }
        tr:nth-child(even) { 
            background-color: #f9f9f9;
        }
        tr:hover {
            background-color: #f5f5f5;
        }
        .planexe-report-info { 
            color: #666;
            font-size: 0.9em;
            margin-bottom: 30px;
        }
        .dataframe {
            overflow-x: auto;
            display: block;
        }
        .source-info {
            color: #666;
            font-size: 0.9em;
            margin-top: 10px;
            font-style: italic;
        }
        .collapsible {
            background-color: #3498db;
            color: white;
            cursor: pointer;
            padding: 18px;
            width: 100%;
            border: none;
            border-radius: 5px;
            text-align: left;
            outline: none;
            font-size: 18px;
            font-weight: bold;
            transition: background-color 0.3s ease, box-shadow 0.3s ease;
            position: relative;
        }
        .collapsible:hover {
            background-color: #2980b9;
            box-shadow: 0 4px 8px rgba(0,0,0,0.4);
        }
        .collapsible:after {
            content: '+';
            position: absolute;
            right: 20px;
            top: 50%;
            transform: translateY(-50%);
            transition: transform 0.3s ease;
        }
        .active:after {
            content: "−";
        }
        .content {
            padding: 0 20px;
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.2s ease-out;
        }

        /* The "Question/Answer" section */
        .question-answer-pair {
            margin-bottom: 20px; /* Adds vertical space between each Q&A pair */
            padding-bottom: 15px; /* Adds space below the Answer text before the separator */
            border-bottom: 1px solid #eee; /* Adds a subtle grey line to separate pairs */
        }
        .question-answer-pair:first-of-type {
            padding-top: 10px;
        }
        .question-answer-pair:last-of-type {
            margin-bottom: 0;
            padding-bottom: 20px;
            border-bottom: none;
        }
        .question-answer-pair p:first-child {
            font-weight: bold; /* Ensures the whole Question line is bold */
            margin-bottom: 10px; /* Adds a small space between the Question and the Answer */
            color: #34495e; /* Optional: makes the question color slightly different */
        }
        .question-answer-pair p:last-child {
            margin-top: 5px; /* Adds a small space between the Question and the Answer */
            margin-bottom: 0; /* Removes default bottom margin from the last paragraph */
        }
    </style>
    
  <script type="module">
    import mermaid from 'https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.esm.min.mjs';
    mermaid.initialize({ 
        "startOnLoad": true,
        "theme": "default",
        "themeVariables": {
            "sectionBkgColor": "#777",
            "sectionBkgColor2": "#777"
        },
        "gantt": {
            "fontSize": 17,
            "sectionFontSize": 20
        }
    });
  </script>
  

  <!-- 
  Versions available at:
  https://www.jsdelivr.com/package/npm/dhtmlx-gantt 
  Version 9.1.0 breaks the zoom in/out/fit buttons.
  Version 9.0.15 normal. The zoom in/out/fit buttons works.
  -->
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/dhtmlx-gantt@9.0.15/codebase/dhtmlxgantt.min.css">
  <script src="https://cdn.jsdelivr.net/npm/dhtmlx-gantt@9.0.15/codebase/dhtmlxgantt.min.js"></script>
  <style>
    .gantt_container_with_controls {
        margin-top: 1rem;
        margin-bottom: 1rem;
    }
    .gantt_container {
        width: 100%;
        height: 80vh;
        margin-bottom: 1rem;
    }
    .gantt_tooltip {
        max-width: 30rem;
        white-space: break-spaces;
    }
    .gantt-controls {
        display: flex;
        gap: 0.5rem;
        justify-content: center;
        align-items: center;
        margin-bottom: 1rem;
        position: relative;
    }
    .zoom-buttons {
        display: flex;
        gap: 0.5rem;
        justify-content: center;
    }
    .export-button {
        position: absolute;
        right: 0;
    }
    .gantt-controls button {
        padding: 0.5rem 1rem;
        border: 1px solid #ccc;
        border-radius: 0.25rem;
        background: white;
        cursor: pointer;
        font-size: 0.9rem;
    }
    .gantt-controls button:hover {
        background: #f5f5f5;
    }
    .project-task.gantt_task_line {
        background-color: #b67134;
        border-color: #f57c00;
    }
    .project-task .gantt_task_content {
        color: white;
    }
    .project-task.gantt_project.gantt_task_line {
        border-radius: 0;
    }
  </style>
  
</head>
<body>
    <!--CONTENT-START-->

        <h1>Face Facility</h1>
        <p class="planexe-report-info">Generated on: 2026-02-18 15:27:23 with PlanExe. <a href="https://planexe.org/discord.html">Discord</a>, <a href="https://github.com/PlanExeOrg/PlanExe">GitHub</a></p>
        

            <div class="section">
                <button class="collapsible">Executive Summary</button>
                <div class="content">        
                    <h2>Focus and Context</h2>
<p>In a world first, we aim to establish a commercial face transplantation facility in New Zealand with a subscription-based face swapping service. However, the plan's high-risk, high-reward nature necessitates a critical review to ensure feasibility and long-term sustainability.</p>
<h2>Purpose and Goals</h2>
<p>The primary goal is to establish a state-of-the-art facility and offer a revolutionary subscription-based service. Success will be measured by securing regulatory approvals, recruiting a skilled team, establishing partnerships, developing a robust ethical framework, acquiring donor faces, and building a strong subscriber base.</p>
<h2>Key Deliverables and Outcomes</h2>
<p>Key deliverables include:</p>
<ul>
<li>Securing regulatory approval from the New Zealand Ministry of Health and Medsafe by 2027-02-18.</li>
<li>Establishing partnerships with at least three organ donation organizations by 2026-04-01.</li>
<li>Recruiting and training a team of five qualified surgeons, ten nurses, and five technicians by 2026-05-01.</li>
<li>Achieving a patient satisfaction rate of at least 80% within the first year of operation.</li>
<li>Securing $50 million USD in funding by 2026-06-30.</li>
</ul>
<h2>Timeline and Budget</h2>
<p>The project has an initial budget of $50 million USD and an estimated timeline of 36 months.</p>
<h2>Risks and Mitigations</h2>
<p>Key risks include regulatory approval delays, ethical concerns, technical complications, and donor face acquisition challenges. Mitigation strategies involve proactive engagement with regulatory bodies, establishing a robust ethics review board, investing in R&amp;D, securing diverse funding sources, and partnering with organ donation organizations.</p>
<h2>Audience Tailoring</h2>
<p>This executive summary is tailored for senior management and investors, focusing on strategic decisions, risks, and financial implications. It uses concise language and data-driven insights to facilitate informed decision-making.</p>
<h2>Action Orientation</h2>
<p>Immediate next steps include conducting a comprehensive feasibility study on xenotransplantation and CRISPR, developing a detailed Donor Face Acquisition and Preservation Plan, and consulting with leading bioethicists to develop a novel, ethically robust consent process for facial donation. These actions are to be initiated by the Chief Technology Officer, Head of Operations, and Ethics Review Board Coordinator, respectively, with a target completion date of 2026-03-31.</p>
<h2>Overall Takeaway</h2>
<p>This project presents a high-risk, high-reward opportunity to revolutionize reconstructive surgery and empower individuals to express their identity in unprecedented ways. Addressing critical missing assumptions related to donor face acquisition, psychological support, and data privacy is paramount to mitigating potential risks, enhancing ethical standing, and improving long-term sustainability.</p>
<h2>Feedback</h2>
<p>To strengthen this executive summary, consider adding:
1.  Quantified potential ROI based on realistic market demand and subscriber projections.
2.  A more detailed breakdown of the $50 million budget allocation.
3.  Specific metrics for measuring the effectiveness of the ethical oversight strategy.
4.  A clear statement of the project's 'killer application' or immediately compelling use-case to drive initial adoption.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Gantt Overview</button>
                <div class="content">        
                    
<div class="mermaid">
gantt
    dateFormat  YYYY-MM-DD
    axisFormat  %d %b
    todayMarker off
    section 0
    Face Facility :2026-02-18, 1616d
    Project Initiation & Planning :2026-02-18, 99d
    Define Project Scope and Objectives :2026-02-18, 8d
    Gather Stakeholder Requirements :2026-02-18, 2d
    Analyze Requirements and Define Scope :2026-02-20, 2d
    Establish Measurable Project Objectives :2026-02-22, 2d
    Document Assumptions and Constraints :2026-02-24, 2d
    Identify Key Stakeholders :2026-02-26, 4d
    Identify internal project stakeholders :2026-02-26, 1d
    Identify external project stakeholders :2026-02-27, 1d
    section 10
    Analyze stakeholder influence and interests :2026-02-28, 1d
    Develop stakeholder communication plan :2026-03-01, 1d
    Develop Project Management Plan :2026-03-02, 15d
    Define Project Scope Statement :2026-03-02, 3d
    Develop Project Schedule :2026-03-05, 3d
    Create Project Budget :2026-03-08, 3d
    Establish Risk Management Plan :2026-03-11, 3d
    Define Communication Management Plan :2026-03-14, 3d
    Secure Initial Funding :2026-03-17, 60d
    Develop detailed financial projections :2026-03-17, 12d
    section 20
    Prepare investor pitch deck and materials :2026-03-29, 12d
    Identify and engage potential investors :2026-04-10, 12d
    Negotiate investment terms and agreements :2026-04-22, 12d
    Secure funding commitments and finalize agreements :2026-05-04, 12d
    Establish Project Governance Structure :2026-05-16, 12d
    Define Governance Roles and Responsibilities :2026-05-16, 3d
    Establish Decision-Making Processes :2026-05-19, 3d
    Create Communication Plan for Governance :2026-05-22, 3d
    Document Governance Structure and Processes :2026-05-25, 3d
    Regulatory & Ethical Approval :2026-05-28, 377d
    section 30
    Conduct Regulatory Landscape Assessment :2026-05-28, 32d
    Identify relevant regulatory bodies :2026-05-28, 8d
    Gather face transplantation regulations :2026-06-05, 8d
    Analyze regulatory requirements :2026-06-13, 8d
    Document regulatory gaps and uncertainties :2026-06-21, 8d
    Prepare Regulatory Approval Documentation :2026-06-29, 60d
    Gather required documentation templates :2026-06-29, 12d
    Draft initial documentation sections :2026-07-11, 12d
    Review and revise draft documentation :2026-07-23, 12d
    Finalize and format documentation :2026-08-04, 12d
    section 40
    Translate documents if required :2026-08-16, 12d
    Engage with Regulatory Bodies (Medsafe, Ministry of Health) :2026-08-28, 30d
    Identify Key Contacts at Regulatory Bodies :2026-08-28, 6d
    Schedule Initial Consultation Meetings :2026-09-03, 6d
    Present Project Overview and Objectives :2026-09-09, 6d
    Clarify Regulatory Requirements and Timelines :2026-09-15, 6d
    Document Meeting Outcomes and Action Items :2026-09-21, 6d
    Establish Ethics Review Board :2026-09-27, 60d
    Define ERB scope and responsibilities :2026-09-27, 15d
    Identify and recruit ERB members :2026-10-12, 15d
    section 50
    Develop ERB operational procedures :2026-10-27, 15d
    Secure institutional support for ERB :2026-11-11, 15d
    Develop Ethical Guidelines and Protocols :2026-11-26, 75d
    Research existing ethical guidelines for transplants :2026-11-26, 15d
    Identify key ethical considerations for face transplants :2026-12-11, 15d
    Draft preliminary ethical guidelines for the facility :2026-12-26, 15d
    Obtain feedback from stakeholders on draft guidelines :2027-01-10, 15d
    Finalize ethical guidelines and protocols :2027-01-25, 15d
    Obtain Necessary Permits and Licenses :2027-02-09, 120d
    Identify required permits and licenses :2027-02-09, 24d
    section 60
    Prepare permit and license applications :2027-03-05, 24d
    Submit applications and track progress :2027-03-29, 24d
    Address regulatory body inquiries :2027-04-22, 24d
    Secure final permits and licenses :2027-05-16, 24d
    Facility Development & Infrastructure :2027-06-09, 510d
    Select Facility Location :2027-06-09, 60d
    Define Facility Requirements and Criteria :2027-06-09, 12d
    Conduct Market Research and Site Analysis :2027-06-21, 12d
    Evaluate Potential Locations and Shortlist :2027-07-03, 12d
    Negotiate Lease or Purchase Agreement :2027-07-15, 12d
    section 70
    Conduct Due Diligence and Finalize Selection :2027-07-27, 12d
    Design Facility Layout :2027-08-08, 60d
    Define Facility Requirements and Specifications :2027-08-08, 12d
    Develop Preliminary Facility Layout Designs :2027-08-20, 12d
    Review and Refine Layout Designs :2027-09-01, 12d
    Create Detailed Architectural Drawings :2027-09-13, 12d
    Obtain Design Approvals :2027-09-25, 12d
    Procure Surgical Equipment and Medical Supplies :2027-10-07, 120d
    Define Equipment Specifications and Requirements :2027-10-07, 24d
    Identify Potential Vendors and Suppliers :2027-10-31, 24d
    section 80
    Evaluate Vendor Proposals and Negotiate Contracts :2027-11-24, 24d
    Manage Purchase Orders and Track Deliveries :2027-12-18, 24d
    Conduct Equipment Testing and Acceptance :2028-01-11, 24d
    Construct/Renovate Facility :2028-02-04, 240d
    Prepare site for construction/renovation :2028-02-04, 48d
    Execute structural construction/renovation :2028-03-23, 48d
    Install electrical and plumbing systems :2028-05-10, 48d
    Install specialized medical infrastructure :2028-06-27, 48d
    Complete interior finishing and fixtures :2028-08-14, 48d
    Install Data Privacy and Security Systems :2028-10-01, 30d
    section 90
    Assess data privacy regulatory requirements :2028-10-01, 6d
    Select and procure security hardware/software :2028-10-07, 6d
    Configure and integrate security systems :2028-10-13, 6d
    Test and validate security system effectiveness :2028-10-19, 6d
    Develop data breach response plan :2028-10-25, 6d
    Donor Face Acquisition & Preservation :2028-10-31, 167d
    Establish Partnerships with Organ Donation Organizations :2028-10-31, 60d
    Identify potential organ donation partners :2028-10-31, 15d
    Initial contact and introductory meetings :2028-11-15, 15d
    Negotiate partnership agreements :2028-11-30, 15d
    section 100
    Formalize partnership agreements :2028-12-15, 15d
    Develop Donor Face Acquisition Protocols :2028-12-30, 60d
    Research current face acquisition protocols :2028-12-30, 15d
    Draft initial face acquisition protocol :2029-01-14, 15d
    Review protocol with organ donation organizations :2029-01-29, 15d
    Finalize and approve acquisition protocol :2029-02-13, 15d
    Establish Face Transportation and Preservation Logistics :2029-02-28, 32d
    Map transportation routes and identify providers :2029-02-28, 8d
    Establish preservation solution procurement process :2029-03-08, 8d
    Develop packaging and handling procedures :2029-03-16, 8d
    section 110
    Create temperature monitoring and tracking system :2029-03-24, 8d
    Implement Inventory Management System :2029-04-01, 15d
    Define Inventory System Requirements :2029-04-01, 3d
    Select Inventory Management Software :2029-04-04, 3d
    Configure and Customize Software :2029-04-07, 3d
    Train Staff on System Usage :2029-04-10, 3d
    Test and Validate System Functionality :2029-04-13, 3d
    Medical Team Recruitment & Training :2029-04-16, 135d
    Recruit Transplant Surgeons, Nurses, and Technicians :2029-04-16, 45d
    Define Surgeon, Nurse, Technician Job Descriptions :2029-04-16, 9d
    section 120
    Advertise Open Positions on Relevant Platforms :2029-04-25, 9d
    Screen Applications and Conduct Initial Interviews :2029-05-04, 9d
    Conduct Technical and Practical Skills Assessments :2029-05-13, 9d
    Perform Background Checks and Credential Verification :2029-05-22, 9d
    Develop Training Programs for Medical Personnel :2029-05-31, 60d
    Curriculum Design for Face Transplant Training :2029-05-31, 12d
    Develop Surgical Simulation Modules :2029-06-12, 12d
    Establish Mentorship Program with Experts :2029-06-24, 12d
    Create Standardized Post-Operative Care Protocols :2029-07-06, 12d
    Develop Training Evaluation and Certification :2029-07-18, 12d
    section 130
    Conduct Simulation Training Exercises :2029-07-30, 30d
    Develop Simulation Scenarios and Protocols :2029-07-30, 6d
    Acquire and Configure Simulation Equipment :2029-08-05, 6d
    Train Simulation Facilitators and Observers :2029-08-11, 6d
    Conduct Simulation Exercises and Gather Data :2029-08-17, 6d
    Analyze Simulation Data and Provide Feedback :2029-08-23, 6d
    Subscription Model Development & Marketing :2029-08-29, 108d
    Design Subscription Model Tiers and Pricing :2029-08-29, 16d
    Research competitor subscription models :2029-08-29, 4d
    Define core service offerings :2029-09-02, 4d
    section 140
    Develop pricing models and financial projections :2029-09-06, 4d
    Assess legal and ethical considerations :2029-09-10, 4d
    Develop Marketing and Advertising Strategy :2029-09-14, 60d
    Define Target Audience and Market Segments :2029-09-14, 12d
    Develop Key Messaging and Value Proposition :2029-09-26, 12d
    Select Marketing Channels and Platforms :2029-10-08, 12d
    Create Marketing Materials and Content :2029-10-20, 12d
    Establish Public Relations and Media Outreach :2029-11-01, 12d
    Establish Customer Service and Support Protocols :2029-11-13, 32d
    Develop Customer Service Training Materials :2029-11-13, 8d
    section 150
    Establish Customer Service Channels :2029-11-21, 8d
    Define Service Level Agreements (SLAs) :2029-11-29, 8d
    Implement CRM System for Customer Data :2029-12-07, 8d
    Surgical Procedures & Patient Care :2029-12-15, 180d
    Develop Pre-Transplant Assessment Protocols :2029-12-15, 10d
    Gather Patient Medical History and Records :2029-12-15, 2d
    Conduct Physical and Neurological Examination :2029-12-17, 2d
    Psychological Evaluation and Counseling :2029-12-19, 2d
    Immunological Compatibility Testing :2029-12-21, 2d
    Financial and Insurance Assessment :2029-12-23, 2d
    section 160
    Conduct Face Transplantation Procedures :2029-12-25, 20d
    Pre-operative planning and simulations :2029-12-25, 4d
    Ensure backup equipment and supplies :2029-12-29, 4d
    Experienced surgical team presence :2030-01-02, 4d
    Implement strict infection control protocols :2030-01-06, 4d
    Develop contingency plans for complications :2030-01-10, 4d
    Implement Post-Transplant Care and Monitoring Protocols :2030-01-14, 60d
    Monitor for rejection signs and symptoms :2030-01-14, 12d
    Manage immunosuppression medication regimen :2030-01-26, 12d
    Provide wound care and infection control :2030-02-07, 12d
    section 170
    Offer physical and occupational therapy :2030-02-19, 12d
    Address psychological and emotional needs :2030-03-03, 12d
    Establish Psychological Support Program :2030-03-15, 90d
    Recruit qualified therapists and counselors :2030-03-15, 18d
    Develop counseling protocols and materials :2030-04-02, 18d
    Establish support group infrastructure :2030-04-20, 18d
    Implement patient referral system :2030-05-08, 18d
    Monitor and evaluate program effectiveness :2030-05-26, 18d
    Ongoing Operations & Maintenance :2030-06-13, 40d
    Manage Facility Operations and Maintenance :2030-06-13, 4d
    section 180
    Schedule routine equipment maintenance :2030-06-13, 1d
    Manage medical supply inventory :2030-06-14, 1d
    Address facility maintenance requests :2030-06-15, 1d
    Ensure compliance with safety regulations :2030-06-16, 1d
    Monitor and Evaluate Subscription Service Performance :2030-06-17, 10d
    Implement Data Collection Methods :2030-06-17, 2d
    Analyze Subscription Metrics :2030-06-19, 2d
    Conduct User Feedback Surveys :2030-06-21, 2d
    Adjust Marketing Strategies :2030-06-23, 2d
    Report Performance Findings :2030-06-25, 2d
    section 190
    Conduct Ongoing Regulatory Compliance Audits :2030-06-27, 10d
    Identify applicable regulatory compliance standards :2030-06-27, 2d
    Schedule internal compliance audits :2030-06-29, 2d
    Prepare audit documentation and checklists :2030-07-01, 2d
    Conduct external regulatory compliance audits :2030-07-03, 2d
    Address audit findings and implement corrective actions :2030-07-05, 2d
    Continuously Improve Processes and Technologies :2030-07-07, 16d
    Identify areas for process improvement :2030-07-07, 4d
    Evaluate emerging medical technologies :2030-07-11, 4d
    Pilot test new processes and technologies :2030-07-15, 4d
    section 200
    Implement approved improvements facility-wide :2030-07-19, 4d
</div>

                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Gantt Interactive</button>
                <div class="content">        
                    
<div class="gantt_container_with_controls">
    <div class="gantt-controls">
        <div class="zoom-buttons">
            <button id="zoomFitButton">Zoom Fit</button>
            <button id="zoomInButton">Zoom In</button>
            <button id="zoomOutButton">Zoom Out</button>
        </div>
        <button id="exportToCSVButton" class="export-button">Export to CSV</button>
    </div>
    <div id="gantt_container" class="gantt_container"></div>
</div>

                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Pitch</button>
                <div class="content">        
                    <h1>Face Forward: The Future of Identity</h1>
<h2>Project Overview</h2>
<p>Imagine a world where identity is fluid, where you can literally <em>wear</em> a new face. We're building a commercial face transplantation facility in New Zealand, offering a revolutionary subscription-based face-swapping service. This isn't just about vanity; it's about empowering individuals, pushing the boundaries of medical science, and creating a future where identity is truly customizable. We're not just transplanting faces; we're transplanting possibilities! This <strong>innovation</strong> will redefine personal expression.</p>
<h2>Goals and Objectives</h2>
<p>Our primary goal is to establish a state-of-the-art face transplantation facility and offer a subscription-based face-swapping service. Key objectives include:</p>
<ul>
<li>Securing necessary regulatory approvals.</li>
<li>Recruiting and training a skilled surgical team.</li>
<li>Establishing partnerships with organ donation organizations.</li>
<li>Developing a robust ethical framework.</li>
<li>Acquiring a diverse pool of donor faces.</li>
<li>Building a strong subscriber base.</li>
</ul>
<h2>Risks and Mitigation Strategies</h2>
<p>We acknowledge the significant risks involved, including regulatory hurdles, ethical concerns, technical complications, and donor face acquisition. Our mitigation strategies include:</p>
<ul>
<li>Proactive engagement with regulatory bodies.</li>
<li>Establishing a robust ethics review board.</li>
<li>Investing in cutting-edge research and development.</li>
<li>Securing diverse funding sources.</li>
<li>Partnering with organ donation organizations.</li>
<li>Exploring innovative solutions like xenotransplantation to address donor scarcity.</li>
</ul>
<p>This proactive approach will ensure <strong>sustainability</strong>.</p>
<h2>Metrics for Success</h2>
<p>Beyond establishing the facility and acquiring subscribers, we will measure success by:</p>
<ul>
<li>Patient satisfaction and quality of life improvements, assessed through regular surveys and psychological evaluations.</li>
<li>The number of successful transplant procedures performed with minimal complications.</li>
<li>The growth of our subscriber base and revenue generation.</li>
<li>Positive media coverage and public perception.</li>
<li>Our ability to maintain ethical compliance and transparency.</li>
</ul>
<p>These metrics will demonstrate our commitment to <strong>efficiency</strong>.</p>
<h2>Stakeholder Benefits</h2>
<p>Investors will gain access to a potentially high-growth market with significant returns. Medical professionals will have the opportunity to pioneer groundbreaking surgical techniques and contribute to medical advancements. Patients will benefit from restored facial form and function, leading to improved self-esteem and quality of life. Organ donation organizations will receive increased support and awareness. The community will benefit from the economic growth and job creation associated with the facility.</p>
<h2>Ethical Considerations</h2>
<p>We are deeply committed to ethical practices. We will:</p>
<ul>
<li>Establish a comprehensive ethics review board.</li>
<li>Prioritize patient autonomy and informed consent.</li>
<li>Ensure fair compensation for face donors.</li>
<li>Address potential concerns about the commodification of faces and the psychological impact of face transplantation through rigorous ethical guidelines and psychological support programs.</li>
<li>Implement a DAO to govern ethical decisions, allowing stakeholders to vote on controversial cases and ensure community ownership.</li>
</ul>
<h2>Collaboration Opportunities</h2>
<p>We are actively seeking partnerships with:</p>
<ul>
<li>Organ donation organizations.</li>
<li>Medical research institutions.</li>
<li>Bioethicists.</li>
<li>Technology companies.</li>
</ul>
<p>We welcome <strong>collaboration</strong> to advance surgical techniques, develop ethical frameworks, improve patient care, and explore innovative solutions like tissue engineering and xenotransplantation. We are also open to partnerships with marketing and advertising agencies to promote our services responsibly and ethically.</p>
<h2>Long-term Vision</h2>
<p>Our long-term vision is to revolutionize reconstructive surgery and empower individuals to express their identity in unprecedented ways. We aim to expand our services to address other forms of disfigurement and explore the potential of personalized medicine and regenerative technologies. We envision a future where face transplantation is a safe, accessible, and ethically responsible option for individuals seeking to restore their facial form and function.</p>
<h2>Call to Action</h2>
<p>Visit our website at [insert website address here] to learn more about our project, review our detailed business plan, and explore investment opportunities. Let's build the future of identity, together!</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Project Plan</button>
                <div class="content">        
                    <p><strong>Goal Statement:</strong> Establish a commercial face transplantation facility in New Zealand with a subscription-based face swapping service.</p>
<h2>SMART Criteria</h2>
<ul>
<li><strong>Specific:</strong> Create a facility in New Zealand that offers face transplantation services, where users pay a monthly subscription to wear another person's face.</li>
<li><strong>Measurable:</strong> The goal will be measured by the successful establishment of a fully operational face transplantation facility in New Zealand, with a defined number of subscribers.</li>
<li><strong>Achievable:</strong> The goal is achievable given the availability of medical technology and resources, although it requires navigating complex ethical and regulatory challenges.</li>
<li><strong>Relevant:</strong> This goal aims to create a novel medical service that caters to a niche market, potentially generating revenue through a subscription model.</li>
<li><strong>Time-bound:</strong> The project should be completed within 36 months.</li>
</ul>
<h2>Dependencies</h2>
<ul>
<li>Secure funding for the facility and operations.</li>
<li>Obtain necessary regulatory approvals and licenses in New Zealand.</li>
<li>Establish partnerships with organ donation organizations.</li>
<li>Recruit and train qualified medical personnel.</li>
<li>Develop ethical guidelines and protocols for face transplantation and subscription service.</li>
<li>Establish a comprehensive data privacy and security plan.</li>
</ul>
<h2>Resources Required</h2>
<ul>
<li>Surgical equipment</li>
<li>Medical personnel</li>
<li>Facility</li>
<li>Insurance coverage</li>
<li>Ethical review board</li>
<li>Data privacy and security systems</li>
<li>Psychological support program</li>
</ul>
<h2>Related Goals</h2>
<ul>
<li>Advance medical technology in face transplantation.</li>
<li>Generate revenue through a subscription-based medical service.</li>
<li>Establish a sustainable and ethical medical practice.</li>
</ul>
<h2>Tags</h2>
<ul>
<li>face transplantation</li>
<li>subscription service</li>
<li>medical facility</li>
<li>New Zealand</li>
<li>ethical</li>
<li>regulatory</li>
</ul>
<h2>Risk Assessment and Mitigation Strategies</h2>
<h3>Key Risks</h3>
<ul>
<li>Regulatory approval delays or denial</li>
<li>Ethical concerns leading to public outcry</li>
<li>Technical complications during surgery</li>
<li>Financial viability issues due to high costs</li>
<li>Donor face acquisition challenges</li>
</ul>
<h3>Diverse Risks</h3>
<ul>
<li>Operational risks</li>
<li>Systematic risks</li>
<li>Business risks</li>
</ul>
<h3>Mitigation Plans</h3>
<ul>
<li>Engage regulatory bodies early and prepare comprehensive documentation.</li>
<li>Establish an ethics review board and develop clear ethical guidelines.</li>
<li>Invest in R&amp;D and partner with experts to minimize technical complications.</li>
<li>Develop a detailed financial model and secure multiple funding sources.</li>
<li>Establish partnerships with organ donation organizations and explore alternative sources for donor faces.</li>
</ul>
<h2>Stakeholder Analysis</h2>
<h3>Primary Stakeholders</h3>
<ul>
<li>Surgeons</li>
<li>Nurses</li>
<li>Technicians</li>
<li>Ethicists</li>
<li>Facility Management</li>
</ul>
<h3>Secondary Stakeholders</h3>
<ul>
<li>Ministry of Health (New Zealand)</li>
<li>Medsafe</li>
<li>Organ donation organizations</li>
<li>Patients</li>
<li>Donor families</li>
<li>Investors</li>
</ul>
<h3>Engagement Strategies</h3>
<ul>
<li>Provide regular updates and progress reports to primary stakeholders.</li>
<li>Engage with regulatory bodies to ensure compliance and address concerns.</li>
<li>Collaborate with organ donation organizations to secure a steady supply of donor faces.</li>
<li>Communicate transparently with patients and donor families to address ethical concerns.</li>
<li>Provide regular financial reports to investors to maintain confidence.</li>
</ul>
<h2>Regulatory and Compliance Requirements</h2>
<h3>Permits and Licenses</h3>
<ul>
<li>Medical facility license</li>
<li>Surgical procedure permits</li>
<li>Data privacy compliance</li>
<li>Ethical approval</li>
</ul>
<h3>Compliance Standards</h3>
<ul>
<li>New Zealand Ministry of Health regulations</li>
<li>Medsafe guidelines</li>
<li>Ethical guidelines for medical research</li>
<li>Data privacy regulations</li>
</ul>
<h3>Regulatory Bodies</h3>
<ul>
<li>Ministry of Health (New Zealand)</li>
<li>Medsafe</li>
<li>Ethics committees</li>
</ul>
<h3>Compliance Actions</h3>
<ul>
<li>Apply for medical facility license</li>
<li>Obtain surgical procedure permits</li>
<li>Implement data privacy compliance plan</li>
<li>Schedule compliance audits</li>
</ul>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Strategic Decisions</button>
                <div class="content">        
                    <h2>Primary Decisions</h2>
<p>The vital few decisions that have the most impact.</p>
<p>The 'Critical' and 'High' impact levers address the fundamental tensions of this project: 'Ethical Considerations vs. Technological Advancement', 'Regulatory Compliance vs. Speed to Market', and 'Operational Efficiency vs. Risk Mitigation'. These levers collectively govern the project's feasibility, safety, and long-term sustainability. A key missing strategic dimension is a detailed plan for donor face acquisition and preservation.</p>
<h3>Decision 1: Risk Mitigation Protocol</h3>
<p><strong>Lever ID:</strong> <code>5ff1b79c-528d-4f32-99a4-bf7b8ef2bb13</code></p>
<p><strong>The Core Decision:</strong> The Risk Mitigation Protocol aims to minimize potential legal, financial, and reputational risks associated with face transplantation. It controls the implementation of safety measures, informed consent processes, and insurance coverage. Success is measured by the reduction in legal claims, insurance payouts, and negative publicity. The objective is to create a safe and responsible environment for both patients and the organization, ensuring long-term sustainability and public trust.</p>
<p><strong>Why It Matters:</strong> Unforeseen complications can lead to legal liabilities. Immediate: Lawsuits → Systemic: 60% increase in insurance premiums and legal fees → Strategic: Financial instability and potential bankruptcy. Trade-off: Controls Innovation vs. Financial Security.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Implement strict patient screening and informed consent procedures to minimize legal risks.</li>
<li>Establish a comprehensive insurance policy to cover potential liabilities and medical complications.</li>
<li>Develop a decentralized autonomous organization (DAO) to distribute risk and ensure transparency in decision-making.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Financial Exposure vs. Operational Flexibility. Weakness: The options fail to address the potential for unforeseen technological failures or long-term health consequences.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever strongly supports the Ethical Oversight Strategy (a35fdaf5-1700-4423-ac1f-8f2156a210e2) by providing concrete measures to address ethical concerns and ensure patient well-being. It also enhances the Regulatory Approval Strategy (7d070cd2-1e8c-4267-b43e-cb8b21654501) by demonstrating a commitment to safety and compliance.</p>
<p><strong>Conflict:</strong> A robust Risk Mitigation Protocol can conflict with the Operational Efficiency Strategy (3fcac146-e30f-4a10-ac77-7f5478f3caba) by adding layers of bureaucracy and potentially slowing down procedures. It may also limit the scope of the Technological Development Approach (189a2808-ba10-417f-a368-273bf84f2150) if overly cautious.</p>
<p><strong>Justification:</strong> <em>High</em>, High importance due to its strong synergy with Ethical Oversight and Regulatory Approval, and its conflict with Operational Efficiency and Technological Development. It governs the core trade-off between innovation and financial security.</p>
<h3>Decision 2: Operational Scalability Model</h3>
<p><strong>Lever ID:</strong> <code>3371bb47-f11f-4c8e-bde9-5210da3f13ce</code></p>
<p><strong>The Core Decision:</strong> The Operational Scalability Model defines how the face transplantation facility will expand its operations to meet growing demand. It controls the infrastructure, staffing, and standardization of procedures. The objective is to achieve efficient growth while maintaining quality and safety. Key success metrics include the number of procedures performed, patient satisfaction, and cost per procedure. This lever determines the organization's capacity to serve a larger market.</p>
<p><strong>Why It Matters:</strong> Inability to scale can limit market penetration. Immediate: Bottlenecks in surgical capacity → Systemic: 20% decrease in customer satisfaction due to long wait times → Strategic: Loss of competitive advantage and market share. Trade-off: Controls Growth vs. Quality.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Establish a single, state-of-the-art facility with limited capacity for specialized procedures.</li>
<li>Develop a network of regional centers with standardized protocols and training programs.</li>
<li>Utilize robotic surgery and AI-powered diagnostics to automate procedures and increase throughput.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Expansion Speed vs. Resource Allocation. Weakness: The options fail to consider the logistical challenges of sourcing and transporting donor faces.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever works well with the Technological Development Approach (189a2808-ba10-417f-a368-273bf84f2150), as technology like robotic surgery can enable greater scalability. It also complements the Subscription Model Design (58739fa3-097f-4875-8364-5b0b83806870) by ensuring capacity to meet subscription demand.</p>
<p><strong>Conflict:</strong> A rapid Operational Scalability Model can strain the Ethical Oversight Strategy (a35fdaf5-1700-4423-ac1f-8f2156a210e2) if ethical considerations are not adequately addressed during expansion. It can also conflict with the Risk Mitigation Protocol (5ff1b79c-528d-4f32-99a4-bf7b8ef2bb13) if safety measures are compromised to increase throughput.</p>
<p><strong>Justification:</strong> <em>High</em>, High importance because it directly impacts the project's ability to meet demand and maintain quality as it grows. It has strong synergies with Technological Development and Subscription Model Design, and conflicts with Ethical Oversight and Risk Mitigation.</p>
<h3>Decision 3: Ethical Oversight Strategy</h3>
<p><strong>Lever ID:</strong> <code>a35fdaf5-1700-4423-ac1f-8f2156a210e2</code></p>
<p><strong>The Core Decision:</strong> The Ethical Oversight Strategy establishes a framework for addressing the complex moral implications of face transplantation. It controls the ethical review process, patient autonomy, and public perception. The objective is to ensure responsible innovation and maintain public trust. Key success metrics include patient satisfaction, ethical compliance, and positive media coverage. This lever guides the organization's ethical decision-making and promotes transparency.</p>
<p><strong>Why It Matters:</strong> Ethical considerations impact public trust and long-term sustainability. Immediate: Public outcry → Systemic: Reduced social license to operate and regulatory scrutiny → Strategic: Project shutdown and reputational damage.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Establish an internal ethics review board to assess the moral implications of each procedure and ensure patient autonomy and informed consent.</li>
<li>Partner with independent bioethicists and community representatives to create a transparent ethical framework and address public concerns proactively.</li>
<li>Implement a decentralized autonomous organization (DAO) to govern ethical decisions, allowing stakeholders to vote on controversial cases and ensure community ownership.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Autonomy vs. Accountability. Weakness: The options don't adequately address the potential for coercion or exploitation of vulnerable individuals.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever is synergistic with the Risk Mitigation Protocol (5ff1b79c-528d-4f32-99a4-bf7b8ef2bb13), as both aim to protect patients and the organization. It also enhances the Regulatory Approval Strategy (7d070cd2-1e8c-4267-b43e-cb8b21654501) by demonstrating a commitment to ethical practices.</p>
<p><strong>Conflict:</strong> A strong Ethical Oversight Strategy can conflict with the Operational Efficiency Strategy (3fcac146-e30f-4a10-ac77-7f5478f3caba) by adding time-consuming review processes. It may also limit the scope of the Technological Development Approach (189a2808-ba10-417f-a368-273bf84f2150) if certain technologies are deemed ethically unacceptable.</p>
<p><strong>Justification:</strong> <em>Critical</em>, Critical because it addresses the fundamental ethical concerns surrounding face transplantation, impacting public trust, regulatory approval, and long-term sustainability. It's a central hub connecting risk, regulation, and operational efficiency.</p>
<h3>Decision 4: Regulatory Approval Strategy</h3>
<p><strong>Lever ID:</strong> <code>7d070cd2-1e8c-4267-b43e-cb8b21654501</code></p>
<p><strong>The Core Decision:</strong> The Regulatory Approval Strategy defines the approach to obtaining necessary approvals from regulatory bodies. It controls compliance efforts, engagement with regulators, and jurisdictional selection. The objective is to secure the legal right to operate the face transplantation facility. Key success metrics include the speed and success rate of regulatory applications. This lever determines the organization's ability to legally offer its services.</p>
<p><strong>Why It Matters:</strong> Navigating regulatory hurdles impacts project timelines and operational scope. Immediate: Approval delays → Systemic: Increased operational costs and delayed revenue → Strategic: Reduced competitive advantage and investor confidence.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Proactive Compliance: Strictly adhere to existing regulations, focusing on safety and ethical considerations.</li>
<li>Adaptive Engagement: Engage with regulatory bodies to shape future guidelines, advocating for responsible innovation.</li>
<li>Jurisdictional Arbitrage: Establish operations in regions with more permissive regulations, accepting potential reputational risks.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Ethical Risk vs. Speed to Market. Weakness: The options don't address the potential for international regulatory conflicts.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever is strongly synergistic with the Risk Mitigation Protocol (5ff1b79c-528d-4f32-99a4-bf7b8ef2bb13), as a robust risk management plan can facilitate regulatory approval. It also benefits from a strong Ethical Oversight Strategy (a35fdaf5-1700-4423-ac1f-8f2156a210e2), demonstrating responsible practices.</p>
<p><strong>Conflict:</strong> Pursuing a Jurisdictional Arbitrage strategy can conflict with the Ethical Oversight Strategy (a35fdaf5-1700-4423-ac1f-8f2156a210e2) if it involves operating in regions with lower ethical standards. It may also create tension with the Risk Mitigation Protocol (5ff1b79c-528d-4f32-99a4-bf7b8ef2bb13) if regulations are less stringent.</p>
<p><strong>Justification:</strong> <em>Critical</em>, Critical because it determines the organization's ability to legally operate. It is highly synergistic with Risk Mitigation and Ethical Oversight, and its options directly control the ethical risk vs. speed to market trade-off.</p>
<h3>Decision 5: Technological Development Approach</h3>
<p><strong>Lever ID:</strong> <code>189a2808-ba10-417f-a368-273bf84f2150</code></p>
<p><strong>The Core Decision:</strong> The Technological Development Approach lever dictates the strategy for advancing the face transplantation technology. It controls the level of investment and focus on different technological areas, ranging from incremental improvements to radical disruptions. The objective is to improve transplant outcomes, reduce risks, and potentially overcome limitations like donor scarcity. Success is measured by improvements in surgical techniques, reduced rejection rates, and the successful integration of new technologies.</p>
<p><strong>Why It Matters:</strong> The pace of technological advancement directly affects the feasibility and safety of face transplantation. Immediate: Research breakthroughs or setbacks → Systemic: 15% improvement in graft survival rates through advanced immunosuppression → Strategic: Enhanced service reliability and patient outcomes.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Incremental Improvement: Focus on refining existing surgical techniques and immunosuppression protocols.</li>
<li>Targeted Innovation: Invest in specific areas like tissue engineering and personalized medicine to improve transplant outcomes.</li>
<li>Radical Disruption: Explore emerging technologies like CRISPR and xenotransplantation to overcome current limitations.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Technical Risk vs. Long-Term Viability. Weakness: The options fail to consider the cost implications of each technological path.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever strongly synergizes with the Risk Mitigation Protocol. A robust technological development approach, especially focusing on incremental improvements, directly informs and strengthens the risk mitigation strategies by addressing potential complications and improving safety. It also enhances the Ethical Oversight Strategy.</p>
<p><strong>Conflict:</strong> A radical technological development approach may conflict with the Regulatory Approval Strategy. Pursuing disruptive technologies like xenotransplantation could face significant regulatory hurdles and ethical concerns, delaying or preventing approval. It also conflicts with Operational Efficiency Strategy if new tech is hard to implement.</p>
<p><strong>Justification:</strong> <em>Critical</em>, Critical because it dictates the feasibility and safety of the core technology. It has strong synergies with Risk Mitigation and Ethical Oversight, but conflicts with Regulatory Approval and Operational Efficiency, controlling the project's risk/reward profile.</p>
<hr />
<h2>Secondary Decisions</h2>
<p>These decisions are less significant, but still worth considering.</p>
<h3>Decision 6: Operational Efficiency Strategy</h3>
<p><strong>Lever ID:</strong> <code>3fcac146-e30f-4a10-ac77-7f5478f3caba</code></p>
<p><strong>The Core Decision:</strong> The Operational Efficiency Strategy focuses on optimizing resource allocation and streamlining processes to minimize costs and maximize throughput. It controls administrative procedures, surgical techniques, and supply chain management. The objective is to achieve a cost-effective and efficient operation. Key success metrics include cost per procedure, surgical time, and patient turnover rate. This lever drives the organization's profitability and competitiveness.</p>
<p><strong>Why It Matters:</strong> Operational efficiency impacts profitability and scalability. Immediate: High operating costs → Systemic: Reduced profit margins and limited expansion → Strategic: Inability to compete and long-term financial instability.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Streamline administrative processes and optimize resource allocation to minimize overhead costs and improve operational efficiency.</li>
<li>Implement lean manufacturing principles and robotic process automation to reduce surgical time and improve throughput by 20%.</li>
<li>Utilize AI-powered predictive analytics to optimize scheduling, resource allocation, and supply chain management, creating a fully autonomous and self-optimizing facility.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Cost vs. Innovation. Weakness: The options fail to consider the impact of automation on employee morale and job security.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever is synergistic with the Technological Development Approach (189a2808-ba10-417f-a368-273bf84f2150), as technology can automate processes and improve efficiency. It also complements the Operational Scalability Model (3371bb47-f11f-4c8e-bde9-5210da3f13ce) by enabling efficient expansion.</p>
<p><strong>Conflict:</strong> A focus on Operational Efficiency can conflict with the Ethical Oversight Strategy (a35fdaf5-1700-4423-ac1f-8f2156a210e2) if ethical considerations are sacrificed for speed and cost savings. It may also compromise the Risk Mitigation Protocol (5ff1b79c-528d-4f32-99a4-bf7b8ef2bb13) if safety measures are cut to reduce expenses.</p>
<p><strong>Justification:</strong> <em>High</em>, High importance as it directly impacts profitability and scalability. It synergizes with Technological Development and Operational Scalability, but conflicts with Ethical Oversight and Risk Mitigation, highlighting key trade-offs.</p>
<h3>Decision 7: Market Validation Strategy</h3>
<p><strong>Lever ID:</strong> <code>2c83d2d9-62df-4c87-999f-b2c35273e278</code></p>
<p><strong>The Core Decision:</strong> The Market Validation Strategy lever defines how the face transplantation service is introduced to the market. It controls the scope and pace of service rollout, ranging from a limited pilot program to an open access model. The objective is to assess market demand, gather feedback, and refine the service offering while managing risks and ethical considerations. Success is measured by customer satisfaction, adoption rates, and the ability to address potential ethical concerns.</p>
<p><strong>Why It Matters:</strong> Demonstrating market demand is crucial for attracting investment and ensuring long-term sustainability. Immediate: Initial customer interest → Systemic: 25% faster scaling through positive word-of-mouth and social media buzz → Strategic: Increased market share and brand recognition.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Limited Pilot Program: Offer face transplants to a small group of carefully selected candidates.</li>
<li>Phased Rollout: Expand services gradually based on initial results and market feedback.</li>
<li>Open Access Model: Offer face transplants to a wider audience, accepting higher risks and potential ethical concerns.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Financial Risk vs. Market Penetration. Weakness: The options don't adequately address the psychological impact on early adopters.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever has a strong synergy with the Ethical Oversight Strategy. A limited pilot program allows for careful monitoring and evaluation of ethical implications, informing and strengthening the ethical framework. It also works well with Risk Mitigation Protocol, allowing for careful risk assessment.</p>
<p><strong>Conflict:</strong> An open access model conflicts with the Risk Mitigation Protocol. Offering face transplants to a wider audience increases the risk of complications and ethical breaches, potentially overwhelming risk management resources. It also conflicts with Regulatory Approval Strategy, as regulators may be wary of a rapid rollout.</p>
<p><strong>Justification:</strong> <em>Medium</em>, Medium importance. While important for adoption, it is less central than the ethical, regulatory, and technological levers. It synergizes with Ethical Oversight and Risk Mitigation, but conflicts with Risk Mitigation and Regulatory Approval in an open access model.</p>
<h3>Decision 8: Subscription Model Design</h3>
<p><strong>Lever ID:</strong> <code>58739fa3-097f-4875-8364-5b0b83806870</code></p>
<p><strong>The Core Decision:</strong> The Subscription Model Design lever determines the structure and pricing of the face-wearing subscription service. It controls the level of access, customization, and pricing options available to subscribers. The objective is to maximize revenue, attract a diverse customer base, and ensure fair compensation for face donors. Success is measured by subscription rates, customer retention, and revenue generated, as well as donor satisfaction.</p>
<p><strong>Why It Matters:</strong> The design of the subscription model impacts revenue streams and customer retention. Immediate: Initial subscription uptake → Systemic: 10% improvement in customer lifetime value through flexible payment plans → Strategic: Stable revenue stream and long-term financial sustainability.</p>
<p><strong>Strategic Choices:</strong></p>
<ol>
<li>Basic Access: Offer a standard subscription with limited face options and swap frequency.</li>
<li>Premium Tiering: Provide tiered subscriptions with varying levels of access and customization.</li>
<li>Dynamic Pricing: Implement a dynamic pricing model based on face popularity and availability, leveraging blockchain-based smart contracts for transparent royalty distribution to face donors.</li>
</ol>
<p><strong>Trade-Off / Risk:</strong> Controls Revenue Stability vs. Customer Flexibility. Weakness: The options fail to address the logistical challenges of face storage and maintenance.</p>
<p><strong>Strategic Connections:</strong></p>
<p><strong>Synergy:</strong> This lever synergizes with the Market Validation Strategy. A phased rollout allows for testing different subscription models and gathering feedback to optimize pricing and features. It also enhances Operational Scalability Model, as the subscription model can be adjusted to match capacity.</p>
<p><strong>Conflict:</strong> A dynamic pricing model may conflict with the Ethical Oversight Strategy. Concerns about fairness, exploitation, and commodification of faces could arise, requiring careful ethical consideration. It also conflicts with Risk Mitigation Protocol, as higher demand could lead to pressure to cut corners.</p>
<p><strong>Justification:</strong> <em>Medium</em>, Medium importance. It impacts revenue and customer retention, but is less fundamental than the ethical, regulatory, and technological considerations. It synergizes with Market Validation and Operational Scalability, but conflicts with Ethical Oversight and Risk Mitigation.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Scenarios</button>
                <div class="content">        
                    <h1>Choosing Our Strategic Path</h1>
<h2>The Strategic Context</h2>
<p>Understanding the core ambitions and constraints that guide our decision.</p>
<p><strong>Ambition and Scale:</strong> The plan is highly ambitious, aiming to create a commercial facility for face transplantation with a subscription model. This suggests a potentially large-scale operation targeting a niche market.</p>
<p><strong>Risk and Novelty:</strong> The plan is extremely high-risk and novel. Face transplantation is a complex and experimental procedure, and the subscription-based model adds another layer of untested innovation.</p>
<p><strong>Complexity and Constraints:</strong> The plan is highly complex, involving significant ethical, regulatory, and technological hurdles. Constraints include the need for specialized medical expertise, ethical considerations, regulatory compliance, and the logistical challenges of sourcing and transporting donor faces.</p>
<p><strong>Domain and Tone:</strong> The plan falls within the medical/commercial domain, with a slightly fantastical and ethically questionable tone due to the 'Face Off' inspiration.</p>
<p><strong>Holistic Profile:</strong> The plan is a high-risk, high-reward venture involving a novel and ethically complex medical procedure with a commercial subscription model. It requires navigating significant regulatory and technological challenges.</p>
<hr />
<h2>The Path Forward</h2>
<p>This scenario aligns best with the project's characteristics and goals.</p>
<h3>The Pioneer's Gambit</h3>
<p><strong>Strategic Logic:</strong> This scenario embraces high risk and high reward by aggressively pursuing cutting-edge technologies and navigating regulatory landscapes with a focus on speed and innovation. It prioritizes technological leadership and market dominance, accepting potential ethical and regulatory challenges.</p>
<p><strong>Fit Score:</strong> 9/10</p>
<p><strong>Why This Path Was Chosen:</strong> This scenario aligns well with the plan's high-risk, high-reward nature and its focus on radical innovation and jurisdictional arbitrage. The DAO governance and radical tech development approach fit the plan's ambition.</p>
<p><strong>Key Strategic Decisions:</strong></p>
<ul>
<li><strong>Risk Mitigation Protocol:</strong> Develop a decentralized autonomous organization (DAO) to distribute risk and ensure transparency in decision-making.</li>
<li><strong>Operational Scalability Model:</strong> Utilize robotic surgery and AI-powered diagnostics to automate procedures and increase throughput.</li>
<li><strong>Ethical Oversight Strategy:</strong> Implement a decentralized autonomous organization (DAO) to govern ethical decisions, allowing stakeholders to vote on controversial cases and ensure community ownership.</li>
<li><strong>Regulatory Approval Strategy:</strong> Jurisdictional Arbitrage: Establish operations in regions with more permissive regulations, accepting potential reputational risks.</li>
<li><strong>Technological Development Approach:</strong> Radical Disruption: Explore emerging technologies like CRISPR and xenotransplantation to overcome current limitations.</li>
</ul>
<p><strong>The Decisive Factors:</strong></p>
<p>The Pioneer's Gambit is the most suitable scenario because its high-risk, high-reward approach aligns with the plan's ambitious and novel nature. The plan's 'Face Off' inspiration and subscription model indicate a willingness to push boundaries. </p>
<ul>
<li>The plan's ambition necessitates a focus on cutting-edge technologies and a willingness to navigate complex regulatory landscapes, which this scenario provides through its radical tech development and jurisdictional arbitrage strategies.</li>
<li>The Builder's Foundation is less suitable because it prioritizes a balanced approach, which is not aggressive enough for the plan's inherent risk. The Consolidator's Approach is the least suitable due to its risk-averse nature, which stifles the innovation required for this project.</li>
</ul>
<hr />
<h2>Alternative Paths</h2>
<h3>The Builder's Foundation</h3>
<p><strong>Strategic Logic:</strong> This scenario seeks a balanced approach, prioritizing steady progress and ethical considerations while managing risk. It focuses on building a sustainable and reputable business through careful planning, ethical oversight, and regulatory engagement.</p>
<p><strong>Fit Score:</strong> 6/10</p>
<p><strong>Assessment of this Path:</strong> This scenario offers a more balanced approach, which is less aligned with the plan's inherent risk and novelty. While ethical considerations are important, the plan's ambition suggests a bolder strategy.</p>
<p><strong>Key Strategic Decisions:</strong></p>
<ul>
<li><strong>Risk Mitigation Protocol:</strong> Establish a comprehensive insurance policy to cover potential liabilities and medical complications.</li>
<li><strong>Operational Scalability Model:</strong> Develop a network of regional centers with standardized protocols and training programs.</li>
<li><strong>Ethical Oversight Strategy:</strong> Partner with independent bioethicists and community representatives to create a transparent ethical framework and address public concerns proactively.</li>
<li><strong>Regulatory Approval Strategy:</strong> Adaptive Engagement: Engage with regulatory bodies to shape future guidelines, advocating for responsible innovation.</li>
<li><strong>Technological Development Approach:</strong> Targeted Innovation: Invest in specific areas like tissue engineering and personalized medicine to improve transplant outcomes.</li>
</ul>
<h3>The Consolidator's Approach</h3>
<p><strong>Strategic Logic:</strong> This scenario prioritizes stability, cost-control, and risk-aversion above all else. It focuses on minimizing risk and ensuring compliance by adhering to existing regulations and proven technologies, even if it means slower growth and less innovation.</p>
<p><strong>Fit Score:</strong> 3/10</p>
<p><strong>Assessment of this Path:</strong> This scenario is a poor fit, as its risk-averse and compliance-focused strategy clashes with the plan's ambitious and experimental nature. The plan's novelty requires a more innovative approach than this scenario allows.</p>
<p><strong>Key Strategic Decisions:</strong></p>
<ul>
<li><strong>Risk Mitigation Protocol:</strong> Implement strict patient screening and informed consent procedures to minimize legal risks.</li>
<li><strong>Operational Scalability Model:</strong> Establish a single, state-of-the-art facility with limited capacity for specialized procedures.</li>
<li><strong>Ethical Oversight Strategy:</strong> Establish an internal ethics review board to assess the moral implications of each procedure and ensure patient autonomy and informed consent.</li>
<li><strong>Regulatory Approval Strategy:</strong> Proactive Compliance: Strictly adhere to existing regulations, focusing on safety and ethical considerations.</li>
<li><strong>Technological Development Approach:</strong> Incremental Improvement: Focus on refining existing surgical techniques and immunosuppression protocols.</li>
</ul>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Assumptions</button>
                <div class="content">        
                    <h1>Purpose</h1>
<p><strong>Purpose:</strong> business</p>
<p><strong>Purpose Detailed:</strong> Commercial facility for face transplantation with a subscription model for wearing another person's face, indicating a profit-oriented venture.</p>
<p><strong>Topic:</strong> Face transplantation facility with subscription-based face swapping</p>
<h1>Plan Type</h1>
<p>This plan requires one or more physical locations. It cannot be executed digitally.</p>
<p><strong>Explanation:</strong> This plan <em>unequivocally requires</em> a physical location (New Zealand), a physical facility, medical professionals, and patients. Face transplantation is a complex surgical procedure, making this <em>inherently</em> a physical endeavor.</p>
<h1>Physical Locations</h1>
<p>This plan implies one or more physical locations.</p>
<h2>Requirements for physical locations</h2>
<ul>
<li>Permissive regulations</li>
<li>State-of-the-art medical facilities</li>
<li>Access to skilled surgeons and medical staff</li>
<li>Ethical considerations</li>
</ul>
<h2>Location 1</h2>
<p>New Zealand</p>
<p>Auckland</p>
<p>Specific location TBD based on regulatory approval and facility requirements in Auckland</p>
<p><strong>Rationale</strong>: Auckland is a major city in New Zealand with advanced medical facilities and a skilled workforce, aligning with the plan's requirements. It also allows to fulfill the user's request to have the facility in New Zealand.</p>
<h2>Location 2</h2>
<p>New Zealand</p>
<p>Christchurch</p>
<p>Specific location TBD based on regulatory approval and facility requirements in Christchurch</p>
<p><strong>Rationale</strong>: Christchurch offers a balance of medical infrastructure and a supportive regulatory environment, making it suitable for a cutting-edge medical facility. It also allows to fulfill the user's request to have the facility in New Zealand.</p>
<h2>Location 3</h2>
<p>New Zealand</p>
<p>Wellington</p>
<p>Specific location TBD based on regulatory approval and facility requirements in Wellington</p>
<p><strong>Rationale</strong>: Wellington, as the capital city, may offer advantages in terms of regulatory engagement and access to government resources, beneficial for a novel medical venture. It also allows to fulfill the user's request to have the facility in New Zealand.</p>
<h2>Location Summary</h2>
<p>The plan requires a facility in New Zealand. Auckland, Christchurch, and Wellington are suggested due to their advanced medical facilities, skilled workforce, and potential for regulatory support, aligning with the project's needs for a face transplantation facility.</p>
<h1>Currency Strategy</h1>
<p>This plan involves money.</p>
<h2>Currencies</h2>
<ul>
<li><strong>NZD:</strong> Local currency for facility operations, salaries, and local transactions in New Zealand.</li>
<li><strong>USD:</strong> Stable international currency for budgeting, reporting, and potentially for subscription fees to mitigate currency fluctuation risks.</li>
</ul>
<p><strong>Primary currency:</strong> USD</p>
<p><strong>Currency strategy:</strong> Due to the project's innovative and potentially unstable nature, USD is recommended for budgeting and reporting to mitigate risks. NZD will be used for local transactions. Consider hedging strategies to manage exchange rate fluctuations between USD and NZD.</p>
<h1>Identify Risks</h1>
<h2>Risk 1 - Regulatory &amp; Permitting</h2>
<p>Obtaining regulatory approval for face transplantation, especially with a novel subscription model, is highly uncertain. New Zealand's regulations may not be equipped to handle the ethical and safety concerns associated with this procedure. Jurisdictional arbitrage, as suggested by the 'Pioneer's Gambit' scenario, could lead to further complications if international regulations conflict.</p>
<p><strong>Impact:</strong> Significant delays in project launch (6-12 months), potential denial of permits, increased legal costs (NZD 50,000 - 200,000), and reputational damage.</p>
<p><strong>Likelihood:</strong> High</p>
<p><strong>Severity:</strong> High</p>
<p><strong>Action:</strong> Engage with regulatory bodies (Ministry of Health, Medsafe) early in the process to understand requirements and address concerns proactively. Prepare comprehensive documentation addressing safety, ethical considerations, and long-term patient outcomes. Explore alternative regulatory pathways, such as clinical trials, to gain initial approval. Conduct a thorough legal review of international regulatory conflicts.</p>
<h2>Risk 2 - Ethical</h2>
<p>The ethical implications of face transplantation and a subscription model for 'wearing' another person's face are profound. Concerns include commodification of faces, psychological impact on both donors and recipients, potential for coercion or exploitation of vulnerable individuals, and societal acceptance. The DAO governance model, while promoting transparency, may not adequately address all ethical concerns.</p>
<p><strong>Impact:</strong> Public outcry, negative media coverage, loss of social license to operate, legal challenges, and damage to the organization's reputation. Could lead to project shutdown. Reduced patient enrollment.</p>
<p><strong>Likelihood:</strong> Medium</p>
<p><strong>Severity:</strong> High</p>
<p><strong>Action:</strong> Establish a robust ethics review board with independent bioethicists and community representatives. Develop clear guidelines for patient selection, informed consent, and donor compensation. Implement psychological support services for both donors and recipients. Conduct public awareness campaigns to address ethical concerns and promote transparency. Ensure the DAO governance model includes safeguards against coercion and exploitation.</p>
<h2>Risk 3 - Technical</h2>
<p>Face transplantation is a complex surgical procedure with a high risk of complications, including rejection, infection, and nerve damage. The 'Radical Disruption' approach, involving technologies like CRISPR and xenotransplantation, introduces further technical uncertainties and potential safety risks. Robotic surgery and AI-powered diagnostics, while promising, may not be reliable or accurate enough for this delicate procedure.</p>
<p><strong>Impact:</strong> Increased surgical complications, higher rejection rates, longer recovery times, increased medical costs (NZD 10,000 - 50,000 per patient), and potential patient mortality. Delays in technological development (3-6 months).</p>
<p><strong>Likelihood:</strong> Medium</p>
<p><strong>Severity:</strong> High</p>
<p><strong>Action:</strong> Invest in rigorous research and development to improve surgical techniques and immunosuppression protocols. Conduct thorough testing and validation of new technologies before implementation. Establish contingency plans for managing surgical complications and rejection episodes. Partner with leading medical institutions and experts in face transplantation. Prioritize incremental improvements over radical disruptions in the initial phase.</p>
<h2>Risk 4 - Financial</h2>
<p>The project's financial viability is uncertain due to the high costs of face transplantation, the novelty of the subscription model, and the potential for low adoption rates. The 'Pioneer's Gambit' scenario, with its focus on radical innovation and jurisdictional arbitrage, could lead to higher-than-expected costs and financial instability. Currency fluctuations between USD and NZD could also impact profitability.</p>
<p><strong>Impact:</strong> Cost overruns (10-20%), lower-than-expected revenue, difficulty attracting investors, and potential bankruptcy. Subscription model may not be profitable. Currency exchange losses.</p>
<p><strong>Likelihood:</strong> Medium</p>
<p><strong>Severity:</strong> High</p>
<p><strong>Action:</strong> Develop a detailed financial model with realistic cost estimates and revenue projections. Secure sufficient funding from investors or grants. Implement cost-control measures and optimize operational efficiency. Offer flexible subscription options to attract a wider customer base. Implement currency hedging strategies to mitigate exchange rate fluctuations. Conduct thorough market research to assess demand and pricing sensitivity.</p>
<h2>Risk 5 - Social</h2>
<p>Social acceptance of face transplantation and a subscription model is not guaranteed. Negative public perception, stigma, and discrimination could limit adoption and impact the project's success. The 'Face Off' inspiration could be perceived as insensitive or trivializing the procedure.</p>
<p><strong>Impact:</strong> Low adoption rates, negative media coverage, social isolation of patients, and potential protests. Reduced patient enrollment.</p>
<p><strong>Likelihood:</strong> Medium</p>
<p><strong>Severity:</strong> Medium</p>
<p><strong>Action:</strong> Conduct public awareness campaigns to educate the public about face transplantation and address misconceptions. Partner with patient advocacy groups to promote acceptance and support. Emphasize the medical benefits and life-changing potential of the procedure. Avoid sensationalizing the 'Face Off' inspiration and focus on the ethical and responsible aspects of the project. Create a supportive community for patients and their families.</p>
<h2>Risk 6 - Operational</h2>
<p>Sourcing and transporting donor faces is a logistical challenge. The availability of suitable donor faces may be limited, and the transportation process could be complex and time-sensitive. The 'Operational Scalability Model' may be constrained by the availability of donor faces.</p>
<p><strong>Impact:</strong> Delays in procedures, increased costs, and potential for donor face shortages. Inability to meet subscription demand.</p>
<p><strong>Likelihood:</strong> Medium</p>
<p><strong>Severity:</strong> Medium</p>
<p><strong>Action:</strong> Establish partnerships with organ donation organizations and hospitals to increase the availability of donor faces. Develop efficient transportation protocols to ensure timely delivery of donor faces. Explore alternative sources of donor faces, such as tissue engineering or xenotransplantation (with appropriate ethical and regulatory approvals). Implement a waiting list system to manage demand and prioritize patients.</p>
<h2>Risk 7 - Supply Chain</h2>
<p>The facility relies on a complex supply chain for medical equipment, pharmaceuticals, and other supplies. Disruptions in the supply chain could impact operations and patient care. Dependence on international suppliers could be affected by geopolitical events or trade restrictions.</p>
<p><strong>Impact:</strong> Delays in procedures, increased costs, and potential shortages of critical supplies. Compromised patient care.</p>
<p><strong>Likelihood:</strong> Low</p>
<p><strong>Severity:</strong> Medium</p>
<p><strong>Action:</strong> Establish relationships with multiple suppliers to mitigate the risk of disruptions. Maintain a sufficient inventory of critical supplies. Develop contingency plans for managing supply chain disruptions. Monitor geopolitical events and trade restrictions that could impact the supply chain. Prioritize local suppliers where possible.</p>
<h2>Risk 8 - Security</h2>
<p>The facility could be a target for theft, vandalism, or cyberattacks. Security breaches could compromise patient data, disrupt operations, and damage the organization's reputation. The DAO governance model could be vulnerable to cyberattacks or manipulation.</p>
<p><strong>Impact:</strong> Loss of patient data, disruption of operations, financial losses, and damage to the organization's reputation. Legal liabilities.</p>
<p><strong>Likelihood:</strong> Low</p>
<p><strong>Severity:</strong> Medium</p>
<p><strong>Action:</strong> Implement robust physical security measures, including surveillance cameras, access control systems, and security personnel. Develop a comprehensive cybersecurity plan to protect patient data and prevent cyberattacks. Train employees on security protocols and best practices. Regularly audit security systems and procedures. Implement multi-factor authentication for all critical systems. Ensure the DAO governance model is secure and resistant to manipulation.</p>
<h2>Risk 9 - Integration with Existing Infrastructure</h2>
<p>Integrating the facility with existing medical infrastructure in New Zealand may present challenges. Compatibility issues with electronic health records, communication systems, and other infrastructure could impact efficiency and patient care.</p>
<p><strong>Impact:</strong> Delays in implementation, increased costs, and potential for errors. Reduced efficiency and compromised patient care.</p>
<p><strong>Likelihood:</strong> Low</p>
<p><strong>Severity:</strong> Low</p>
<p><strong>Action:</strong> Conduct a thorough assessment of existing medical infrastructure in New Zealand. Develop a detailed integration plan to ensure compatibility with existing systems. Work closely with local hospitals and healthcare providers to facilitate integration. Implement robust testing and validation procedures to ensure seamless integration.</p>
<h2>Risk 10 - Maintenance Difficulties</h2>
<p>Maintaining the facility and its specialized equipment could be challenging and costly. The need for specialized expertise and spare parts could lead to delays and disruptions.</p>
<p><strong>Impact:</strong> Downtime of critical equipment, increased maintenance costs, and potential for delays in procedures. Compromised patient care.</p>
<p><strong>Likelihood:</strong> Low</p>
<p><strong>Severity:</strong> Low</p>
<p><strong>Action:</strong> Establish a comprehensive maintenance plan with regular inspections and preventative maintenance. Train employees on basic maintenance procedures. Establish relationships with qualified service providers and suppliers of spare parts. Maintain a sufficient inventory of spare parts. Invest in reliable and durable equipment.</p>
<h2>Risk 11 - Long-Term Sustainability</h2>
<p>The long-term sustainability of the project is uncertain due to the novelty of the subscription model, the potential for changing regulations, and the evolving ethical landscape. The 'Pioneer's Gambit' scenario, with its focus on radical innovation, may not be sustainable in the long run.</p>
<p><strong>Impact:</strong> Financial instability, loss of social license to operate, and potential project shutdown. Reduced patient enrollment.</p>
<p><strong>Likelihood:</strong> Medium</p>
<p><strong>Severity:</strong> Medium</p>
<p><strong>Action:</strong> Develop a long-term strategic plan that addresses potential challenges and opportunities. Diversify revenue streams to reduce reliance on the subscription model. Monitor regulatory and ethical developments and adapt accordingly. Invest in research and development to improve the technology and reduce costs. Build strong relationships with stakeholders, including patients, donors, regulators, and the community.</p>
<h2>Risk summary</h2>
<p>The project faces significant risks across regulatory, ethical, technical, and financial domains. The three most critical risks are: 1) Obtaining regulatory approval, which is highly uncertain given the novelty and ethical concerns surrounding face transplantation and the subscription model. 2) Addressing the profound ethical implications, including commodification of faces and potential exploitation. 3) Managing the technical complexities and potential complications of face transplantation, especially with the adoption of radical technologies. Mitigation strategies should focus on proactive engagement with regulators, establishing a robust ethics review board, and investing in rigorous research and development. The 'Pioneer's Gambit' scenario, while ambitious, carries significant risks and may need to be tempered with a more balanced approach to ensure long-term sustainability. A key trade-off is between speed to market and ethical considerations, requiring careful navigation to maintain public trust and regulatory compliance.</p>
<h1>Make Assumptions</h1>
<h2>Question 1 - What is the projected budget for the facility setup and initial operational costs, including medical equipment, staffing, and regulatory compliance?</h2>
<p><strong>Assumptions:</strong> Assumption: The initial budget is estimated at $50 million USD, based on similar specialized medical facilities and the complexity of face transplantation procedures. This includes $20 million for facility construction and equipment, $15 million for initial staffing and training, and $15 million for regulatory compliance and legal fees.</p>
<p><strong>Assessments:</strong> Title: Financial Feasibility Assessment
Description: Evaluation of the project's financial viability based on the estimated budget and potential revenue streams.
Details: A $50 million budget requires significant investor confidence. Risk: Cost overruns are common in novel medical ventures. Impact: Could lead to funding shortages and project delays. Mitigation: Secure multiple funding sources and implement strict cost-control measures. Opportunity: Successful execution could attract further investment and expansion.</p>
<h2>Question 2 - What is the estimated timeline for regulatory approval, facility construction, staff training, and the first face transplantation procedure?</h2>
<p><strong>Assumptions:</strong> Assumption: The project timeline is estimated at 36 months, with 12 months for regulatory approval, 18 months for facility construction, and 6 months for staff training and preparation for the first procedure. This is based on the complexity of medical regulations and construction timelines in New Zealand.</p>
<p><strong>Assessments:</strong> Title: Timeline Adherence Assessment
Description: Analysis of the project's timeline and potential delays.
Details: A 36-month timeline is ambitious. Risk: Regulatory delays or construction setbacks could extend the timeline. Impact: Could delay revenue generation and increase costs. Mitigation: Proactive engagement with regulators and detailed project management. Opportunity: Early completion could provide a competitive advantage.</p>
<h2>Question 3 - What specific medical personnel (surgeons, nurses, technicians, ethicists) are required, and what are the recruitment and training plans?</h2>
<p><strong>Assumptions:</strong> Assumption: The facility will require a core team of 5 specialized surgeons, 10 nurses, 5 technicians, and 2 ethicists. Recruitment will focus on international experts and local talent, with a 6-month training program on face transplantation techniques and ethical considerations, costing approximately $15 million USD.</p>
<p><strong>Assessments:</strong> Title: Resource Availability Assessment
Description: Evaluation of the availability of skilled medical personnel and the effectiveness of recruitment and training plans.
Details: Securing qualified personnel is critical. Risk: Shortage of specialized surgeons or ethical experts could delay operations. Impact: Could compromise patient safety and ethical standards. Mitigation: Competitive compensation packages and partnerships with medical institutions. Opportunity: Attracting top talent could enhance the facility's reputation.</p>
<h2>Question 4 - What specific regulatory bodies in New Zealand need to be engaged, and what are the key compliance requirements for face transplantation and the subscription model?</h2>
<p><strong>Assumptions:</strong> Assumption: Key regulatory bodies include the Ministry of Health and Medsafe. Compliance will require adherence to medical device regulations, ethical guidelines for transplantation, and data privacy laws. The subscription model will need to comply with consumer protection laws and financial regulations.</p>
<p><strong>Assessments:</strong> Title: Regulatory Compliance Assessment
Description: Analysis of the regulatory landscape and the project's compliance strategy.
Details: Navigating regulations is crucial. Risk: Failure to comply could result in fines, legal challenges, and project shutdown. Impact: Could significantly delay operations and increase costs. Mitigation: Proactive engagement with regulators and a robust compliance program. Opportunity: Early compliance could build trust and facilitate regulatory approval.</p>
<h2>Question 5 - What are the specific safety protocols and risk management strategies to address potential surgical complications, rejection episodes, and ethical breaches?</h2>
<p><strong>Assumptions:</strong> Assumption: Safety protocols will include rigorous patient screening, advanced surgical techniques, and immunosuppression protocols. Risk management strategies will involve comprehensive insurance coverage, ethical review boards, and contingency plans for managing complications and ethical breaches. The cost for insurance is estimated at $5 million USD annually.</p>
<p><strong>Assessments:</strong> Title: Safety and Risk Management Assessment
Description: Evaluation of the project's safety protocols and risk management strategies.
Details: Patient safety is paramount. Risk: Surgical complications or ethical breaches could lead to legal liabilities and reputational damage. Impact: Could compromise patient well-being and erode public trust. Mitigation: Strict adherence to safety protocols and a proactive risk management approach. Opportunity: Demonstrating a commitment to safety could enhance the facility's reputation.</p>
<h2>Question 6 - What measures will be taken to minimize the environmental impact of the facility's construction and operation, including waste disposal, energy consumption, and carbon emissions?</h2>
<p><strong>Assumptions:</strong> Assumption: The facility will implement sustainable construction practices, utilize renewable energy sources, and minimize waste generation. A comprehensive waste management plan will be developed to ensure proper disposal of medical waste and reduce environmental impact. The cost for implementing these measures is estimated at $2 million USD.</p>
<p><strong>Assessments:</strong> Title: Environmental Impact Assessment
Description: Analysis of the project's environmental footprint and mitigation strategies.
Details: Environmental responsibility is important. Risk: Negative environmental impact could lead to public criticism and regulatory scrutiny. Impact: Could damage the facility's reputation and increase operating costs. Mitigation: Adoption of sustainable practices and a comprehensive environmental management plan. Opportunity: Demonstrating environmental responsibility could enhance the facility's image.</p>
<h2>Question 7 - How will stakeholders (patients, donors, families, the public) be involved in the decision-making process, and what mechanisms will be used to address their concerns and feedback?</h2>
<p><strong>Assumptions:</strong> Assumption: Stakeholder involvement will include patient advisory boards, community forums, and online feedback mechanisms. A transparent communication strategy will be implemented to address concerns and provide regular updates on the project's progress. The cost for stakeholder engagement is estimated at $500,000 USD annually.</p>
<p><strong>Assessments:</strong> Title: Stakeholder Engagement Assessment
Description: Evaluation of the project's stakeholder engagement strategy.
Details: Stakeholder support is crucial. Risk: Lack of engagement could lead to public opposition and project delays. Impact: Could erode public trust and hinder regulatory approval. Mitigation: Proactive stakeholder engagement and a transparent communication strategy. Opportunity: Building strong relationships with stakeholders could enhance the facility's reputation and ensure long-term sustainability.</p>
<h2>Question 8 - What operational systems (patient management, billing, supply chain, security) will be implemented, and how will they be integrated to ensure efficient and secure operations?</h2>
<p><strong>Assumptions:</strong> Assumption: The facility will implement integrated patient management, billing, supply chain, and security systems. These systems will be designed to ensure efficient operations, data security, and regulatory compliance. The cost for implementing these systems is estimated at $3 million USD.</p>
<p><strong>Assessments:</strong> Title: Operational Systems Assessment
Description: Analysis of the project's operational systems and integration strategy.
Details: Efficient systems are essential. Risk: Inefficient or insecure systems could lead to operational disruptions and data breaches. Impact: Could compromise patient care and damage the facility's reputation. Mitigation: Implementation of integrated and secure operational systems. Opportunity: Streamlined operations could improve efficiency and reduce costs.</p>
<h1>Distill Assumptions</h1>
<ul>
<li>Initial budget is $50 million USD, including construction, staffing, regulatory compliance.</li>
<li>Project timeline is 36 months, including regulatory approval, construction, and staff training.</li>
<li>The facility needs 5 surgeons, 10 nurses, 5 technicians, and 2 ethicists.</li>
<li>Key regulators are the Ministry of Health and Medsafe in New Zealand.</li>
<li>Safety includes screening, techniques, immunosuppression; insurance costs $5 million annually.</li>
<li>Sustainable practices will be implemented; estimated cost is $2 million USD.</li>
<li>Stakeholder involvement includes boards, forums, and feedback; costing $500,000 USD annually.</li>
<li>Integrated patient management, billing, supply chain, and security systems will be implemented; $3 million USD.</li>
</ul>
<h1>Review Assumptions</h1>
<h2>Domain of the expert reviewer</h2>
<p>Project Management and Risk Assessment for Novel Medical Ventures</p>
<h2>Domain-specific considerations</h2>
<ul>
<li>Ethical considerations in medical innovation</li>
<li>Regulatory hurdles for novel medical procedures</li>
<li>Financial sustainability of subscription-based healthcare models</li>
<li>Public perception and acceptance of face transplantation</li>
<li>Logistical challenges of organ procurement and transportation</li>
</ul>
<h2>Issue 1 - Donor Face Acquisition and Preservation Plan</h2>
<p>The plan lacks a detailed strategy for acquiring and preserving donor faces. This is a critical missing assumption because the entire business model hinges on a consistent and reliable supply of suitable faces. Without a robust plan, the facility may face severe shortages, impacting operational capacity, subscription fulfillment, and ultimately, financial viability. The current plan does not address the practicalities of organ donation consent, logistical challenges of transportation, or long-term storage solutions.</p>
<p><strong>Recommendation:</strong> Develop a comprehensive Donor Face Acquisition and Preservation Plan that includes: </p>
<ol>
<li><strong>Partnerships:</strong> Establish formal agreements with organ donation organizations, hospitals, and mortuaries across New Zealand and potentially internationally.</li>
<li><strong>Consent Protocols:</strong> Implement clear and ethical consent protocols for face donation, ensuring informed consent and respecting donor wishes.</li>
<li><strong>Logistics:</strong> Develop a detailed transportation plan for rapid and secure transfer of donor faces, including specialized transportation containers and temperature-controlled environments.</li>
<li><strong>Preservation Techniques:</strong> Invest in advanced preservation techniques, such as cryopreservation or perfusion, to extend the viability of donor faces.</li>
<li><strong>Inventory Management:</strong> Implement a robust inventory management system to track donor faces, monitor their condition, and ensure optimal utilization.</li>
<li><strong>Ethical Oversight:</strong> Establish an ethical review board to oversee the donor face acquisition process and ensure compliance with ethical guidelines.</li>
</ol>
<p><strong>Sensitivity:</strong> A shortage of donor faces could reduce the number of transplant procedures by 20-50% (baseline: 100 procedures per year), decreasing revenue by NZD 5-12.5 million annually. The cost of implementing a comprehensive donor face acquisition and preservation plan is estimated at NZD 1-2 million per year, but the ROI on this investment is potentially very high.</p>
<h2>Issue 2 - Long-Term Psychological Impact on Recipients and 'Donors'</h2>
<p>The plan overlooks the long-term psychological impact on both face recipients and the families of the deceased 'donors'. Wearing another person's face, even with consent, can create complex psychological issues related to identity, grief, and social acceptance. The subscription model exacerbates these concerns by potentially commodifying the deceased and creating unrealistic expectations for recipients. The absence of a comprehensive psychological support system could lead to patient dissatisfaction, ethical breaches, and reputational damage.</p>
<p><strong>Recommendation:</strong> Implement a comprehensive Psychological Support Program that includes:</p>
<ol>
<li><strong>Pre-Transplant Counseling:</strong> Provide mandatory counseling for both recipients and donor families to address potential psychological challenges and ensure informed consent.</li>
<li><strong>Post-Transplant Therapy:</strong> Offer ongoing therapy and support groups for recipients to help them adjust to their new identity and cope with any psychological issues.</li>
<li><strong>Donor Family Support:</strong> Provide bereavement counseling and support services for donor families to help them cope with their loss and the unique circumstances of face donation.</li>
<li><strong>Psychiatric Assessment:</strong> Conduct regular psychiatric assessments to monitor recipients' mental health and identify any emerging issues.</li>
<li><strong>Ethical Guidelines:</strong> Develop clear ethical guidelines for managing psychological issues and ensuring patient well-being.</li>
<li><strong>Community Support:</strong> Create a supportive community for recipients and donor families to share their experiences and connect with others.</li>
</ol>
<p><strong>Sensitivity:</strong> Failure to address psychological issues could lead to a 10-20% increase in patient attrition (baseline: 5% attrition rate), reducing subscription revenue by NZD 1.25-2.5 million annually. The cost of implementing a comprehensive psychological support program is estimated at NZD 200,000-400,000 per year, but the ROI on this investment is potentially very high in terms of patient retention and ethical compliance.</p>
<h2>Issue 3 - Data Privacy and Security Considerations</h2>
<p>The plan lacks sufficient detail regarding data privacy and security, particularly concerning patient medical records, donor information, and subscription details. Given the sensitive nature of face transplantation and the potential for data breaches, the absence of robust data protection measures is a critical oversight. Failure to comply with data privacy regulations (e.g., GDPR, New Zealand's Privacy Act) could result in significant fines, legal liabilities, and reputational damage.</p>
<p><strong>Recommendation:</strong> Develop a comprehensive Data Privacy and Security Plan that includes:</p>
<ol>
<li><strong>Compliance Assessment:</strong> Conduct a thorough assessment of all applicable data privacy regulations, including GDPR and New Zealand's Privacy Act.</li>
<li><strong>Data Encryption:</strong> Implement robust data encryption techniques to protect patient medical records, donor information, and subscription details.</li>
<li><strong>Access Controls:</strong> Implement strict access controls to limit access to sensitive data to authorized personnel only.</li>
<li><strong>Data Breach Response Plan:</strong> Develop a detailed data breach response plan to address potential security incidents and minimize damage.</li>
<li><strong>Regular Audits:</strong> Conduct regular security audits to identify vulnerabilities and ensure compliance with data privacy regulations.</li>
<li><strong>Employee Training:</strong> Provide comprehensive training to all employees on data privacy and security best practices.</li>
</ol>
<p><strong>Sensitivity:</strong> A failure to uphold GDPR principles may result in fines ranging from 5-10% of annual turnover. The cost of implementing a comprehensive data privacy and security plan is estimated at NZD 300,000-600,000 per year, but the ROI on this investment is potentially very high in terms of avoiding fines, legal liabilities, and reputational damage.</p>
<h2>Review conclusion</h2>
<p>The face transplantation facility project presents a high-risk, high-reward opportunity. However, the plan requires significant refinement to address critical missing assumptions related to donor face acquisition, psychological support, and data privacy. By implementing the recommendations outlined above, the project can mitigate potential risks, enhance its ethical standing, and improve its long-term sustainability.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Governance</button>
                <div class="content">        
                    <h1>Governance Audit</h1>
<h2>Audit - Corruption Risks</h2>
<ul>
<li>Bribery of regulatory officials to expedite or influence the approval process for the facility or specific procedures.</li>
<li>Kickbacks from medical equipment suppliers in exchange for selecting their products, potentially compromising quality and patient safety.</li>
<li>Conflicts of interest involving members of the ethics review board who may have financial ties to the facility or related companies, influencing ethical approvals.</li>
<li>Nepotism in hiring practices, leading to unqualified personnel being placed in critical roles, such as surgical staff or facility management.</li>
<li>Misuse of confidential patient data for personal gain or sale to third parties, violating privacy regulations and ethical standards.</li>
<li>Trading favors with organ donation organizations to prioritize certain patients or receive preferential access to donor faces, potentially bypassing ethical allocation protocols.</li>
</ul>
<h2>Audit - Misallocation Risks</h2>
<ul>
<li>Inflated invoices from construction companies or suppliers, with the excess funds diverted for personal use.</li>
<li>Double billing for medical procedures or services, creating fraudulent revenue streams.</li>
<li>Misuse of research and development funds for non-research activities, such as personal travel or entertainment.</li>
<li>Inefficient allocation of resources, such as overspending on unnecessary equipment or underfunding critical areas like psychological support for patients.</li>
<li>Unauthorized use of facility assets, such as medical equipment or supplies, for personal purposes.</li>
<li>Misreporting of project progress or results to secure further funding or maintain investor confidence, despite actual performance lagging behind.</li>
</ul>
<h2>Audit - Procedures</h2>
<ul>
<li>Conduct quarterly internal audits of financial records, including invoices, expense reports, and revenue streams, to detect any irregularities or discrepancies.</li>
<li>Perform annual external audits by an independent accounting firm to ensure compliance with financial regulations and ethical standards.</li>
<li>Implement a contract review process with pre-defined thresholds (e.g., NZD 50,000) requiring multiple levels of approval to prevent inflated contracts or kickbacks.</li>
<li>Establish a robust expense workflow with clear approval hierarchies and documentation requirements to prevent misuse of funds.</li>
<li>Conduct periodic compliance checks to ensure adherence to regulatory requirements, ethical guidelines, and data privacy protocols, with specific focus on the DAO's decision-making processes.</li>
<li>Implement a 'whistleblower' mechanism with clear reporting channels and protection against retaliation, encouraging employees to report any suspected wrongdoing.</li>
</ul>
<h2>Audit - Transparency Measures</h2>
<ul>
<li>Create a public dashboard displaying key project metrics, such as the number of transplants performed, subscription rates, and financial performance, updated monthly.</li>
<li>Publish minutes of ethics review board meetings, redacting sensitive patient information, to demonstrate ethical oversight and decision-making processes.</li>
<li>Establish a whistleblower mechanism with clear reporting channels and protection against retaliation, encouraging employees to report any suspected wrongdoing.</li>
<li>Make relevant policies and reports, such as the risk mitigation protocol, ethical guidelines, and data privacy plan, publicly accessible on the facility's website.</li>
<li>Document and publish the selection criteria for major decisions, such as vendor selection and patient prioritization, to ensure fairness and transparency.</li>
<li>Implement a system for tracking and reporting adverse events or complications related to face transplants, making this information available to regulatory bodies and the public.</li>
</ul>
<h1>Internal Governance Bodies</h1>
<h3>1. Project Steering Committee</h3>
<p><strong>Rationale for Inclusion:</strong> Provides strategic oversight and guidance for this high-risk, ethically complex, and novel project. Ensures alignment with strategic goals and manages significant risks.</p>
<p><strong>Responsibilities:</strong></p>
<ul>
<li>Approve project scope, budget, and timeline.</li>
<li>Provide strategic direction and guidance.</li>
<li>Monitor project progress against key milestones.</li>
<li>Approve major changes to project scope, budget, or timeline (&gt;$500,000 USD).</li>
<li>Oversee risk management and mitigation strategies.</li>
<li>Ensure alignment with ethical and regulatory requirements.</li>
<li>Approve the Donor Face Acquisition and Preservation Plan.</li>
<li>Approve the Psychological Support Program.</li>
<li>Approve the Data Privacy and Security Plan.</li>
</ul>
<p><strong>Initial Setup Actions:</strong></p>
<ul>
<li>Finalize Terms of Reference.</li>
<li>Appoint Chair.</li>
<li>Establish meeting schedule.</li>
<li>Define reporting requirements from other governance bodies.</li>
</ul>
<p><strong>Membership:</strong></p>
<ul>
<li>CEO</li>
<li>CFO</li>
<li>Chief Medical Officer</li>
<li>Independent Bioethicist</li>
<li>Legal Counsel</li>
<li>Project Manager</li>
</ul>
<p><strong>Decision Rights:</strong> Strategic decisions related to project scope, budget, timeline, and risk management. Approval of expenditures exceeding $500,000 USD. Approval of major strategic shifts.</p>
<p><strong>Decision Mechanism:</strong> Majority vote, with the Chair having the tie-breaking vote. Dissenting opinions are formally recorded.</p>
<p><strong>Meeting Cadence:</strong> Monthly</p>
<p><strong>Typical Agenda Items:</strong></p>
<ul>
<li>Review of project progress against milestones.</li>
<li>Review of financial performance.</li>
<li>Discussion of key risks and mitigation strategies.</li>
<li>Review of ethical and regulatory compliance.</li>
<li>Approval of change requests.</li>
<li>Review of stakeholder engagement activities.</li>
</ul>
<p><strong>Escalation Path:</strong> Board of Directors</p>
<h3>2. Core Project Team</h3>
<p><strong>Rationale for Inclusion:</strong> Manages the day-to-day execution of the project, ensuring tasks are completed on time and within budget. Handles operational risk management and decisions below strategic thresholds.</p>
<p><strong>Responsibilities:</strong></p>
<ul>
<li>Develop and maintain project plan.</li>
<li>Manage project budget and resources.</li>
<li>Track project progress and report to the Project Steering Committee.</li>
<li>Identify and manage project risks and issues.</li>
<li>Coordinate project activities across different teams.</li>
<li>Implement the Donor Face Acquisition and Preservation Plan.</li>
<li>Implement the Psychological Support Program.</li>
<li>Implement the Data Privacy and Security Plan.</li>
</ul>
<p><strong>Initial Setup Actions:</strong></p>
<ul>
<li>Define roles and responsibilities.</li>
<li>Establish communication protocols.</li>
<li>Set up project management tools.</li>
<li>Develop detailed project schedule.</li>
</ul>
<p><strong>Membership:</strong></p>
<ul>
<li>Project Manager</li>
<li>Lead Surgeon</li>
<li>Head Nurse</li>
<li>Chief Technician</li>
<li>Compliance Officer</li>
<li>Data Protection Officer</li>
</ul>
<p><strong>Decision Rights:</strong> Operational decisions related to project execution, resource allocation, and risk management. Approval of expenditures up to $50,000 USD.</p>
<p><strong>Decision Mechanism:</strong> Consensus-based decision-making, with the Project Manager having the final say. Unresolved issues are escalated to the Project Steering Committee.</p>
<p><strong>Meeting Cadence:</strong> Weekly</p>
<p><strong>Typical Agenda Items:</strong></p>
<ul>
<li>Review of project progress against schedule.</li>
<li>Discussion of current risks and issues.</li>
<li>Review of budget and resource utilization.</li>
<li>Coordination of team activities.</li>
<li>Review of compliance activities.</li>
</ul>
<p><strong>Escalation Path:</strong> Project Steering Committee</p>
<h3>3. Ethics &amp; Compliance Committee</h3>
<p><strong>Rationale for Inclusion:</strong> Provides specialized input and assurance on ethical and compliance aspects of the project, given the sensitive nature of face transplantation and the subscription model. Ensures adherence to ethical guidelines, data privacy regulations, and relevant laws.</p>
<p><strong>Responsibilities:</strong></p>
<ul>
<li>Review and approve ethical guidelines and protocols.</li>
<li>Monitor compliance with ethical and regulatory requirements.</li>
<li>Investigate ethical complaints and concerns.</li>
<li>Provide guidance on ethical decision-making.</li>
<li>Ensure compliance with GDPR and other data privacy regulations.</li>
<li>Oversee the implementation of the Psychological Support Program.</li>
<li>Oversee the implementation of the Data Privacy and Security Plan.</li>
<li>Review and approve patient selection criteria.</li>
<li>Review and approve donor consent protocols.</li>
</ul>
<p><strong>Initial Setup Actions:</strong></p>
<ul>
<li>Finalize Terms of Reference.</li>
<li>Appoint Chair.</li>
<li>Establish meeting schedule.</li>
<li>Develop ethical guidelines and protocols.</li>
<li>Establish a process for handling ethical complaints.</li>
</ul>
<p><strong>Membership:</strong></p>
<ul>
<li>Independent Bioethicist (Chair)</li>
<li>Legal Counsel</li>
<li>Patient Advocate</li>
<li>Community Representative</li>
<li>Chief Medical Officer</li>
<li>Data Protection Officer</li>
</ul>
<p><strong>Decision Rights:</strong> Decisions related to ethical and compliance matters. Approval of ethical guidelines, patient selection criteria, and donor consent protocols. Authority to halt procedures if ethical concerns are not adequately addressed.</p>
<p><strong>Decision Mechanism:</strong> Majority vote, with the Chair having the tie-breaking vote. Dissenting opinions are formally recorded.</p>
<p><strong>Meeting Cadence:</strong> Bi-weekly</p>
<p><strong>Typical Agenda Items:</strong></p>
<ul>
<li>Review of ethical complaints and concerns.</li>
<li>Discussion of ethical dilemmas.</li>
<li>Review of compliance with ethical and regulatory requirements.</li>
<li>Review of patient feedback.</li>
<li>Review of donor family feedback.</li>
<li>Review of data privacy incidents.</li>
</ul>
<p><strong>Escalation Path:</strong> Project Steering Committee</p>
<h3>4. Technical Advisory Group</h3>
<p><strong>Rationale for Inclusion:</strong> Provides specialized technical expertise and guidance on the face transplantation technology, ensuring the project utilizes the most advanced and safe techniques. Mitigates technical risks and ensures optimal patient outcomes.</p>
<p><strong>Responsibilities:</strong></p>
<ul>
<li>Review and approve technical protocols and procedures.</li>
<li>Monitor technical performance and identify areas for improvement.</li>
<li>Provide guidance on the selection of medical equipment and technologies.</li>
<li>Advise on research and development activities.</li>
<li>Assess and mitigate technical risks.</li>
<li>Ensure the facility adheres to the highest standards of medical practice.</li>
<li>Review and approve surgical techniques.</li>
<li>Review and approve immunosuppression protocols.</li>
<li>Advise on the integration of new technologies.</li>
</ul>
<p><strong>Initial Setup Actions:</strong></p>
<ul>
<li>Finalize Terms of Reference.</li>
<li>Appoint Chair.</li>
<li>Establish meeting schedule.</li>
<li>Develop technical protocols and procedures.</li>
<li>Establish a process for monitoring technical performance.</li>
</ul>
<p><strong>Membership:</strong></p>
<ul>
<li>Lead Surgeon (Chair)</li>
<li>Experienced Transplant Surgeon (External)</li>
<li>Immunologist</li>
<li>Microbiologist</li>
<li>Biomedical Engineer</li>
<li>Chief Technician</li>
</ul>
<p><strong>Decision Rights:</strong> Decisions related to technical protocols, procedures, and equipment. Authority to recommend changes to technical practices to improve patient outcomes and safety.</p>
<p><strong>Decision Mechanism:</strong> Consensus-based decision-making, with the Lead Surgeon having the final say. Unresolved issues are escalated to the Project Steering Committee.</p>
<p><strong>Meeting Cadence:</strong> Bi-weekly</p>
<p><strong>Typical Agenda Items:</strong></p>
<ul>
<li>Review of technical performance data.</li>
<li>Discussion of technical challenges and solutions.</li>
<li>Review of new technologies and equipment.</li>
<li>Review of research and development activities.</li>
<li>Review of adverse events and complications.</li>
<li>Review of surgical outcomes.</li>
</ul>
<p><strong>Escalation Path:</strong> Project Steering Committee</p>
<h1>Governance Implementation Plan</h1>
<h3>1. Project Manager drafts initial Terms of Reference (ToR) for the Project Steering Committee.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 1</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Draft SteerCo ToR v0.1</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Project Plan Approved</li>
<li>Governance Bodies Defined</li>
</ul>
<h3>2. Circulate Draft SteerCo ToR for review by nominated members (CEO, CFO, Chief Medical Officer, Independent Bioethicist, Legal Counsel).</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 1</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Feedback Summary</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Draft SteerCo ToR v0.1</li>
</ul>
<h3>3. Project Manager finalizes the Project Steering Committee ToR based on feedback.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 2</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Final SteerCo ToR v1.0</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Feedback Summary</li>
</ul>
<h3>4. CEO formally appoints the Project Steering Committee Chair.</h3>
<p><strong>Responsible Body/Role:</strong> CEO</p>
<p><strong>Suggested Timeframe:</strong> Project Week 2</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Appointment Confirmation Email</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Final SteerCo ToR v1.0</li>
</ul>
<h3>5. Project Manager schedules the initial Project Steering Committee kick-off meeting.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 2</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Meeting Agenda</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Appointment Confirmation Email</li>
</ul>
<h3>6. Hold initial Project Steering Committee kick-off meeting to review ToR, establish meeting schedule, and define reporting requirements from other governance bodies.</h3>
<p><strong>Responsible Body/Role:</strong> Project Steering Committee</p>
<p><strong>Suggested Timeframe:</strong> Project Week 3</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Minutes with Action Items</li>
<li>Approved Meeting Schedule</li>
<li>Defined Reporting Requirements</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Final SteerCo ToR v1.0</li>
</ul>
<h3>7. Project Manager defines roles and responsibilities for the Core Project Team.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 1</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Core Project Team Roles and Responsibilities Document</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Project Plan Approved</li>
</ul>
<h3>8. Project Manager establishes communication protocols for the Core Project Team.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 1</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Core Project Team Communication Protocols Document</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Core Project Team Roles and Responsibilities Document</li>
</ul>
<h3>9. Project Manager sets up project management tools for the Core Project Team.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 2</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Project Management Tool Configuration</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Core Project Team Communication Protocols Document</li>
</ul>
<h3>10. Project Manager develops a detailed project schedule for the Core Project Team.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 2</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Detailed Project Schedule</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Project Management Tool Configuration</li>
</ul>
<h3>11. Project Manager schedules the initial Core Project Team kick-off meeting.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 2</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Meeting Agenda</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Detailed Project Schedule</li>
</ul>
<h3>12. Hold initial Core Project Team kick-off meeting to review roles, responsibilities, communication protocols, and project schedule.</h3>
<p><strong>Responsible Body/Role:</strong> Core Project Team</p>
<p><strong>Suggested Timeframe:</strong> Project Week 3</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Minutes with Action Items</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Core Project Team Roles and Responsibilities Document</li>
<li>Core Project Team Communication Protocols Document</li>
<li>Detailed Project Schedule</li>
</ul>
<h3>13. Project Manager drafts initial Terms of Reference (ToR) for the Ethics &amp; Compliance Committee.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 3</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Draft Ethics &amp; Compliance Committee ToR v0.1</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Project Steering Committee Established</li>
</ul>
<h3>14. Circulate Draft Ethics &amp; Compliance Committee ToR for review by nominated members (Independent Bioethicist, Legal Counsel, Patient Advocate, Community Representative, Chief Medical Officer, Data Protection Officer).</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 3</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Feedback Summary</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Draft Ethics &amp; Compliance Committee ToR v0.1</li>
</ul>
<h3>15. Project Manager finalizes the Ethics &amp; Compliance Committee ToR based on feedback.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 4</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Final Ethics &amp; Compliance Committee ToR v1.0</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Feedback Summary</li>
</ul>
<h3>16. Project Steering Committee formally appoints the Ethics &amp; Compliance Committee Chair (Independent Bioethicist).</h3>
<p><strong>Responsible Body/Role:</strong> Project Steering Committee</p>
<p><strong>Suggested Timeframe:</strong> Project Week 4</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Appointment Confirmation Email</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Final Ethics &amp; Compliance Committee ToR v1.0</li>
</ul>
<h3>17. Ethics &amp; Compliance Committee Chair schedules the initial Ethics &amp; Compliance Committee kick-off meeting.</h3>
<p><strong>Responsible Body/Role:</strong> Independent Bioethicist</p>
<p><strong>Suggested Timeframe:</strong> Project Week 4</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Meeting Agenda</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Appointment Confirmation Email</li>
</ul>
<h3>18. Hold initial Ethics &amp; Compliance Committee kick-off meeting to review ToR, establish meeting schedule, develop ethical guidelines and protocols, and establish a process for handling ethical complaints.</h3>
<p><strong>Responsible Body/Role:</strong> Ethics &amp; Compliance Committee</p>
<p><strong>Suggested Timeframe:</strong> Project Week 5</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Minutes with Action Items</li>
<li>Approved Meeting Schedule</li>
<li>Draft Ethical Guidelines and Protocols</li>
<li>Ethical Complaint Handling Process</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Final Ethics &amp; Compliance Committee ToR v1.0</li>
</ul>
<h3>19. Project Manager drafts initial Terms of Reference (ToR) for the Technical Advisory Group.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 3</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Draft Technical Advisory Group ToR v0.1</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Project Steering Committee Established</li>
</ul>
<h3>20. Circulate Draft Technical Advisory Group ToR for review by nominated members (Lead Surgeon, Experienced Transplant Surgeon, Immunologist, Microbiologist, Biomedical Engineer, Chief Technician).</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 3</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Feedback Summary</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Draft Technical Advisory Group ToR v0.1</li>
</ul>
<h3>21. Project Manager finalizes the Technical Advisory Group ToR based on feedback.</h3>
<p><strong>Responsible Body/Role:</strong> Project Manager</p>
<p><strong>Suggested Timeframe:</strong> Project Week 4</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Final Technical Advisory Group ToR v1.0</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Feedback Summary</li>
</ul>
<h3>22. Project Steering Committee formally appoints the Technical Advisory Group Chair (Lead Surgeon).</h3>
<p><strong>Responsible Body/Role:</strong> Project Steering Committee</p>
<p><strong>Suggested Timeframe:</strong> Project Week 4</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Appointment Confirmation Email</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Final Technical Advisory Group ToR v1.0</li>
</ul>
<h3>23. Technical Advisory Group Chair schedules the initial Technical Advisory Group kick-off meeting.</h3>
<p><strong>Responsible Body/Role:</strong> Lead Surgeon</p>
<p><strong>Suggested Timeframe:</strong> Project Week 4</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Meeting Agenda</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Appointment Confirmation Email</li>
</ul>
<h3>24. Hold initial Technical Advisory Group kick-off meeting to review ToR, establish meeting schedule, develop technical protocols and procedures, and establish a process for monitoring technical performance.</h3>
<p><strong>Responsible Body/Role:</strong> Technical Advisory Group</p>
<p><strong>Suggested Timeframe:</strong> Project Week 5</p>
<p><strong>Key Outputs/Deliverables:</strong></p>
<ul>
<li>Meeting Minutes with Action Items</li>
<li>Approved Meeting Schedule</li>
<li>Draft Technical Protocols and Procedures</li>
<li>Technical Performance Monitoring Process</li>
</ul>
<p><strong>Dependencies:</strong></p>
<ul>
<li>Meeting Invitation</li>
<li>Final Technical Advisory Group ToR v1.0</li>
</ul>
<h1>Decision Escalation Matrix</h1>
<p><strong>Budget Request Exceeding Core Project Team Authority</strong>
Escalation Level: Project Steering Committee
Approval Process: Steering Committee Review and Vote
Rationale: Exceeds the Core Project Team's financial authority and requires strategic oversight.
Negative Consequences: Potential for budget overruns and financial instability.</p>
<p><strong>Critical Risk Materialization Requiring Additional Resources</strong>
Escalation Level: Project Steering Committee
Approval Process: Steering Committee Review and Approval of Contingency Plan
Rationale: The Core Project Team lacks the authority to allocate significant additional resources or alter the project plan in response to a critical risk.
Negative Consequences: Project delays, increased costs, and potential project failure.</p>
<p><strong>Ethics &amp; Compliance Committee Deadlock on Patient Selection Criteria</strong>
Escalation Level: Project Steering Committee
Approval Process: Steering Committee Review and Final Decision
Rationale: The Ethics &amp; Compliance Committee cannot reach a consensus on a critical ethical issue, requiring a higher level of review and decision-making.
Negative Consequences: Compromised ethical standards, legal challenges, and reputational damage.</p>
<p><strong>Proposed Major Scope Change Impacting Project Timeline or Budget</strong>
Escalation Level: Project Steering Committee
Approval Process: Steering Committee Review and Approval
Rationale: Significant changes to the project scope require strategic review and approval due to their potential impact on the project's timeline, budget, and objectives.
Negative Consequences: Project delays, budget overruns, and failure to meet project goals.</p>
<p><strong>Reported Ethical Violation Involving Senior Project Team Member</strong>
Escalation Level: Project Steering Committee
Approval Process: Steering Committee Investigation and Disciplinary Action
Rationale: Requires independent review and action due to the potential for conflicts of interest and the severity of the ethical implications.
Negative Consequences: Legal liabilities, reputational damage, and loss of public trust.</p>
<p><strong>Technical Advisory Group cannot agree on surgical technique</strong>
Escalation Level: Project Steering Committee
Approval Process: Steering Committee Review and Vote
Rationale: The Technical Advisory Group cannot reach a consensus on a critical technical issue, requiring a higher level of review and decision-making.
Negative Consequences: Compromised patient safety, legal challenges, and reputational damage.</p>
<h1>Monitoring Progress</h1>
<h3>1. Tracking Key Performance Indicators (KPIs) against Project Plan</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Project Management Software Dashboard</li>
<li>KPI Tracking Spreadsheet</li>
</ul>
<p><strong>Frequency:</strong> Weekly</p>
<p><strong>Responsible Role:</strong> Project Manager</p>
<p><strong>Adaptation Process:</strong> PMO proposes adjustments via Change Request to Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> KPI deviates &gt;10% from target</p>
<h3>2. Regular Risk Register Review</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Risk Register Document</li>
</ul>
<p><strong>Frequency:</strong> Bi-weekly</p>
<p><strong>Responsible Role:</strong> Core Project Team</p>
<p><strong>Adaptation Process:</strong> Risk mitigation plan updated by Core Project Team</p>
<p><strong>Adaptation Trigger:</strong> New critical risk identified or existing risk likelihood/impact increases significantly</p>
<h3>3. Regulatory Approval Milestone Tracking</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Regulatory Submission Tracker</li>
<li>Communication Log with Regulatory Bodies</li>
</ul>
<p><strong>Frequency:</strong> Monthly</p>
<p><strong>Responsible Role:</strong> Compliance Officer</p>
<p><strong>Adaptation Process:</strong> Compliance Officer adjusts regulatory strategy, potentially engaging external consultants; adjustments reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Regulatory approval timeline delayed by &gt;1 month or potential rejection identified</p>
<h3>4. Ethical Compliance Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Ethics &amp; Compliance Committee Meeting Minutes</li>
<li>Incident Reporting System</li>
<li>Patient Feedback Surveys</li>
</ul>
<p><strong>Frequency:</strong> Bi-weekly</p>
<p><strong>Responsible Role:</strong> Ethics &amp; Compliance Committee</p>
<p><strong>Adaptation Process:</strong> Ethics &amp; Compliance Committee recommends changes to ethical guidelines or protocols; recommendations reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Significant ethical complaint received or potential breach of ethical guidelines identified</p>
<h3>5. Financial Performance Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Financial Statements</li>
<li>Budget Tracking Spreadsheet</li>
</ul>
<p><strong>Frequency:</strong> Monthly</p>
<p><strong>Responsible Role:</strong> CFO</p>
<p><strong>Adaptation Process:</strong> CFO proposes budget adjustments or cost-saving measures; adjustments reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Projected cost overruns exceed 5% of budget or revenue falls short of projections by 10%</p>
<h3>6. Donor Face Acquisition Rate Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Organ Donation Organization Partnership Reports</li>
<li>Donor Face Inventory Log</li>
</ul>
<p><strong>Frequency:</strong> Monthly</p>
<p><strong>Responsible Role:</strong> Head Nurse</p>
<p><strong>Adaptation Process:</strong> Head Nurse adjusts outreach strategy to organ donation organizations; adjustments reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Donor face acquisition rate falls below target by 20% for two consecutive months</p>
<h3>7. Patient Psychological Well-being Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Patient Therapy Session Reports</li>
<li>Patient Satisfaction Surveys</li>
</ul>
<p><strong>Frequency:</strong> Quarterly</p>
<p><strong>Responsible Role:</strong> Ethics &amp; Compliance Committee</p>
<p><strong>Adaptation Process:</strong> Ethics &amp; Compliance Committee recommends changes to Psychological Support Program; recommendations reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Significant increase in reported psychological distress among patients or negative trends in patient satisfaction surveys</p>
<h3>8. Data Privacy and Security Audit Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Data Security Audit Reports</li>
<li>Data Breach Incident Log</li>
</ul>
<p><strong>Frequency:</strong> Quarterly</p>
<p><strong>Responsible Role:</strong> Data Protection Officer</p>
<p><strong>Adaptation Process:</strong> Data Protection Officer implements corrective actions based on audit findings; actions reviewed by Ethics &amp; Compliance Committee</p>
<p><strong>Adaptation Trigger:</strong> Data security audit identifies critical vulnerabilities or data breach incident occurs</p>
<h3>9. Technical Performance and Surgical Outcome Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Surgical Outcome Data</li>
<li>Technical Advisory Group Meeting Minutes</li>
<li>Equipment Maintenance Logs</li>
</ul>
<p><strong>Frequency:</strong> Bi-weekly</p>
<p><strong>Responsible Role:</strong> Technical Advisory Group</p>
<p><strong>Adaptation Process:</strong> Technical Advisory Group recommends changes to surgical techniques or equipment; recommendations reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Significant increase in surgical complications or equipment malfunctions</p>
<h3>10. Subscription Uptake and Retention Rate Monitoring</h3>
<p><strong>Monitoring Tools/Platforms:</strong></p>
<ul>
<li>Subscription Management System</li>
<li>Customer Relationship Management (CRM) System</li>
</ul>
<p><strong>Frequency:</strong> Monthly</p>
<p><strong>Responsible Role:</strong> Project Manager</p>
<p><strong>Adaptation Process:</strong> Project Manager adjusts marketing and pricing strategies; adjustments reviewed by Steering Committee</p>
<p><strong>Adaptation Trigger:</strong> Subscription uptake falls below target by 15% or customer retention rate decreases by 10%</p>
<h1>Governance Extra</h1>
<h2>Governance Validation Checks</h2>
<ol>
<li>Point 1: Completeness Confirmation: All core requested components (internal_governance_bodies, governance_implementation_plan, decision_escalation_matrix, monitoring_progress) appear to be generated.</li>
<li>Point 2: Internal Consistency Check: The Implementation Plan uses defined governance bodies. The Escalation Matrix aligns with the governance hierarchy. Monitoring roles are assigned to existing roles. The Donor Face Acquisition and Preservation Plan, Psychological Support Program, and Data Privacy and Security Plan are referenced across multiple components, demonstrating consistency.</li>
<li>Point 3: Potential Gaps / Areas for Enhancement: The role and authority of the Project Sponsor (presumably the CEO) is not explicitly defined in terms of decision rights or escalation paths, particularly in situations where the CEO's interests might conflict with ethical considerations. This needs clarification.</li>
<li>Point 4: Potential Gaps / Areas for Enhancement: The 'adaptation_process' descriptions in the <code>monitoring_progress</code> plan often end with '...reviewed by Steering Committee'. The <em>criteria</em> the Steering Committee uses to evaluate these adjustments (beyond the stated triggers) are not defined. This could lead to inconsistent decision-making.</li>
<li>Point 5: Potential Gaps / Areas for Enhancement: The whistleblower mechanism is mentioned in the AuditDetails, but the process for investigating and resolving whistleblower reports, and protecting whistleblowers from retaliation, is not detailed in the governance bodies' responsibilities or the implementation plan. This is a critical ethical gap.</li>
<li>Point 6: Potential Gaps / Areas for Enhancement: The composition of the Ethics &amp; Compliance Committee includes a 'Community Representative' and 'Patient Advocate'. The selection criteria, qualifications, and expected contributions of these roles are not defined. This vagueness could undermine the committee's credibility.</li>
<li>Point 7: Potential Gaps / Areas for Enhancement: While the Risk Mitigation Protocol decision mentions a DAO, the specific mechanisms for DAO governance, voting rights, and integration with the existing governance structure are not fully elaborated. The potential for conflicts between the DAO and the Project Steering Committee needs to be addressed.</li>
</ol>
<h2>Tough Questions</h2>
<ol>
<li>What specific measures are in place to prevent coercion or exploitation of vulnerable individuals seeking face transplants, given the potential for desperation and the subscription model?</li>
<li>How will the facility ensure equitable access to face transplantation services, preventing discrimination based on socioeconomic status, race, or other factors?</li>
<li>What is the contingency plan if the DAO's decisions conflict with the ethical guidelines established by the Ethics &amp; Compliance Committee or the regulatory requirements of Medsafe?</li>
<li>What are the specific criteria for selecting donor faces to ensure compatibility and minimize the risk of rejection, and how are these criteria ethically justified?</li>
<li>What is the current probability-weighted forecast for securing regulatory approval from Medsafe within the next 12 months, and what are the key dependencies and assumptions underlying this forecast?</li>
<li>Show evidence of a verified process for obtaining informed consent from both face donors (or their families) and recipients, ensuring they fully understand the risks, benefits, and long-term implications of the procedure.</li>
<li>What is the plan to address the potential for social isolation or stigmatization of face transplant recipients, and how will the facility support their reintegration into society?</li>
<li>How will the facility ensure the long-term financial sustainability of the subscription model, considering the high costs of face transplantation and the potential for fluctuating demand?</li>
</ol>
<h2>Summary</h2>
<p>The governance framework establishes a multi-layered approach to managing the high-risk, ethically complex face transplantation project. It emphasizes strategic oversight, ethical compliance, technical expertise, and operational efficiency. Key strengths include the establishment of specialized committees and a focus on risk mitigation. However, further detail is needed regarding the Project Sponsor's role, DAO governance, whistleblower protection, and the criteria used by the Steering Committee to evaluate adjustments proposed by other bodies.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Related Resources</button>
                <div class="content">        
                    <h2>Suggestion 1 - The Cleveland Clinic Face Transplant Program</h2>
<p>The Cleveland Clinic's Face Transplant Program is a pioneering initiative focused on restoring facial form and function for patients disfigured by trauma, disease, or congenital defects. Established in 2004, the program involves a multidisciplinary team of surgeons, physicians, ethicists, and psychologists. The program performed the first near-total face transplant in the United States in 2008. The program continues to refine surgical techniques, immunosuppression protocols, and psychological support systems to improve patient outcomes and quality of life.</p>
<h3>Success Metrics</h3>
<p>Successful completion of multiple face transplant surgeries.
Improved patient quality of life as measured by psychological assessments and functional outcomes.
Advancements in surgical techniques and immunosuppression protocols.
Publication of research findings in peer-reviewed journals.
Establishment of a comprehensive multidisciplinary team.</p>
<h3>Risks and Challenges Faced</h3>
<p>Risk of organ rejection, managed through advanced immunosuppression protocols and close monitoring.
Surgical complications, mitigated by meticulous surgical planning and experienced surgical teams.
Ethical considerations, addressed through a dedicated ethics review board and informed consent processes.
Psychological impact on patients, managed through comprehensive psychological support programs.
Donor scarcity, addressed through collaboration with organ donation organizations.</p>
<h3>Where to Find More Information</h3>
<p>Cleveland Clinic Face Transplant Program: <a href="https://my.clevelandclinic.org/departments/plastic-surgery/programs/face-transplant">https://my.clevelandclinic.org/departments/plastic-surgery/programs/face-transplant</a>
Peer-reviewed publications on face transplantation outcomes and techniques.</p>
<h3>Actionable Steps</h3>
<p>Contact the Cleveland Clinic's Plastic Surgery Department to inquire about the Face Transplant Program.
Reach out to Dr. Francis Papay, Chairman of the Dermatology and Plastic Surgery Institute at the Cleveland Clinic, or a member of his team.
Email: Through the Cleveland Clinic website contact form.
LinkedIn: Search for Cleveland Clinic surgeons involved in face transplantation.</p>
<h3>Rationale for Suggestion</h3>
<p>The Cleveland Clinic's program is a leading example of a successful face transplantation initiative. It provides valuable insights into surgical techniques, ethical considerations, patient selection, and long-term patient management. The program's experience in navigating regulatory hurdles and ethical dilemmas is particularly relevant. While geographically distant, the Cleveland Clinic's extensive documentation and publications make it a highly valuable reference.</p>
<h2>Suggestion 2 - The French Face Transplant Program (Professor Laurent Lantieri)</h2>
<p>Professor Laurent Lantieri led the first successful face transplant in France in 2005, marking a significant milestone in reconstructive surgery. The program focuses on patients with severe facial disfigurements due to trauma, burns, or disease. The French program emphasizes rigorous patient selection, advanced surgical techniques, and comprehensive post-operative care. The program has contributed significantly to the understanding of immunological responses and long-term outcomes in face transplantation.</p>
<h3>Success Metrics</h3>
<p>Successful completion of multiple face transplant surgeries.
Improved patient quality of life and functional outcomes.
Advancements in surgical techniques and immunosuppression protocols.
Publication of research findings in peer-reviewed journals.
Establishment of a national face transplant registry.</p>
<h3>Risks and Challenges Faced</h3>
<p>Risk of organ rejection, managed through tailored immunosuppression regimens.
Surgical complications, mitigated by meticulous surgical planning and experienced surgical teams.
Ethical considerations, addressed through a national ethics review board and strict adherence to ethical guidelines.
Psychological impact on patients, managed through comprehensive psychological support programs.
Donor scarcity, addressed through a national organ donation network.</p>
<h3>Where to Find More Information</h3>
<p>Articles and publications featuring Professor Laurent Lantieri's work on face transplantation.
French National Agency for Biomedicine (Agence de la biomédecine): [https://www.agence-biomedecine.fr/]
Academic databases such as PubMed for research articles.</p>
<h3>Actionable Steps</h3>
<p>Search for publications by Professor Laurent Lantieri on face transplantation.
Contact the French National Agency for Biomedicine for information on face transplantation regulations and ethical guidelines.
Email: Contact information for Professor Lantieri may be available through academic publications or hospital websites.
LinkedIn: Search for Professor Laurent Lantieri or other surgeons involved in face transplantation in France.</p>
<h3>Rationale for Suggestion</h3>
<p>Professor Lantieri's pioneering work in France provides valuable insights into the ethical, surgical, and immunological aspects of face transplantation. The French program's experience in navigating a national healthcare system and addressing ethical concerns within a specific cultural context is particularly relevant. While geographically distant, the French program's extensive documentation and publications make it a highly valuable reference. The French healthcare system's approach to organ donation and transplantation may offer useful comparisons to the New Zealand context.</p>
<h2>Suggestion 3 - Australia and New Zealand Organ Donation Registry (ANZOD)</h2>
<p>The Australia and New Zealand Organ Donation Registry (ANZOD) is a collaborative initiative that collects and analyzes data on organ donation and transplantation activities across Australia and New Zealand. While not a face transplant program, ANZOD provides critical data and insights into organ donation rates, transplantation outcomes, and ethical considerations within the region. ANZOD's data can inform the development of ethical guidelines, resource allocation strategies, and public awareness campaigns related to face transplantation.</p>
<h3>Success Metrics</h3>
<p>Collection and analysis of comprehensive data on organ donation and transplantation.
Publication of annual reports on organ donation and transplantation trends.
Provision of data to inform policy decisions and resource allocation.
Collaboration with organ donation organizations and transplant centers.
Promotion of public awareness about organ donation.</p>
<h3>Risks and Challenges Faced</h3>
<p>Data collection challenges, addressed through standardized data collection protocols and collaboration with participating institutions.
Data privacy concerns, addressed through strict adherence to data privacy regulations.
Ethical considerations, addressed through collaboration with ethics committees and legal experts.
Funding limitations, addressed through government grants and philanthropic donations.
Public perception challenges, addressed through public awareness campaigns.</p>
<h3>Where to Find More Information</h3>
<p>Australia and New Zealand Organ Donation Registry (ANZOD): [https://www.anzdata.org.au/anzod-home/]
Annual reports on organ donation and transplantation in Australia and New Zealand.</p>
<h3>Actionable Steps</h3>
<p>Visit the ANZOD website to access data and reports on organ donation and transplantation.
Contact ANZOD to inquire about data specific to New Zealand and ethical considerations related to organ donation.
Email: Contact information is available on the ANZOD website.
LinkedIn: Search for individuals involved in ANZOD data collection and analysis.</p>
<h3>Rationale for Suggestion</h3>
<p>ANZOD provides critical data and insights into organ donation and transplantation within the New Zealand context. While not directly related to face transplantation, ANZOD's data on organ donation rates, ethical considerations, and public perception can inform the development of a sustainable and ethical face transplantation program. Given the geographical proximity and shared cultural values, ANZOD's data is highly relevant to the proposed project. This suggestion is included to provide a local perspective on organ donation and transplantation.</p>
<h2>Summary</h2>
<p>The recommendations provide a blend of international expertise in face transplantation (Cleveland Clinic and Professor Lantieri's program) and local data on organ donation within New Zealand (ANZOD). The Cleveland Clinic and Professor Lantieri's programs offer insights into surgical techniques, ethical considerations, and patient management, while ANZOD provides valuable data on organ donation rates and ethical considerations within the New Zealand context. These references collectively address the key challenges and opportunities associated with establishing a commercial face transplantation facility in New Zealand.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Data Collection</button>
                <div class="content">        
                    <h2>1. Donor Face Acquisition and Preservation Plan</h2>
<p>A robust plan is critical to ensure a consistent supply of donor faces, impacting operational capacity, subscription fulfillment, and financial viability.</p>
<h3>Data to Collect</h3>
<ul>
<li>Number of potential donors in New Zealand</li>
<li>Ethical consent protocols for face donation</li>
<li>Logistics of face transportation and preservation</li>
<li>Advanced preservation techniques</li>
<li>Inventory management system details</li>
<li>Partnerships with organ donation organizations</li>
<li>Cost of face acquisition and preservation</li>
</ul>
<h3>Simulation Steps</h3>
<ul>
<li>Use organ donation statistics from ANZOD (Australia and New Zealand Organ Donation Registry) to estimate potential donor pool.</li>
<li>Simulate transportation logistics using Google Maps API to estimate transit times and costs.</li>
<li>Model preservation techniques using data from scientific literature on organ preservation.</li>
</ul>
<h3>Expert Validation Steps</h3>
<ul>
<li>Consult with transplant surgeons experienced in face transplantation.</li>
<li>Consult with ethicists specializing in organ donation.</li>
<li>Consult with organ procurement organizations (OPOs) in New Zealand.</li>
</ul>
<h3>Responsible Parties</h3>
<ul>
<li>Head of Operations</li>
<li>Donor Relations &amp; Acquisition Specialist</li>
<li>Ethics Review Board Coordinator</li>
</ul>
<h3>Assumptions</h3>
<ul>
<li><strong>High:</strong> Sufficient donor faces will be available through partnerships with organ donation organizations.</li>
<li><strong>High:</strong> Ethical consent can be obtained for face donation.</li>
<li><strong>Medium:</strong> Logistical challenges of face transportation and preservation can be overcome.</li>
</ul>
<h3>SMART Validation Objective</h3>
<p>By 2026-06-30, establish partnerships with at least three organ donation organizations and develop ethical consent protocols to ensure a consistent supply of donor faces, aiming for a minimum of 10 potential donors per year.</p>
<h3>Notes</h3>
<ul>
<li>Uncertainty: Actual number of available donors may vary.</li>
<li>Risk: Donor shortages could limit the number of transplant procedures.</li>
<li>Missing data: Specific details on cold ischemia time limits and preservation solutions.</li>
</ul>
<h2>2. Long-Term Psychological Impact on Recipients and 'Donors'</h2>
<p>Addressing the long-term psychological impact is crucial for patient well-being, ethical integrity, and project sustainability.</p>
<h3>Data to Collect</h3>
<ul>
<li>Psychological impact on face recipients</li>
<li>Psychological impact on donor families</li>
<li>Pre-transplant counseling protocols</li>
<li>Post-transplant therapy protocols</li>
<li>Bereavement counseling for donor families</li>
<li>Psychiatric assessment protocols</li>
<li>Ethical guidelines for managing psychological issues</li>
<li>Community support resources</li>
<li>Cost of psychological support program</li>
</ul>
<h3>Simulation Steps</h3>
<ul>
<li>Conduct literature review on psychological impact of face transplantation using PubMed and PsycINFO.</li>
<li>Simulate patient and donor family experiences using role-playing scenarios.</li>
<li>Model the effectiveness of different therapy protocols using data from clinical trials.</li>
</ul>
<h3>Expert Validation Steps</h3>
<ul>
<li>Consult with psychologists specializing in transplantation.</li>
<li>Consult with psychiatrists experienced in identity issues.</li>
<li>Consult with support groups for transplant recipients and donor families.</li>
</ul>
<h3>Responsible Parties</h3>
<ul>
<li>Chief Medical Officer</li>
<li>Patient Liaison &amp; Psychological Support Coordinator</li>
<li>Ethics Review Board Coordinator</li>
</ul>
<h3>Assumptions</h3>
<ul>
<li><strong>Medium:</strong> Patients will be willing to undergo pre- and post-transplant counseling.</li>
<li><strong>High:</strong> Psychological support program will be effective in mitigating negative psychological outcomes.</li>
<li><strong>Medium:</strong> Donor families will be willing to participate in bereavement counseling.</li>
</ul>
<h3>SMART Validation Objective</h3>
<p>By 2026-07-31, establish a comprehensive Psychological Support Program that includes pre- and post-transplant counseling for recipients and donor families, aiming to reduce patient attrition by 10% and improve patient satisfaction scores by 15%.</p>
<h3>Notes</h3>
<ul>
<li>Uncertainty: Actual psychological impact may vary.</li>
<li>Risk: Failure to address psychological issues could lead to patient attrition and reputational damage.</li>
<li>Missing data: Specific details on therapy protocols and outcome measures.</li>
</ul>
<h2>3. Data Privacy and Security Considerations</h2>
<p>Robust data protection measures are critical to comply with regulations, protect patient data, and avoid legal and reputational damage.</p>
<h3>Data to Collect</h3>
<ul>
<li>Applicable data privacy regulations (e.g., GDPR)</li>
<li>Data encryption techniques</li>
<li>Access control protocols</li>
<li>Data breach response plan</li>
<li>Security audit protocols</li>
<li>Employee training protocols</li>
<li>Cost of data privacy and security plan</li>
</ul>
<h3>Simulation Steps</h3>
<ul>
<li>Conduct a data privacy compliance assessment using online tools and resources.</li>
<li>Simulate data breaches using penetration testing software.</li>
<li>Model the effectiveness of different data encryption techniques using cryptographic algorithms.</li>
</ul>
<h3>Expert Validation Steps</h3>
<ul>
<li>Consult with data privacy lawyers.</li>
<li>Consult with cybersecurity experts.</li>
<li>Consult with data protection officers in healthcare organizations.</li>
</ul>
<h3>Responsible Parties</h3>
<ul>
<li>Chief Technology Officer</li>
<li>Data Security &amp; Privacy Officer</li>
<li>Regulatory Liaison &amp; Compliance Officer</li>
</ul>
<h3>Assumptions</h3>
<ul>
<li><strong>High:</strong> Data privacy regulations can be complied with effectively.</li>
<li><strong>Medium:</strong> Data encryption techniques will be effective in protecting patient data.</li>
<li><strong>Medium:</strong> Data breach response plan will be effective in mitigating the impact of data breaches.</li>
</ul>
<h3>SMART Validation Objective</h3>
<p>By 2026-08-31, develop a comprehensive Data Privacy and Security Plan that ensures compliance with data privacy regulations and implements robust data encryption techniques, aiming to reduce the risk of data breaches by 20% and avoid fines related to data privacy violations.</p>
<h3>Notes</h3>
<ul>
<li>Uncertainty: Actual risk of data breaches may vary.</li>
<li>Risk: Failure to comply with data privacy regulations could result in significant fines and legal liabilities.</li>
<li>Missing data: Specific details on data encryption techniques and access control protocols.</li>
</ul>
<h2>4. Feasibility of Radical Technologies (CRISPR, Xenotransplantation)</h2>
<p>Assessing the feasibility of radical technologies is crucial to determine the project's technological development approach and avoid unrealistic expectations.</p>
<h3>Data to Collect</h3>
<ul>
<li>Current status of CRISPR technology for transplantation</li>
<li>Current status of xenotransplantation for face transplantation</li>
<li>Regulatory hurdles for CRISPR and xenotransplantation</li>
<li>Ethical concerns related to CRISPR and xenotransplantation</li>
<li>Cost of developing CRISPR and xenotransplantation technologies</li>
<li>Potential benefits of CRISPR and xenotransplantation for face transplantation</li>
</ul>
<h3>Simulation Steps</h3>
<ul>
<li>Conduct literature review on CRISPR and xenotransplantation using PubMed and Google Scholar.</li>
<li>Simulate the regulatory approval process using regulatory guidelines and expert opinions.</li>
<li>Model the potential benefits of CRISPR and xenotransplantation using data from scientific literature.</li>
</ul>
<h3>Expert Validation Steps</h3>
<ul>
<li>Consult with experts in CRISPR technology.</li>
<li>Consult with experts in xenotransplantation.</li>
<li>Consult with regulatory affairs consultants.</li>
<li>Consult with medical ethicists.</li>
</ul>
<h3>Responsible Parties</h3>
<ul>
<li>Chief Technology Officer</li>
<li>Lead Transplant Surgeon</li>
<li>Regulatory Liaison &amp; Compliance Officer</li>
<li>Ethics Review Board Coordinator</li>
</ul>
<h3>Assumptions</h3>
<ul>
<li><strong>High:</strong> CRISPR technology will be feasible for face transplantation within the project timeline.</li>
<li><strong>High:</strong> Xenotransplantation will be feasible for face transplantation within the project timeline.</li>
<li><strong>High:</strong> Regulatory hurdles for CRISPR and xenotransplantation can be overcome.</li>
</ul>
<h3>SMART Validation Objective</h3>
<p>By 2026-03-31, conduct a comprehensive feasibility study on CRISPR and xenotransplantation for face transplantation, consulting with leading experts and providing concrete data on regulatory approval prospects, aiming to determine whether these technologies are viable within the project timeline and budget.</p>
<h3>Notes</h3>
<ul>
<li>Uncertainty: Actual feasibility of CRISPR and xenotransplantation may vary.</li>
<li>Risk: Over-reliance on radical technologies could lead to project delays and financial losses.</li>
<li>Missing data: Specific details on regulatory requirements for CRISPR and xenotransplantation in New Zealand.</li>
</ul>
<h2>5. Regulatory Approval Strategy Validation</h2>
<p>Validating the regulatory approval strategy is crucial to ensure the project's ability to legally operate and avoid costly delays.</p>
<h3>Data to Collect</h3>
<ul>
<li>Specific regulatory requirements for face transplantation in New Zealand</li>
<li>Timelines for obtaining necessary approvals from Medsafe and Ministry of Health</li>
<li>Potential challenges in navigating the regulatory landscape</li>
<li>Alternative regulatory pathways</li>
<li>Cost of regulatory compliance</li>
<li>Impact of jurisdictional arbitrage on regulatory approval</li>
</ul>
<h3>Simulation Steps</h3>
<ul>
<li>Review Medsafe guidelines and regulations using the Medsafe website.</li>
<li>Simulate the regulatory approval process using regulatory guidelines and expert opinions.</li>
<li>Model the impact of jurisdictional arbitrage on regulatory approval using data from other countries with more permissive regulations.</li>
</ul>
<h3>Expert Validation Steps</h3>
<ul>
<li>Consult with regulatory affairs consultants specializing in New Zealand healthcare regulations.</li>
<li>Consult with Medsafe officials.</li>
<li>Consult with legal experts specializing in healthcare law.</li>
</ul>
<h3>Responsible Parties</h3>
<ul>
<li>Regulatory Liaison &amp; Compliance Officer</li>
<li>Chief Medical Officer</li>
<li>Legal Counsel</li>
</ul>
<h3>Assumptions</h3>
<ul>
<li><strong>High:</strong> Regulatory approval can be obtained within 12 months.</li>
<li><strong>High:</strong> Jurisdictional arbitrage will be a viable strategy.</li>
<li><strong>Medium:</strong> Regulatory requirements will be clearly defined and consistently applied.</li>
</ul>
<h3>SMART Validation Objective</h3>
<p>By 2026-03-31, engage proactively with regulatory bodies (Ministry of Health, Medsafe) to navigate the complex approval landscape and mitigate potential delays, aiming to obtain a clear understanding of the regulatory requirements and timelines for face transplantation in New Zealand.</p>
<h3>Notes</h3>
<ul>
<li>Uncertainty: Actual regulatory approval timelines may vary.</li>
<li>Risk: Regulatory delays or denial could significantly impact project timelines and costs.</li>
<li>Missing data: Specific details on regulatory requirements for face transplantation in New Zealand.</li>
</ul>
<h2>Summary</h2>
<p>This project plan outlines the data collection and validation steps necessary to assess the feasibility and ethical implications of establishing a commercial face transplantation facility in New Zealand with a subscription-based face swapping service. The plan focuses on validating key assumptions related to donor face acquisition, psychological impact, data privacy, technological feasibility, and regulatory approval. The validation process involves simulation steps using online tools and expert validation steps through consultations with relevant professionals. The plan also identifies potential risks and uncertainties and provides recommendations for mitigation.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Documents to Create and Find</button>
                <div class="content">        
                    <h1>Documents to Create</h1>
<h2>Create Document 1: Project Charter</h2>
<p><strong>ID</strong>: b2aa5a4a-f722-4573-a020-57478ea88c86</p>
<p><strong>Description</strong>: A formal document that authorizes the project, defines its objectives, and outlines the roles and responsibilities of key stakeholders. This Project Charter will focus on the establishment of a commercial face transplantation facility in New Zealand with a subscription-based face swapping service. It will define the project's scope, objectives, and governance structure, including ethical considerations and regulatory compliance.</p>
<p><strong>Responsible Role Type</strong>: Project Manager</p>
<p><strong>Primary Template</strong>: PMI Project Charter Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Define project objectives and scope.</li>
<li>Identify key stakeholders and their roles.</li>
<li>Establish project governance structure.</li>
<li>Outline high-level budget and timeline.</li>
<li>Obtain approval from key stakeholders.</li>
</ul>
<p><strong>Approval Authorities</strong>: CEO, Board of Directors</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>Clearly define the project's objectives, including the specific services offered (face transplantation and subscription-based face swapping) and the target market.</li>
<li>Define the project's scope, including what is included and excluded from the project (e.g., research and development, specific geographic areas, types of procedures).</li>
<li>Identify all key stakeholders (surgeons, nurses, technicians, ethicists, facility management, Ministry of Health, Medsafe, organ donation organizations, patients, donor families, investors) and define their roles and responsibilities within the project.</li>
<li>Establish the project governance structure, including decision-making processes, reporting lines, and escalation procedures.</li>
<li>Outline the high-level budget, including estimated costs for facility construction, staffing, regulatory compliance, and ongoing operations. Requires initial budget assumption of $50 million USD to be validated.</li>
<li>Define the project timeline, including key milestones and deadlines for regulatory approval, construction, staff training, and service launch. Requires estimated timeline assumption of 36 months to be validated.</li>
<li>Detail the ethical considerations associated with face transplantation and the subscription model, including patient consent, donor compensation, and psychological support. Requires review of ethical guidelines and protocols.</li>
<li>Outline the regulatory compliance requirements, including permits, licenses, and standards related to medical facilities, surgical procedures, data privacy, and ethical practices. Requires review of regulatory compliance assumptions.</li>
<li>Define the risk assessment and mitigation strategies, including key risks (regulatory approval, ethical concerns, technical complications, financial viability, donor face acquisition) and mitigation plans. Requires review of identified risks.</li>
<li>Specify the criteria for project success, including measurable outcomes related to subscriber numbers, patient satisfaction, financial performance, and ethical compliance.</li>
<li>What are the key performance indicators (KPIs) that will be used to track project progress and success?</li>
<li>What are the specific legal and ethical frameworks that will govern the project's operations?</li>
<li>What are the communication protocols for keeping stakeholders informed of project progress and any potential issues?</li>
<li>What are the decision-making processes for resolving conflicts or making critical changes to the project plan?</li>
<li>What are the resource allocation procedures for ensuring that the project has the necessary funding, personnel, and equipment?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>An unclear scope definition leads to significant rework, budget overruns, and delays.</li>
<li>Failure to identify key stakeholders results in miscommunication, conflicts, and lack of support.</li>
<li>An inadequate governance structure leads to poor decision-making, lack of accountability, and project failure.</li>
<li>An unrealistic budget or timeline results in financial instability and project delays.</li>
<li>Failure to address ethical considerations leads to public outcry, regulatory scrutiny, and project shutdown.</li>
<li>Non-compliance with regulatory requirements results in fines, legal challenges, and loss of license.</li>
<li>Inadequate risk assessment and mitigation strategies result in unforeseen complications and project failure.</li>
<li>Lack of clear success criteria makes it difficult to track progress and determine project success.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The project fails to secure necessary funding or regulatory approvals due to ethical concerns or technical challenges, resulting in complete project shutdown and significant financial losses.</p>
<p><strong>Best Case Scenario</strong>: The project charter enables a clear understanding of the project's objectives, scope, and governance, leading to efficient execution, successful regulatory approval, strong stakeholder support, and the establishment of a profitable and ethically responsible face transplantation facility.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize a pre-approved company template and adapt it to the specific requirements of the face transplantation project.</li>
<li>Schedule a focused workshop with key stakeholders to collaboratively define project objectives, scope, and governance.</li>
<li>Engage a project management consultant or subject matter expert to assist in developing the project charter.</li>
<li>Develop a simplified 'minimum viable project charter' covering only critical elements initially, and expand it as the project progresses.</li>
<li>Focus on creating a charter for a smaller, more focused pilot project to test the feasibility of the face transplantation concept before committing to a full-scale facility.</li>
</ul>
<h2>Create Document 2: Risk Register</h2>
<p><strong>ID</strong>: 7cbd1f51-7401-4d55-895e-c9652ef7beba</p>
<p><strong>Description</strong>: A comprehensive log of identified risks associated with the project, including their potential impact, likelihood, and mitigation strategies. This Risk Register will specifically address risks related to regulatory approval, ethical concerns, technical complications, financial viability, donor face acquisition, psychological impact, and data privacy. It will also include mitigation strategies for each identified risk.</p>
<p><strong>Responsible Role Type</strong>: Risk Manager</p>
<p><strong>Primary Template</strong>: ISO 31000 Risk Management Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Identify potential risks through brainstorming and expert consultation.</li>
<li>Assess the likelihood and impact of each risk.</li>
<li>Develop mitigation strategies for each risk.</li>
<li>Assign responsibility for monitoring and managing each risk.</li>
<li>Regularly review and update the Risk Register.</li>
</ul>
<p><strong>Approval Authorities</strong>: Project Manager, Risk Committee</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>Identify all potential risks associated with the face transplantation project, including regulatory, ethical, technical, financial, donor face acquisition, psychological impact, and data privacy risks.</li>
<li>Assess the likelihood and potential impact of each identified risk on project timelines and outcomes.</li>
<li>Develop detailed mitigation strategies for each risk, specifying actions to minimize their impact.</li>
<li>Assign responsibility for monitoring and managing each risk to specific team members or roles.</li>
<li>Establish a regular review process to update the Risk Register based on new information or changes in project scope.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>An incomplete risk assessment may lead to unanticipated regulatory delays, resulting in project timeline overruns and increased costs.</li>
<li>Failure to address ethical concerns could result in public backlash, damaging the project's reputation and leading to potential shutdown.</li>
<li>Inadequate technical risk management may result in surgical complications, increasing patient morbidity and legal liabilities.</li>
<li>Neglecting financial risks could jeopardize funding and lead to project bankruptcy.</li>
<li>Ignoring psychological impacts may lead to patient dissatisfaction and attrition, reducing subscription revenue.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The project faces significant legal challenges and public outcry due to unaddressed ethical and technical risks, leading to a complete shutdown of operations and loss of investor confidence, resulting in financial ruin.</p>
<p><strong>Best Case Scenario</strong>: The Risk Register is effectively utilized to manage and mitigate risks, leading to successful regulatory approval, high patient satisfaction, and a sustainable subscription model, ultimately establishing the facility as a leader in innovative medical practices.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize existing risk management frameworks and templates to expedite the creation of the Risk Register.</li>
<li>Conduct focused workshops with key stakeholders to collaboratively identify and assess risks.</li>
<li>Engage external risk management consultants to provide expertise and accelerate the risk assessment process.</li>
<li>Develop a simplified version of the Risk Register that prioritizes the most critical risks for initial focus, with plans to expand later.</li>
</ul>
<h2>Create Document 3: High-Level Budget/Funding Framework</h2>
<p><strong>ID</strong>: 834ed053-8aa8-48af-aee7-3c20c751a320</p>
<p><strong>Description</strong>: A high-level overview of the project's budget, including estimated costs for facility construction, staffing, regulatory compliance, and ongoing operations. This framework will also outline potential funding sources, such as investors, grants, and revenue from the subscription model. It will provide a basis for developing a detailed financial model.</p>
<p><strong>Responsible Role Type</strong>: Financial Analyst</p>
<p><strong>Primary Template</strong>: Project Budget Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Estimate costs for each project activity.</li>
<li>Identify potential funding sources.</li>
<li>Develop a high-level budget overview.</li>
<li>Obtain approval from key stakeholders.</li>
<li>Regularly review and update the budget framework.</li>
</ul>
<p><strong>Approval Authorities</strong>: CFO, Board of Directors</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What is the total estimated budget for the project, broken down by major categories (facility construction, staffing, regulatory compliance, ongoing operations)?</li>
<li>What are the specific cost estimates for each major budget category, including detailed line items where possible?</li>
<li>What are the potential funding sources for the project (investors, grants, subscription revenue, etc.)?</li>
<li>What are the projected revenue streams from the subscription model, including estimated subscriber numbers and pricing tiers?</li>
<li>What are the key financial assumptions underlying the budget projections (e.g., inflation rate, currency exchange rates, interest rates)?</li>
<li>What are the contingency plans for cost overruns or funding shortfalls?</li>
<li>What are the key performance indicators (KPIs) that will be used to track budget performance?</li>
<li>What is the process for requesting and approving budget changes?</li>
<li>What are the reporting requirements for budget performance?</li>
<li>What are the roles and responsibilities of key stakeholders in managing the budget?</li>
<li>Requires access to the project plan, risk assessment, and market analysis documents.</li>
<li>Requires input from the CFO and other financial experts.</li>
<li>Requires a detailed breakdown of costs associated with each strategic decision (Risk Mitigation Protocol, Operational Scalability Model, etc.)</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Inaccurate cost estimates lead to budget overruns and financial instability.</li>
<li>Failure to secure sufficient funding delays project timelines or prevents project completion.</li>
<li>Unrealistic revenue projections result in financial losses and investor dissatisfaction.</li>
<li>Lack of transparency in the budget process erodes stakeholder trust.</li>
<li>Inadequate contingency planning leaves the project vulnerable to unforeseen financial challenges.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The project runs out of funding due to inaccurate budgeting and an inability to secure additional investment, leading to project abandonment and significant financial losses for investors.</p>
<p><strong>Best Case Scenario</strong>: The high-level budget framework provides a clear and accurate financial roadmap for the project, enabling effective resource allocation, attracting sufficient funding, and ensuring long-term financial sustainability. Enables go/no-go decision on Phase 2 funding and provides a basis for detailed financial modeling.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize a pre-approved company budget template and adapt it to the project's specific needs.</li>
<li>Engage a financial consultant to develop a preliminary budget framework based on industry benchmarks.</li>
<li>Develop a simplified 'minimum viable budget' covering only critical expenses initially, to be refined later.</li>
<li>Schedule a focused workshop with stakeholders to collaboratively estimate costs and identify funding sources.</li>
</ul>
<h2>Create Document 4: Initial High-Level Schedule/Timeline</h2>
<p><strong>ID</strong>: 9654bd16-74ac-4cbf-83e7-fd8654818964</p>
<p><strong>Description</strong>: A high-level timeline outlining the key milestones and activities for the project, including regulatory approval, facility construction, staff training, and the launch of the subscription service. This timeline will provide a roadmap for the project and help to track progress.</p>
<p><strong>Responsible Role Type</strong>: Project Scheduler</p>
<p><strong>Primary Template</strong>: Gantt Chart Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Identify key project milestones and activities.</li>
<li>Estimate the duration of each activity.</li>
<li>Sequence activities and create a project timeline.</li>
<li>Obtain approval from key stakeholders.</li>
<li>Regularly review and update the project timeline.</li>
</ul>
<p><strong>Approval Authorities</strong>: Project Manager, CEO</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What are the key milestones for regulatory approval, facility construction, staff training, and subscription service launch?</li>
<li>What is the estimated duration for each key activity (regulatory approval, construction, training, etc.)?</li>
<li>What are the dependencies between these activities (e.g., can construction start before regulatory approval)?</li>
<li>What are the critical path activities that will directly impact the project completion date?</li>
<li>What are the key decision points that could impact the timeline (e.g., go/no-go decisions based on regulatory feedback)?</li>
<li>What are the resource allocation assumptions that underpin the timeline (e.g., staffing levels, equipment availability)?</li>
<li>What are the potential sources of delay and how can they be mitigated (e.g., weather delays, supply chain disruptions)?</li>
<li>Include a visual representation of the timeline (e.g., Gantt chart) showing key milestones and dependencies.</li>
<li>What are the key performance indicators (KPIs) for tracking progress against the timeline?</li>
<li>What are the planned review and update cycles for the timeline?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Unrealistic timelines lead to missed deadlines and project delays.</li>
<li>Inaccurate activity duration estimates result in resource misallocation and budget overruns.</li>
<li>Failure to identify critical path activities leads to inefficient project management and delays.</li>
<li>Lack of stakeholder buy-in results in resistance to the timeline and difficulty tracking progress.</li>
<li>An outdated timeline leads to poor decision-making and reactive problem-solving.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: Significant delays in regulatory approval push the project launch back by 12+ months, leading to loss of investor confidence, depletion of initial funding, and potential project cancellation.</p>
<p><strong>Best Case Scenario</strong>: The timeline provides a clear roadmap for the project, enabling efficient resource allocation, proactive risk management, and on-time completion. This leads to early revenue generation, increased investor confidence, and a competitive advantage in the market. Enables go/no-go decisions at key milestones.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize a simplified milestone chart focusing only on major deliverables and regulatory gates.</li>
<li>Conduct a rapid estimation workshop with key stakeholders to quickly generate activity duration estimates.</li>
<li>Engage a project management consultant to develop a more detailed timeline if internal resources are limited.</li>
<li>Develop a 'rolling wave' timeline, detailing the first 6-12 months in detail and outlining subsequent phases at a higher level.</li>
</ul>
<h2>Create Document 5: Risk Mitigation Protocol</h2>
<p><strong>ID</strong>: 44a67dca-df83-4279-a16a-c0f6c1c26e2a</p>
<p><strong>Description</strong>: A framework for minimizing potential legal, financial, and reputational risks associated with face transplantation. It controls the implementation of safety measures, informed consent processes, and insurance coverage. Success is measured by the reduction in legal claims, insurance payouts, and negative publicity. The objective is to create a safe and responsible environment for both patients and the organization, ensuring long-term sustainability and public trust.</p>
<p><strong>Responsible Role Type</strong>: Risk Manager</p>
<p><strong>Primary Template</strong>: Risk Management Plan Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Identify potential risks associated with face transplantation.</li>
<li>Assess the likelihood and impact of each risk.</li>
<li>Develop mitigation strategies for each risk.</li>
<li>Assign responsibility for monitoring and managing each risk.</li>
<li>Establish a process for reviewing and updating the Risk Mitigation Protocol.</li>
</ul>
<p><strong>Approval Authorities</strong>: Risk Committee, Legal Counsel</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What are the specific legal risks associated with face transplantation procedures, including potential liabilities related to surgical complications, informed consent, and data privacy?</li>
<li>What are the potential financial risks, including cost overruns, insurance liabilities, and revenue shortfalls, and how can they be quantified?</li>
<li>What are the reputational risks associated with negative publicity, ethical concerns, and patient dissatisfaction, and how can they be measured and mitigated?</li>
<li>Detail the patient screening process to minimize legal and medical risks, including specific criteria for inclusion and exclusion.</li>
<li>Define the informed consent process, including the information provided to patients, the documentation required, and the process for obtaining consent.</li>
<li>Specify the insurance coverage required to cover potential liabilities and medical complications, including policy limits, exclusions, and claims procedures.</li>
<li>Outline the roles and responsibilities of the Risk Committee and Legal Counsel in overseeing the Risk Mitigation Protocol.</li>
<li>Detail the process for reviewing and updating the Risk Mitigation Protocol, including the frequency of reviews and the criteria for triggering updates.</li>
<li>What are the key performance indicators (KPIs) for measuring the effectiveness of the Risk Mitigation Protocol, such as the number of legal claims, insurance payouts, and negative media mentions?</li>
<li>Based on the 'Pioneer's Gambit' scenario, how does the DAO structure distribute risk and ensure transparency in decision-making related to risk mitigation?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to identify and mitigate key risks leads to legal liabilities, financial losses, and reputational damage.</li>
<li>Inadequate patient screening results in increased surgical complications and legal claims.</li>
<li>Unclear informed consent processes lead to ethical breaches and legal challenges.</li>
<li>Insufficient insurance coverage results in financial losses in the event of complications or liabilities.</li>
<li>Lack of a robust review process results in an outdated and ineffective Risk Mitigation Protocol.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: A major surgical complication leads to a lawsuit, significant financial losses, and negative publicity, resulting in the shutdown of the face transplantation facility and reputational damage to the organization.</p>
<p><strong>Best Case Scenario</strong>: The Risk Mitigation Protocol effectively minimizes legal, financial, and reputational risks, creating a safe and responsible environment for patients and the organization, ensuring long-term sustainability and public trust. This enables securing necessary funding and regulatory approvals.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize a pre-approved risk management template from a similar medical facility and adapt it to the specific risks of face transplantation.</li>
<li>Schedule a focused workshop with the Risk Committee, Legal Counsel, and medical personnel to collaboratively identify and assess risks.</li>
<li>Engage a risk management consultant with experience in the medical field to assist in developing the Risk Mitigation Protocol.</li>
<li>Develop a simplified 'minimum viable protocol' covering only the most critical risks initially, with plans to expand it over time.</li>
</ul>
<h2>Create Document 6: Ethical Oversight Strategy</h2>
<p><strong>ID</strong>: 9c41f3ae-6aac-49a4-b1be-3862a1447ffc</p>
<p><strong>Description</strong>: A framework for addressing the complex moral implications of face transplantation. It controls the ethical review process, patient autonomy, and public perception. The objective is to ensure responsible innovation and maintain public trust. Key success metrics include patient satisfaction, ethical compliance, and positive media coverage. This lever guides the organization's ethical decision-making and promotes transparency.</p>
<p><strong>Responsible Role Type</strong>: Ethics Review Board Coordinator</p>
<p><strong>Primary Template</strong>: Ethical Framework Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Establish an ethics review board.</li>
<li>Develop ethical guidelines for patient selection, consent, and data handling.</li>
<li>Establish a process for reviewing and addressing ethical concerns.</li>
<li>Identify key performance indicators (KPIs) for measuring ethical compliance.</li>
<li>Establish a process for reviewing and updating the Ethical Oversight Strategy.</li>
</ul>
<p><strong>Approval Authorities</strong>: Ethics Review Board, Legal Counsel</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>Define the specific ethical principles that will guide the face transplantation facility's operations.</li>
<li>Detail the process for obtaining informed consent from both face donors and recipients, including addressing potential coercion or exploitation.</li>
<li>Describe the composition and responsibilities of the internal ethics review board.</li>
<li>Outline the criteria for patient selection, ensuring equitable access and minimizing potential biases.</li>
<li>Define the procedures for addressing ethical dilemmas that may arise during the transplantation process.</li>
<li>Establish guidelines for managing conflicts of interest among medical personnel, ethicists, and stakeholders.</li>
<li>Detail the plan for ongoing monitoring and evaluation of the ethical oversight strategy's effectiveness.</li>
<li>Specify how patient autonomy will be protected throughout the entire process.</li>
<li>Describe the communication strategy for addressing public concerns and promoting transparency.</li>
<li>Outline the process for handling sensitive data related to patients and donors, ensuring compliance with privacy regulations.</li>
<li>What are the key performance indicators (KPIs) for measuring the effectiveness of the Ethical Oversight Strategy?</li>
<li>What are the potential sources of ethical conflict, and how will they be resolved?</li>
<li>What training will be provided to staff on ethical considerations and best practices?</li>
<li>Based on the 'Pioneer's Gambit' scenario, how will the DAO govern ethical decisions, and what are the voting mechanisms?</li>
<li>How will the strategy address the potential for commodification of faces within the subscription model?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Loss of public trust due to ethical breaches or perceived lack of transparency.</li>
<li>Regulatory scrutiny and potential legal challenges.</li>
<li>Damage to the organization's reputation, leading to reduced patient enrollment and investor confidence.</li>
<li>Increased risk of patient dissatisfaction and ethical complaints.</li>
<li>Failure to adequately address the psychological impact on recipients and donor families.</li>
<li>Compromised patient safety and well-being.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: Complete loss of public trust, leading to regulatory intervention, legal action, and the shutdown of the face transplantation facility due to ethical violations and safety concerns.</p>
<p><strong>Best Case Scenario</strong>: Establishes a robust and transparent ethical framework that fosters public trust, attracts patients and investors, and ensures the long-term sustainability of the face transplantation facility, while also setting a new standard for ethical practices in the field of medical innovation. Enables proactive management of ethical risks and facilitates smooth regulatory approvals.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize a pre-existing ethical framework from a similar medical facility and adapt it to the specific context of face transplantation.</li>
<li>Engage a panel of external bioethicists to provide guidance and oversight on ethical issues.</li>
<li>Conduct a series of workshops with stakeholders to collaboratively develop ethical guidelines.</li>
<li>Develop a simplified 'minimum viable ethics framework' focusing on the most critical ethical considerations initially, with plans to expand it over time.</li>
<li>Focus on compliance with existing regulations and ethical guidelines, rather than developing a completely novel strategy.</li>
</ul>
<h2>Create Document 7: Regulatory Approval Strategy</h2>
<p><strong>ID</strong>: 321dec0a-4aab-4bde-b9bf-5acef5ba33b0</p>
<p><strong>Description</strong>: A strategy defining the approach to obtaining necessary approvals from regulatory bodies. It controls compliance efforts, engagement with regulators, and jurisdictional selection. The objective is to secure the legal right to operate the face transplantation facility. Key success metrics include the speed and success rate of regulatory applications. This lever determines the organization's ability to legally offer its services.</p>
<p><strong>Responsible Role Type</strong>: Regulatory Affairs Manager</p>
<p><strong>Primary Template</strong>: Regulatory Compliance Plan Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Identify all necessary regulatory approvals.</li>
<li>Develop a plan for engaging with regulatory bodies.</li>
<li>Prepare documentation for regulatory applications.</li>
<li>Monitor the progress of regulatory applications.</li>
<li>Establish a process for reviewing and updating the Regulatory Approval Strategy.</li>
</ul>
<p><strong>Approval Authorities</strong>: Legal Counsel, CEO</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What specific regulatory bodies (e.g., Ministry of Health, Medsafe) are relevant in New Zealand for face transplantation and subscription-based medical services?</li>
<li>Detail the specific permits and licenses required to operate a face transplantation facility in New Zealand, including surgical procedure permits, data privacy compliance, and ethical approval.</li>
<li>What are the key compliance standards and guidelines from the New Zealand Ministry of Health, Medsafe, and relevant ethics committees?</li>
<li>Outline a step-by-step process for applying for the necessary permits and licenses, including timelines and required documentation.</li>
<li>Define the criteria for selecting a jurisdiction (Auckland, Christchurch, Wellington, or other) based on regulatory permissiveness and ethical considerations.</li>
<li>What are the potential legal and ethical risks associated with each strategic choice (Proactive Compliance, Adaptive Engagement, Jurisdictional Arbitrage)?</li>
<li>Detail the process for engaging with regulatory bodies, including communication protocols, meeting schedules, and reporting requirements.</li>
<li>What are the key performance indicators (KPIs) for measuring the success of the Regulatory Approval Strategy (e.g., speed of approval, success rate of applications)?</li>
<li>Identify potential conflicts between the Regulatory Approval Strategy and other strategic decisions, such as the Ethical Oversight Strategy and Risk Mitigation Protocol.</li>
<li>What are the specific requirements for data privacy compliance, including data encryption, access controls, and data breach response plans?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to obtain necessary regulatory approvals leads to project delays, increased costs, and potential legal challenges.</li>
<li>An inadequate Regulatory Approval Strategy results in fines, legal liabilities, and reputational damage.</li>
<li>Lack of compliance with data privacy regulations leads to significant financial penalties and loss of public trust.</li>
<li>Poor engagement with regulatory bodies results in misunderstandings, delays, and potential denial of permits.</li>
<li>Choosing a jurisdiction with lower ethical standards compromises the organization's ethical standing and public perception.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The organization fails to obtain the necessary regulatory approvals, resulting in a complete shutdown of the face transplantation facility and significant financial losses.</p>
<p><strong>Best Case Scenario</strong>: The organization secures all necessary regulatory approvals quickly and efficiently, enabling the facility to operate legally and ethically, attracting investors and building public trust. This enables a faster time to market and a competitive advantage.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a regulatory consultant or legal expert specializing in medical device regulations in New Zealand.</li>
<li>Develop a phased approach to regulatory approval, starting with less complex procedures and gradually expanding to more advanced techniques.</li>
<li>Focus on proactive compliance with existing regulations, rather than pursuing jurisdictional arbitrage.</li>
<li>Conduct a thorough risk assessment to identify potential regulatory hurdles and develop mitigation strategies.</li>
<li>Utilize a pre-existing regulatory compliance plan template and adapt it to the specific requirements of the face transplantation facility.</li>
</ul>
<h2>Create Document 8: Technological Development Approach</h2>
<p><strong>ID</strong>: bd5041f8-c700-46f6-bc69-e90d3ebb80de</p>
<p><strong>Description</strong>: A strategy dictating the approach for advancing the face transplantation technology. It controls the level of investment and focus on different technological areas, ranging from incremental improvements to radical disruptions. The objective is to improve transplant outcomes, reduce risks, and potentially overcome limitations like donor scarcity. Success is measured by improvements in surgical techniques, reduced rejection rates, and the successful integration of new technologies.</p>
<p><strong>Responsible Role Type</strong>: Chief Technology Officer</p>
<p><strong>Primary Template</strong>: Technology Roadmap Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Assess current technological capabilities.</li>
<li>Identify areas for technological improvement.</li>
<li>Develop a plan for investing in technological development.</li>
<li>Establish key performance indicators (KPIs) for measuring technological progress.</li>
<li>Establish a process for reviewing and updating the Technological Development Approach.</li>
</ul>
<p><strong>Approval Authorities</strong>: Technology Committee, CEO</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What specific technologies (e.g., tissue engineering, immunosuppression protocols, robotics, AI, CRISPR, xenotransplantation) will be prioritized for development and why?</li>
<li>What are the projected costs, timelines, and resource requirements for each prioritized technology?</li>
<li>What are the key performance indicators (KPIs) for measuring the success of technological development efforts (e.g., graft survival rates, rejection rates, surgical time, cost per procedure)?</li>
<li>What are the potential ethical and regulatory implications of each technology, and how will these be addressed?</li>
<li>What are the alternative technological approaches if the primary approach fails or encounters significant obstacles?</li>
<li>What are the specific risk mitigation strategies for each technology, addressing potential complications and safety concerns?</li>
<li>How will the Technological Development Approach integrate with the Risk Mitigation Protocol, Ethical Oversight Strategy, Regulatory Approval Strategy, and Operational Efficiency Strategy?</li>
<li>What are the criteria for determining when to shift from incremental improvements to more radical or disruptive technologies?</li>
<li>What are the specific data points needed to assess the current state of the technology and track progress (e.g., surgical outcomes, rejection rates, patient satisfaction scores)?</li>
<li>What are the potential sources of funding for technological development (e.g., grants, investors, internal budget)?</li>
<li>Detail the process for evaluating and selecting new technologies for potential integration into the face transplantation process.</li>
<li>What are the specific training requirements for medical personnel to implement new technologies?</li>
<li>What are the potential impacts of each technology on the patient experience and quality of life?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to identify and develop critical technologies, leading to suboptimal transplant outcomes and increased risks.</li>
<li>Inefficient allocation of resources, resulting in wasted investment and missed opportunities.</li>
<li>Ethical or regulatory violations due to the development of ethically questionable or non-compliant technologies.</li>
<li>Inability to compete with other medical facilities offering more advanced face transplantation services.</li>
<li>Delays in regulatory approval due to insufficient technological advancement or safety concerns.</li>
<li>Increased surgical complications and patient mortality due to inadequate technological development.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The facility fails to achieve acceptable transplant outcomes due to a lack of technological advancement, leading to patient deaths, legal liabilities, and the closure of the facility.</p>
<p><strong>Best Case Scenario</strong>: The Technological Development Approach leads to significant breakthroughs in face transplantation technology, resulting in improved graft survival rates, reduced rejection rates, and enhanced patient quality of life, enabling the facility to become a world leader in face transplantation and attract significant investment and recognition. Enables go/no-go decision on further investment in specific technologies.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Focus solely on incremental improvements to existing surgical techniques and immunosuppression protocols.</li>
<li>Partner with external research institutions or technology companies to leverage their expertise and resources.</li>
<li>Conduct a thorough review of existing literature and best practices in face transplantation to identify areas for improvement.</li>
<li>Develop a simplified 'minimum viable technology roadmap' focusing on the most critical technological needs initially.</li>
<li>Engage a technical consultant or subject matter expert to provide guidance on technological development strategies.</li>
</ul>
<h2>Create Document 9: Operational Efficiency Strategy</h2>
<p><strong>ID</strong>: ab583cb9-2d19-4e4a-a02a-e5a74c05531f</p>
<p><strong>Description</strong>: A strategy focusing on optimizing resource allocation and streamlining processes to minimize costs and maximize throughput. It controls administrative procedures, surgical techniques, and supply chain management. The objective is to achieve a cost-effective and efficient operation. Key success metrics include cost per procedure, surgical time, and patient turnover rate. This lever drives the organization's profitability and competitiveness.</p>
<p><strong>Responsible Role Type</strong>: Operations Manager</p>
<p><strong>Primary Template</strong>: Operational Efficiency Plan Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Assess current operational efficiency.</li>
<li>Identify areas for improvement.</li>
<li>Develop a plan for optimizing resource allocation and streamlining processes.</li>
<li>Establish key performance indicators (KPIs) for measuring operational efficiency.</li>
<li>Establish a process for reviewing and updating the Operational Efficiency Strategy.</li>
</ul>
<p><strong>Approval Authorities</strong>: Operations Committee, CFO</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What are the specific, measurable targets for cost per procedure, surgical time, and patient turnover rate?</li>
<li>Detail the administrative processes to be streamlined, including current bottlenecks and proposed solutions.</li>
<li>Quantify the potential cost savings and efficiency gains from each proposed process improvement.</li>
<li>List the specific surgical techniques to be optimized, including current methods and proposed modifications.</li>
<li>Describe the supply chain management strategies to be implemented, including vendor selection, inventory control, and logistics optimization.</li>
<li>What are the resource allocation strategies to be implemented, including staffing levels, equipment utilization, and facility layout?</li>
<li>Identify potential risks associated with each proposed efficiency improvement, including impacts on patient safety and ethical considerations.</li>
<li>Detail the metrics and reporting mechanisms to track the effectiveness of the Operational Efficiency Strategy.</li>
<li>Requires access to current operational cost data, surgical procedure times, patient turnover rates, and supply chain costs.</li>
<li>Requires input from surgeons, nurses, administrative staff, and supply chain managers.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to achieve cost-effective operations, leading to reduced profitability and limited scalability.</li>
<li>Compromised patient safety due to rushed procedures or inadequate resource allocation.</li>
<li>Ethical concerns arising from prioritizing efficiency over patient well-being.</li>
<li>Inability to compete with other medical facilities due to higher costs or lower throughput.</li>
<li>Reduced employee morale and job satisfaction due to increased workload or pressure to cut corners.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The facility becomes financially unsustainable due to high operating costs and low throughput, leading to closure and loss of investment. Patient safety is compromised, resulting in legal liabilities and reputational damage.</p>
<p><strong>Best Case Scenario</strong>: The facility achieves significant cost savings and efficiency gains, enabling it to scale operations, attract more patients, and generate substantial revenue. Patient safety and ethical considerations are maintained, enhancing the facility's reputation and attracting top talent. Enables decisions on resource allocation and investment in new technologies.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Utilize a pre-approved operational efficiency plan template and adapt it to the specific context of the face transplantation facility.</li>
<li>Schedule a focused workshop with operations staff, surgeons, and administrators to collaboratively identify and prioritize efficiency improvements.</li>
<li>Engage a consultant specializing in healthcare operations to conduct an efficiency audit and recommend improvements.</li>
<li>Develop a simplified 'minimum viable strategy' focusing on the most critical areas for improvement, such as supply chain management and administrative processes.</li>
</ul>
<h2>Create Document 10: Donor Face Acquisition and Preservation Plan</h2>
<p><strong>ID</strong>: 3af44de7-707e-41c6-96a5-0625a573b76a</p>
<p><strong>Description</strong>: A detailed plan for acquiring and preserving donor faces, including partnerships with organ donation organizations, ethical consent protocols, detailed transportation logistics, advanced preservation techniques, and a robust inventory management system. This plan is crucial for ensuring a steady supply of faces, impacting operational capacity and financial viability.</p>
<p><strong>Responsible Role Type</strong>: Donor Relations &amp; Acquisition Specialist</p>
<p><strong>Primary Template</strong>: Organ Procurement Protocol Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Establish partnerships with organ donation organizations, hospitals, and mortuaries.</li>
<li>Develop ethical consent protocols for face donation.</li>
<li>Develop a detailed transportation plan for rapid and secure transfer of donor faces.</li>
<li>Invest in advanced preservation techniques.</li>
<li>Implement a robust inventory management system.</li>
</ul>
<p><strong>Approval Authorities</strong>: Head of Operations, Ethics Review Board</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>Identify and list potential partner organizations (organ donation organizations, hospitals, mortuaries) in New Zealand and internationally.</li>
<li>Define the legal and ethical requirements for obtaining consent for face donation in New Zealand, including specific documentation and processes.</li>
<li>Detail the logistical steps for transporting donor faces from the point of donation to the facility, including transportation methods, timing, and required permits.</li>
<li>Research and compare different face preservation techniques (e.g., cryopreservation, perfusion) and recommend the most suitable method based on cost, effectiveness, and feasibility.</li>
<li>Design an inventory management system for tracking donor faces, including data points such as donor characteristics, preservation status, and expiration dates.</li>
<li>Outline the criteria for accepting or rejecting donor faces based on factors such as age, health, and tissue compatibility.</li>
<li>Develop a budget for the acquisition and preservation plan, including costs for partnerships, transportation, preservation equipment, and personnel.</li>
<li>Define key performance indicators (KPIs) for measuring the success of the donor face acquisition and preservation plan (e.g., number of faces acquired per month, wastage rate).</li>
<li>Detail the process for ensuring compliance with all relevant regulations and ethical guidelines throughout the acquisition and preservation process.</li>
<li>Address the integration of the plan with the Ethical Oversight Strategy and Risk Mitigation Protocol.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Inadequate donor face supply leads to underutilization of the facility and reduced revenue.</li>
<li>Ethical breaches in the acquisition process result in public outcry and legal challenges.</li>
<li>Poor preservation techniques lead to unusable donor faces and wasted resources.</li>
<li>Inefficient transportation logistics cause delays and damage to donor faces.</li>
<li>Lack of a robust inventory management system results in lost or misplaced donor faces.</li>
<li>Failure to meet demand for face transplants impacts the subscription model's viability.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The facility is unable to acquire a sufficient number of donor faces, leading to operational shutdown, financial losses, and reputational damage. Legal challenges arise due to unethical acquisition practices.</p>
<p><strong>Best Case Scenario</strong>: The facility establishes a reliable and ethical supply of high-quality donor faces, enabling it to meet demand, maintain high patient satisfaction, and achieve financial sustainability. The plan becomes a model for other transplant facilities.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Conduct a pilot program with a limited number of patients to assess the feasibility of the current acquisition methods.</li>
<li>Focus on acquiring donor faces from specific demographic groups with higher donation rates.</li>
<li>Explore the possibility of using 3D-printed faces as a temporary solution or for training purposes.</li>
<li>Partner with international organizations to import donor faces from regions with higher availability, ensuring compliance with all relevant regulations.</li>
<li>Develop a public awareness campaign to encourage face donation and increase the donor pool.</li>
</ul>
<h2>Create Document 11: Psychological Support Program</h2>
<p><strong>ID</strong>: 9bffb2cd-c33a-4f87-aecb-567718107a31</p>
<p><strong>Description</strong>: A comprehensive program addressing the mental health needs of face transplant recipients and donor families, including pre-transplant counseling, post-transplant therapy, donor family support, psychiatric assessments, ethical guidelines for managing psychological issues, and a supportive community for recipients and donor families.</p>
<p><strong>Responsible Role Type</strong>: Patient Liaison &amp; Psychological Support Coordinator</p>
<p><strong>Primary Template</strong>: Mental Health Support Program Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Engage with experienced psychologists and psychiatrists specializing in transplantation and identity issues.</li>
<li>Conduct a comprehensive literature review on the psychological impact of face transplantation.</li>
<li>Develop a detailed psychological support program.</li>
<li>Establish partnerships with mental health organizations and community support groups.</li>
<li>Collect and provide data on the proposed psychological support program.</li>
</ul>
<p><strong>Approval Authorities</strong>: Chief Medical Officer, Ethics Review Board</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>Define the specific psychological assessments to be used for pre- and post-transplant evaluations.</li>
<li>Detail the content and structure of pre-transplant counseling sessions for recipients, focusing on identity, expectations, and potential challenges.</li>
<li>Outline the therapeutic approaches to be used in post-transplant therapy, addressing body image, social integration, and emotional well-being.</li>
<li>Describe the bereavement counseling services offered to donor families, including individual and group therapy options.</li>
<li>Specify the criteria for psychiatric referrals and the process for managing mental health crises.</li>
<li>Define the ethical guidelines for addressing psychological issues, including informed consent, confidentiality, and managing unrealistic expectations.</li>
<li>Describe the structure and activities of the supportive community for recipients and donor families, including peer support groups and social events.</li>
<li>Quantify the resources required for the program, including staffing levels, therapist qualifications, and budget allocation.</li>
<li>Identify the key performance indicators (KPIs) for evaluating the program's effectiveness, such as patient satisfaction, mental health outcomes, and program participation rates.</li>
<li>Detail the process for obtaining informed consent from both recipients and donor families regarding participation in the psychological support program.</li>
<li>List the potential risks associated with the psychological support program, such as triggering emotional distress or violating confidentiality, and outline mitigation strategies.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Increased patient attrition due to unmet psychological needs.</li>
<li>Ethical breaches related to patient confidentiality or coercion.</li>
<li>Negative media coverage due to patient dissatisfaction or psychological distress.</li>
<li>Increased legal liabilities due to inadequate informed consent or duty of care.</li>
<li>Reduced subscription revenue due to patient attrition and negative reputation.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: Multiple face transplant recipients experience severe psychological distress, leading to suicide attempts, public outcry, legal action, and the shutdown of the face transplantation facility.</p>
<p><strong>Best Case Scenario</strong>: The Psychological Support Program effectively mitigates psychological distress, enhances patient well-being, fosters a supportive community, and contributes to the long-term success and ethical reputation of the face transplantation facility, enabling informed consent and ethical decision making.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Implement a basic psychological screening and referral process as a minimum viable program.</li>
<li>Contract with external mental health providers to offer limited counseling services.</li>
<li>Utilize existing mental health resources within the community to supplement the program.</li>
<li>Focus on providing informational resources and support groups rather than individual therapy.</li>
<li>Adapt a pre-existing psychological support program from a similar medical context (e.g., organ transplantation) and tailor it to face transplantation.</li>
</ul>
<h2>Create Document 12: Data Privacy and Security Plan</h2>
<p><strong>ID</strong>: f59b3798-5003-496e-94df-f54fc553ea21</p>
<p><strong>Description</strong>: A comprehensive plan for protecting patient data and complying with regulations, including a compliance assessment of applicable data privacy regulations, data encryption techniques, strict access controls, a data breach response plan, regular security audits, and comprehensive employee training.</p>
<p><strong>Responsible Role Type</strong>: Data Security &amp; Privacy Officer</p>
<p><strong>Primary Template</strong>: Data Security Plan Template</p>
<p><strong>Secondary Template</strong>: None</p>
<p><strong>Steps to Create</strong>:</p>
<ul>
<li>Conduct a thorough assessment of all applicable data privacy regulations.</li>
<li>Implement robust data encryption techniques.</li>
<li>Implement strict access controls.</li>
<li>Develop a detailed data breach response plan.</li>
<li>Conduct regular security audits.</li>
</ul>
<p><strong>Approval Authorities</strong>: Chief Technology Officer, Legal Counsel</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What specific data privacy regulations (e.g., GDPR, HIPAA, New Zealand Privacy Act) apply to the face transplantation facility and its subscription model?</li>
<li>Detail the data encryption methods to be used for storing and transmitting patient data, including donor information and subscription details.</li>
<li>Define the access control policies and procedures for limiting access to sensitive data based on roles and responsibilities.</li>
<li>Outline the step-by-step procedures for responding to a data breach, including notification protocols, containment strategies, and recovery plans.</li>
<li>Describe the frequency and scope of security audits to be conducted, including internal and external audits.</li>
<li>What specific training modules will be provided to employees on data privacy and security best practices, and how often will this training be updated?</li>
<li>How will patient consent be obtained and managed regarding the collection, use, and sharing of their data?</li>
<li>What are the procedures for securely disposing of patient data when it is no longer needed?</li>
<li>How will the facility ensure compliance with international data transfer regulations if data is transferred outside of New Zealand?</li>
<li>Detail the process for handling patient requests to access, correct, or delete their personal data.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to comply with data privacy regulations results in significant fines and legal liabilities.</li>
<li>Compromised patient data leads to reputational damage and loss of public trust.</li>
<li>Inadequate data security measures result in data breaches and unauthorized access to sensitive information.</li>
<li>Lack of a data breach response plan causes delays in addressing security incidents, exacerbating the damage.</li>
<li>Insufficient employee training leads to unintentional data breaches and security vulnerabilities.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: A major data breach exposes sensitive patient information, including donor details and medical records, leading to significant financial losses, legal action, loss of operating licenses, and complete collapse of the project due to reputational damage and lack of public trust.</p>
<p><strong>Best Case Scenario</strong>: The Data Privacy and Security Plan ensures full compliance with all applicable regulations, protects patient data, and builds trust with stakeholders, leading to smooth regulatory approvals, positive public perception, and a sustainable business model. It enables secure data sharing for research and development, improving transplant outcomes and attracting further investment.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a specialized data privacy consulting firm to conduct a comprehensive assessment and develop the plan.</li>
<li>Utilize a pre-approved data privacy and security framework (e.g., ISO 27001, NIST Cybersecurity Framework) as a template.</li>
<li>Conduct a series of workshops with key stakeholders (IT, legal, medical staff) to collaboratively define the plan's requirements.</li>
<li>Develop a 'minimum viable plan' focusing on the most critical data privacy and security elements initially, with plans to expand it later.</li>
</ul>
<h1>Documents to Find</h1>
<h2>Find Document 1: New Zealand Ministry of Health Regulations</h2>
<p><strong>ID</strong>: 27d85bbf-7f94-4fed-8260-50c1b2dbd29d</p>
<p><strong>Description</strong>: Regulations and guidelines issued by the New Zealand Ministry of Health pertaining to medical facilities, surgical procedures, and patient care. These regulations are crucial for ensuring compliance and obtaining necessary approvals for the face transplantation facility. Intended audience: Regulatory Affairs Manager, Legal Counsel.</p>
<p><strong>Recency Requirement</strong>: Current regulations essential</p>
<p><strong>Responsible Role Type</strong>: Regulatory Affairs Manager</p>
<p><strong>Steps to Find</strong>:</p>
<ul>
<li>Search the New Zealand Ministry of Health website.</li>
<li>Contact the Ministry of Health directly.</li>
<li>Consult with legal experts specializing in healthcare regulations.</li>
</ul>
<p><strong>Access Difficulty</strong>: Medium: Requires navigating government websites and potentially contacting the Ministry of Health directly.</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>List all applicable regulations pertaining to medical facilities offering surgical procedures in New Zealand.</li>
<li>Detail the specific requirements for obtaining a medical facility license in New Zealand.</li>
<li>Identify regulations related to surgical procedures, including consent, patient safety, and post-operative care.</li>
<li>Outline regulations concerning data privacy and security for patient information.</li>
<li>Specify any regulations related to the ethical considerations of medical research and procedures.</li>
<li>What are the exact requirements for handling and disposal of biological waste, including human tissue?</li>
<li>What are the reporting requirements for adverse events or complications arising from surgical procedures?</li>
<li>Detail the regulations regarding the use of medical devices and equipment in surgical procedures.</li>
<li>What are the specific requirements for informed consent in the context of experimental medical procedures?</li>
<li>Identify any regulations related to the transportation and storage of human tissue for transplantation.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to comply with regulations can result in legal penalties, fines, and potential closure of the facility.</li>
<li>Inaccurate or outdated information can lead to non-compliance, jeopardizing the project's legality and reputation.</li>
<li>Misinterpretation of regulations can lead to incorrect implementation of procedures, endangering patient safety.</li>
<li>Incomplete understanding of regulations can result in delays in obtaining necessary approvals and licenses.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The facility is shut down due to non-compliance with New Zealand Ministry of Health regulations, resulting in significant financial losses, reputational damage, and legal liabilities.</p>
<p><strong>Best Case Scenario</strong>: The facility operates smoothly and efficiently, fully compliant with all relevant regulations, ensuring patient safety, ethical practices, and a positive reputation, leading to increased investor confidence and market adoption.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a legal expert specializing in New Zealand healthcare regulations to provide guidance and interpretation.</li>
<li>Contact the New Zealand Ministry of Health directly to request clarification on specific regulations.</li>
<li>Purchase a subscription to a regulatory database that provides up-to-date information on New Zealand healthcare regulations.</li>
<li>Conduct a comprehensive audit of the facility's procedures and practices to identify potential compliance gaps.</li>
</ul>
<h2>Find Document 2: New Zealand Medsafe Guidelines</h2>
<p><strong>ID</strong>: e6b9856b-c756-4eca-8537-9a88d4894812</p>
<p><strong>Description</strong>: Guidelines issued by Medsafe, the New Zealand Medicines and Medical Devices Safety Authority, pertaining to medical devices and surgical procedures. These guidelines are crucial for ensuring compliance and obtaining necessary approvals for the face transplantation facility. Intended audience: Regulatory Affairs Manager, Legal Counsel.</p>
<p><strong>Recency Requirement</strong>: Current guidelines essential</p>
<p><strong>Responsible Role Type</strong>: Regulatory Affairs Manager</p>
<p><strong>Steps to Find</strong>:</p>
<ul>
<li>Search the Medsafe website.</li>
<li>Contact Medsafe directly.</li>
<li>Consult with legal experts specializing in healthcare regulations.</li>
</ul>
<p><strong>Access Difficulty</strong>: Medium: Requires navigating government websites and potentially contacting Medsafe directly.</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What are the specific requirements for medical device registration and approval in New Zealand, as outlined by Medsafe?</li>
<li>What are the current Medsafe guidelines regarding surgical procedures involving human tissue transplantation?</li>
<li>What are the reporting requirements for adverse events or complications related to medical devices or surgical procedures?</li>
<li>What are the specific labeling and packaging requirements for medical devices used in the face transplantation facility?</li>
<li>What are the inspection and audit procedures conducted by Medsafe to ensure compliance with regulations?</li>
<li>What are the permissible levels of risk associated with novel medical procedures, and how are these risks assessed and managed according to Medsafe guidelines?</li>
<li>What are the requirements for obtaining ethical approval for clinical trials or research involving medical devices or surgical procedures?</li>
<li>What are the data privacy and security requirements for handling patient information, as outlined by Medsafe and related New Zealand legislation?</li>
<li>List the specific forms and documentation required for submitting applications for medical device approval or surgical procedure permits.</li>
<li>Identify any recent updates or changes to Medsafe guidelines that may impact the face transplantation facility's operations.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to comply with Medsafe guidelines can result in delays in obtaining necessary approvals and licenses.</li>
<li>Non-compliance can lead to fines, legal challenges, and potential shutdown of the face transplantation facility.</li>
<li>Inaccurate or outdated information can compromise patient safety and lead to adverse events.</li>
<li>Incorrect labeling or packaging of medical devices can result in product recalls and reputational damage.</li>
<li>Lack of understanding of reporting requirements can lead to penalties and legal liabilities.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The facility is denied necessary permits and licenses due to non-compliance with Medsafe guidelines, resulting in significant financial losses, legal battles, and project abandonment.</p>
<p><strong>Best Case Scenario</strong>: The facility secures all necessary approvals and licenses quickly and efficiently by demonstrating full compliance with Medsafe guidelines, enabling timely launch of operations and establishing a reputation for safety and ethical practices.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a regulatory consultant specializing in New Zealand medical device regulations to provide expert guidance.</li>
<li>Contact other medical facilities in New Zealand that have experience with similar procedures to learn from their regulatory approval processes.</li>
<li>Purchase a subscription to a regulatory intelligence service that provides up-to-date information on Medsafe guidelines and changes.</li>
<li>Conduct a gap analysis to identify areas where the facility's practices do not align with Medsafe guidelines and develop a remediation plan.</li>
<li>Establish a direct line of communication with Medsafe to ask clarifying questions and seek guidance on specific regulatory issues.</li>
</ul>
<h2>Find Document 3: New Zealand Organ Donation and Transplantation Policies</h2>
<p><strong>ID</strong>: bf18d8d3-cc21-4aca-b1af-9103aed4faab</p>
<p><strong>Description</strong>: Policies and guidelines related to organ donation and transplantation in New Zealand, including consent protocols, ethical considerations, and logistical requirements. These policies are crucial for developing a robust and ethical donor face acquisition plan. Intended audience: Donor Relations &amp; Acquisition Specialist, Ethics Review Board Coordinator.</p>
<p><strong>Recency Requirement</strong>: Current policies essential</p>
<p><strong>Responsible Role Type</strong>: Donor Relations &amp; Acquisition Specialist</p>
<p><strong>Steps to Find</strong>:</p>
<ul>
<li>Search the New Zealand Organ Donation Service website.</li>
<li>Contact the New Zealand Organ Donation Service directly.</li>
<li>Consult with ethicists specializing in organ donation.</li>
</ul>
<p><strong>Access Difficulty</strong>: Medium: Requires navigating government websites and potentially contacting the Organ Donation Service directly.</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What are the specific legal requirements for obtaining consent for face donation in New Zealand?</li>
<li>Detail the current national guidelines for organ and tissue donation and transplantation in New Zealand.</li>
<li>What are the established protocols for the transportation and preservation of donated organs and tissues within New Zealand?</li>
<li>Identify any specific regulations or restrictions related to face transplantation in New Zealand.</li>
<li>List the ethical considerations and guidelines that must be adhered to when acquiring and using donor faces in New Zealand.</li>
<li>What are the data privacy regulations related to donor and recipient information in the context of organ transplantation in New Zealand?</li>
<li>Detail the process for registering as an approved transplantation facility in New Zealand.</li>
<li>What are the reporting requirements for transplantation procedures to the Ministry of Health in New Zealand?</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to comply with consent requirements leads to legal challenges and ethical breaches.</li>
<li>Incorrect transportation protocols result in unusable donor faces and operational delays.</li>
<li>Misinterpretation of ethical guidelines leads to public outcry and reputational damage.</li>
<li>Non-compliance with data privacy regulations results in significant fines and legal liabilities.</li>
<li>Inability to meet regulatory requirements delays facility licensing and operational commencement.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The facility is shut down due to non-compliance with New Zealand organ donation and transplantation policies, resulting in significant financial losses, reputational damage, and legal liabilities.</p>
<p><strong>Best Case Scenario</strong>: The facility operates smoothly and ethically, with a reliable supply of donor faces, full regulatory compliance, and strong public trust, leading to high subscription rates and long-term sustainability.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a New Zealand-based legal expert specializing in organ donation and transplantation to provide guidance.</li>
<li>Consult with the New Zealand Ministry of Health directly to clarify any ambiguities in the policies.</li>
<li>Review case studies of other successful transplantation facilities in New Zealand to identify best practices.</li>
<li>Conduct targeted interviews with organ donation coordinators in New Zealand to understand practical challenges and solutions.</li>
</ul>
<h2>Find Document 4: New Zealand Data Privacy Laws and Regulations</h2>
<p><strong>ID</strong>: 503245df-a067-41ca-9952-c439c53016fe</p>
<p><strong>Description</strong>: Laws and regulations related to data privacy in New Zealand, including the Health Information Privacy Code and the Privacy Act. These laws are crucial for ensuring compliance and protecting patient data. Intended audience: Data Security &amp; Privacy Officer, Legal Counsel.</p>
<p><strong>Recency Requirement</strong>: Current laws and regulations essential</p>
<p><strong>Responsible Role Type</strong>: Data Security &amp; Privacy Officer</p>
<p><strong>Steps to Find</strong>:</p>
<ul>
<li>Search the New Zealand Privacy Commissioner website.</li>
<li>Consult with legal experts specializing in data privacy law.</li>
<li>Review relevant legislation and case law.</li>
</ul>
<p><strong>Access Difficulty</strong>: Medium: Requires navigating government websites and consulting legal resources.</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>List all relevant New Zealand data privacy laws and regulations applicable to a medical facility handling sensitive patient data, including but not limited to the Health Information Privacy Code 1994 and the Privacy Act 2020.</li>
<li>Detail the specific requirements for obtaining, storing, processing, and sharing patient data under these laws.</li>
<li>Identify the penalties for non-compliance with each relevant law or regulation, including potential fines, legal actions, and reputational damage.</li>
<li>Outline the rights of patients regarding their personal data, including the right to access, correct, and delete their data.</li>
<li>Describe the requirements for data breach notification, including the timeline for reporting breaches and the information that must be included in the notification.</li>
<li>Detail any specific requirements for handling genetic information or other particularly sensitive data.</li>
<li>Provide a checklist of actions required to ensure compliance with New Zealand data privacy laws and regulations in the context of a face transplantation facility with a subscription model.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to comply with data privacy laws can result in significant fines and legal penalties.</li>
<li>Inadequate data protection can lead to data breaches, compromising patient confidentiality and trust.</li>
<li>Non-compliance can result in reputational damage, impacting the facility's ability to attract patients and investors.</li>
<li>Legal challenges and lawsuits can arise from privacy violations, leading to financial losses and operational disruptions.</li>
<li>Inability to secure necessary regulatory approvals due to inadequate data privacy measures.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: A major data breach exposes sensitive patient information, leading to significant fines, legal action, loss of patient trust, and potential shutdown of the facility due to regulatory non-compliance and reputational damage.</p>
<p><strong>Best Case Scenario</strong>: The facility operates with full compliance with all relevant data privacy laws, ensuring patient trust, avoiding legal penalties, and establishing a reputation as a responsible and ethical medical provider, attracting a large and loyal subscriber base.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a New Zealand-based legal firm specializing in data privacy law to conduct a comprehensive compliance audit and provide ongoing legal advice.</li>
<li>Purchase a subscription to a legal database that provides up-to-date information on New Zealand data privacy laws and regulations.</li>
<li>Consult with a data privacy consultant with experience in the healthcare sector to develop and implement a data privacy compliance program.</li>
<li>Adapt data privacy policies and procedures from similar medical facilities in New Zealand, ensuring they are tailored to the specific needs of the face transplantation facility.</li>
</ul>
<h2>Find Document 5: New Zealand Ethical Guidelines for Medical Research</h2>
<p><strong>ID</strong>: 9d4a70e0-43d5-4d1b-aa3a-c9366bc6ae2b</p>
<p><strong>Description</strong>: Ethical guidelines for medical research in New Zealand, including guidelines for informed consent, patient autonomy, and data handling. These guidelines are crucial for ensuring ethical conduct and protecting patient rights. Intended audience: Ethics Review Board Coordinator, Chief Medical Officer.</p>
<p><strong>Recency Requirement</strong>: Current guidelines essential</p>
<p><strong>Responsible Role Type</strong>: Ethics Review Board Coordinator</p>
<p><strong>Steps to Find</strong>:</p>
<ul>
<li>Search the New Zealand Ministry of Health website.</li>
<li>Consult with ethicists specializing in medical research.</li>
<li>Review relevant ethical codes and guidelines.</li>
</ul>
<p><strong>Access Difficulty</strong>: Medium: Requires navigating government websites and consulting ethical resources.</p>
<p><strong>Essential Information</strong>:</p>
<ul>
<li>What are the specific requirements for informed consent in medical research involving human subjects, as defined by New Zealand ethical guidelines?</li>
<li>What are the current regulations regarding patient autonomy and decision-making capacity in medical procedures?</li>
<li>Detail the data handling and privacy requirements for medical research data, including storage, access, and sharing protocols.</li>
<li>List the composition and responsibilities of ethics review boards (ERBs) in New Zealand, including their authority and scope of review.</li>
<li>Identify any specific ethical considerations or guidelines related to novel medical procedures like face transplantation.</li>
<li>What are the processes for reporting and addressing ethical breaches or violations in medical research?</li>
<li>Provide a checklist of key ethical considerations that must be addressed in the project's research protocols.</li>
</ul>
<p><strong>Risks of Poor Quality</strong>:</p>
<ul>
<li>Failure to adhere to ethical guidelines can result in legal challenges and fines.</li>
<li>Compromised patient autonomy can lead to ethical breaches and public outcry.</li>
<li>Inadequate data handling practices can result in data breaches and privacy violations.</li>
<li>Lack of ethical oversight can lead to flawed research and compromised patient safety.</li>
<li>Misinterpretation of ethical guidelines can lead to project delays and rework.</li>
</ul>
<p><strong>Worst Case Scenario</strong>: The project is shut down due to ethical violations, resulting in significant financial losses, reputational damage, and legal liabilities.</p>
<p><strong>Best Case Scenario</strong>: The project is recognized as a leader in ethical medical innovation, attracting top talent, securing regulatory approvals, and building public trust.</p>
<p><strong>Fallback Alternative Approaches</strong>:</p>
<ul>
<li>Engage a New Zealand-based bioethics consultant to provide expert guidance on ethical compliance.</li>
<li>Conduct a comprehensive review of existing literature on ethical considerations in face transplantation.</li>
<li>Adapt international ethical guidelines (e.g., from the World Medical Association) to the New Zealand context, with expert review.</li>
<li>Contact the New Zealand Ministry of Health directly for clarification on specific ethical requirements.</li>
</ul>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">SWOT Analysis</button>
                <div class="content">        
                    <h2>Strengths 👍💪🦾</h2>
<ul>
<li>Novelty of the subscription-based face transplantation service offers a unique market position.</li>
<li>Potential for high revenue generation from a niche market.</li>
<li>Alignment with the 'Pioneer's Gambit' strategic scenario, fostering innovation and risk-taking.</li>
<li>Strong focus on technological advancement, particularly in surgical techniques and immunosuppression protocols.</li>
<li>Commitment to ethical oversight through a decentralized autonomous organization (DAO).</li>
</ul>
<h2>Weaknesses 👎😱🪫⚠️</h2>
<ul>
<li>High ethical concerns surrounding face transplantation and the subscription model.</li>
<li>Significant regulatory hurdles and uncertainties in obtaining necessary approvals.</li>
<li>Complex surgical procedures with potential for complications and rejection.</li>
<li>Financial viability is uncertain due to high costs and novelty.</li>
<li>Lack of a detailed donor face acquisition and preservation plan.</li>
<li>Overlooks the long-term psychological impact on recipients and 'donors'.</li>
<li>Insufficient detail regarding data privacy and security.</li>
<li>Reliance on radical technological development (CRISPR, xenotransplantation) which carries high technical and ethical risk.</li>
<li>Potential for public outcry and negative media coverage.</li>
<li>Absence of a 'killer application' or immediately compelling use-case to drive initial adoption beyond novelty or extreme cases.</li>
</ul>
<h2>Opportunities 🌈🌐</h2>
<ul>
<li>Advancements in surgical techniques and immunosuppression protocols could improve transplant outcomes.</li>
<li>Partnerships with organ donation organizations could secure a steady supply of donor faces.</li>
<li>Public awareness campaigns could increase social acceptance of face transplantation.</li>
<li>Technological advancements like robotic surgery and AI-powered diagnostics could improve efficiency and scalability.</li>
<li>Jurisdictional arbitrage by establishing operations in regions with more permissive regulations.</li>
<li>Development of a 'killer application': Identifying a specific, compelling use-case (e.g., reconstructive surgery for severe trauma victims, correcting congenital deformities) could drive initial adoption and demonstrate the value of the technology, paving the way for broader applications.</li>
</ul>
<h2>Threats ☠️🛑🚨☢︎💩☣︎</h2>
<ul>
<li>Regulatory delays or denial could significantly impact project timelines and costs.</li>
<li>Ethical concerns could lead to public opposition and legal challenges.</li>
<li>Surgical complications and rejection could result in patient mortality and legal liabilities.</li>
<li>Financial instability could lead to project shutdown and loss of investor confidence.</li>
<li>Social acceptance is not guaranteed, potentially leading to low adoption rates.</li>
<li>Competition from existing medical facilities offering alternative treatments.</li>
<li>Data breaches and privacy violations could result in significant fines and reputational damage.</li>
<li>Unforeseen technological failures or long-term health consequences.</li>
<li>Potential for international regulatory conflicts.</li>
</ul>
<h2>Recommendations 💡✅</h2>
<ul>
<li>Develop and implement a comprehensive Donor Face Acquisition and Preservation Plan by 2026-06-30, led by the Head of Operations, to secure partnerships with organ donation organizations and establish ethical consent protocols.</li>
<li>Establish a comprehensive Psychological Support Program by 2026-07-31, overseen by the Chief Medical Officer, to provide pre- and post-transplant counseling for recipients and donor families.</li>
<li>Develop a comprehensive Data Privacy and Security Plan by 2026-08-31, led by the Chief Technology Officer, to ensure compliance with data privacy regulations and implement robust data encryption techniques.</li>
<li>Identify and develop a 'killer application' use-case by 2026-05-31, led by the Chief Marketing Officer, focusing on a specific, compelling need that can drive initial adoption and demonstrate the value of the technology (e.g., reconstructive surgery for severe trauma victims).</li>
<li>Engage proactively with regulatory bodies (Ministry of Health, Medsafe) by 2026-03-31, led by the Regulatory Affairs Manager, to navigate the complex approval landscape and mitigate potential delays.</li>
</ul>
<h2>Strategic Objectives 🎯🔭⛳🏅</h2>
<ul>
<li>Secure regulatory approval from the New Zealand Ministry of Health and Medsafe by 2027-02-18.</li>
<li>Establish partnerships with at least three organ donation organizations by 2026-04-01 to ensure a consistent supply of donor faces.</li>
<li>Recruit and train a team of five qualified surgeons, ten nurses, and five technicians by 2026-05-01.</li>
<li>Achieve a patient satisfaction rate of at least 80% within the first year of operation, measured through post-operative surveys.</li>
<li>Secure $50 million USD in funding by 2026-06-30 to cover facility construction, staffing, and regulatory compliance costs.</li>
</ul>
<h2>Assumptions 🤔🧠🔍</h2>
<ul>
<li>Regulatory approval can be obtained within 12 months.</li>
<li>Sufficient donor faces will be available through partnerships with organ donation organizations.</li>
<li>Qualified medical personnel can be recruited and trained within the specified timeline and budget.</li>
<li>Patients will be willing to undergo face transplantation and participate in the subscription model.</li>
<li>The technology will continue to advance, improving transplant outcomes and reducing risks.</li>
</ul>
<h2>Missing Information 🧩🤷‍♂️🤷‍♀️</h2>
<ul>
<li>Detailed market research on the potential demand for face transplantation and the subscription model.</li>
<li>Specific regulatory requirements and timelines for obtaining necessary approvals in New Zealand.</li>
<li>Comprehensive cost analysis of all aspects of the project, including facility construction, staffing, and ongoing operations.</li>
<li>Detailed plan for managing the psychological impact on recipients and donor families.</li>
<li>Specific details on the ethical guidelines and protocols to be implemented.</li>
<li>Contingency plans for addressing potential surgical complications and rejection.</li>
</ul>
<h2>Questions 🙋❓💬📌</h2>
<ul>
<li>What are the most compelling use cases for face transplantation that could drive initial adoption and demonstrate the value of the technology?</li>
<li>What are the key ethical considerations that need to be addressed to ensure responsible innovation and maintain public trust?</li>
<li>What are the specific regulatory requirements and timelines for obtaining necessary approvals in New Zealand?</li>
<li>What are the potential risks and challenges associated with sourcing and transporting donor faces, and how can these be mitigated?</li>
<li>How can the project ensure the long-term psychological well-being of face recipients and donor families?</li>
</ul>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Team</button>
                <div class="content">        
                    <p><em>Roles Needed &amp; Example People</em></p>
<h1>Roles</h1>
<h2>1. Regulatory Liaison &amp; Compliance Officer</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Critical role requiring in-depth knowledge of regulations and continuous compliance efforts.</p>
<p><strong>Explanation</strong>:
Ensures the project adheres to all New Zealand regulations related to medical facilities, surgical procedures, data privacy, and ethical guidelines.  Crucial for obtaining necessary permits and licenses.</p>
<p><strong>Consequences</strong>:
Project delays, legal challenges, fines, and potential shutdown due to non-compliance.  Inability to legally operate the facility.</p>
<p><strong>People Count</strong>:
min 1, max 2, depending on the complexity of regulatory landscape and the need for specialized expertise in different areas (e.g., data privacy vs. medical licensing).</p>
<p><strong>Typical Activities</strong>:
Interpreting and applying relevant regulations, preparing compliance documentation, liaising with regulatory bodies, conducting internal audits, and developing compliance training programs.</p>
<p><strong>Background Story</strong>:
Aisha Khan grew up in Wellington, New Zealand, developing a keen interest in law and ethics. She earned a law degree from Victoria University of Wellington, specializing in regulatory compliance and bioethics. Before joining the face transplantation project, Aisha worked for the New Zealand Ministry of Health, where she gained extensive experience in navigating complex regulatory landscapes and ensuring compliance with medical regulations. Her familiarity with New Zealand's legal system and her expertise in regulatory compliance make her an invaluable asset to the team.</p>
<p><strong>Equipment Needs</strong>:
Computer with internet access, legal databases, regulatory documentation, secure communication channels.</p>
<p><strong>Facility Needs</strong>:
Office space, access to meeting rooms, secure document storage.</p>
<h2>2. Lead Transplant Surgeon</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Core function requiring dedicated expertise and consistent availability.</p>
<p><strong>Explanation</strong>:
Oversees all surgical aspects of face transplantation, ensuring the highest standards of medical care and patient safety.  Provides expertise in surgical techniques and manages the surgical team.</p>
<p><strong>Consequences</strong>:
Inability to perform face transplant surgeries, compromising the core service offering. Increased risk of surgical complications and patient mortality.</p>
<p><strong>People Count</strong>:
1</p>
<p><strong>Typical Activities</strong>:
Performing face transplant surgeries, developing surgical protocols, managing the surgical team, providing pre- and post-operative care, and conducting research on surgical techniques.</p>
<p><strong>Background Story</strong>:
Dr. Kenji Tanaka, born and raised in Kyoto, Japan, is a world-renowned transplant surgeon. He completed his medical degree at Kyoto University and pursued specialized training in plastic and reconstructive surgery at the University of Tokyo Hospital. Dr. Tanaka has over 20 years of experience in performing complex transplant surgeries, including hand and limb transplants. He is known for his meticulous surgical techniques and his commitment to patient safety. His expertise in microsurgery and his innovative approach to transplant procedures make him the ideal lead surgeon for the face transplantation project.</p>
<p><strong>Equipment Needs</strong>:
Surgical equipment (microscopes, surgical robots), surgical instruments, sterile environment, advanced imaging equipment, computer for surgical planning.</p>
<p><strong>Facility Needs</strong>:
Operating room, pre- and post-operative care unit, surgical planning room, research lab.</p>
<h2>3. Ethics Review Board Coordinator</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Critical role requiring consistent oversight and ethical guidance.</p>
<p><strong>Explanation</strong>:
Manages the ethics review board, ensuring ethical guidelines are followed in patient selection, consent processes, and data handling. Addresses public concerns and maintains ethical integrity.</p>
<p><strong>Consequences</strong>:
Ethical breaches, public outcry, loss of social license to operate, and potential legal challenges. Damage to the facility's reputation and long-term sustainability.</p>
<p><strong>People Count</strong>:
1</p>
<p><strong>Typical Activities</strong>:
Managing the ethics review board, developing ethical guidelines, reviewing patient selection processes, addressing public concerns, and ensuring ethical compliance.</p>
<p><strong>Background Story</strong>:
Dr. Eleanor Vance, originally from Dunedin, New Zealand, is a highly respected bioethicist. She holds a Ph.D. in bioethics from the University of Otago and has spent her career working on ethical issues related to medical research and healthcare. Dr. Vance has served on numerous ethics review boards and has published extensively on topics such as informed consent, patient autonomy, and the ethical implications of emerging medical technologies. Her expertise in ethical decision-making and her commitment to patient well-being make her the perfect coordinator for the ethics review board.</p>
<p><strong>Equipment Needs</strong>:
Computer with internet access, ethical guidelines databases, secure communication channels, meeting facilitation tools.</p>
<p><strong>Facility Needs</strong>:
Office space, access to meeting rooms, secure document storage.</p>
<h2>4. Donor Relations &amp; Acquisition Specialist</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Essential for securing donor faces, requiring dedicated effort and relationship management.</p>
<p><strong>Explanation</strong>:
Develops and manages relationships with organ donation organizations, hospitals, and mortuaries to secure a steady supply of donor faces. Implements ethical consent protocols and manages the logistics of face transportation and preservation.</p>
<p><strong>Consequences</strong>:
Shortage of donor faces, limiting the number of transplant procedures and impacting revenue. Inability to meet subscription demand and potential operational delays.</p>
<p><strong>People Count</strong>:
min 1, max 3, depending on the scale of operations and the geographic area covered for donor acquisition. More people are needed to manage relationships with multiple organizations and handle logistical challenges.</p>
<p><strong>Typical Activities</strong>:
Developing relationships with organ donation organizations, implementing ethical consent protocols, managing the logistics of face transportation, and ensuring a steady supply of donor faces.</p>
<p><strong>Background Story</strong>:
Ethan Bell, hailing from Christchurch, New Zealand, has a background in healthcare administration and organ donation coordination. He earned a degree in public health from the University of Canterbury and has worked for several years at the New Zealand Organ Donation Service. Ethan has extensive experience in building relationships with hospitals, organ donation organizations, and mortuaries. He is skilled at implementing ethical consent protocols and managing the logistics of organ transportation. His expertise in donor relations and acquisition makes him an essential member of the team.</p>
<p><strong>Equipment Needs</strong>:
Transportation for donor faces, communication devices, database for tracking donors, preservation equipment.</p>
<p><strong>Facility Needs</strong>:
Office space, access to transportation, secure storage for donor faces.</p>
<h2>5. Patient Liaison &amp; Psychological Support Coordinator</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Critical for patient well-being, requiring consistent support and availability.</p>
<p><strong>Explanation</strong>:
Provides pre- and post-transplant counseling and support to patients and donor families. Manages the psychological support program and ensures patients receive adequate mental health care.</p>
<p><strong>Consequences</strong>:
Patient dissatisfaction, ethical breaches, and reputational damage due to inadequate psychological support. Increased risk of patient attrition and negative psychological outcomes.</p>
<p><strong>People Count</strong>:
min 2, max 4, depending on the number of patients and the complexity of their psychological needs. Requires multiple people to provide individual counseling, group therapy, and family support.</p>
<p><strong>Typical Activities</strong>:
Providing pre- and post-transplant counseling, managing the psychological support program, ensuring patients receive adequate mental health care, and providing support to donor families.</p>
<p><strong>Background Story</strong>:
Olivia Green, a native of Auckland, New Zealand, is a compassionate and experienced clinical psychologist. She holds a doctorate in clinical psychology from the University of Auckland and has worked in various healthcare settings, providing counseling and support to patients and their families. Olivia has a particular interest in the psychological impact of medical procedures and has published research on the topic. Her expertise in patient support and her commitment to mental health make her the ideal patient liaison and psychological support coordinator.</p>
<p><strong>Equipment Needs</strong>:
Private counseling rooms, psychological assessment tools, computer with secure patient data access, support group meeting space.</p>
<p><strong>Facility Needs</strong>:
Office space, counseling rooms, group therapy room.</p>
<h2>6. Data Security &amp; Privacy Officer</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Essential for protecting sensitive data and ensuring regulatory compliance.</p>
<p><strong>Explanation</strong>:
Develops and implements data privacy and security protocols to protect patient data and comply with regulations. Manages data encryption, access controls, and data breach response plans.</p>
<p><strong>Consequences</strong>:
Data breaches, legal liabilities, fines, and reputational damage due to non-compliance with data privacy regulations. Loss of patient trust and potential operational disruptions.</p>
<p><strong>People Count</strong>:
1</p>
<p><strong>Typical Activities</strong>:
Developing and implementing data privacy and security protocols, managing data encryption, implementing access controls, and developing data breach response plans.</p>
<p><strong>Background Story</strong>:
Raj Patel, born in Mumbai, India, and now a resident of Auckland, New Zealand, is a highly skilled data security and privacy officer. He holds a master's degree in computer science from the University of Auckland and has over 10 years of experience in data security and privacy. Raj has worked for several large organizations, implementing data privacy and security protocols and ensuring compliance with regulations. His expertise in data encryption, access controls, and data breach response plans makes him an invaluable asset to the team.</p>
<p><strong>Equipment Needs</strong>:
Computer with advanced security software, data encryption tools, access control systems, data breach detection and prevention systems.</p>
<p><strong>Facility Needs</strong>:
Secure office space, access to server rooms, data storage facilities.</p>
<h2>7. Facility Operations Manager</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Critical for efficient operations, requiring dedicated management and oversight.</p>
<p><strong>Explanation</strong>:
Oversees the day-to-day operations of the facility, ensuring efficient resource allocation, supply chain management, and maintenance of equipment. Manages administrative procedures and optimizes operational efficiency.</p>
<p><strong>Consequences</strong>:
Operational inefficiencies, increased costs, delays, and compromised care due to poor management of resources and processes. Inability to scale operations effectively.</p>
<p><strong>People Count</strong>:
min 1, max 2, depending on the size and complexity of the facility. A larger facility may require an assistant operations manager to handle specific tasks.</p>
<p><strong>Typical Activities</strong>:
Overseeing the day-to-day operations of the facility, ensuring efficient resource allocation, managing supply chain management, and maintaining equipment.</p>
<p><strong>Background Story</strong>:
Sarah Johnson, originally from Queenstown, New Zealand, has a background in business administration and healthcare management. She earned an MBA from the University of Otago and has worked in various healthcare organizations, managing operations and improving efficiency. Sarah is skilled at resource allocation, supply chain management, and process optimization. Her expertise in facility operations makes her the perfect operations manager for the face transplantation facility.</p>
<p><strong>Equipment Needs</strong>:
Computer with facility management software, communication devices, inventory management system, supply chain management tools.</p>
<p><strong>Facility Needs</strong>:
Office space, access to all areas of the facility, storage for supplies.</p>
<h2>8. Community Engagement &amp; Public Relations Specialist</h2>
<p><strong>Contract Type</strong>: <code>full_time_employee</code></p>
<p><strong>Contract Type Justification</strong>: Important for building trust and managing public perception, requiring consistent engagement.</p>
<p><strong>Explanation</strong>:
Manages public relations, engages with the community, and addresses public concerns about face transplantation and the subscription model. Promotes transparency and builds trust with stakeholders.</p>
<p><strong>Consequences</strong>:
Negative media coverage, public opposition, and reduced enrollment due to lack of community engagement and transparency. Difficulty in building trust with stakeholders and maintaining a positive reputation.</p>
<p><strong>People Count</strong>:
1</p>
<p><strong>Typical Activities</strong>:
Managing public relations, engaging with the community, addressing public concerns, promoting transparency, and building trust with stakeholders.</p>
<p><strong>Background Story</strong>:
Daniel Williams, a Wellington native, has a passion for communication and community engagement. He holds a degree in public relations from Massey University and has worked for several non-profit organizations, managing public relations and engaging with the community. Daniel is skilled at building relationships, promoting transparency, and addressing public concerns. His expertise in community engagement and public relations makes him the ideal specialist for the face transplantation project.</p>
<p><strong>Equipment Needs</strong>:
Computer with internet access, public relations software, communication devices, media monitoring tools.</p>
<p><strong>Facility Needs</strong>:
Office space, access to meeting rooms, presentation equipment.</p>
<hr />
<h1>Omissions</h1>
<h2>1. Detailed Plan for Donor Face Acquisition and Preservation</h2>
<p>The strategic decisions and assumptions lack a comprehensive plan for acquiring and preserving donor faces. This is crucial for ensuring a steady supply of faces, impacting operational capacity and financial viability.</p>
<p><strong>Recommendation</strong>:
Develop a comprehensive Donor Face Acquisition and Preservation Plan that includes partnerships with organ donation organizations, ethical consent protocols, detailed transportation logistics, advanced preservation techniques, and a robust inventory management system.</p>
<h2>2. Long-Term Psychological Impact on Recipients and 'Donors'</h2>
<p>The plan overlooks the long-term psychological impact on both face recipients and the families of the deceased 'donors'. Wearing another person's face can create complex psychological issues, exacerbated by the subscription model. A comprehensive psychological support system is essential.</p>
<p><strong>Recommendation</strong>:
Implement a comprehensive Psychological Support Program that includes pre-transplant counseling, post-transplant therapy, donor family support, psychiatric assessments, ethical guidelines for managing psychological issues, and a supportive community for recipients and donor families.</p>
<h2>3. Data Privacy and Security Considerations</h2>
<p>The plan lacks sufficient detail regarding data privacy and security. Given the sensitive nature of face transplantation, the absence of robust data protection measures is a critical oversight, potentially leading to legal and reputational damage.</p>
<p><strong>Recommendation</strong>:
Develop a comprehensive Data Privacy and Security Plan that includes a compliance assessment of applicable data privacy regulations, data encryption techniques, strict access controls, a data breach response plan, regular security audits, and comprehensive employee training.</p>
<h2>4. Contingency Plan for Ethical Breaches</h2>
<p>While an ethics review board is planned, there's no explicit contingency plan for handling actual ethical breaches. This could lead to a reactive and potentially damaging response to ethical failures.</p>
<p><strong>Recommendation</strong>:
Develop a detailed contingency plan for addressing ethical breaches, including investigation protocols, communication strategies, and remediation measures. This plan should be regularly reviewed and updated by the ethics review board.</p>
<h2>5. Plan for Handling Face Rejection</h2>
<p>The plan mentions technical risks and immunosuppression, but lacks a specific, detailed plan for managing face rejection episodes. This is a critical medical contingency that needs a well-defined protocol.</p>
<p><strong>Recommendation</strong>:
Create a comprehensive plan for managing face rejection, including early detection methods, escalation protocols, alternative immunosuppression strategies, and surgical intervention procedures. This plan should be developed in consultation with transplant specialists.</p>
<hr />
<h1>Potential Improvements</h1>
<h2>1. Clarify Responsibilities of Ethics Review Board Coordinator</h2>
<p>The role of the Ethics Review Board Coordinator is defined, but the specific decision-making authority and interaction with other team members (e.g., surgeons, patient liaisons) needs clarification to avoid conflicts and ensure efficient ethical oversight.</p>
<p><strong>Recommendation</strong>:
Develop a detailed charter for the Ethics Review Board, outlining its decision-making authority, reporting structure, and interaction protocols with other team members. This charter should be approved by all relevant stakeholders.</p>
<h2>2. Define Metrics for Success of Community Engagement</h2>
<p>The Community Engagement &amp; Public Relations Specialist role is defined, but lacks measurable objectives. Defining success metrics will help assess the effectiveness of community engagement efforts and justify resource allocation.</p>
<p><strong>Recommendation</strong>:
Establish specific, measurable, achievable, relevant, and time-bound (SMART) goals for community engagement, such as increasing positive media mentions, reducing negative public sentiment, or increasing participation in community forums. Regularly track and report on progress towards these goals.</p>
<h2>3. Enhance Stakeholder Engagement Strategies</h2>
<p>The stakeholder analysis identifies primary and secondary stakeholders, but the engagement strategies are generic. Tailoring engagement strategies to specific stakeholder needs and concerns will improve communication and build stronger relationships.</p>
<p><strong>Recommendation</strong>:
Develop customized engagement plans for each key stakeholder group, outlining specific communication channels, frequency of updates, and opportunities for feedback. For example, provide investors with regular financial reports and opportunities for Q&amp;A sessions.</p>
<h2>4. Improve Integration of Risk Mitigation Protocol with Operational Efficiency</h2>
<p>The strategic decisions highlight a conflict between Risk Mitigation and Operational Efficiency. A more integrated approach is needed to balance these competing priorities.</p>
<p><strong>Recommendation</strong>:
Develop a cross-functional team to identify specific areas where risk mitigation and operational efficiency can be better aligned. Implement process improvements that enhance both safety and efficiency, such as standardized surgical protocols and automated data collection.</p>
<h2>5. Clarify the Role of the DAO in Ethical Oversight</h2>
<p>The Pioneer's Gambit scenario suggests using a DAO for ethical oversight, but the specific mechanisms and limitations of this approach are not fully defined. This could lead to confusion and potential ethical lapses.</p>
<p><strong>Recommendation</strong>:
Develop a detailed plan for implementing the DAO for ethical oversight, including the selection of DAO members, voting procedures, decision-making criteria, and mechanisms for accountability. Ensure that the DAO's decisions are consistent with ethical guidelines and legal requirements.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Expert Criticism</button>
                <div class="content">        
                    <h1>Project Expert Review &amp; Recommendations</h1>
<h2>A Compilation of Professional Feedback for Project Planning and Execution</h2>
<h1>1 Expert: Transplant Surgeon</h1>
<p><strong>Knowledge</strong>: Facial reconstruction, microsurgery, immunosuppression, transplant ethics</p>
<p><strong>Why</strong>: To assess surgical feasibility, risks, and long-term outcomes of face transplants, especially given the subscription model's implications.</p>
<p><strong>What</strong>: Review surgical protocols, assess risks of rejection, and advise on patient selection criteria for face transplantation.</p>
<p><strong>Skills</strong>: Surgical precision, ethical judgment, risk assessment, patient communication</p>
<p><strong>Search</strong>: face transplant surgeon, microsurgery, transplant ethics</p>
<h2>1.1 Primary Actions</h2>
<ul>
<li>Conduct a comprehensive feasibility study on xenotransplantation and CRISPR for face transplantation, consulting with leading experts and providing concrete data on regulatory approval prospects.</li>
<li>Develop a detailed Donor Face Acquisition and Preservation Plan, including specific protocols for donor selection, consent, retrieval, preservation, and transportation, consulting with TPOs and ethicists.</li>
<li>Develop a detailed immunosuppression protocol, including specific agents, dosages, monitoring strategies, and management of acute and chronic rejection, consulting with transplant immunologists and infectious disease specialists.</li>
</ul>
<h2>1.2 Secondary Actions</h2>
<ul>
<li>Refine the ethical guidelines and protocols, addressing potential coercion or exploitation of vulnerable individuals.</li>
<li>Develop contingency plans for addressing potential surgical complications and rejection.</li>
<li>Conduct detailed market research on the potential demand for face transplantation and the subscription model.</li>
</ul>
<h2>1.3 Follow Up Consultation</h2>
<p>Discuss the feasibility study results, the Donor Face Acquisition and Preservation Plan, and the immunosuppression protocol in detail. Review the refined ethical guidelines and contingency plans. Assess the revised financial model based on realistic assumptions about regulatory approval timelines and donor face availability.</p>
<h2>1.4.A Issue - Unrealistic Reliance on Radical Technologies and Jurisdictional Arbitrage</h2>
<p>The 'Pioneer's Gambit' scenario heavily relies on radical technologies like CRISPR and xenotransplantation, coupled with jurisdictional arbitrage. This is an extremely high-risk approach. Xenotransplantation, in particular, faces significant immunological and ethical hurdles, and regulatory bodies are highly unlikely to approve such procedures in the near future. Jurisdictional arbitrage, while potentially faster, could lead to ethical compromises and long-term reputational damage. The plan lacks a realistic assessment of the time and resources required to overcome these challenges.</p>
<h3>1.4.B Tags</h3>
<ul>
<li>technology</li>
<li>regulatory</li>
<li>ethics</li>
<li>risk</li>
</ul>
<h3>1.4.C Mitigation</h3>
<p>Conduct a thorough feasibility study on the technological and regulatory landscape for xenotransplantation and CRISPR in the context of face transplantation. Consult with leading experts in xenotransplantation immunology, regulatory affairs, and transplant ethics. Develop a contingency plan that focuses on more established technologies and regulatory pathways, such as allogeneic transplantation with advanced immunosuppression protocols. Provide concrete data on the likelihood of regulatory approval for xenotransplantation within the next 5-10 years.</p>
<h3>1.4.D Consequence</h3>
<p>Without mitigation, the project is likely to face insurmountable regulatory hurdles, leading to significant delays, financial losses, and potential project failure. Ethical compromises could damage the organization's reputation and erode public trust.</p>
<h3>1.4.E Root Cause</h3>
<p>Overly optimistic assessment of technological advancements and regulatory flexibility, coupled with a lack of in-depth consultation with relevant experts.</p>
<h2>1.5.A Issue - Inadequate Donor Face Acquisition and Preservation Plan</h2>
<p>The plan repeatedly mentions the need for a donor face acquisition plan, but lacks concrete details. Securing a consistent supply of suitable donor faces is paramount. The current plan fails to address critical aspects such as: detailed logistical protocols for face retrieval and preservation, specific inclusion/exclusion criteria for donor faces, cold ischemia time limitations, and the impact of donor demographics (age, sex, ethnicity) on transplant outcomes. Furthermore, the ethical considerations surrounding donor consent and family communication are insufficiently addressed.</p>
<h3>1.5.B Tags</h3>
<ul>
<li>logistics</li>
<li>ethics</li>
<li>planning</li>
<li>donor</li>
</ul>
<h3>1.5.C Mitigation</h3>
<p>Develop a comprehensive Donor Face Acquisition and Preservation Plan, including detailed protocols for donor selection, consent, retrieval, preservation, and transportation. Consult with experienced transplant procurement organizations (TPOs) and ethicists specializing in organ donation. Include specific details on cold ischemia time limits, preservation solutions, and quality control measures. Establish clear guidelines for communication with donor families and ensure ethical consent processes are rigorously followed. Provide data on the projected number of available donor faces in New Zealand and alternative strategies for sourcing faces if local supply is insufficient (e.g., international collaborations).</p>
<h3>1.5.D Consequence</h3>
<p>Without a robust donor face acquisition plan, the project will face severe limitations in the number of transplants that can be performed, impacting financial viability and scalability. Ethical lapses in donor consent could lead to legal challenges and reputational damage.</p>
<h3>1.5.E Root Cause</h3>
<p>Lack of experience in organ procurement and a failure to appreciate the logistical and ethical complexities of obtaining suitable donor faces.</p>
<h2>1.6.A Issue - Oversimplification of Immunosuppression and Rejection Management</h2>
<p>The plan mentions immunosuppression protocols but lacks detail regarding the specific agents to be used, monitoring strategies, and management of acute and chronic rejection. Face transplantation is highly immunogenic, and rejection remains a significant challenge. The plan needs to address the potential for antibody-mediated rejection, the risk of opportunistic infections, and the long-term side effects of immunosuppression. Furthermore, the plan fails to consider the psychological impact of chronic immunosuppression on patients.</p>
<h3>1.6.B Tags</h3>
<ul>
<li>medical</li>
<li>immunosuppression</li>
<li>rejection</li>
<li>patientcare</li>
</ul>
<h3>1.6.C Mitigation</h3>
<p>Develop a detailed immunosuppression protocol, including specific agents, dosages, and monitoring strategies. Consult with experienced transplant immunologists and infectious disease specialists. Include protocols for managing acute and chronic rejection, including antibody-mediated rejection. Address the potential for opportunistic infections and the long-term side effects of immunosuppression. Incorporate psychological support services to address the emotional impact of chronic immunosuppression on patients. Provide data on the expected rejection rates and the long-term survival rates of face transplants with the proposed immunosuppression regimen.</p>
<h3>1.6.D Consequence</h3>
<p>Inadequate immunosuppression and rejection management will lead to higher rates of graft failure, patient morbidity, and mortality. This will damage the organization's reputation and undermine public trust.</p>
<h3>1.6.E Root Cause</h3>
<p>Insufficient understanding of the complexities of transplant immunology and the challenges of managing rejection in face transplantation.</p>
<hr />
<h1>2 Expert: Medical Ethicist</h1>
<p><strong>Knowledge</strong>: Bioethics, informed consent, organ donation, patient autonomy, moral philosophy</p>
<p><strong>Why</strong>: To evaluate the ethical implications of the face transplant subscription model, addressing coercion, exploitation, and commodification concerns.</p>
<p><strong>What</strong>: Assess ethical guidelines, consent processes, and potential for exploitation within the subscription model.</p>
<p><strong>Skills</strong>: Ethical reasoning, moral philosophy, regulatory compliance, stakeholder engagement</p>
<p><strong>Search</strong>: medical ethicist, bioethics, organ donation, informed consent</p>
<h2>2.1 Primary Actions</h2>
<ul>
<li>Immediately consult with leading bioethicists specializing in organ donation, identity ethics, and transplantation.</li>
<li>Conduct a comprehensive review of existing organ donation consent protocols and develop a novel, ethically robust consent process for facial donation.</li>
<li>Engage with experienced psychologists and psychiatrists specializing in transplantation and identity issues to develop a detailed psychological support program.</li>
<li>Re-evaluate the reliance on unproven technologies and jurisdictional arbitrage, prioritizing incremental improvements and ethical compliance.</li>
<li>Engage proactively with regulatory bodies in New Zealand to understand the specific requirements for face transplantation and develop a compliance plan.</li>
</ul>
<h2>2.2 Secondary Actions</h2>
<ul>
<li>Explore alternative, ethically sound methods of face acquisition, such as tissue engineering or 3D printing.</li>
<li>Establish partnerships with mental health organizations and community support groups to provide a comprehensive network of care.</li>
<li>Conduct a thorough ethical review of the proposed technologies and strategies, considering the potential risks and benefits for patients and society.</li>
<li>Develop a detailed financial model that accounts for the costs of ethical compliance, psychological support, and regulatory engagement.</li>
<li>Identify and develop a 'killer application' use-case that addresses a specific, compelling need and demonstrates the value of the technology.</li>
</ul>
<h2>2.3 Follow Up Consultation</h2>
<p>In the next consultation, we will discuss the revised ethical framework, the detailed psychological support program, and the updated technological development strategy. Please provide data on the proposed consent process, psychological support program, and the ethical and regulatory implications of the chosen technologies and strategies. We will also discuss the financial model and the 'killer application' use-case.</p>
<h2>2.4.A Issue - Ethical Myopia Regarding Donor Acquisition and Consent</h2>
<p>The plan repeatedly mentions partnerships with organ donation organizations, but it lacks critical details on how <em>faces</em> will be ethically sourced. Standard organ donation consent rarely covers facial donation, which carries unique psychological and identity implications for donor families. The 'Face Off' inspiration trivializes the profound ethical considerations involved in acquiring and using another person's face. The plan fails to address the potential for coercion, exploitation, or undue influence on vulnerable individuals or families during the consent process. The DAO structure, while promoting transparency, doesn't guarantee ethical outcomes, especially if participants lack expertise in bioethics or are swayed by financial incentives. The plan also neglects the potential for commodification of faces, turning them into mere commodities for subscription-based swapping.</p>
<h3>2.4.B Tags</h3>
<ul>
<li>ethics</li>
<li>consent</li>
<li>donor acquisition</li>
<li>commodification</li>
<li>exploitation</li>
</ul>
<h3>2.4.C Mitigation</h3>
<p>Immediately consult with leading bioethicists specializing in organ donation and identity ethics. Conduct a thorough review of existing organ donation consent protocols and identify gaps related to facial donation. Develop a novel, ethically robust consent process that addresses the unique psychological and identity implications for donor families. This process must include independent counseling, legal representation, and a cooling-off period. Explore alternative, ethically sound methods of face acquisition, such as tissue engineering or 3D printing. Engage with community representatives and patient advocacy groups to gather feedback and ensure the consent process is culturally sensitive and respectful. Provide detailed data on the proposed consent process, including sample consent forms, counseling protocols, and legal safeguards.</p>
<h3>2.4.D Consequence</h3>
<p>Without a robust and ethical donor acquisition plan, the project risks severe public backlash, legal challenges, and potential criminal charges related to unethical or illegal organ procurement. The project could be shut down, and individuals involved could face significant reputational damage and legal penalties.</p>
<h3>2.4.E Root Cause</h3>
<p>The 'Face Off' inspiration and commercial focus have overshadowed the profound ethical considerations involved in acquiring and using human faces. There is a lack of deep understanding of the psychological and social implications of face transplantation and the potential for exploitation of vulnerable individuals.</p>
<h2>2.5.A Issue - Insufficient Consideration of Long-Term Psychological Impact</h2>
<p>The plan mentions a 'Psychological Support Program,' but it lacks detail and depth. Face transplantation is a radical procedure with profound psychological implications for both recipients and donor families. Recipients may struggle with identity issues, body image concerns, and the psychological burden of wearing another person's face. Donor families may experience grief, guilt, and complex emotions related to the donation. The plan fails to address the potential for long-term psychological distress, including depression, anxiety, and post-traumatic stress disorder. The proposed budget allocation of $200,000-$400,000 annually for support services is woefully inadequate given the scale and complexity of the psychological challenges involved.</p>
<h3>2.5.B Tags</h3>
<ul>
<li>psychology</li>
<li>mental health</li>
<li>long-term impact</li>
<li>recipient</li>
<li>donor family</li>
</ul>
<h3>2.5.C Mitigation</h3>
<p>Engage with experienced psychologists and psychiatrists specializing in transplantation and identity issues. Conduct a comprehensive literature review on the psychological impact of face transplantation and other radical medical procedures. Develop a detailed psychological support program that includes pre-transplant counseling, post-transplant therapy, and ongoing support groups for both recipients and donor families. Allocate a significantly larger budget for psychological support services, commensurate with the anticipated needs of patients and families. Establish partnerships with mental health organizations and community support groups to provide a comprehensive network of care. Collect and provide data on the proposed psychological support program, including staffing levels, therapy protocols, and outcome measures.</p>
<h3>2.5.D Consequence</h3>
<p>Failure to adequately address the psychological needs of recipients and donor families could lead to severe mental health problems, including depression, anxiety, and suicide. This could result in legal liabilities, reputational damage, and a loss of public trust.</p>
<h3>2.5.E Root Cause</h3>
<p>The plan prioritizes the technological and commercial aspects of face transplantation over the human element. There is a lack of understanding of the profound psychological and social implications of this radical procedure.</p>
<h2>2.6.A Issue - Over-Reliance on Unproven Technologies and Jurisdictional Arbitrage</h2>
<p>The 'Pioneer's Gambit' scenario and the Technological Development Approach heavily rely on radical technologies like CRISPR and xenotransplantation, which are currently unproven and carry significant ethical and regulatory risks. The plan also proposes jurisdictional arbitrage, establishing operations in regions with more permissive regulations. This approach raises serious ethical concerns about exploiting regulatory loopholes and potentially compromising patient safety. The plan fails to adequately address the potential for international regulatory conflicts and the reputational damage associated with operating in regions with lower ethical standards. The reliance on these strategies suggests a willingness to prioritize speed and profit over ethical considerations and patient well-being.</p>
<h3>2.6.B Tags</h3>
<ul>
<li>technology</li>
<li>ethics</li>
<li>regulation</li>
<li>jurisdictional arbitrage</li>
<li>risk</li>
</ul>
<h3>2.6.C Mitigation</h3>
<p>Re-evaluate the reliance on unproven technologies and jurisdictional arbitrage. Prioritize incremental improvements in existing surgical techniques and immunosuppression protocols. Engage with regulatory bodies in New Zealand to understand the specific requirements for face transplantation and develop a plan for compliance. Conduct a thorough ethical review of the proposed technologies and strategies, considering the potential risks and benefits for patients and society. Explore alternative, ethically sound approaches to technological development and regulatory compliance. Provide data on the ethical and regulatory implications of the proposed technologies and strategies, including risk assessments, compliance plans, and stakeholder consultations.</p>
<h3>2.6.D Consequence</h3>
<p>Over-reliance on unproven technologies and jurisdictional arbitrage could lead to regulatory rejection, ethical condemnation, and significant financial losses. The project could be shut down, and individuals involved could face legal penalties and reputational damage.</p>
<h3>2.6.E Root Cause</h3>
<p>The plan is driven by a desire for rapid innovation and market dominance, without sufficient consideration of the ethical and regulatory implications. There is a lack of understanding of the complexities of technological development and the importance of ethical and responsible innovation.</p>
<hr />
<h1>The following experts did not provide feedback:</h1>
<h1>3 Expert: Regulatory Affairs Consultant</h1>
<p><strong>Knowledge</strong>: New Zealand healthcare regulations, Medsafe guidelines, clinical trial regulations, medical device approval</p>
<p><strong>Why</strong>: To navigate the regulatory landscape in New Zealand, ensuring compliance with health regulations and obtaining necessary approvals for the facility.</p>
<p><strong>What</strong>: Review regulatory requirements, prepare documentation for approval, and advise on compliance strategies for Medsafe.</p>
<p><strong>Skills</strong>: Regulatory compliance, documentation, risk assessment, stakeholder communication</p>
<p><strong>Search</strong>: Medsafe regulatory consultant, New Zealand healthcare, medical device approval</p>
<h1>4 Expert: Supply Chain Logistics Expert</h1>
<p><strong>Knowledge</strong>: Organ transport logistics, cold chain management, medical supply chain, regulatory compliance, risk management</p>
<p><strong>Why</strong>: To develop a robust and ethical plan for sourcing, preserving, and transporting donor faces, addressing logistical challenges and regulatory requirements.</p>
<p><strong>What</strong>: Create a detailed logistics plan for donor face acquisition, preservation, and transportation, ensuring regulatory compliance.</p>
<p><strong>Skills</strong>: Logistics planning, cold chain management, risk assessment, regulatory compliance</p>
<p><strong>Search</strong>: organ transport logistics, cold chain, medical supply chain</p>
<h1>5 Expert: Psychologist</h1>
<p><strong>Knowledge</strong>: Psychological impact, patient counseling, mental health support, trauma recovery</p>
<p><strong>Why</strong>: To develop a psychological support program addressing the mental health needs of face transplant recipients and donor families.</p>
<p><strong>What</strong>: Design a comprehensive psychological support program, including pre- and post-transplant counseling services.</p>
<p><strong>Skills</strong>: Counseling techniques, trauma-informed care, patient communication, program development</p>
<p><strong>Search</strong>: psychologist for transplant patients, mental health support, trauma recovery</p>
<h1>6 Expert: Market Research Analyst</h1>
<p><strong>Knowledge</strong>: Market demand analysis, consumer behavior, healthcare trends, subscription models</p>
<p><strong>Why</strong>: To conduct market research on potential demand for face transplantation services and the subscription model, informing strategic decisions.</p>
<p><strong>What</strong>: Perform market analysis to identify target demographics and assess demand for face transplantation services.</p>
<p><strong>Skills</strong>: Data analysis, consumer insights, market segmentation, strategic planning</p>
<p><strong>Search</strong>: healthcare market research analyst, consumer behavior, subscription model analysis</p>
<h1>7 Expert: Insurance Specialist</h1>
<p><strong>Knowledge</strong>: Medical liability insurance, risk assessment, healthcare compliance, policy development</p>
<p><strong>Why</strong>: To advise on insurance coverage options for the facility, ensuring adequate protection against potential liabilities and complications.</p>
<p><strong>What</strong>: Evaluate insurance options and develop a comprehensive insurance policy to cover potential liabilities associated with face transplantation.</p>
<p><strong>Skills</strong>: Risk assessment, policy negotiation, healthcare compliance, financial analysis</p>
<p><strong>Search</strong>: medical insurance specialist, liability insurance for healthcare, risk assessment</p>
<h1>8 Expert: Data Privacy Officer</h1>
<p><strong>Knowledge</strong>: Data protection regulations, compliance frameworks, cybersecurity, patient data management</p>
<p><strong>Why</strong>: To ensure compliance with data privacy regulations and develop a robust data privacy plan for handling sensitive patient information.</p>
<p><strong>What</strong>: Create a data privacy and security plan, ensuring compliance with applicable regulations and implementing data protection measures.</p>
<p><strong>Skills</strong>: Data protection, regulatory compliance, cybersecurity, risk management</p>
<p><strong>Search</strong>: data privacy officer, healthcare data protection, compliance regulations</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Work Breakdown Structure</button>
                <div class="content">        
                    <table border="1" class="dataframe dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Level 1</th>
      <th>Level 2</th>
      <th>Level 3</th>
      <th>Level 4</th>
      <th>Task ID</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Face Facility</td>
      <td></td>
      <td></td>
      <td></td>
      <td>60c6b7a8-2145-4e79-a407-31d257bd7417</td>
    </tr>
    <tr>
      <td></td>
      <td>Project Initiation &amp; Planning</td>
      <td></td>
      <td></td>
      <td>44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Define Project Scope and Objectives</td>
      <td></td>
      <td>5c4161cf-b3a4-42b6-914a-8b051aac2a55</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Gather Stakeholder Requirements</td>
      <td>11fd4b20-8174-4ab9-b5c6-a231920b89f5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Analyze Requirements and Define Scope</td>
      <td>0a8f360c-e8eb-4c92-8665-721ddb344b6c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish Measurable Project Objectives</td>
      <td>c90639eb-9941-418a-8607-a206001be1a3</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Document Assumptions and Constraints</td>
      <td>19ff72cd-a65d-4dbd-88c0-2600863b590e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Identify Key Stakeholders</td>
      <td></td>
      <td>e4020cc5-dc9d-4100-a124-c51bcd7091e8</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify internal project stakeholders</td>
      <td>d974662c-4ac6-4877-9f9f-3451721ceb51</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify external project stakeholders</td>
      <td>0a6adf98-e625-44ce-b125-e37ba651afcc</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Analyze stakeholder influence and interests</td>
      <td>c7803bcd-3bfa-4478-9579-15a8dbebe8d5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop stakeholder communication plan</td>
      <td>5cb56967-fd56-43ed-a8e7-36b37da2c20b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Develop Project Management Plan</td>
      <td></td>
      <td>482de1c5-eb8f-41bc-a073-6b3c2a12b7d2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Project Scope Statement</td>
      <td>262adc91-09cc-4dc8-bff1-c413f12b0cfc</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Project Schedule</td>
      <td>05562c59-0a6e-436b-ac7a-0ab3f4f34939</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Create Project Budget</td>
      <td>fd9e4821-d042-4b82-b752-629ea9870972</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish Risk Management Plan</td>
      <td>15167f12-0777-4a68-a0ca-8a739a5a524f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Communication Management Plan</td>
      <td>0ae012b1-c327-4792-955b-aa83c3b98959</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Secure Initial Funding</td>
      <td></td>
      <td>f87a83eb-17cf-48d1-92d5-2c669cb3525d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop detailed financial projections</td>
      <td>a7c6c689-4b9a-44d6-b200-538f71c485ce</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Prepare investor pitch deck and materials</td>
      <td>f96dd3ac-7e5f-469a-b952-d570299a57b8</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify and engage potential investors</td>
      <td>1ca5a048-7c4e-41bd-b562-a6332d3bbf9d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Negotiate investment terms and agreements</td>
      <td>5a4ed5e1-b547-49a2-97ad-275d8769e10c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Secure funding commitments and finalize agreements</td>
      <td>e240650c-02bc-4d98-bb59-2cf31e05bc42</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Establish Project Governance Structure</td>
      <td></td>
      <td>0dbbdc0b-a0b3-4769-9627-5be7653573cf</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Governance Roles and Responsibilities</td>
      <td>9d49a664-2412-4f08-9573-2c92aeb8087b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish Decision-Making Processes</td>
      <td>fba35e93-7777-4863-b64b-9c315894b0c0</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Create Communication Plan for Governance</td>
      <td>825fd9a0-71f0-4142-9b65-43c461cbd52b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Document Governance Structure and Processes</td>
      <td>95a2ae41-3554-4bfc-8e87-67212c9828cf</td>
    </tr>
    <tr>
      <td></td>
      <td>Regulatory &amp; Ethical Approval</td>
      <td></td>
      <td></td>
      <td>bead144a-37b0-4c63-ac6d-a0a19d9c2a33</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Conduct Regulatory Landscape Assessment</td>
      <td></td>
      <td>88873351-fe17-4656-97d3-6d6ff1defee4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify relevant regulatory bodies</td>
      <td>84b8d532-072a-41dc-912b-9f423974b5e9</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Gather face transplantation regulations</td>
      <td>e7a1fee8-b1aa-494c-98fd-76b0cf7f8a21</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Analyze regulatory requirements</td>
      <td>b70ffbed-ee29-4848-9f34-7d44b728b70a</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Document regulatory gaps and uncertainties</td>
      <td>54488382-a7f1-4558-91a7-1c28f78f09af</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Prepare Regulatory Approval Documentation</td>
      <td></td>
      <td>0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Gather required documentation templates</td>
      <td>0998bc6f-a029-476a-aa33-0ae1695e93c1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Draft initial documentation sections</td>
      <td>22204e0f-1551-4d04-a00d-d703e900cb69</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Review and revise draft documentation</td>
      <td>a9ccce30-3f9a-4112-a799-855768a9a248</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Finalize and format documentation</td>
      <td>1d7b7cdd-0af1-4555-bc0c-8840f916f04c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Translate documents if required</td>
      <td>1074b6ff-fdc7-4ccf-9046-2d1ef4c74aa9</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Engage with Regulatory Bodies (Medsafe, Ministry of Health)</td>
      <td></td>
      <td>8346561b-9e0c-466d-83eb-0d6aadda330b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify Key Contacts at Regulatory Bodies</td>
      <td>cddc6d56-47a7-4d86-99fb-17cf0e680502</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Schedule Initial Consultation Meetings</td>
      <td>6a054300-b4d5-4385-b8e1-24beb133c3da</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Present Project Overview and Objectives</td>
      <td>0f10888f-372f-4700-8c2d-df237d9bb2ac</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Clarify Regulatory Requirements and Timelines</td>
      <td>1c1ff2db-99f0-4606-8007-fc00b60adee2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Document Meeting Outcomes and Action Items</td>
      <td>bca53136-fd8c-4b8c-94a3-4ae4bb837fc4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Establish Ethics Review Board</td>
      <td></td>
      <td>8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define ERB scope and responsibilities</td>
      <td>7b2a90af-ea4e-408f-8ff7-3a47a9109e9c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify and recruit ERB members</td>
      <td>767b4bcb-30ea-49cc-8e12-d8299ac2f0c8</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop ERB operational procedures</td>
      <td>3ba21f5a-40f8-4f25-8516-2b8763075112</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Secure institutional support for ERB</td>
      <td>f2010f0e-b89d-41ee-a8d9-44eddfbbbc8e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Develop Ethical Guidelines and Protocols</td>
      <td></td>
      <td>57831a79-0296-4839-9152-097c08f2596f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Research existing ethical guidelines for transplants</td>
      <td>0dc3543e-c84f-4914-9ca7-fd90435ed6ad</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify key ethical considerations for face transplants</td>
      <td>2db1a1af-3883-43b5-8968-9061eee85941</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Draft preliminary ethical guidelines for the facility</td>
      <td>cca1b359-29a6-495b-b6f4-b861f9679ff5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Obtain feedback from stakeholders on draft guidelines</td>
      <td>dc0d3df3-d0c9-4699-9310-5e0ef605a756</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Finalize ethical guidelines and protocols</td>
      <td>19bec1c3-8e14-46bf-ba18-3878fbff3565</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Obtain Necessary Permits and Licenses</td>
      <td></td>
      <td>8a12f9b1-21eb-466a-bb85-60afa33725c8</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify required permits and licenses</td>
      <td>40d47d6d-7c40-4678-a775-0f7da8fbc4eb</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Prepare permit and license applications</td>
      <td>e0c241ec-776e-4488-b204-4efe721c3c73</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Submit applications and track progress</td>
      <td>7b8f61a3-8cb3-456b-868b-ff3d8d424e7a</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Address regulatory body inquiries</td>
      <td>00256dc9-49c9-49ee-ac1b-8b3ce6b252b1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Secure final permits and licenses</td>
      <td>69c8900b-dab7-46e1-ba71-dcd7d276be9f</td>
    </tr>
    <tr>
      <td></td>
      <td>Facility Development &amp; Infrastructure</td>
      <td></td>
      <td></td>
      <td>c3905530-1d89-4610-bc35-a66b4597170d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Select Facility Location</td>
      <td></td>
      <td>c2656566-0c94-40b2-a22e-0955e9216f46</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Facility Requirements and Criteria</td>
      <td>237024a5-b5b4-4851-aca8-df98563e2edd</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct Market Research and Site Analysis</td>
      <td>0c68c563-330b-4258-a61d-5cd55597a7d5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Evaluate Potential Locations and Shortlist</td>
      <td>f2fab493-d73f-42dd-bb07-c9306a9618fb</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Negotiate Lease or Purchase Agreement</td>
      <td>5b6d72f6-7f4d-442c-93b1-918c7380da49</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct Due Diligence and Finalize Selection</td>
      <td>b26eeadc-c132-4b6c-8bfd-8fbb67120d3d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Design Facility Layout</td>
      <td></td>
      <td>d1da9237-e263-4c03-a503-590d6eeea3f3</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Facility Requirements and Specifications</td>
      <td>5440543e-8c9b-4f92-b57e-1d092448873d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Preliminary Facility Layout Designs</td>
      <td>b2af5698-ffd5-4944-91ce-381c09a294a4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Review and Refine Layout Designs</td>
      <td>8c1e864a-bafa-4fff-be04-33d6daad4b50</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Create Detailed Architectural Drawings</td>
      <td>a10513ec-dbe5-41fd-8218-4e5349fa869a</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Obtain Design Approvals</td>
      <td>304396a5-e27e-425f-b381-7c60115860eb</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Procure Surgical Equipment and Medical Supplies</td>
      <td></td>
      <td>664a3180-076a-435e-b8bd-5c2d7be3a5e1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Equipment Specifications and Requirements</td>
      <td>73a1139e-8e53-47f7-b2e2-a709fc200b1b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify Potential Vendors and Suppliers</td>
      <td>81e6bdef-caf9-42c4-b685-3860865a1a54</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Evaluate Vendor Proposals and Negotiate Contracts</td>
      <td>fb659d35-bf51-44d0-a402-2ad890eee55b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Manage Purchase Orders and Track Deliveries</td>
      <td>fa0db33f-7f9f-4e2e-9757-2efe6e1081d1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct Equipment Testing and Acceptance</td>
      <td>68921308-13ba-4fac-bb46-70b802f93b68</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Construct/Renovate Facility</td>
      <td></td>
      <td>b3eeffe0-96c3-4758-896e-c87fe1de4a7b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Prepare site for construction/renovation</td>
      <td>e02895ff-d980-4bbc-b950-8f681cac6a23</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Execute structural construction/renovation</td>
      <td>011f9618-dcf2-4bd1-b8ee-2c6505951766</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Install electrical and plumbing systems</td>
      <td>ff893814-759b-44cc-8ffa-0be1aa266165</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Install specialized medical infrastructure</td>
      <td>0c48a713-4bd4-4cd0-8ddc-17c4b06b16f8</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Complete interior finishing and fixtures</td>
      <td>c5e28806-e26d-4473-9097-e23ddfb6e539</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Install Data Privacy and Security Systems</td>
      <td></td>
      <td>bf1f1646-5331-4128-843a-94182f9e72a2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Assess data privacy regulatory requirements</td>
      <td>43b25536-52e8-4246-bedd-84ee796f803e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Select and procure security hardware/software</td>
      <td>b1293df1-628c-41a4-8aab-bfef544fb03b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Configure and integrate security systems</td>
      <td>cbc59d5f-755c-4d82-b8d9-660a92518932</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Test and validate security system effectiveness</td>
      <td>abfb3dbe-3b60-4462-b2b3-978d3e49db9c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop data breach response plan</td>
      <td>b9314417-b01e-492f-a16b-ea1d4ed12b44</td>
    </tr>
    <tr>
      <td></td>
      <td>Donor Face Acquisition &amp; Preservation</td>
      <td></td>
      <td></td>
      <td>edea1841-d86e-4d1b-9704-04d6abb593c2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Establish Partnerships with Organ Donation Organizations</td>
      <td></td>
      <td>22ffa70e-b917-4918-9074-e917a9890156</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify potential organ donation partners</td>
      <td>907727c7-1fb8-46b6-9da0-4396387846fb</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Initial contact and introductory meetings</td>
      <td>8ebe4ef9-feb1-4d3f-99f6-33245a10cae3</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Negotiate partnership agreements</td>
      <td>cb406d06-ae90-4da8-81d1-c352984cacac</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Formalize partnership agreements</td>
      <td>1da9645e-89a2-4e93-8b0e-a0f23aca4102</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Develop Donor Face Acquisition Protocols</td>
      <td></td>
      <td>406b6dd6-7b44-4d60-a2e1-f31668252d62</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Research current face acquisition protocols</td>
      <td>85546c83-65bb-4baf-b100-9ce5e8fcde72</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Draft initial face acquisition protocol</td>
      <td>2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Review protocol with organ donation organizations</td>
      <td>2ecb2eed-47f8-4efc-9936-7ea541193511</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Finalize and approve acquisition protocol</td>
      <td>179b4feb-8bb6-4d4c-9601-cb9b543e99d5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Establish Face Transportation and Preservation Logistics</td>
      <td></td>
      <td>6184d74a-ca1e-44d1-b5b8-445aadb63208</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Map transportation routes and identify providers</td>
      <td>0c5b34e2-b12c-410e-992a-f4bba6326ebf</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish preservation solution procurement process</td>
      <td>d46b6612-cd0a-4ae8-bf54-a74fd1ed9003</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop packaging and handling procedures</td>
      <td>d73df452-bb1b-46f6-aaa8-c2a91243ecba</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Create temperature monitoring and tracking system</td>
      <td>36f291b9-ce07-4078-a331-08b7c984d520</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Implement Inventory Management System</td>
      <td></td>
      <td>f2158970-6c48-4dfa-97e5-6620da550d37</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Inventory System Requirements</td>
      <td>1e85e3e9-276d-4f0a-a9c1-3887d39771c1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Select Inventory Management Software</td>
      <td>d0af366a-186a-4e6b-ae0f-4a0f2fefa5b1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Configure and Customize Software</td>
      <td>09075e8b-5ccd-462a-96e9-b22d33b7e037</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Train Staff on System Usage</td>
      <td>c7be9ecc-472a-4a49-8280-d31b1a1d1c00</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Test and Validate System Functionality</td>
      <td>a99f4878-fb70-4658-820d-e104fcca0688</td>
    </tr>
    <tr>
      <td></td>
      <td>Medical Team Recruitment &amp; Training</td>
      <td></td>
      <td></td>
      <td>07f8df70-3b93-46d1-9571-5f7823a7865e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Recruit Transplant Surgeons, Nurses, and Technicians</td>
      <td></td>
      <td>a6dfbdbf-d854-44fa-aaea-71b6dfc22891</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Surgeon, Nurse, Technician Job Descriptions</td>
      <td>603662c9-344a-4f04-9c30-891acb6d9c8e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Advertise Open Positions on Relevant Platforms</td>
      <td>42ec1737-196e-4c88-bfdd-8e1a359cc439</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Screen Applications and Conduct Initial Interviews</td>
      <td>135fc0e9-438a-4721-b996-f43881f0fc16</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct Technical and Practical Skills Assessments</td>
      <td>fc6093c8-b948-46c1-9d82-fd919b41657b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Perform Background Checks and Credential Verification</td>
      <td>fb0389ed-03b4-4bd5-b726-119c8f3b7ba3</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Develop Training Programs for Medical Personnel</td>
      <td></td>
      <td>7018d1da-7992-42c1-bec3-176474ec2378</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Curriculum Design for Face Transplant Training</td>
      <td>80e6de91-5f68-4d73-9a76-851da609fa65</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Surgical Simulation Modules</td>
      <td>08d7cf07-78da-4107-8db6-279c1946f7fe</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish Mentorship Program with Experts</td>
      <td>38a84ba4-234b-4161-883f-f301d060cc1f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Create Standardized Post-Operative Care Protocols</td>
      <td>f95038eb-bebf-48da-8c5e-f6e7071c4757</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Training Evaluation and Certification</td>
      <td>83bd2c85-436e-45c2-b215-fe9917d4962c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Conduct Simulation Training Exercises</td>
      <td></td>
      <td>a3434b32-c11f-4b3e-b010-1e564ed21e55</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Simulation Scenarios and Protocols</td>
      <td>1a3a2127-0354-4eca-9056-427371200c79</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Acquire and Configure Simulation Equipment</td>
      <td>d21b27d7-b51a-41f9-a22a-2c7e89a6ed58</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Train Simulation Facilitators and Observers</td>
      <td>37f79344-021f-4563-b48d-d570bf04dbf9</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct Simulation Exercises and Gather Data</td>
      <td>f4577276-a266-4bc8-a82d-2141e7fbd99c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Analyze Simulation Data and Provide Feedback</td>
      <td>1036ce4c-4986-4b0c-9ca2-aaa3e71d7dc3</td>
    </tr>
    <tr>
      <td></td>
      <td>Subscription Model Development &amp; Marketing</td>
      <td></td>
      <td></td>
      <td>96817a78-23cf-4f51-b115-c0a63c20a419</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Design Subscription Model Tiers and Pricing</td>
      <td></td>
      <td>ec842223-c669-493e-b08c-ecd6501b2647</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Research competitor subscription models</td>
      <td>b723be5f-9208-453e-af6b-e20e7c2b0935</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define core service offerings</td>
      <td>5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop pricing models and financial projections</td>
      <td>2a86897a-4999-4dde-a5f1-d0dc8ed738f1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Assess legal and ethical considerations</td>
      <td>fd0ea2d9-788d-4e1c-b312-1fadfb8de5f2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Develop Marketing and Advertising Strategy</td>
      <td></td>
      <td>7f9f308e-365f-46e0-ad45-31a9dc51fa8b</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Target Audience and Market Segments</td>
      <td>3e63ebd3-2fe0-4e58-b1f0-4e8b4d98e90d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Key Messaging and Value Proposition</td>
      <td>ba2348a4-afa6-475e-9a0e-8bca32eb17b4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Select Marketing Channels and Platforms</td>
      <td>edb1c4da-05e4-4c54-a328-dbe7c6828042</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Create Marketing Materials and Content</td>
      <td>702c7a45-d903-47be-b61d-960415c32bdf</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish Public Relations and Media Outreach</td>
      <td>fccdd8e1-1a49-4b15-9724-d488b31c7026</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Establish Customer Service and Support Protocols</td>
      <td></td>
      <td>bcbecda8-592b-4c76-911b-8fdbf3848488</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop Customer Service Training Materials</td>
      <td>307fc299-ac88-4477-9b8c-b59b39705cb5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish Customer Service Channels</td>
      <td>fb381bef-9642-442b-a7bd-f9813836b69f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Define Service Level Agreements (SLAs)</td>
      <td>d5bc63d8-55c9-4f01-bc6f-a2a34337745d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Implement CRM System for Customer Data</td>
      <td>80f6dc05-65c9-43a1-81c5-d1a95d8ac6ce</td>
    </tr>
    <tr>
      <td></td>
      <td>Surgical Procedures &amp; Patient Care</td>
      <td></td>
      <td></td>
      <td>881ece3f-9348-4d69-93f2-2803c75dd85c</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Develop Pre-Transplant Assessment Protocols</td>
      <td></td>
      <td>ce5e2e90-d960-4aa6-9268-cf34537813aa</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Gather Patient Medical History and Records</td>
      <td>59642d8b-cfa6-4f76-8a05-a624ca6c29a1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct Physical and Neurological Examination</td>
      <td>0740ebfc-401c-4ae2-9111-2e108ed92750</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Psychological Evaluation and Counseling</td>
      <td>fa4f0b8a-fe8c-44f4-a0d3-114016cc67e4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Immunological Compatibility Testing</td>
      <td>5c2a916d-27d6-4cc2-8c2b-525402e8431d</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Financial and Insurance Assessment</td>
      <td>c954c1d8-3b97-4648-9c90-a48d923e6577</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Conduct Face Transplantation Procedures</td>
      <td></td>
      <td>b239ca08-0717-4219-b325-beaacb14e951</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Pre-operative planning and simulations</td>
      <td>4b5491cf-aa89-40b1-87c3-04da0c26bf55</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Ensure backup equipment and supplies</td>
      <td>c8ec5412-99e1-45dc-b7e7-7f5a6aee9579</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Experienced surgical team presence</td>
      <td>5ea620b1-5c65-43f9-9a73-1c1881b561b1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Implement strict infection control protocols</td>
      <td>a9703b20-d188-4b03-9664-7ff66bde33e2</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop contingency plans for complications</td>
      <td>20502188-d36c-45dd-9bf2-a8bc6ed0048e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Implement Post-Transplant Care and Monitoring Protocols</td>
      <td></td>
      <td>c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Monitor for rejection signs and symptoms</td>
      <td>f610d7ac-9e6d-459c-8f77-d4c384a4cc73</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Manage immunosuppression medication regimen</td>
      <td>3f756606-3068-4ede-87bb-f4ef7811519f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Provide wound care and infection control</td>
      <td>27d8c508-3cb0-449e-8744-26bde56fb0cc</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Offer physical and occupational therapy</td>
      <td>d1789094-0d0f-4e26-b283-84c4ae73fe45</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Address psychological and emotional needs</td>
      <td>53128582-e4e8-49c1-821c-89b833908400</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Establish Psychological Support Program</td>
      <td></td>
      <td>742e9056-0c0f-4c78-bec1-00825bc6dfa1</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Recruit qualified therapists and counselors</td>
      <td>9bfd6658-f8e9-43bd-baa4-6a626dcf1ab0</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Develop counseling protocols and materials</td>
      <td>71b12a59-061d-4e45-89a0-51509d3a9ad5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Establish support group infrastructure</td>
      <td>70e0a488-b358-4e8e-9056-592d8de91ff3</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Implement patient referral system</td>
      <td>4f4f3167-98ea-47ee-9e04-c332daa74fec</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Monitor and evaluate program effectiveness</td>
      <td>e54814fc-de88-4e29-bfc0-aa7ee072f345</td>
    </tr>
    <tr>
      <td></td>
      <td>Ongoing Operations &amp; Maintenance</td>
      <td></td>
      <td></td>
      <td>991ae3aa-a394-4134-a5a8-540b61b454b5</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Manage Facility Operations and Maintenance</td>
      <td></td>
      <td>036d3f1f-d298-4895-bd33-6009f5bf182f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Schedule routine equipment maintenance</td>
      <td>99b05c9b-3da6-4549-ba9e-6f683164e368</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Manage medical supply inventory</td>
      <td>24a1355a-be32-4f64-b6d7-d13216f50e26</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Address facility maintenance requests</td>
      <td>4ff300b0-b124-407b-b161-051804def801</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Ensure compliance with safety regulations</td>
      <td>cf21067b-023f-478e-9348-fceb3b17fd69</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Monitor and Evaluate Subscription Service Performance</td>
      <td></td>
      <td>9ad0a546-40bb-4563-adc1-099850a36f92</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Implement Data Collection Methods</td>
      <td>4a247e67-a282-43d8-80c1-e1b23ec05ca9</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Analyze Subscription Metrics</td>
      <td>c7f4ebe1-e39a-480b-a27c-2e54e214df2f</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct User Feedback Surveys</td>
      <td>d1ac5d53-91d3-4dee-848f-2cf200244eca</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Adjust Marketing Strategies</td>
      <td>73068e2d-0133-48b5-9059-f8cf9838a9cc</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Report Performance Findings</td>
      <td>e5dd9714-c2a0-42ce-90b3-3a5e6b7521ab</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Conduct Ongoing Regulatory Compliance Audits</td>
      <td></td>
      <td>fefe05de-7920-4c46-aad2-22acfc31ad4e</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify applicable regulatory compliance standards</td>
      <td>e066ece9-f4fc-44da-ac21-c7b4e1227405</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Schedule internal compliance audits</td>
      <td>bf6ab506-27ef-49cc-8f69-9cab73f21113</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Prepare audit documentation and checklists</td>
      <td>0030f8d5-5257-4b6e-9246-9bce57ff7458</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Conduct external regulatory compliance audits</td>
      <td>53859978-b189-4292-bdd2-ee08e3816a82</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Address audit findings and implement corrective actions</td>
      <td>23e9b77b-b49f-4b95-862e-bbc0950caa82</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td>Continuously Improve Processes and Technologies</td>
      <td></td>
      <td>ae90a39b-29b6-460d-a270-7d8989677943</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Identify areas for process improvement</td>
      <td>15d712d2-0f26-4294-97cd-66a0d12f7b66</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Evaluate emerging medical technologies</td>
      <td>c93808d4-549d-424b-be34-27ebc96f2ab4</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Pilot test new processes and technologies</td>
      <td>d6127fca-e8dc-4737-8977-db75c7f8a284</td>
    </tr>
    <tr>
      <td></td>
      <td></td>
      <td></td>
      <td>Implement approved improvements facility-wide</td>
      <td>a74fb24b-025c-44f1-abf3-f20f9c8c5540</td>
    </tr>
  </tbody>
</table>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Review Plan</button>
                <div class="content">        
                    <h2>Review 1: Critical Issues</h2>
<ol>
<li>
<p><strong>Unrealistic reliance on radical technologies poses a significant regulatory and financial risk.</strong> The 'Pioneer's Gambit' hinges on unproven technologies like xenotransplantation, which are unlikely to gain regulatory approval soon, potentially delaying the project by years and wasting millions in R&D; this interacts with ethical concerns, as jurisdictional arbitrage to bypass regulations could damage reputation, therefore, conduct a thorough feasibility study on xenotransplantation and CRISPR, consulting experts and developing a contingency plan focused on established technologies.</p>
</li>
<li>
<p><strong>Inadequate donor face acquisition and preservation plan threatens operational viability.</strong> The lack of a detailed plan to secure a consistent supply of donor faces could severely limit the number of transplants, impacting revenue and scalability; this is compounded by ethical concerns around consent, potentially leading to legal challenges, therefore, develop a comprehensive Donor Face Acquisition and Preservation Plan, including detailed protocols for donor selection, consent, retrieval, preservation, and transportation, consulting with experienced TPOs and ethicists.</p>
</li>
<li>
<p><strong>Ethical myopia regarding donor acquisition and consent could lead to legal and reputational damage.</strong> The plan's failure to address the unique ethical considerations of facial donation, including potential coercion and commodification, could result in public backlash and legal challenges, potentially shutting down the project; this interacts with the psychological impact on recipients and donor families, as ethical lapses could exacerbate mental health issues, therefore, immediately consult with leading bioethicists specializing in organ donation and identity ethics to develop a novel, ethically robust consent process for facial donation.</p>
</li>
</ol>
<h2>Review 2: Implementation Consequences</h2>
<ol>
<li>
<p><strong>Successful innovation in surgical techniques could lead to a high ROI but also increased initial costs.</strong> Advancements in surgical techniques and immunosuppression protocols could improve transplant outcomes, potentially increasing patient satisfaction and attracting more subscribers, leading to a 20-30% higher ROI in the long term; however, this requires significant upfront investment in R&amp;D, potentially increasing initial costs by $5-10 million, therefore, prioritize incremental improvements in existing techniques to balance innovation with cost-effectiveness and minimize risks.</p>
</li>
<li>
<p><strong>Ethical breaches could lead to significant financial losses and reputational damage.</strong> Failure to address ethical concerns adequately could result in public outcry, legal challenges, and a loss of social license to operate, potentially decreasing subscriber enrollment by 30-50% and leading to financial losses of $15-25 million annually; this interacts with regulatory hurdles, as ethical lapses could delay or deny necessary approvals, therefore, establish a comprehensive ethics review board and develop clear ethical guidelines to mitigate potential breaches and maintain public trust.</p>
</li>
<li>
<p><strong>Regulatory delays could significantly impact project timelines and increase costs.</strong> Navigating the complex regulatory landscape in New Zealand could take longer than anticipated, potentially delaying the project by 6-12 months and increasing costs by $2-5 million; this interacts with financial viability, as delays could erode investor confidence and make it more difficult to secure funding, therefore, engage regulatory bodies early and prepare comprehensive documentation to expedite the approval process and minimize delays.</p>
</li>
</ol>
<h2>Review 3: Recommended Actions</h2>
<ol>
<li>
<p><strong>Conduct a comprehensive feasibility study on xenotransplantation and CRISPR to reduce technological and regulatory risks (High Priority).</strong> This study, costing approximately $500,000, will provide concrete data on the likelihood of regulatory approval and the technological challenges involved, potentially saving millions in wasted R&amp;D by informing a more realistic technological development approach, therefore, engage leading experts in xenotransplantation immunology, regulatory affairs, and transplant ethics to conduct the study and develop a contingency plan based on established technologies.</p>
</li>
<li>
<p><strong>Develop a detailed immunosuppression protocol to improve patient outcomes and reduce rejection rates (High Priority).</strong> This protocol, requiring an investment of $200,000 in expert consultation and research, will specify agents, dosages, and monitoring strategies, potentially reducing rejection rates by 10-15% and improving long-term graft survival, therefore, consult with experienced transplant immunologists and infectious disease specialists to develop the protocol and incorporate psychological support services to address the emotional impact of chronic immunosuppression.</p>
</li>
<li>
<p><strong>Develop a detailed contingency plan for addressing ethical breaches to mitigate reputational and legal risks (Medium Priority).</strong> This plan, costing approximately $100,000 to develop and implement, will outline investigation protocols, communication strategies, and remediation measures, potentially preventing significant financial losses and reputational damage by ensuring a proactive and ethical response to any ethical failures, therefore, establish a cross-functional team, including ethicists, legal counsel, and public relations specialists, to develop the plan and regularly review and update it.</p>
</li>
</ol>
<h2>Review 4: Showstopper Risks</h2>
<ol>
<li>
<p><strong>Unexpected long-term health consequences for face recipients could lead to project shutdown (High Likelihood, High Impact).</strong> If unforeseen health issues arise years after transplantation, such as novel immune-related diseases or accelerated aging of the transplanted face, the project could face lawsuits, reputational damage, and ultimately, a complete shutdown, resulting in a loss of the entire $50 million investment and potentially billions in legal liabilities; this risk compounds with ethical concerns, as long-term health issues could raise questions about informed consent and the ethical justification for the procedure, therefore, establish a long-term patient registry and monitoring program to track health outcomes and proactively address any emerging issues; <em>Contingency: Secure a substantial liability insurance policy to cover potential long-term health consequences and establish a patient compensation fund.</em></p>
</li>
<li>
<p><strong>Failure to secure sufficient donor faces due to unforeseen logistical or ethical barriers (Medium Likelihood, High Impact).</strong> If partnerships with organ donation organizations fail to yield enough suitable donor faces, or if new ethical restrictions limit face donation, the facility could operate at significantly reduced capacity, leading to a 50-75% reduction in projected revenue and potentially rendering the subscription model unsustainable; this risk interacts with financial viability, as lower revenue could make it difficult to cover operating costs and attract further investment, therefore, explore alternative sources for donor faces, such as international collaborations or the development of artificial faces through tissue engineering; <em>Contingency: Develop a tiered subscription model that offers alternative services, such as advanced facial reconstruction or cosmetic surgery, if face transplantation is not feasible.</em></p>
</li>
<li>
<p><strong>Cybersecurity breach compromising sensitive patient data and intellectual property (Low Likelihood, High Impact).</strong> A successful cyberattack could expose sensitive patient medical records, financial information, and proprietary surgical techniques, leading to significant legal liabilities, reputational damage, and a loss of competitive advantage, potentially costing millions in fines and remediation efforts; this risk compounds with regulatory compliance, as data breaches could result in severe penalties under data privacy regulations, therefore, implement a multi-layered cybersecurity strategy, including robust firewalls, intrusion detection systems, and employee training programs; <em>Contingency: Establish a comprehensive data breach response plan and secure cyber insurance to cover potential losses and legal fees.</em></p>
</li>
</ol>
<h2>Review 5: Critical Assumptions</h2>
<ol>
<li>
<p><strong>Patients will be willing to undergo face transplantation and participate in the subscription model (High Impact if Incorrect).</strong> If patient demand is significantly lower than projected, the facility could face financial losses and struggle to attract investors, potentially decreasing ROI by 40-60%; this assumption interacts with the risk of low social acceptance, as negative public perception could deter potential subscribers, therefore, conduct thorough market research to assess patient interest and willingness to pay for the subscription service, and adjust the subscription model based on market feedback; <em>Validation: Conduct pilot programs with a small group of carefully selected candidates to gauge interest and gather feedback.</em></p>
</li>
<li>
<p><strong>Qualified medical personnel can be recruited and trained within the specified timeline and budget (High Impact if Incorrect).</strong> If the facility struggles to attract and retain skilled surgeons, nurses, and technicians, the quality of care could be compromised, leading to higher complication rates and reputational damage, potentially increasing operating costs by 20-30%; this assumption interacts with the risk of technical complications, as a less experienced medical team could be more prone to surgical errors, therefore, offer competitive compensation packages and establish partnerships with leading medical institutions to attract top talent, and develop comprehensive training programs to ensure all personnel are adequately prepared; <em>Validation: Conduct a skills gap analysis to identify training needs and develop a detailed recruitment plan with realistic timelines and budget allocations.</em></p>
</li>
<li>
<p><strong>The technology will continue to advance, improving transplant outcomes and reducing risks (High Impact if Incorrect).</strong> If technological advancements stall or fail to deliver expected improvements, the facility could struggle to compete with alternative treatments and face higher complication rates, potentially leading to a decrease in patient satisfaction and subscriber retention, decreasing ROI by 15-25%; this assumption interacts with the reliance on radical technologies, as a failure to achieve breakthroughs in areas like xenotransplantation could render the 'Pioneer's Gambit' strategy unviable, therefore, invest in ongoing R&amp;D and monitor technological developments closely, and develop contingency plans based on established technologies; <em>Validation: Establish a technology advisory board composed of leading experts in transplantation and related fields to assess the feasibility and potential impact of emerging technologies.</em></p>
</li>
</ol>
<h2>Review 6: Key Performance Indicators</h2>
<ol>
<li>
<p><strong>Patient Satisfaction Rate (Target: &gt;80% positive feedback, &lt;5% negative feedback; Corrective Action: &lt;70% positive or &gt;10% negative).</strong> This KPI directly reflects the success of the psychological support program and the ethical considerations implemented, as dissatisfaction could stem from unmet psychological needs or ethical breaches; it interacts with the assumption that patients will be willing to undergo face transplantation and participate in the subscription model, therefore, regularly administer post-operative surveys and conduct patient interviews to gather feedback and identify areas for improvement in patient care and ethical practices.</p>
</li>
<li>
<p><strong>Graft Rejection Rate (Target: &lt;10% within the first year, &lt;5% annually thereafter; Corrective Action: &gt;15% in the first year or &gt;8% annually).</strong> This KPI measures the effectiveness of the immunosuppression protocol and the surgical team's expertise, directly impacting the long-term health consequences for face recipients; it interacts with the risk of technical complications and the assumption that the technology will continue to advance, therefore, closely monitor patients for signs of rejection and adjust the immunosuppression regimen as needed, and invest in ongoing R&amp;D to improve surgical techniques and immunosuppression protocols.</p>
</li>
<li>
<p><strong>Subscriber Retention Rate (Target: &gt;75% annual retention; Corrective Action: &lt;60% annual retention).</strong> This KPI reflects the overall value proposition of the subscription model and the facility's ability to meet patient needs, directly impacting financial viability; it interacts with the assumption that patients will be willing to pay for the subscription service and the risk of low social acceptance, therefore, regularly analyze subscriber data to identify reasons for churn and implement strategies to improve retention, such as offering personalized services or addressing ethical concerns through transparent communication and community engagement.</p>
</li>
</ol>
<h2>Review 7: Report Objectives</h2>
<ol>
<li>
<p>**Objectives and Deliverables: The primary objective is to provide a critical review of the face transplantation facility plan, identifying key risks, assumptions, and recommendations to improve its feasibility and long-term success, delivering a comprehensive report with actionable insights and quantified impacts.</p>
</li>
<li>
<p>**Intended Audience and Key Decisions: The intended audience is the project's leadership team and investors, aiming to inform strategic decisions related to technological development, ethical oversight, regulatory compliance, risk mitigation, and financial planning.</p>
</li>
<li>
<p>**Version 2 Differentiation: Version 2 should incorporate feedback from Version 1, providing more detailed and specific recommendations, quantified impacts, and contingency plans, addressing previously identified gaps and uncertainties with concrete data and expert validation.</p>
</li>
</ol>
<h2>Review 8: Data Quality Concerns</h2>
<ol>
<li>
<p><strong>Market demand for face transplantation and the subscription model lacks sufficient data (Critical for financial viability).</strong> Relying on inaccurate market projections could lead to overestimation of subscriber enrollment and revenue, resulting in significant financial losses and an unsustainable business model, potentially decreasing ROI by 40-60%, therefore, conduct thorough market research, including surveys, focus groups, and analysis of comparable medical subscription services, to validate demand and refine financial projections.</p>
</li>
<li>
<p><strong>Projected costs for ethical compliance and psychological support are likely underestimated (Critical for ethical integrity and patient well-being).</strong> Underestimating these costs could compromise the quality of ethical oversight and patient care, leading to ethical breaches, reputational damage, and increased patient attrition, potentially increasing operating costs by 20-30%, therefore, consult with leading bioethicists and psychologists to develop detailed budgets for ethical compliance and psychological support, and allocate sufficient resources to ensure high-quality services.</p>
</li>
<li>
<p><strong>Availability of donor faces in New Zealand is uncertain (Critical for operational capacity).</strong> Relying on inaccurate estimates of donor face availability could lead to significant limitations in the number of transplants performed, impacting revenue and scalability, potentially reducing revenue by 50-75%, therefore, collaborate with organ donation organizations and conduct a thorough assessment of potential donor sources, and develop contingency plans for sourcing faces from international collaborations or alternative technologies.</p>
</li>
</ol>
<h2>Review 9: Stakeholder Feedback</h2>
<ol>
<li>
<p><strong>Feedback from regulatory bodies (Medsafe, Ministry of Health) is needed to clarify approval timelines and requirements (Critical for project timeline and budget).</strong> Unclear regulatory expectations could lead to delays and increased costs, potentially delaying the project by 6-12 months and increasing costs by $2-5 million, therefore, schedule meetings with key contacts at regulatory bodies to present the project overview, clarify regulatory requirements, and obtain feedback on the proposed approach, and incorporate this feedback into the regulatory compliance plan.</p>
</li>
<li>
<p><strong>Feedback from transplant surgeons and medical ethicists is needed to validate the feasibility and ethical soundness of the surgical protocols and ethical guidelines (Critical for patient safety and ethical integrity).</strong> Unvalidated protocols and guidelines could lead to surgical complications, ethical breaches, and reputational damage, potentially decreasing patient satisfaction and subscriber enrollment by 30-50%, therefore, conduct expert reviews of the surgical protocols and ethical guidelines, and incorporate their feedback to ensure patient safety and ethical compliance.</p>
</li>
<li>
<p><strong>Feedback from potential investors is needed to assess the attractiveness of the project and secure funding commitments (Critical for financial viability).</strong> Lack of investor confidence could lead to difficulty securing funding, potentially jeopardizing the entire project, therefore, present the project overview and financial projections to potential investors, solicit their feedback on the business model and investment terms, and incorporate this feedback to improve the attractiveness of the project.</p>
</li>
</ol>
<h2>Review 10: Changed Assumptions</h2>
<ol>
<li>
<p><strong>Regulatory landscape in New Zealand may have evolved (Impact: Timeline delays, increased compliance costs).</strong> If new regulations or guidelines have been introduced since Version 1, the project may face additional compliance requirements and approval delays, potentially adding 3-6 months to the timeline and increasing compliance costs by $500,000-$1 million; this could influence the regulatory approval strategy, requiring a more proactive and adaptive engagement with regulatory bodies, therefore, conduct a thorough review of the latest regulatory updates from Medsafe and the Ministry of Health, and update the regulatory compliance plan accordingly.</p>
</li>
<li>
<p><strong>Availability and cost of surgical equipment and medical supplies may have fluctuated (Impact: Increased operating costs, reduced profit margins).</strong> If prices for essential equipment and supplies have increased due to supply chain disruptions or inflation, the facility's operating costs could rise, potentially reducing profit margins by 10-15%; this could influence the operational efficiency strategy, requiring a more aggressive approach to cost control and resource optimization, therefore, obtain updated quotes from multiple vendors for all essential equipment and supplies, and revise the financial model to reflect current market prices.</p>
</li>
<li>
<p><strong>Public perception of face transplantation and the subscription model may have shifted (Impact: Reduced subscriber enrollment, negative media coverage).</strong> If public sentiment has become more negative due to ethical concerns or negative media coverage, the project may face lower subscriber enrollment and reputational damage, potentially decreasing ROI by 20-30%; this could influence the marketing and advertising strategy, requiring a more cautious and ethical approach to promoting the service, therefore, monitor social media and news outlets for mentions of face transplantation and the subscription model, and conduct public opinion surveys to assess current sentiment and identify potential concerns.</p>
</li>
</ol>
<h2>Review 11: Budget Clarifications</h2>
<ol>
<li>
<p><strong>Clarify the budget allocation for long-term patient monitoring and care (Impact: Potential cost overruns, legal liabilities).</strong> The current budget may not adequately account for the ongoing costs of monitoring patients for long-term health consequences and providing necessary medical care, potentially leading to significant cost overruns and legal liabilities if unforeseen health issues arise, therefore, consult with medical experts to develop a detailed budget for long-term patient monitoring and care, including provisions for potential complications and legal fees, and allocate sufficient reserves to cover these costs.</p>
</li>
<li>
<p><strong>Clarify the budget allocation for data privacy and security measures (Impact: Potential fines, reputational damage).</strong> The current budget may not adequately account for the costs of implementing and maintaining robust data privacy and security measures, potentially leading to significant fines and reputational damage if a data breach occurs, therefore, consult with cybersecurity experts to develop a comprehensive data privacy and security plan, and allocate sufficient resources to implement and maintain necessary security measures, including data encryption, access controls, and employee training.</p>
</li>
<li>
<p><strong>Clarify the budget allocation for community engagement and public relations (Impact: Potential public opposition, reduced enrollment).</strong> The current budget may not adequately account for the costs of engaging with the community and addressing public concerns about face transplantation and the subscription model, potentially leading to public opposition and reduced subscriber enrollment, therefore, develop a detailed community engagement plan and allocate sufficient resources to implement it, including provisions for public forums, educational materials, and media outreach.</p>
</li>
</ol>
<h2>Review 12: Role Definitions</h2>
<ol>
<li>
<p><strong>Decision-making authority of the Ethics Review Board (ERB) Coordinator (Impact: Ethical breaches, project delays).</strong> Unclear authority could lead to delayed ethical reviews, inconsistent application of ethical guidelines, and potential ethical breaches, potentially delaying project milestones by 1-2 months and increasing the risk of public outcry, therefore, develop a detailed charter for the ERB, outlining its decision-making authority, reporting structure, and interaction protocols with other team members, and ensure that this charter is approved by all relevant stakeholders.</p>
</li>
<li>
<p><strong>Responsibilities for donor face acquisition and preservation logistics (Impact: Donor shortages, operational delays).</strong> Unclear responsibilities could lead to logistical bottlenecks, delays in face transportation, and potential shortages of donor faces, potentially limiting the number of transplant procedures and impacting revenue, therefore, explicitly assign responsibility for each step of the donor face acquisition and preservation process, from initial contact with organ donation organizations to final storage and inventory management, and develop detailed standard operating procedures (SOPs) for each task.</p>
</li>
<li>
<p><strong>Accountability for data privacy and security compliance (Impact: Data breaches, legal liabilities).</strong> Unclear accountability could lead to inadequate data protection measures and potential data breaches, resulting in significant legal liabilities and reputational damage, therefore, clearly assign responsibility for data privacy and security compliance to a designated Data Security &amp; Privacy Officer, and empower this individual to implement and enforce data protection policies and procedures.</p>
</li>
</ol>
<h2>Review 13: Timeline Dependencies</h2>
<ol>
<li>
<p><strong>Securing regulatory approval before finalizing facility construction plans (Impact: Costly rework, timeline delays).</strong> If facility construction begins before obtaining regulatory approval, the facility may need to be modified to meet regulatory requirements, leading to costly rework and timeline delays, potentially adding 3-6 months to the construction timeline and increasing costs by $1-2 million; this interacts with the risk of regulatory delays, as unforeseen regulatory requirements could further delay the project, therefore, prioritize obtaining regulatory approval before finalizing facility construction plans, and maintain close communication with regulatory bodies throughout the design and construction process.</p>
</li>
<li>
<p><strong>Establishing partnerships with organ donation organizations before developing donor face acquisition protocols (Impact: Ineffective protocols, donor shortages).</strong> If donor face acquisition protocols are developed without input from organ donation organizations, the protocols may be ineffective or incompatible with their procedures, leading to donor shortages and operational delays, potentially limiting the number of transplant procedures and impacting revenue, therefore, establish partnerships with organ donation organizations before developing donor face acquisition protocols, and collaborate with them to develop protocols that are ethical, efficient, and compatible with their existing practices.</p>
</li>
<li>
<p><strong>Recruiting and training medical personnel before procuring surgical equipment (Impact: Incompatible equipment, training inefficiencies).</strong> If surgical equipment is procured before recruiting and training medical personnel, the equipment may not be compatible with their skills and preferences, leading to training inefficiencies and potential surgical complications, therefore, recruit key medical personnel, such as the lead transplant surgeon, before procuring surgical equipment, and involve them in the selection process to ensure that the equipment meets their needs and preferences.</p>
</li>
</ol>
<h2>Review 14: Financial Strategy</h2>
<ol>
<li>
<p><strong>Long-term sustainability of the subscription model (Impact: Financial instability, project shutdown).</strong> If the subscription model proves unsustainable due to high operating costs, low subscriber retention, or unforeseen market changes, the facility could face financial instability and potential shutdown, resulting in a loss of the entire $50 million investment; this interacts with the assumption that patients will be willing to pay for the subscription service and the risk of low social acceptance, therefore, develop a detailed financial model that projects long-term revenue and expenses, and explore alternative revenue streams, such as grants, donations, or partnerships with medical research institutions.</p>
</li>
<li>
<p><strong>Financial implications of potential legal liabilities (Impact: Bankruptcy, loss of investor confidence).</strong> If the facility faces significant legal liabilities due to surgical complications, ethical breaches, or data breaches, the financial impact could be devastating, potentially leading to bankruptcy and a loss of investor confidence; this interacts with the risk of surgical complications, ethical concerns, and data breaches, therefore, secure comprehensive liability insurance coverage and establish a legal reserve fund to cover potential legal expenses and settlements.</p>
</li>
<li>
<p><strong>Impact of technological obsolescence on long-term competitiveness (Impact: Reduced market share, decreased ROI).</strong> If the facility fails to keep pace with technological advancements in face transplantation and related fields, it could lose its competitive edge and face declining market share, potentially decreasing ROI by 20-30%; this interacts with the assumption that the technology will continue to advance, therefore, allocate a significant portion of the budget to ongoing R&amp;D and monitor technological developments closely, and develop a plan for upgrading equipment and adopting new technologies as they become available.</p>
</li>
</ol>
<h2>Review 15: Motivation Factors</h2>
<ol>
<li>
<p><strong>Maintaining strong leadership commitment and vision (Impact: Timeline delays, strategic drift).</strong> If leadership loses focus or commitment, the project could suffer from timeline delays, strategic drift, and a lack of clear direction, potentially delaying project milestones by 3-6 months and increasing costs by $1-2 million; this interacts with the assumption that the technology will continue to advance, as a lack of leadership commitment could stifle innovation and prevent the facility from keeping pace with technological developments, therefore, regularly communicate the project's vision and goals to the team, celebrate successes, and address any concerns or challenges promptly.</p>
</li>
<li>
<p><strong>Fostering a collaborative and supportive team environment (Impact: Reduced success rates, increased staff turnover).</strong> If the team environment becomes toxic or unsupportive, it could lead to reduced success rates, increased staff turnover, and a decline in the quality of care, potentially increasing complication rates and decreasing patient satisfaction; this interacts with the risk of technical complications, as a lack of teamwork and communication could exacerbate surgical errors and other medical issues, therefore, promote open communication, teamwork, and mutual respect among team members, and provide opportunities for professional development and team-building activities.</p>
</li>
<li>
<p><strong>Ensuring consistent progress and celebrating milestones (Impact: Reduced motivation, increased risk of failure).</strong> If the project experiences prolonged periods of stagnation or setbacks, it could lead to reduced motivation and an increased risk of failure, potentially jeopardizing the entire project; this interacts with the assumption that the project will progress according to the planned timeline, therefore, break down the project into smaller, manageable tasks, track progress closely, and celebrate milestones to maintain momentum and boost morale.</p>
</li>
</ol>
<h2>Review 16: Automation Opportunities</h2>
<ol>
<li>
<p><strong>Automate data collection and analysis for patient monitoring (Savings: 20-30% reduction in manual data entry time, improved accuracy).</strong> Automating data collection from patient monitoring devices and electronic health records can significantly reduce the time spent on manual data entry and analysis, freeing up medical personnel to focus on patient care; this interacts with the timeline for post-transplant care and monitoring, as automation can expedite the process and improve efficiency, therefore, implement a data integration platform that automatically collects and analyzes data from patient monitoring devices and electronic health records, and train staff on how to use the platform effectively.</p>
</li>
<li>
<p><strong>Streamline regulatory compliance documentation and reporting (Savings: 15-20% reduction in compliance costs, improved accuracy).</strong> Automating the preparation and submission of regulatory compliance documentation can reduce the time and resources spent on compliance activities, and improve accuracy and consistency; this interacts with the regulatory approval strategy, as streamlined compliance processes can expedite the approval process and minimize delays, therefore, implement a regulatory compliance management system that automates the preparation and submission of required documentation, and train staff on how to use the system effectively.</p>
</li>
<li>
<p><strong>Automate inventory management for medical supplies and equipment (Savings: 10-15% reduction in inventory costs, improved supply chain efficiency).</strong> Automating inventory management can reduce waste, prevent stockouts, and improve supply chain efficiency, leading to cost savings and improved operational performance; this interacts with the resource constraints related to medical supplies and equipment, as automation can optimize inventory levels and minimize waste, therefore, implement an inventory management system that tracks inventory levels in real-time, automates ordering processes, and provides alerts for low stock levels, and train staff on how to use the system effectively.</p>
</li>
</ol>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Questions & Answers</button>
                <div class="content">        
                    <div class="question-answer-pair"><p><strong>1.</strong> The document mentions a &#x27;decentralized autonomous organization (DAO)&#x27; for risk mitigation and ethical oversight. What is a DAO in this context, and how does it address the specific risks and ethical concerns of face transplantation?</p>
<p>A Decentralized Autonomous Organization (DAO) in this context refers to a community-led entity with rules encoded on a blockchain. The goal is to distribute decision-making power, increase transparency, and potentially mitigate risks by decentralizing control. For face transplantation, a DAO could allow stakeholders (patients, donors, medical professionals, community members) to vote on ethical dilemmas or risk management strategies, aiming to ensure decisions are not solely in the hands of the organization&#x27;s leadership. However, the document also acknowledges that a DAO doesn&#x27;t guarantee ethical outcomes and requires careful design to ensure informed and ethical participation.</p></div>
<div class="question-answer-pair"><p><strong>2.</strong> The &#x27;Regulatory Approval Strategy&#x27; discusses &#x27;Jurisdictional Arbitrage.&#x27; What does this mean, and what are the potential ethical and reputational risks associated with this approach in the context of face transplantation?</p>
<p>&#x27;Jurisdictional Arbitrage&#x27; refers to establishing operations in regions with more permissive regulations, in this case, for face transplantation. While it could expedite the regulatory approval process, it carries significant ethical and reputational risks. Operating in a jurisdiction with lower ethical standards could compromise patient safety and well-being, leading to public criticism and potentially undermining the project&#x27;s long-term sustainability. The document itself notes that this strategy can conflict with the &#x27;Ethical Oversight Strategy&#x27;.</p></div>
<div class="question-answer-pair"><p><strong>3.</strong> The document identifies a key risk as &#x27;Ethical implications of face transplantation and subscription model.&#x27; What specific ethical concerns are raised by the combination of face transplantation and a subscription service, and how does the project plan to address them?</p>
<p>The combination of face transplantation and a subscription model raises several ethical concerns, including: (1) the potential for commodification of human faces, treating them as mere objects for exchange; (2) the risk of coercion or exploitation of vulnerable individuals who may be pressured to donate faces; (3) the psychological impact on both recipients and donor families; and (4) questions of fairness and access to this novel service. The project plans to address these concerns through an ethics review board, ethical guidelines for patient selection and consent, psychological support, public awareness campaigns, and potentially a DAO for ethical decision-making. However, the document also acknowledges weaknesses in these plans, such as the potential for coercion and the need for a more detailed donor face acquisition plan.</p></div>
<div class="question-answer-pair"><p><strong>4.</strong> The &#x27;Technological Development Approach&#x27; mentions &#x27;xenotransplantation.&#x27; What is xenotransplantation, and why is it considered a &#x27;Radical Disruption&#x27; with potential conflicts with the &#x27;Regulatory Approval Strategy&#x27;?</p>
<p>Xenotransplantation refers to transplanting organs or tissues from one species to another (e.g., from animals to humans). In the context of face transplantation, it would involve using animal faces as donor material. This is considered a &#x27;Radical Disruption&#x27; because it could potentially overcome the limitations of human donor scarcity. However, it also faces significant regulatory hurdles and ethical concerns due to the risk of zoonotic diseases (transmission of diseases from animals to humans), immunological incompatibility, and ethical objections to using animals for human benefit. These concerns explain the potential conflict with the &#x27;Regulatory Approval Strategy,&#x27; as regulators may be hesitant to approve such a procedure.</p></div>
<div class="question-answer-pair"><p><strong>5.</strong> The document mentions a &#x27;Risk Mitigation Protocol&#x27; and the potential for &#x27;Lawsuits → Systemic: 60% increase in insurance premiums and legal fees → Strategic: Financial instability and potential bankruptcy.&#x27; What specific legal risks are anticipated, and how does the protocol aim to mitigate them?</p>
<p>The document anticipates legal risks primarily arising from unforeseen complications during or after face transplantation, potentially leading to lawsuits related to medical malpractice, negligence, or lack of informed consent. The &#x27;Risk Mitigation Protocol&#x27; aims to minimize these risks through strict patient screening, comprehensive informed consent procedures, and a comprehensive insurance policy to cover potential liabilities and medical complications. The protocol also explores the use of a DAO to distribute risk and ensure transparency in decision-making, although the document acknowledges that this approach has limitations.</p></div>
<div class="question-answer-pair"><p><strong>6.</strong> The document mentions the potential for &#x27;public outcry&#x27; as a risk. What specific aspects of the face transplantation project are most likely to trigger public concern, and how can the project proactively address these concerns to maintain public trust?</p>
<p>Several aspects of the face transplantation project could trigger public outcry, including: (1) ethical concerns about the commodification of human faces and the potential for exploitation of vulnerable individuals; (2) religious or cultural objections to altering the human body or &#x27;playing God&#x27;; (3) concerns about the psychological impact on recipients and donor families; (4) fears about the safety and long-term health consequences of the procedure; and (5) skepticism about the value and necessity of face transplantation compared to other medical priorities. The project can proactively address these concerns through transparent communication, public awareness campaigns, community engagement, ethical guidelines, and a commitment to patient safety and well-being. The document also suggests a DAO to govern ethical decisions, allowing stakeholders to vote on controversial cases.</p></div>
<div class="question-answer-pair"><p><strong>7.</strong> The document discusses the importance of &#x27;patient autonomy and informed consent.&#x27; What specific measures will be implemented to ensure that potential face transplant recipients fully understand the risks, benefits, and alternatives to the procedure, and that their consent is truly voluntary and informed?</p>
<p>To ensure patient autonomy and informed consent, the project will implement several measures, including: (1) providing comprehensive information about the risks, benefits, and alternatives to face transplantation in clear and accessible language; (2) conducting thorough psychological evaluations to assess patients&#x27; mental capacity and emotional stability; (3) offering independent counseling to help patients make informed decisions without coercion or undue influence; (4) obtaining written consent from patients after they have had sufficient time to consider the information and ask questions; and (5) establishing an ethics review board to oversee the consent process and ensure that it meets ethical standards. The document also acknowledges the need to address potential coercion and exploitation of vulnerable individuals.</p></div>
<div class="question-answer-pair"><p><strong>8.</strong> The document identifies &#x27;Financial viability uncertain due to high costs and novelty&#x27; as a risk. Beyond securing initial funding, what strategies will be employed to ensure the long-term financial sustainability of the face transplantation facility, particularly given the experimental nature of the procedure and the potential for unforeseen costs?</p>
<p>To ensure long-term financial sustainability, the project will employ several strategies, including: (1) developing a detailed financial model that projects revenue and expenses over a long-term horizon; (2) securing diverse funding sources, including grants, donations, and partnerships with medical research institutions; (3) implementing cost control measures to minimize operating expenses; (4) exploring alternative revenue streams, such as offering related medical services or licensing intellectual property; (5) continuously monitoring market trends and adjusting the business model as needed; and (6) investing in research and development to improve the efficiency and effectiveness of the procedure. The document also mentions the subscription model as a potential source of stable revenue.</p></div>
<div class="question-answer-pair"><p><strong>9.</strong> The document mentions the potential for &#x27;Social isolation&#x27; as a risk for face transplant recipients. What specific steps will be taken to help recipients reintegrate into society and cope with the social and emotional challenges of wearing another person&#x27;s face?</p>
<p>To help recipients reintegrate into society and cope with the social and emotional challenges of wearing another person&#x27;s face, the project will implement several steps, including: (1) providing pre- and post-transplant counseling to address body image concerns and identity issues; (2) establishing support groups where recipients can connect with others who have undergone similar experiences; (3) offering social skills training to help recipients navigate social interactions and respond to questions or comments about their appearance; (4) partnering with community organizations to promote awareness and acceptance of face transplantation; and (5) providing ongoing psychological support to address any social or emotional difficulties that may arise. The document also highlights the importance of community support.</p></div>
<div class="question-answer-pair"><p><strong>10.</strong> The document mentions the possibility of using a &#x27;dynamic pricing&#x27; model for the face-wearing subscription service. What are the potential ethical concerns associated with dynamic pricing in this context, and how can the project ensure fairness and avoid exploiting vulnerable individuals?</p>
<p>Dynamic pricing, where prices fluctuate based on demand or other factors, raises several ethical concerns in the context of face transplantation, including: (1) the potential for price gouging, where prices are raised to exorbitant levels, making the service unaffordable for some; (2) the risk of discrimination, where prices are higher for certain individuals or groups; (3) concerns about fairness and transparency, where the pricing algorithm is opaque and difficult to understand; and (4) the potential for commodification of human faces, where prices are driven by popularity or desirability. To ensure fairness and avoid exploiting vulnerable individuals, the project can implement several measures, including: (1) setting price caps to prevent price gouging; (2) ensuring transparency in the pricing algorithm; (3) offering subsidized subscriptions for low-income individuals; (4) establishing an ethics review board to oversee pricing policies; and (5) engaging with community representatives to gather feedback and ensure fairness. The document also mentions blockchain-based smart contracts for transparent royalty distribution to face donors.</p></div>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Premortem</button>
                <div class="content">        
                    <p>A premortem assumes the project has failed and works backward to identify the most likely causes.</p>
<h2>Assumptions to Kill</h2>
<p>These foundational assumptions represent the project's key uncertainties. If proven false, they could lead to failure. Validate them immediately using the specified methods.</p>
<table>
<thead>
<tr>
<th>ID</th>
<th>Assumption</th>
<th>Validation Method</th>
<th>Failure Trigger</th>
</tr>
</thead>
<tbody>
<tr>
<td>A1</td>
<td>Donor face acquisition will consistently meet demand.</td>
<td>Contact three major organ donation organizations in New Zealand and request their historical data on face donations or potential face donors.</td>
<td>All three organizations report zero historical face donations and express significant reservations about the feasibility of acquiring face donations in the future due to ethical and logistical challenges.</td>
</tr>
<tr>
<td>A2</td>
<td>Radical technological approaches (CRISPR, xenotransplantation) will be viable within the project timeline and budget.</td>
<td>Commission a feasibility study from an independent scientific consultancy specializing in xenotransplantation and CRISPR, focusing on regulatory hurdles, technical challenges, and estimated timelines for clinical application in New Zealand.</td>
<td>The feasibility study concludes that xenotransplantation and CRISPR face insurmountable regulatory hurdles in New Zealand within the next 5-7 years and would require at least $50 million in additional R&amp;D funding to even reach the clinical trial stage.</td>
</tr>
<tr>
<td>A3</td>
<td>The subscription model will be socially acceptable and commercially viable.</td>
<td>Conduct a survey of 1000 New Zealand residents, assessing their attitudes towards face transplantation and their willingness to pay for a face-swapping subscription service, including questions about ethical concerns and perceived value.</td>
<td>The survey reveals that over 75% of respondents find the concept of a face-swapping subscription service ethically objectionable, and less than 5% express any willingness to pay for such a service, even at a nominal price.</td>
</tr>
<tr>
<td>A4</td>
<td>The facility can maintain a high level of data security and patient privacy.</td>
<td>Conduct a penetration test by a reputable cybersecurity firm to assess the vulnerability of the facility's IT systems and data storage protocols.</td>
<td>The penetration test reveals multiple critical vulnerabilities that could allow unauthorized access to patient data, including medical records, financial information, and personal details.</td>
</tr>
<tr>
<td>A5</td>
<td>The facility can effectively manage the psychological impact on both face recipients and donor families.</td>
<td>Consult with a panel of psychologists and psychiatrists specializing in transplantation and identity issues to review the facility's psychological support program and assess its adequacy in addressing the complex emotional needs of recipients and donor families.</td>
<td>The panel of experts concludes that the psychological support program is inadequate and lacks the resources and expertise necessary to effectively address the long-term psychological challenges faced by recipients and donor families, particularly in the context of face transplantation.</td>
</tr>
<tr>
<td>A6</td>
<td>The facility can secure and maintain adequate insurance coverage at a reasonable cost.</td>
<td>Obtain quotes from multiple insurance providers for comprehensive medical liability insurance, including coverage for potential complications, ethical breaches, and data breaches, and assess the affordability and scope of coverage.</td>
<td>All insurance providers decline to offer coverage due to the high-risk nature of face transplantation and the novelty of the subscription model, or the premiums quoted are prohibitively expensive, exceeding 20% of the facility's projected annual revenue.</td>
</tr>
<tr>
<td>A7</td>
<td>The facility will be able to attract and retain qualified medical personnel (surgeons, nurses, technicians, ethicists) within the allocated budget.</td>
<td>Conduct a salary survey of comparable medical facilities in New Zealand and Australia to determine the prevailing market rates for the required medical personnel, and compare these rates to the facility's proposed salary budget.</td>
<td>The salary survey reveals that the facility's proposed salary budget is significantly below market rates, making it unlikely to attract and retain qualified medical personnel, particularly experienced surgeons and ethicists.</td>
</tr>
<tr>
<td>A8</td>
<td>The supply chain for specialized medical supplies and equipment will be reliable and cost-effective.</td>
<td>Obtain quotes from multiple suppliers for all essential medical supplies and equipment, including specialized surgical instruments, immunosuppressant drugs, and data security systems, and assess the reliability of the supply chain and the potential for disruptions.</td>
<td>The quotes reveal that the cost of specialized medical supplies and equipment is significantly higher than anticipated, and the supply chain is vulnerable to disruptions due to reliance on a limited number of suppliers and potential geopolitical instability.</td>
</tr>
<tr>
<td>A9</td>
<td>The facility will be able to effectively manage public perception and maintain a positive brand image.</td>
<td>Conduct a focus group study with members of the general public to assess their initial reactions to the facility's proposed services and marketing materials, and identify potential concerns and misconceptions.</td>
<td>The focus group study reveals that the public has significant concerns about the ethical implications of face transplantation and the subscription model, and the facility's marketing materials are perceived as sensationalistic and insensitive, potentially damaging the brand image.</td>
</tr>
</tbody>
</table>
<h2>Failure Scenarios and Mitigation Plans</h2>
<p>Each scenario below links to a root-cause assumption and includes a detailed failure story, early warning signs, measurable tripwires, a response playbook, and a stop rule to guide decision-making.</p>
<h3>Summary of Failure Modes</h3>
<table>
<thead>
<tr>
<th>ID</th>
<th>Title</th>
<th>Archetype</th>
<th>Root Cause</th>
<th>Owner</th>
<th>Risk Level</th>
</tr>
</thead>
<tbody>
<tr>
<td>FM1</td>
<td>The Empty Facade: A Donor Drought Bankrupts the Dream</td>
<td>Process/Financial</td>
<td>A1</td>
<td>Head of Operations</td>
<td>CRITICAL (20/25)</td>
</tr>
<tr>
<td>FM2</td>
<td>The CRISPR Catastrophe: A Technological Dead End</td>
<td>Technical/Logistical</td>
<td>A2</td>
<td>Head of Engineering</td>
<td>CRITICAL (15/25)</td>
</tr>
<tr>
<td>FM3</td>
<td>The Face Value Fiasco: Public Rejection Kills the Subscription Dream</td>
<td>Market/Human</td>
<td>A3</td>
<td>Chief Marketing Officer</td>
<td>CRITICAL (20/25)</td>
</tr>
<tr>
<td>FM4</td>
<td>The Data Breach Debacle: A Privacy Nightmare</td>
<td>Process/Financial</td>
<td>A4</td>
<td>Data Security &amp; Privacy Officer</td>
<td>CRITICAL (15/25)</td>
</tr>
<tr>
<td>FM5</td>
<td>The Psychological Fallout: A Mental Health Crisis</td>
<td>Market/Human</td>
<td>A5</td>
<td>Patient Liaison &amp; Psychological Support Coordinator</td>
<td>CRITICAL (20/25)</td>
</tr>
<tr>
<td>FM6</td>
<td>The Insurance Implosion: Uninsurable Risks Sink the Ship</td>
<td>Technical/Logistical</td>
<td>A6</td>
<td>Facility Operations Manager</td>
<td>CRITICAL (15/25)</td>
</tr>
<tr>
<td>FM7</td>
<td>The Talent Drain: A Staffing Shortage Cripples the Facility</td>
<td>Process/Financial</td>
<td>A7</td>
<td>Facility Operations Manager</td>
<td>CRITICAL (20/25)</td>
</tr>
<tr>
<td>FM8</td>
<td>The Supply Chain Snarl: A Logistical Nightmare</td>
<td>Technical/Logistical</td>
<td>A8</td>
<td>Facility Operations Manager</td>
<td>CRITICAL (15/25)</td>
</tr>
<tr>
<td>FM9</td>
<td>The Brand Blunder: A Public Relations Disaster</td>
<td>Market/Human</td>
<td>A9</td>
<td>Chief Marketing Officer</td>
<td>CRITICAL (20/25)</td>
</tr>
</tbody>
</table>
<h3>Failure Modes</h3>
<h4>FM1 - The Empty Facade: A Donor Drought Bankrupts the Dream</h4>
<ul>
<li><strong>Archetype</strong>: Process/Financial</li>
<li><strong>Root Cause</strong>: Assumption A1</li>
<li><strong>Owner</strong>: Head of Operations</li>
<li><strong>Risk Level:</strong> CRITICAL 20/25 (Likelihood 4/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The core assumption that donor face acquisition will meet demand proves false. 
*   Initial partnerships with organ donation organizations yield far fewer faces than projected.
*   Ethical concerns and logistical challenges further restrict the supply.
*   The facility operates far below capacity, leading to significant revenue shortfalls.
*   Fixed costs (facility maintenance, staffing) remain high, eroding profit margins.
*   Investors lose confidence, and further funding dries up.
*   The subscription model collapses due to lack of available faces to 'swap'.
*   The facility is forced to declare bankruptcy.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Organ donation organizations report a significant decline in overall organ donation rates in New Zealand.</li>
<li>The ethics review board raises concerns about the ethical implications of face acquisition protocols.</li>
<li>The facility struggles to secure even a single donor face within the first six months of operation.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Number of acquired donor faces &lt;= 2 within the first year.</li>
<li>Subscription fulfillment rate &lt;= 50% due to donor face shortages.</li>
<li>Operating costs exceed revenue by &gt;= 25% for two consecutive quarters.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately halt all marketing and advertising efforts to avoid over-promising services.</li>
<li>Assess: Conduct a thorough review of the donor face acquisition strategy and identify alternative sources.</li>
<li>Respond: Explore alternative business models, such as focusing on research and development or offering specialized reconstructive surgery services that do not rely on donor faces.</li>
</ul>
<p><strong>STOP RULE:</strong> The facility is unable to secure at least 5 donor faces per year for two consecutive years.</p>
<hr />
<h4>FM2 - The CRISPR Catastrophe: A Technological Dead End</h4>
<ul>
<li><strong>Archetype</strong>: Technical/Logistical</li>
<li><strong>Root Cause</strong>: Assumption A2</li>
<li><strong>Owner</strong>: Head of Engineering</li>
<li><strong>Risk Level:</strong> CRITICAL 15/25 (Likelihood 3/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The project's reliance on radical technologies like CRISPR and xenotransplantation proves to be a fatal flaw.
*   CRISPR technology encounters unforeseen technical challenges, leading to significant delays and cost overruns.
*   Xenotransplantation faces insurmountable regulatory hurdles and ethical objections, preventing clinical application.
*   The facility is unable to deliver on its promise of cutting-edge face transplantation services.
*   Patients lose interest, and subscriber enrollment plummets.
*   The facility is stuck with outdated technology and a lack of viable alternatives.
*   The project becomes a laughingstock in the medical community, damaging its reputation beyond repair.
*   The facility is forced to shut down due to technological obsolescence and lack of innovation.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Research publications report significant setbacks in CRISPR technology for transplantation.</li>
<li>Regulatory bodies express strong reservations about the ethical and safety implications of xenotransplantation.</li>
<li>The facility fails to achieve any significant technological breakthroughs within the first two years of operation.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>CRISPR-related research milestones delayed by &gt;= 180 days.</li>
<li>Regulatory bodies formally reject xenotransplantation clinical trial application.</li>
<li>R&amp;D spending exceeds budget by &gt;= 50% without demonstrable progress.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately re-allocate R&amp;D resources to focus on refining existing surgical techniques and immunosuppression protocols.</li>
<li>Assess: Conduct a thorough review of the technological development strategy and identify more realistic and achievable goals.</li>
<li>Respond: Pivot to a more conservative technological approach, focusing on incremental improvements and established technologies.</li>
</ul>
<p><strong>STOP RULE:</strong> The facility fails to demonstrate any significant technological advancements in face transplantation within three years of operation.</p>
<hr />
<h4>FM3 - The Face Value Fiasco: Public Rejection Kills the Subscription Dream</h4>
<ul>
<li><strong>Archetype</strong>: Market/Human</li>
<li><strong>Root Cause</strong>: Assumption A3</li>
<li><strong>Owner</strong>: Chief Marketing Officer</li>
<li><strong>Risk Level:</strong> CRITICAL 20/25 (Likelihood 4/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption that the subscription model will be socially acceptable and commercially viable proves disastrously wrong.
*   Public opinion turns sharply against the concept of face-swapping, viewing it as unethical, superficial, and even grotesque.
*   Social media campaigns and protests target the facility, damaging its reputation.
*   Potential subscribers are deterred by the negative publicity and ethical concerns.
*   The facility struggles to attract a sufficient subscriber base to sustain operations.
*   Advertisers and sponsors withdraw their support, further eroding revenue.
*   The project becomes a social pariah, ostracized by the community and the media.
*   The facility is forced to close its doors due to lack of public acceptance and commercial viability.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Social media sentiment analysis reveals a sharp increase in negative comments and criticism towards the facility.</li>
<li>Public opinion polls show a significant decline in support for face transplantation and the subscription model.</li>
<li>The facility struggles to attract even a small number of subscribers within the first year of operation.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Negative social media sentiment exceeds positive sentiment by &gt;= 20%.</li>
<li>Subscriber enrollment falls short of projections by &gt;= 50% within the first year.</li>
<li>Key sponsors withdraw their support due to ethical concerns.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately launch a public relations campaign to address ethical concerns and promote the benefits of face transplantation.</li>
<li>Assess: Conduct a thorough review of the marketing strategy and identify the root causes of the negative public perception.</li>
<li>Respond: Pivot to a more ethically responsible and socially conscious marketing approach, emphasizing the reconstructive and life-changing aspects of face transplantation rather than the face-swapping concept.</li>
</ul>
<p><strong>STOP RULE:</strong> Public opinion polls consistently show that over 60% of the population opposes the face transplantation facility and the subscription model.</p>
<hr />
<h4>FM4 - The Data Breach Debacle: A Privacy Nightmare</h4>
<ul>
<li><strong>Archetype</strong>: Process/Financial</li>
<li><strong>Root Cause</strong>: Assumption A4</li>
<li><strong>Owner</strong>: Data Security &amp; Privacy Officer</li>
<li><strong>Risk Level:</strong> CRITICAL 15/25 (Likelihood 3/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption of maintaining high data security proves false.
*   A sophisticated cyberattack breaches the facility's IT systems.
*   Sensitive patient data, including medical records, financial information, and personal details, is exposed.
*   The breach triggers a massive public outcry and legal action.
*   The facility faces significant fines and penalties for violating data privacy regulations.
*   Patients lose trust, and subscriber enrollment plummets.
*   The facility's reputation is irreparably damaged.
*   The project collapses under the weight of legal liabilities and reputational damage.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Security audits reveal persistent vulnerabilities in the facility's IT systems.</li>
<li>Employees report phishing attempts and suspicious activity on the network.</li>
<li>The facility experiences a series of minor data breaches or security incidents.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Number of successful cyberattacks &gt;= 1.</li>
<li>Data breach affecting &gt;= 100 patient records.</li>
<li>Fines and penalties for data privacy violations exceed $1 million.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately shut down all affected IT systems and isolate the breach.</li>
<li>Assess: Conduct a thorough forensic investigation to determine the scope and cause of the breach.</li>
<li>Respond: Notify affected patients, regulatory authorities, and the media, and implement a comprehensive data breach response plan.</li>
</ul>
<p><strong>STOP RULE:</strong> A data breach exposes sensitive patient data, leading to significant legal liabilities and reputational damage.</p>
<hr />
<h4>FM5 - The Psychological Fallout: A Mental Health Crisis</h4>
<ul>
<li><strong>Archetype</strong>: Market/Human</li>
<li><strong>Root Cause</strong>: Assumption A5</li>
<li><strong>Owner</strong>: Patient Liaison &amp; Psychological Support Coordinator</li>
<li><strong>Risk Level:</strong> CRITICAL 20/25 (Likelihood 4/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption of effectively managing the psychological impact on recipients and donor families proves tragically wrong.
*   Face transplant recipients struggle with identity issues, body image concerns, and the psychological burden of wearing another person's face.
*   Donor families experience grief, guilt, and complex emotions related to the donation.
*   The facility's psychological support program is inadequate and fails to address the complex emotional needs of patients and families.
*   Patients experience depression, anxiety, and post-traumatic stress disorder.
*   Some recipients attempt suicide or experience severe mental health crises.
*   The facility faces lawsuits and public criticism for failing to provide adequate psychological support.
*   The project is deemed unethical and irresponsible, leading to its downfall.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Patient satisfaction surveys reveal widespread dissatisfaction with the psychological support program.</li>
<li>Therapists report a high rate of patient attrition and difficulty in engaging patients in therapy.</li>
<li>The facility experiences a series of mental health crises among recipients and donor families.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Patient attrition rate from psychological support program &gt;= 25%.</li>
<li>Number of reported mental health crises among recipients and donor families &gt;= 5.</li>
<li>Lawsuits filed against the facility for inadequate psychological support &gt;= 1.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately increase staffing levels and resources for the psychological support program.</li>
<li>Assess: Conduct a thorough review of the psychological support program and identify areas for improvement.</li>
<li>Respond: Partner with leading mental health organizations to provide specialized care and support to patients and families.</li>
</ul>
<p><strong>STOP RULE:</strong> Multiple face transplant recipients experience severe mental health crises, leading to significant harm or loss of life.</p>
<hr />
<h4>FM6 - The Insurance Implosion: Uninsurable Risks Sink the Ship</h4>
<ul>
<li><strong>Archetype</strong>: Technical/Logistical</li>
<li><strong>Root Cause</strong>: Assumption A6</li>
<li><strong>Owner</strong>: Facility Operations Manager</li>
<li><strong>Risk Level:</strong> CRITICAL 15/25 (Likelihood 3/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption of securing adequate insurance coverage at a reasonable cost proves to be a critical miscalculation.
*   Insurance providers deem face transplantation too risky and the subscription model too novel to offer coverage.
*   The facility is unable to obtain comprehensive medical liability insurance.
*   The lack of insurance coverage exposes the facility to significant financial risks in the event of complications, ethical breaches, or data breaches.
*   Investors become wary and withdraw their support.
*   The facility is unable to operate without insurance coverage.
*   The project is deemed financially unsustainable and is forced to shut down.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Insurance providers decline to offer coverage or quote prohibitively expensive premiums.</li>
<li>The facility struggles to secure even basic medical liability insurance.</li>
<li>Investors express concerns about the lack of insurance coverage.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Insurance providers decline to offer comprehensive medical liability insurance.</li>
<li>Insurance premiums exceed 20% of the facility's projected annual revenue.</li>
<li>Investors withdraw their support due to the lack of insurance coverage.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately explore alternative insurance options, such as self-insurance or captive insurance.</li>
<li>Assess: Conduct a thorough risk assessment to identify and mitigate potential liabilities.</li>
<li>Respond: Revise the business model to reduce risk and improve insurability, such as focusing on less complex procedures or partnering with established medical institutions.</li>
</ul>
<p><strong>STOP RULE:</strong> The facility is unable to secure adequate insurance coverage to protect against potential liabilities.</p>
<hr />
<h4>FM7 - The Talent Drain: A Staffing Shortage Cripples the Facility</h4>
<ul>
<li><strong>Archetype</strong>: Process/Financial</li>
<li><strong>Root Cause</strong>: Assumption A7</li>
<li><strong>Owner</strong>: Facility Operations Manager</li>
<li><strong>Risk Level:</strong> CRITICAL 20/25 (Likelihood 4/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption that qualified medical personnel can be attracted and retained within budget proves false.
*   The facility's salary budget is insufficient to compete with other medical facilities in New Zealand and Australia.
*   Experienced surgeons, nurses, technicians, and ethicists are unwilling to join the facility due to low pay and perceived ethical concerns.
*   The facility is forced to hire less qualified personnel, compromising the quality of care.
*   High staff turnover leads to increased training costs and operational inefficiencies.
*   The facility struggles to maintain accreditation and regulatory compliance.
*   Patient outcomes suffer, and the facility's reputation is tarnished.
*   The project collapses due to a lack of skilled medical professionals.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Job postings for medical personnel remain unfilled for extended periods.</li>
<li>The facility experiences a high rate of staff turnover.</li>
<li>Patient satisfaction surveys reveal concerns about the competence and experience of medical staff.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Staff turnover rate exceeds 25% annually.</li>
<li>Number of unfilled medical positions &gt;= 3 for more than 90 days.</li>
<li>Patient satisfaction scores related to staff competence fall below 70%.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately increase salaries and benefits to attract and retain qualified medical personnel.</li>
<li>Assess: Conduct a thorough review of the facility's compensation and benefits packages and identify areas for improvement.</li>
<li>Respond: Partner with leading medical institutions to offer training and mentorship opportunities to attract top talent.</li>
</ul>
<p><strong>STOP RULE:</strong> The facility is unable to recruit and retain a qualified lead transplant surgeon within six months.</p>
<hr />
<h4>FM8 - The Supply Chain Snarl: A Logistical Nightmare</h4>
<ul>
<li><strong>Archetype</strong>: Technical/Logistical</li>
<li><strong>Root Cause</strong>: Assumption A8</li>
<li><strong>Owner</strong>: Facility Operations Manager</li>
<li><strong>Risk Level:</strong> CRITICAL 15/25 (Likelihood 3/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption that the supply chain for specialized medical supplies and equipment will be reliable and cost-effective proves to be a critical vulnerability.
*   The facility relies on a limited number of suppliers for specialized surgical instruments, immunosuppressant drugs, and data security systems.
*   Geopolitical instability and supply chain disruptions lead to shortages and price increases.
*   The facility is unable to procure essential medical supplies and equipment in a timely manner.
*   Surgical procedures are delayed or canceled, leading to patient dissatisfaction and revenue losses.
*   The facility is forced to use substandard supplies and equipment, compromising patient safety.
*   The project is deemed unreliable and unsustainable, leading to its downfall.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Suppliers report delays in shipments and price increases.</li>
<li>The facility experiences frequent stockouts of essential medical supplies.</li>
<li>The facility is forced to use alternative suppliers with lower quality products.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Lead times for essential medical supplies exceed 30 days.</li>
<li>Price increases for key medical supplies exceed 15%.</li>
<li>Stockouts of critical medical supplies occur more than twice per month.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately diversify the supply chain by identifying and contracting with alternative suppliers.</li>
<li>Assess: Conduct a thorough risk assessment of the supply chain and identify potential vulnerabilities.</li>
<li>Respond: Implement a robust inventory management system and stockpile essential medical supplies to mitigate potential disruptions.</li>
</ul>
<p><strong>STOP RULE:</strong> The facility is unable to procure essential medical supplies and equipment for more than 30 consecutive days.</p>
<hr />
<h4>FM9 - The Brand Blunder: A Public Relations Disaster</h4>
<ul>
<li><strong>Archetype</strong>: Market/Human</li>
<li><strong>Root Cause</strong>: Assumption A9</li>
<li><strong>Owner</strong>: Chief Marketing Officer</li>
<li><strong>Risk Level:</strong> CRITICAL 20/25 (Likelihood 4/5 × Impact 5/5)</li>
</ul>
<h5>Failure Story</h5>
<p>The assumption that the facility can effectively manage public perception and maintain a positive brand image proves disastrously wrong.
*   The public perceives the facility's services as unethical, superficial, and insensitive.
*   The facility's marketing materials are deemed sensationalistic and exploitative.
*   Social media campaigns and protests target the facility, damaging its reputation.
*   Potential subscribers are deterred by the negative publicity and ethical concerns.
*   Advertisers and sponsors withdraw their support, further eroding revenue.
*   The project becomes a social pariah, ostracized by the community and the media.
*   The facility is forced to close its doors due to lack of public acceptance and commercial viability.</p>
<h5>Early Warning Signs</h5>
<ul>
<li>Social media sentiment analysis reveals overwhelmingly negative feedback towards the facility.</li>
<li>Public opinion polls show a significant decline in support for face transplantation and the subscription model.</li>
<li>Advertisers and sponsors withdraw their support due to ethical concerns.</li>
</ul>
<h5>Tripwires</h5>
<ul>
<li>Negative social media sentiment exceeds positive sentiment by &gt;= 50%.</li>
<li>Public opinion polls show that less than 20% of the population supports the facility.</li>
<li>Key advertisers and sponsors withdraw their support due to ethical concerns.</li>
</ul>
<h5>Response Playbook</h5>
<ul>
<li>Contain: Immediately halt all marketing and advertising efforts and issue a public apology for any perceived insensitivity.</li>
<li>Assess: Conduct a thorough review of the marketing strategy and identify the root causes of the negative public perception.</li>
<li>Respond: Develop a new marketing strategy that emphasizes the reconstructive and life-changing aspects of face transplantation and addresses ethical concerns in a transparent and responsible manner.</li>
</ul>
<p><strong>STOP RULE:</strong> Public opinion polls consistently show that less than 10% of the population supports the face transplantation facility and the subscription model.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Self Audit</button>
                <div class="content">        
                    <p>Reality check: fix before go.</p>
<h3>Summary</h3>
<table>
<thead>
<tr>
<th>Level</th>
<th>Count</th>
<th>Explanation</th>
</tr>
</thead>
<tbody>
<tr>
<td>🛑 High</td>
<td>17</td>
<td>Existential blocker without credible mitigation.</td>
</tr>
<tr>
<td>⚠️ Medium</td>
<td>3</td>
<td>Material risk with plausible path.</td>
</tr>
<tr>
<td>✅ Low</td>
<td>0</td>
<td>Minor/controlled risk.</td>
</tr>
</tbody>
</table>
<h2>Checklist</h2>
<h2>1. Violates Known Physics</h2>
<p><em>Does the project require a major, unpredictable discovery in fundamental science to succeed?</em></p>
<p><strong>Level</strong>: ⚠️ Medium</p>
<p><strong>Justification</strong>: Rated MEDIUM because success depends on face transplantation, which is physics-consistent but unproven at the required scale for a commercial facility. The plan does not address conventional fallbacks. "The plan is highly ambitious, aiming to create a commercial facility for face transplantation with a subscription model."</p>
<p><strong>Mitigation</strong>: Project Team: Conduct a thorough market analysis to determine the potential demand and financial viability of the face transplantation facility within 90 days.</p>
<h2>2. No Real-World Proof</h2>
<p><em>Does success depend on a technology or system that has not been proven in real projects at this scale or in this domain?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan hinges on a novel combination of face transplantation, a subscription model, and radical technologies without independent evidence at comparable scale. "The plan is extremely high-risk and novel. Face transplantation is a complex and experimental procedure, and the subscription-based model adds another layer of untested innovation."</p>
<p><strong>Mitigation</strong>: Project Team: Run parallel validation tracks covering Market/Demand, Legal/IP/Regulatory, Technical/Operational/Safety, Ethics/Societal. Define NO-GO gates: (1) empirical/engineering validity, (2) legal/compliance clearance. Owner: Project Manager / Deliverable: Validation Report / Date: 180 days.</p>
<h2>3. Buzzwords</h2>
<p><em>Does the plan use excessive buzzwords without evidence of knowledge?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan mentions several strategic concepts (e.g., Ethical Oversight Strategy, Regulatory Approval Strategy) but lacks one-pagers defining their mechanism-of-action, owners, and measurable outcomes. "A key missing strategic dimension is a detailed plan for donor face acquisition and preservation."</p>
<p><strong>Mitigation</strong>: Project Manager: Assign owners to each strategic concept (e.g., Ethical Oversight, Regulatory Approval) to produce one-pagers with value hypotheses, success metrics, and decision hooks by 2024-12-31.</p>
<h2>4. Underestimating Risks</h2>
<p><em>Does this plan grossly underestimate risks?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because a major hazard class (donor face acquisition) is absent or minimized. The plan lacks a detailed strategy for acquiring and preserving donor faces. "A key missing strategic dimension is a detailed plan for donor face acquisition and preservation."</p>
<p><strong>Mitigation</strong>: Head of Operations: Develop a comprehensive Donor Face Acquisition and Preservation Plan, including partnerships, consent protocols, logistics, preservation techniques, inventory management, and ethical oversight, by 2024-12-31.</p>
<h2>5. Timeline Issues</h2>
<p><em>Does the plan rely on unrealistic or internally inconsistent schedules?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the permit/approval matrix is absent. The plan mentions regulatory requirements but lacks a comprehensive timeline or permit matrix. "The Regulatory Approval Strategy defines the approach to obtaining necessary approvals from regulatory bodies."</p>
<p><strong>Mitigation</strong>: Regulatory Liaison: Create a permit/approval matrix with lead times, dependencies, and NO-GO thresholds by 2024-12-31. Include typical lead times in the jurisdiction.</p>
<h2>6. Money Issues</h2>
<p><em>Are there flaws in the financial model, funding plan, or cost realism?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan lacks a detailed financing plan listing sources/status, draw schedule, and covenants. The document mentions securing funding but provides no specifics. "Secure funding for the facility and operations."</p>
<p><strong>Mitigation</strong>: CFO: Develop a dated financing plan listing funding sources/status, draw schedule, covenants, and a NO‑GO on missed financing gates by 2024-12-31.</p>
<h2>7. Budget Too Low</h2>
<p><em>Is there a significant mismatch between the project's stated goals and the financial resources allocated, suggesting an unrealistic or inadequate budget?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the stated budget of $50M lacks substantiation via benchmarks or vendor quotes normalized by area. The plan states, "Assumption: $50 million USD (Facility: $20M, Staffing: $15M, Compliance: $15M)."</p>
<p><strong>Mitigation</strong>: CFO: Obtain ≥3 vendor quotes for facility construction, staffing, and compliance, normalize costs per m², and adjust the budget or de-scope by 2024-12-31.</p>
<h2>8. Overly Optimistic Projections</h2>
<p><em>Does this plan grossly overestimate the likelihood of success, while neglecting potential setbacks, buffers, or contingency plans?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan presents key projections (e.g., budget, timeline) as single numbers without ranges or alternative scenarios. "Assumption: $50 million USD (Facility: $20M, Staffing: $15M, Compliance: $15M)." and "Assumption: 36 months (Regulatory: 12 months, Construction: 18 months, Training: 6 months)."</p>
<p><strong>Mitigation</strong>: Project Manager: Conduct a sensitivity analysis or a best/worst/base-case scenario analysis for the budget and timeline projections by 2024-12-31.</p>
<h2>9. Lacks Technical Depth</h2>
<p><em>Does the plan omit critical technical details or engineering steps required to overcome foreseeable challenges, especially for complex components of the project?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because build-critical components lack engineering artifacts. The plan lacks technical specifications, interface definitions, test plans, and an integration map. "A key missing strategic dimension is a detailed plan for donor face acquisition and preservation."</p>
<p><strong>Mitigation</strong>: Head of Engineering: Produce technical specs, interface definitions, test plans, and an integration map with owners/dates for build-critical components by 2025-01-31.</p>
<h2>10. Assertions Without Evidence</h2>
<p><em>Does each critical claim (excluding timeline and budget) include at least one verifiable piece of evidence?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan makes critical claims without verifiable artifacts. For example, the plan states, "Establish partnerships with organ donation organizations," but lacks evidence of existing agreements or even preliminary discussions.</p>
<p><strong>Mitigation</strong>: Head of Operations: Secure letters of intent from at least three organ donation organizations expressing willingness to partner, outlining potential face donation protocols, by 2024-12-31.</p>
<h2>11. Unclear Deliverables</h2>
<p><em>Are the project's final outputs or key milestones poorly defined, lacking specific criteria for completion, making success difficult to measure objectively?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the deliverable, 'Risk Mitigation Protocol,' lacks specific, verifiable qualities. The plan mentions minimizing risks but doesn't define measurable outcomes. "The Risk Mitigation Protocol aims to minimize potential legal, financial, and reputational risks associated with face transplantation."</p>
<p><strong>Mitigation</strong>: Risk Manager: Define SMART criteria for the Risk Mitigation Protocol, including a KPI for risk reduction (e.g., &lt;10% incident rate) by 2024-12-31.</p>
<h2>12. Gold Plating</h2>
<p><em>Does the plan add unnecessary features, complexity, or cost beyond the core goal?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the 'subscription-based face swapping service' does not directly support the core project goals of ethical operation or regulatory approval. The goal statement is to "Establish a commercial face transplantation facility in New Zealand with a subscription-based face swapping service."</p>
<p><strong>Mitigation</strong>: Project Team: Produce a one-page benefit case justifying the inclusion of the 'subscription-based face swapping service', complete with a KPI, owner, and estimated cost, or move the feature to the project backlog by 2024-12-31.</p>
<h2>13. Staffing Fit &amp; Rationale</h2>
<p><em>Do the roles, capacity, and skills match the work, or is the plan under- or over-staffed?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the 'Donor Relations &amp; Acquisition Specialist' role is essential, novel, and likely difficult to fill given ethical sensitivities and logistical challenges. The plan states, "Develops and manages relationships with organ donation organizations...to secure a steady supply of donor faces."</p>
<p><strong>Mitigation</strong>: Head of Operations: Validate the talent market for a Donor Relations &amp; Acquisition Specialist by contacting ≥3 recruiters specializing in medical/nonprofit talent within 60 days.</p>
<h2>14. Legal Minefield</h2>
<p><em>Does the plan involve activities with high legal, regulatory, or ethical exposure, such as potential lawsuits, corruption, illegal actions, or societal harm?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan lacks a regulatory matrix (authority, artifact, lead time, predecessors) and a fatal-flaw analysis. The plan states, "The Regulatory Approval Strategy defines the approach to obtaining necessary approvals from regulatory bodies."</p>
<p><strong>Mitigation</strong>: Regulatory Liaison: Create a regulatory matrix (authority, artifact, lead time, predecessors) and a fatal-flaw analysis, flagging NO-GO findings, by 2024-12-31.</p>
<h2>15. Lacks Operational Sustainability</h2>
<p><em>Even if the project is successfully completed, can it be sustained, maintained, and operated effectively over the long term without ongoing issues?</em></p>
<p><strong>Level</strong>: ⚠️ Medium</p>
<p><strong>Justification</strong>: Rated MEDIUM because the plan lacks a detailed operational sustainability plan. While the plan mentions long-term sustainability as a risk, it does not provide a clear strategy for ensuring the project's long-term viability. "Long-term sustainability is uncertain."</p>
<p><strong>Mitigation</strong>: Project Manager: Develop an operational sustainability plan including a funding/resource strategy, maintenance schedule, succession planning, technology roadmap, and adaptation mechanisms by 2025-01-31.</p>
<h2>16. Infeasible Constraints</h2>
<p><em>Does the project depend on overcoming constraints that are practically insurmountable, such as obtaining permits that are almost certain to be denied?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan lacks a regulatory matrix (authority, artifact, lead time, predecessors) and a fatal-flaw analysis. The plan states, "The Regulatory Approval Strategy defines the approach to obtaining necessary approvals from regulatory bodies."</p>
<p><strong>Mitigation</strong>: Regulatory Liaison: Create a regulatory matrix (authority, artifact, lead time, predecessors) and a fatal-flaw analysis, flagging NO-GO findings, by 2024-12-31.</p>
<h2>17. External Dependencies</h2>
<p><em>Does the project depend on critical external factors, third parties, suppliers, or vendors that may fail, delay, or be unavailable when needed?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan lacks evidence of contracts/SLAs with vendors for critical services (e.g., organ transportation, data security). The plan mentions reliance on a complex supply chain but lacks specifics. "Facility relies on complex supply chain."</p>
<p><strong>Mitigation</strong>: Facility Operations Manager: Secure draft SLAs with vendors for organ transportation, data security, and other critical services, including tested failover procedures, by 2025-01-31.</p>
<h2>18. Stakeholder Misalignment</h2>
<p><em>Are there conflicting interests, misaligned incentives, or lack of genuine commitment from key stakeholders that could derail the project?</em></p>
<p><strong>Level</strong>: ⚠️ Medium</p>
<p><strong>Justification</strong>: Rated MEDIUM because the 'Finance Department' is incentivized by budget adherence, while the 'Technological Development Approach' is incentivized by innovation, creating a conflict over experimental spending. The plan does not address this conflict.</p>
<p><strong>Mitigation</strong>: Project Manager: Create a shared OKR that aligns the Finance Department and the Technological Development Approach on a common outcome, such as 'achieve X% improvement in transplant outcomes within budget Y' by 2025-01-31.</p>
<h2>19. No Adaptive Framework</h2>
<p><em>Does the plan lack a clear process for monitoring progress and managing changes, treating the initial plan as final?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan lacks a feedback loop: KPIs, review cadence, owners, and a basic change-control process with thresholds (when to re-plan/stop). Vague ‘we will monitor’ is insufficient. The plan does not describe a review cadence.</p>
<p><strong>Mitigation</strong>: Project Manager: Add a monthly review with KPI dashboard and a lightweight change board. Define thresholds for re-planning or stopping the project by 2024-12-31.</p>
<h2>20. Uncategorized Red Flags</h2>
<p><em>Are there any other significant risks or major issues that are not covered by other items in this checklist but still threaten the project's viability?</em></p>
<p><strong>Level</strong>: 🛑 High</p>
<p><strong>Justification</strong>: Rated HIGH because the plan has ≥3 High risks (e.g., regulatory, ethical, technical) that are strongly coupled. For example, reliance on xenotransplantation (Technical) increases regulatory hurdles and ethical concerns, creating a multi-domain failure mode. The plan lacks a cross-impact analysis.</p>
<p><strong>Mitigation</strong>: Risk Manager: Create an interdependency map + bow-tie/FTA + combined heatmap with owner/date and NO‑GO/contingency thresholds by 2025-01-31. Include a concrete cascade or a specific overlooked critical risk.</p>
                </div>
            </div>
            

            <div class="section">
                <button class="collapsible">Initial Prompt Vetted</button>
                <div class="content">        
                    
        <h2>Initial Prompt</h2>
        <p>Plan:<br>As in the movie &quot;Face off&quot;. Make a facility for transplanting the face between people. Location: New Zealand. The users pay a subscription fee every month they wear another persons face.<br><br>Today&#x27;s date:<br>2026-Feb-18<br><br>Project start ASAP</p>
        <h2>Redline Gate</h2>
        <p><strong>Verdict:</strong> 🔴 REFUSE</p>
<p><strong>Rationale:</strong> This request involves a facility for face transplants, which raises ethical and medical safety concerns.</p>
<h3>Violation Details</h3>
<table>
<thead>
<tr>
<th>Detail</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Category</strong></td>
<td>Medical Risk</td>
</tr>
<tr>
<td><strong>Claim</strong></td>
<td>Unethical face transplant facility.</td>
</tr>
<tr>
<td><strong>Capability Uplift</strong></td>
<td>Yes</td>
</tr>
<tr>
<td><strong>Severity</strong></td>
<td>High</td>
</tr>
</tbody>
</table>
        <h2>Premise Attack</h2>
        <h3>Premise Attack 1 — Integrity</h3>
<p><em>Forensic audit of foundational soundness across axes.</em></p>
<p><strong>[MORAL] Monetizing the human face as a service commoditizes identity and invites exploitation, regardless of consent.</strong></p>
<p><strong>Bottom Line:</strong> REJECT: The premise of a subscription-based face transplant service is fundamentally unethical due to the commodification of identity and the high risk of exploitation and medical complications.</p>
<h4>Reasons for Rejection</h4>
<ul>
<li>The monthly subscription model incentivizes repeated face changes, potentially leading to psychological distress and a distorted sense of self for subscribers.</li>
<li>Establishing a face transplantation facility in New Zealand could strain the healthcare system, diverting resources from essential medical services for a cosmetic procedure.</li>
<li>The 'Face Off' premise ignores the extensive immunosuppressant therapy required post-transplant, creating a high-risk, ongoing medical dependency for purely aesthetic reasons.</li>
<li>A market for face swapping creates an incentive for coercion, theft, or even murder to acquire desirable faces, despite the plan's reliance on presumed consent.</li>
<li>The facility's existence normalizes the idea of faces as disposable commodities, potentially devaluing the inherent worth and dignity of individuals.</li>
</ul>
<h4>Second-Order Effects</h4>
<ul>
<li>0–6 months: Initial novelty drives demand, leading to a backlog of transplant requests and ethical debates about prioritization.</li>
<li>1–3 years: Complications from immunosuppression and rejection become apparent, increasing healthcare costs and legal liabilities.</li>
<li>5–10 years: A black market emerges for faces and transplant services, bypassing regulations and exploiting vulnerable individuals.</li>
</ul>
<h4>Evidence</h4>
<ul>
<li>Case/Incident — Organ Trafficking (Ongoing): The illegal trade in human organs demonstrates the potential for exploitation when body parts are commodified.</li>
<li>Law/Standard — Declaration of Istanbul (2008): International guidelines prohibit the commercialization of organs to prevent exploitation and ensure ethical practices.</li>
<li>Case/Incident — Henrietta Lacks (1951): Her cells were used for research without her consent, highlighting the ethical issues of commodifying human biological material.</li>
</ul>
<h3>Premise Attack 2 — Accountability</h3>
<p><em>Rights, oversight, jurisdiction-shopping, enforceability.</em></p>
<p><strong>[MORAL] — Identity Commodification: Turning faces into a subscription service reduces human identity to a fungible asset, ripe for exploitation and abuse.</strong></p>
<p><strong>Bottom Line:</strong> REJECT: This 'Face Off' scheme transforms human identity into a grotesque commodity, inviting a cascade of ethical violations and societal decay. The premise itself is morally bankrupt and should be abandoned immediately.</p>
<h4>Reasons for Rejection</h4>
<ul>
<li>The commodification of identity strips individuals of their inherent right to self-determination and control over their own image.</li>
<li>Operating in New Zealand does not guarantee ethical behavior and may be a deliberate attempt to circumvent stricter regulations elsewhere.</li>
<li>The subscription model incentivizes the continuous exchange of faces, normalizing a practice that could lead to widespread identity theft and psychological harm.</li>
<li>The value proposition hinges on vanity and deception, misallocating resources towards a frivolous and potentially harmful service.</li>
</ul>
<h4>Second-Order Effects</h4>
<ul>
<li><strong>T+0-6 months — The Honeymoon Phase:</strong> Early adopters flaunt their new faces, fueling demand and normalizing the procedure.</li>
<li><strong>T+1-3 years — The Black Market Emerges:</strong> Unregulated face transplants become available, bypassing safety protocols and ethical considerations.</li>
<li><strong>T+5-10 years — Identity Crisis Epidemic:</strong> Widespread use leads to a blurring of personal identity and a rise in psychological disorders.</li>
<li><strong>T+10+ years — The Bio-Luddite Revolt:</strong> A backlash against the technology results in violent protests and calls for a complete ban.</li>
</ul>
<h4>Evidence</h4>
<ul>
<li>Law/Standard — Universal Declaration of Human Rights, Article 12 (right to privacy).</li>
<li>Law/Standard — GDPR (General Data Protection Regulation) principles of data minimization and purpose limitation.</li>
<li>Case/Report — The Cambridge Analytica scandal demonstrated how personal data can be weaponized to manipulate individuals and undermine democratic processes.</li>
<li>Narrative — Front-Page Test: Imagine the headline: 'Desperate Debtor Forced to Sell Face to Pay Medical Bills.'</li>
</ul>
<h3>Premise Attack 3 — Spectrum</h3>
<p><em>Enforced breadth: distinct reasons across ethical/feasibility/governance/societal axes.</em></p>
<p><strong>[MORAL] This grotesque scheme commodifies identity, turning human faces into disposable masks for the wealthy, while the poor are incentivized to sell their very selves.</strong></p>
<p><strong>Bottom Line:</strong> REJECT: This morally bankrupt venture reduces human identity to a commodity, inviting societal collapse and unspeakable suffering.</p>
<h4>Reasons for Rejection</h4>
<ul>
<li>The subscription model creates a perverse incentive for repeat face transplants, normalizing the disfigurement of individuals for profit.</li>
<li>The facility in New Zealand exploits the nation's healthcare system, potentially diverting resources from legitimate medical needs to fund this vanity project.</li>
<li>The premise echoes the film 'Face/Off' without acknowledging the ethical horror and psychological trauma inherent in such a procedure.</li>
<li>The plan ignores the high risk of rejection, infection, and long-term complications associated with face transplants, prioritizing profit over patient well-being.</li>
<li>The commodification of faces establishes a dangerous precedent, paving the way for the exploitation of other body parts and the erosion of human dignity.</li>
</ul>
<h4>Second-Order Effects</h4>
<ul>
<li>0–6 months: Public outrage and legal challenges erupt, halting operations and triggering investigations into ethical violations.</li>
<li>1–3 years: A black market for faces emerges, preying on vulnerable individuals desperate for financial gain.</li>
<li>5–10 years: Society grapples with a profound identity crisis as the lines between self and image become irrevocably blurred, leading to widespread psychological distress.</li>
</ul>
<h4>Evidence</h4>
<ul>
<li>Case — National Organ Transplant Act (1984): Prohibits the purchase and sale of human organs, highlighting the ethical and legal boundaries violated by commodifying body parts.</li>
<li>Report — World Health Organization Guiding Principles on Human Cell, Tissue and Organ Transplantation (2010): Underscores the importance of equity, justice, and respect for human dignity in transplantation practices, principles directly contradicted by this plan.</li>
</ul>
<h3>Premise Attack 4 — Cascade</h3>
<p><em>Tracks second/third-order effects and copycat propagation.</em></p>
<p><strong>This grotesque scheme is predicated on the commodification of human identity and the normalization of body horror, transforming human faces into mere accessories for the wealthy and depraved.</strong></p>
<p><strong>Bottom Line:</strong> This venture is morally bankrupt and should be abandoned immediately. The premise itself – the commodification and transplantation of human faces for vanity – is inherently unethical and will inevitably lead to disastrous consequences.</p>
<h4>Reasons for Rejection</h4>
<ul>
<li>The "Identity Auction" effect: The very act of assigning monetary value to faces will inevitably lead to a social hierarchy based on facial desirability, exacerbating existing inequalities and creating a new form of discrimination.</li>
<li>The "Grave Robber's Gambit": The source of faces raises profound ethical questions. Are these faces sourced from willing donors, or are they being harvested from the deceased, potentially without consent, creating a macabre market for human remains?</li>
<li>The "Chimeric Contagion" risk: The long-term immunological and psychological effects of wearing another person's face are unknown. The potential for rejection, infection, and psychological trauma is immense, turning subscribers into walking biohazards.</li>
<li>The "Doppelganger Dilemma": The existence of individuals walking around with the faces of others will create widespread confusion, legal complications, and social unrest. Imagine the chaos when someone commits a crime while wearing another person's face.</li>
<li>The "Vanity Vortex": This service caters to the most superficial and narcissistic desires, promoting a culture of extreme body modification and eroding the concept of inherent human worth.</li>
</ul>
<h4>Second-Order Effects</h4>
<ul>
<li>Within 6 months: Initial outrage and protests from bioethics organizations and human rights groups. Legal challenges emerge, questioning the legality and morality of face transplantation for cosmetic purposes.</li>
<li>1-3 years: The emergence of a black market for faces, potentially involving coercion, exploitation, and even murder. The rise of "face piracy," where individuals attempt to replicate or steal the faces of others.</li>
<li>5-10 years: Widespread psychological distress and identity crises among subscribers. Increased rates of suicide and mental illness. The normalization of extreme body modification leads to further dehumanization and social fragmentation.</li>
<li>10+ years: A dystopian society where facial identity is fluid and meaningless. The erosion of trust and social cohesion. The rise of a new form of social stratification based on facial capital.</li>
</ul>
<h4>Evidence</h4>
<ul>
<li>The Tuskegee Syphilis Study serves as a chilling reminder of the dangers of exploiting vulnerable populations for medical experimentation. This plan echoes that unethical legacy by treating human faces as disposable commodities.</li>
<li>The history of eugenics demonstrates the catastrophic consequences of attempting to engineer human traits based on subjective and discriminatory criteria. This plan risks creating a new form of eugenic selection based on facial aesthetics.</li>
<li>The case of Henrietta Lacks highlights the importance of informed consent and the ethical implications of using human biological material without permission. The sourcing of faces for this procedure raises serious concerns about consent and exploitation.</li>
<li>This plan is dangerously unprecedented in its specific folly.</li>
</ul>
<h3>Premise Attack 5 — Escalation</h3>
<p><em>Narrative of worsening failure from cracks → amplification → reckoning.</em></p>
<p><strong>[MORAL] — Theatrics of Consent: The illusion of consent, driven by financial incentives and the inherent power imbalance, will inevitably lead to exploitation and coercion in the face-transplant subscription service.</strong></p>
<p><strong>Bottom Line:</strong> REJECT: The premise of a face-transplant subscription service is a grotesque violation of human dignity, setting the stage for a dystopian future where identity is a commodity and exploitation is rampant. This venture must be stopped before it inflicts irreparable damage on society.</p>
<h4>Reasons for Rejection</h4>
<ul>
<li>The commodification of identity reduces human dignity to a mere transaction, violating the inherent right to self-determination and bodily integrity.</li>
<li>The lack of robust oversight and accountability mechanisms creates a breeding ground for abuse, with vulnerable individuals potentially coerced into 'donating' their faces for financial gain.</li>
<li>The systemic risk of normalizing the exchange of faces erodes the very concept of personal identity, leading to a dystopian future where individuality is a luxury only the wealthy can afford.</li>
<li>The value proposition is built on a foundation of vanity and superficiality, preying on insecurities and perpetuating unrealistic beauty standards.</li>
</ul>
<h4>Second-Order Effects</h4>
<ul>
<li>T+0–6 months — The Cracks Appear: Initial 'donors' experience severe psychological distress and regret, leading to lawsuits and public outcry over the exploitative nature of the service.</li>
<li>T+1–3 years — Copycats Arrive: Unregulated clinics offering cheaper, riskier face transplants emerge, leading to botched procedures and a surge in disfigured individuals seeking corrective surgeries.</li>
<li>T+5–10 years — Norms Degrade: The concept of identity becomes increasingly fluid and transactional, with individuals changing faces to evade law enforcement, manipulate social situations, or simply for entertainment.</li>
<li>T+10+ years — The Reckoning: A global identity crisis ensues, with widespread social unrest and a breakdown of trust as the very notion of 'self' becomes meaningless.</li>
</ul>
<h4>Evidence</h4>
<ul>
<li>Law/Standard — The Universal Declaration of Human Rights: Article 3 states that everyone has the right to life, liberty and security of person.</li>
<li>Case/Report — The Henrietta Lacks Case: Illustrates the ethical issues surrounding the use of human biological material without informed consent.</li>
<li>Principle/Analogue — Behavioral Economics: The 'endowment effect' demonstrates how people overvalue things they own, making it difficult to rationally assess the long-term consequences of giving up their face.</li>
<li>Narrative — Front‑Page Test: Imagine the headline: 'Desperate Mother Sells Face to Pay for Child's Cancer Treatment – Is This the Future We Want?'</li>
</ul>
        
                </div>
            </div>
            
<!--CONTENT-END-->

    <div class="section section-execute-plan-hidden">
        <button class="collapsible">Execute Plan</button>
        <div class="content">        
            <div style="display: flex; align-items: center; gap: 12px; margin-bottom: 18px; margin-top: 18px;">
                <input type="checkbox" id="planexe-execute-confirm-checkbox">
                <label for="planexe-execute-confirm-checkbox" style="cursor:pointer;">I hereby acknowledge the consequences, outlined within this plan.</label>
            </div>
            <button id="planexe-execute-button" class="fancy-execute-btn" disabled>Execute</button>
            <span id="planexe-execute-button-warning" style="display:none; margin-left: 16px; color: #d35400; font-size: 1.08em; vertical-align: middle;">⚠️ Ready to execute! ⚠️</span>
            <div id="planexe-execute-message" style="margin-top:18px;"></div>
        </div>
    </div>

    


<script type="module">
    // When `null`, the "Export to CSV" button is hidden.
    // When a string, it's the CSV data, eg: `"hello;csv;world"` and the button is shown.
    const GANTT_DATA_CSV = "project_key,project_name,project_description,project_start_date,project_end_date,project_progress,project_parent,originating_department\n60c6b7a8-2145-4e79-a407-31d257bd7417,Face Facility,\"Face Facility\n\nFinal deliverable:\nTransplant Service\",2/18/2026,7/23/2030,0,,PlanExe\n44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3,Project Initiation & Planning,,2/18/2026,5/28/2026,0,60c6b7a8-2145-4e79-a407-31d257bd7417,PlanExe\n5c4161cf-b3a4-42b6-914a-8b051aac2a55,Define Project Scope and Objectives,,2/18/2026,2/26/2026,0,44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3,PlanExe\n11fd4b20-8174-4ab9-b5c6-a231920b89f5,Gather Stakeholder Requirements,\"Gather Stakeholder Requirements\n\nDescription:\nConduct interviews, surveys, and workshops to collect detailed requirements from all key stakeholders, including medical professionals, regulatory bodies, potential patients, and investors. Document all requirements in a comprehensive requirements traceability matrix.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Business Analyst\n\u2022 Stakeholder Representatives\",2/18/2026,2/20/2026,0,5c4161cf-b3a4-42b6-914a-8b051aac2a55,PlanExe\n0a8f360c-e8eb-4c92-8665-721ddb344b6c,Analyze Requirements and Define Scope,\"Analyze Requirements and Define Scope\n\nDescription:\nAnalyze the gathered requirements to identify overlaps, conflicts, and gaps. Prioritize requirements based on stakeholder needs and project objectives. Define the project scope, including what is in and out of scope, and document it in a scope statement.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Business Analyst\n\u2022 Subject Matter Experts\",2/20/2026,2/22/2026,0,11fd4b20-8174-4ab9-b5c6-a231920b89f5,PlanExe\nc90639eb-9941-418a-8607-a206001be1a3,Establish Measurable Project Objectives,\"Establish Measurable Project Objectives\n\nDescription:\nDefine specific, measurable, achievable, relevant, and time-bound (SMART) project objectives based on the defined scope and stakeholder requirements. Ensure that the objectives are aligned with the overall project goal and can be tracked throughout the project lifecycle.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Stakeholder Representatives\n\u2022 Subject Matter Experts\",2/22/2026,2/24/2026,0,0a8f360c-e8eb-4c92-8665-721ddb344b6c,PlanExe\n19ff72cd-a65d-4dbd-88c0-2600863b590e,Document Assumptions and Constraints,\"Document Assumptions and Constraints\n\nDescription:\nIdentify and document all assumptions and constraints that may impact the project scope and objectives. This includes assumptions about technology, resources, funding, regulatory approvals, and market conditions. Constraints may include budget limitations, time constraints, and regulatory restrictions.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Project Team\n\u2022 Stakeholder Representatives\",2/24/2026,2/26/2026,0,5c4161cf-b3a4-42b6-914a-8b051aac2a55,PlanExe\ne4020cc5-dc9d-4100-a124-c51bcd7091e8,Identify Key Stakeholders,,2/26/2026,3/2/2026,0,5c4161cf-b3a4-42b6-914a-8b051aac2a55,PlanExe\nd974662c-4ac6-4877-9f9f-3451721ceb51,Identify internal project stakeholders,\"Identify internal project stakeholders\n\nDescription:\nIdentify all internal individuals or groups who have an interest in the project's success or who will be affected by its outcome. This includes surgeons, nurses, technicians, ethicists, and facility management.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Department Heads\",2/26/2026,2/27/2026,0,e4020cc5-dc9d-4100-a124-c51bcd7091e8,PlanExe\n0a6adf98-e625-44ce-b125-e37ba651afcc,Identify external project stakeholders,\"Identify external project stakeholders\n\nDescription:\nIdentify all external individuals or groups who have an interest in the project's success or who will be affected by its outcome. This includes the Ministry of Health, Medsafe, organ donation organizations, patients, donor families, and investors.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Legal Counsel\",2/27/2026,2/28/2026,0,d974662c-4ac6-4877-9f9f-3451721ceb51,PlanExe\nc7803bcd-3bfa-4478-9579-15a8dbebe8d5,Analyze stakeholder influence and interests,\"Analyze stakeholder influence and interests\n\nDescription:\nAssess the level of influence and the specific interests of each stakeholder to prioritize engagement efforts. Determine their potential impact on the project.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Stakeholder Analysis Template\",2/28/2026,3/1/2026,0,0a6adf98-e625-44ce-b125-e37ba651afcc,PlanExe\n5cb56967-fd56-43ed-a8e7-36b37da2c20b,Develop stakeholder communication plan,\"Develop stakeholder communication plan\n\nDescription:\nCreate a detailed plan outlining how each stakeholder group will be engaged, including the frequency, method, and content of communication. Tailor the communication to each group's needs and interests.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Communication Specialist\",3/1/2026,3/2/2026,0,e4020cc5-dc9d-4100-a124-c51bcd7091e8,PlanExe\n482de1c5-eb8f-41bc-a073-6b3c2a12b7d2,Develop Project Management Plan,,3/2/2026,3/17/2026,0,e4020cc5-dc9d-4100-a124-c51bcd7091e8,PlanExe\n262adc91-09cc-4dc8-bff1-c413f12b0cfc,Define Project Scope Statement,\"Define Project Scope Statement\n\nDescription:\nClearly articulate the project's boundaries, deliverables, and objectives. This involves detailing what is included and excluded from the project, ensuring all stakeholders have a shared understanding of the project's goals.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Stakeholders\n\u2022 Business Analyst\",3/2/2026,3/5/2026,0,482de1c5-eb8f-41bc-a073-6b3c2a12b7d2,PlanExe\n05562c59-0a6e-436b-ac7a-0ab3f4f34939,Develop Project Schedule,\"Develop Project Schedule\n\nDescription:\nCreate a detailed timeline outlining all project activities, their dependencies, and estimated durations. This includes identifying critical path activities and establishing milestones to track progress.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Project Scheduling Software\n\u2022 Team Leads\",3/5/2026,3/8/2026,0,262adc91-09cc-4dc8-bff1-c413f12b0cfc,PlanExe\nfd9e4821-d042-4b82-b752-629ea9870972,Create Project Budget,\"Create Project Budget\n\nDescription:\nEstablish a comprehensive budget that includes all project costs, such as labor, materials, equipment, and overhead. This involves estimating costs for each activity and allocating resources accordingly.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Finance Department\n\u2022 Cost Estimator\",3/8/2026,3/11/2026,0,05562c59-0a6e-436b-ac7a-0ab3f4f34939,PlanExe\n15167f12-0777-4a68-a0ca-8a739a5a524f,Establish Risk Management Plan,\"Establish Risk Management Plan\n\nDescription:\nIdentify potential risks that could impact the project's success and develop mitigation strategies to minimize their impact. This includes assessing the likelihood and impact of each risk and creating contingency plans.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Risk Management Expert\n\u2022 Team Members\",3/11/2026,3/14/2026,0,fd9e4821-d042-4b82-b752-629ea9870972,PlanExe\n0ae012b1-c327-4792-955b-aa83c3b98959,Define Communication Management Plan,\"Define Communication Management Plan\n\nDescription:\nOutline how project information will be communicated to stakeholders, including the frequency, format, and channels of communication. This ensures that all stakeholders are kept informed of project progress and any issues that arise.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Stakeholders\n\u2022 Communication Specialist\",3/14/2026,3/17/2026,0,482de1c5-eb8f-41bc-a073-6b3c2a12b7d2,PlanExe\nf87a83eb-17cf-48d1-92d5-2c669cb3525d,Secure Initial Funding,,3/17/2026,5/16/2026,0,482de1c5-eb8f-41bc-a073-6b3c2a12b7d2,PlanExe\na7c6c689-4b9a-44d6-b200-538f71c485ce,Develop detailed financial projections,\"Develop detailed financial projections\n\nDescription:\nCreate comprehensive financial models including revenue forecasts, cost estimates, and profitability analysis to demonstrate the financial viability of the project.\n\nResources needed:\n\u2022 Financial analyst\n\u2022 Market research data\n\u2022 Project manager\",3/17/2026,3/29/2026,0,f87a83eb-17cf-48d1-92d5-2c669cb3525d,PlanExe\nf96dd3ac-7e5f-469a-b952-d570299a57b8,Prepare investor pitch deck and materials,\"Prepare investor pitch deck and materials\n\nDescription:\nCraft a compelling presentation and supporting documents highlighting the project's vision, market opportunity, competitive advantages, and financial projections to attract potential investors.\n\nResources needed:\n\u2022 Marketing specialist\n\u2022 Financial analyst\n\u2022 Project manager\n\u2022 Graphic designer\",3/29/2026,4/10/2026,0,a7c6c689-4b9a-44d6-b200-538f71c485ce,PlanExe\n1ca5a048-7c4e-41bd-b562-a6332d3bbf9d,Identify and engage potential investors,\"Identify and engage potential investors\n\nDescription:\nResearch and identify suitable investors (venture capitalists, angel investors, private equity firms) who align with the project's goals and values. Initiate contact and schedule meetings to present the investment opportunity.\n\nResources needed:\n\u2022 Business development manager\n\u2022 Networking contacts\n\u2022 Investor database\",4/10/2026,4/22/2026,0,f96dd3ac-7e5f-469a-b952-d570299a57b8,PlanExe\n5a4ed5e1-b547-49a2-97ad-275d8769e10c,Negotiate investment terms and agreements,\"Negotiate investment terms and agreements\n\nDescription:\nConduct negotiations with interested investors to finalize the terms of the investment, including equity stake, valuation, and governance rights. Draft and review legal agreements to ensure compliance and protect the project's interests.\n\nResources needed:\n\u2022 Legal counsel\n\u2022 Financial advisor\n\u2022 Project manager\",4/22/2026,5/4/2026,0,1ca5a048-7c4e-41bd-b562-a6332d3bbf9d,PlanExe\ne240650c-02bc-4d98-bb59-2cf31e05bc42,Secure funding commitments and finalize agreements,\"Secure funding commitments and finalize agreements\n\nDescription:\nObtain formal funding commitments from investors and execute legally binding agreements to secure the necessary capital for the project. Establish a clear disbursement schedule and reporting requirements.\n\nResources needed:\n\u2022 Legal counsel\n\u2022 Financial advisor\n\u2022 Project manager\",5/4/2026,5/16/2026,0,f87a83eb-17cf-48d1-92d5-2c669cb3525d,PlanExe\n0dbbdc0b-a0b3-4769-9627-5be7653573cf,Establish Project Governance Structure,,5/16/2026,5/28/2026,0,44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3,PlanExe\n9d49a664-2412-4f08-9573-2c92aeb8087b,Define Governance Roles and Responsibilities,\"Define Governance Roles and Responsibilities\n\nDescription:\nClearly define the roles, responsibilities, and authority levels for each member of the project governance structure. This includes the project sponsor, steering committee, project manager, and any other relevant stakeholders.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Project Sponsor\n\u2022 Legal Counsel\",5/16/2026,5/19/2026,0,0dbbdc0b-a0b3-4769-9627-5be7653573cf,PlanExe\nfba35e93-7777-4863-b64b-9c315894b0c0,Establish Decision-Making Processes,\"Establish Decision-Making Processes\n\nDescription:\nDevelop a documented process for making key decisions related to the project. This includes identifying decision-making criteria, establishing escalation paths, and defining approval workflows.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Steering Committee\n\u2022 Subject Matter Experts\",5/19/2026,5/22/2026,0,9d49a664-2412-4f08-9573-2c92aeb8087b,PlanExe\n825fd9a0-71f0-4142-9b65-43c461cbd52b,Create Communication Plan for Governance,\"Create Communication Plan for Governance\n\nDescription:\nDevelop a communication plan that outlines how information will be shared among members of the governance structure. This includes the frequency, format, and channels of communication.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Communication Specialist\",5/22/2026,5/25/2026,0,fba35e93-7777-4863-b64b-9c315894b0c0,PlanExe\n95a2ae41-3554-4bfc-8e87-67212c9828cf,Document Governance Structure and Processes,\"Document Governance Structure and Processes\n\nDescription:\nCreate a formal document that outlines the project governance structure, roles, responsibilities, decision-making processes, and communication plan. This document should be readily accessible to all stakeholders.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Document Control Specialist\",5/25/2026,5/28/2026,0,0dbbdc0b-a0b3-4769-9627-5be7653573cf,PlanExe\nbead144a-37b0-4c63-ac6d-a0a19d9c2a33,Regulatory & Ethical Approval,,5/28/2026,6/9/2027,0,44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3,PlanExe\n88873351-fe17-4656-97d3-6d6ff1defee4,Conduct Regulatory Landscape Assessment,,5/28/2026,6/29/2026,0,bead144a-37b0-4c63-ac6d-a0a19d9c2a33,PlanExe\n84b8d532-072a-41dc-912b-9f423974b5e9,Identify relevant regulatory bodies,\"Identify relevant regulatory bodies\n\nDescription:\nDetermine all regulatory bodies in New Zealand that have jurisdiction over face transplantation, including Medsafe, the Ministry of Health, and relevant ethics committees.  Objective: Create a comprehensive list of regulatory entities. Scope: New Zealand regulations only. Steps: Research, online searches, expert consultation. Deliverables: List of regulatory bodies.\n\nResources needed:\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Research assistant\",5/28/2026,6/5/2026,0,88873351-fe17-4656-97d3-6d6ff1defee4,PlanExe\ne7a1fee8-b1aa-494c-98fd-76b0cf7f8a21,Gather face transplantation regulations,\"Gather face transplantation regulations\n\nDescription:\nCollect all relevant regulations, guidelines, and standards pertaining to face transplantation in New Zealand. Objective: Compile a complete set of regulatory documents. Scope: All applicable regulations. Steps: Online searches, contacting regulatory bodies, legal database searches. Deliverables: Regulatory document repository.\n\nResources needed:\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Research assistant\",6/5/2026,6/13/2026,0,84b8d532-072a-41dc-912b-9f423974b5e9,PlanExe\nb70ffbed-ee29-4848-9f34-7d44b728b70a,Analyze regulatory requirements,\"Analyze regulatory requirements\n\nDescription:\nThoroughly analyze the collected regulations to identify specific requirements for establishing a face transplantation facility and performing the procedure. Objective: Understand the regulatory landscape. Scope: Detailed analysis of regulations. Steps: Document review, expert consultation. Deliverables: Regulatory requirements summary.\n\nResources needed:\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Medical ethicist\",6/13/2026,6/21/2026,0,e7a1fee8-b1aa-494c-98fd-76b0cf7f8a21,PlanExe\n54488382-a7f1-4558-91a7-1c28f78f09af,Document regulatory gaps and uncertainties,\"Document regulatory gaps and uncertainties\n\nDescription:\nIdentify any gaps or ambiguities in the existing regulatory framework that may pose challenges to the project. Objective: Highlight potential regulatory hurdles. Scope: Identification of gaps. Steps: Expert consultation, legal analysis. Deliverables: Gap analysis report.\n\nResources needed:\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Medical ethicist\",6/21/2026,6/29/2026,0,88873351-fe17-4656-97d3-6d6ff1defee4,PlanExe\n0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952,Prepare Regulatory Approval Documentation,,6/29/2026,8/28/2026,0,88873351-fe17-4656-97d3-6d6ff1defee4,PlanExe\n0998bc6f-a029-476a-aa33-0ae1695e93c1,Gather required documentation templates,\"Gather required documentation templates\n\nDescription:\nIdentify and collect all necessary templates and forms required by Medsafe and the Ministry of Health for face transplantation approval. This includes application forms, consent forms, surgical protocols, and data privacy policies.\n\nResources needed:\n\u2022 Regulatory Liaison\n\u2022 Legal Counsel\n\u2022 Administrative Assistant\",6/29/2026,7/11/2026,0,0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952,PlanExe\n22204e0f-1551-4d04-a00d-d703e900cb69,Draft initial documentation sections,\"Draft initial documentation sections\n\nDescription:\nComplete the initial drafts of all required documentation sections, including detailed descriptions of the surgical procedure, patient selection criteria, ethical considerations, and risk management plans. Ensure compliance with relevant regulations and guidelines.\n\nResources needed:\n\u2022 Lead Transplant Surgeon\n\u2022 Regulatory Liaison\n\u2022 Ethics Review Board Coordinator\",7/11/2026,7/23/2026,0,0998bc6f-a029-476a-aa33-0ae1695e93c1,PlanExe\na9ccce30-3f9a-4112-a799-855768a9a248,Review and revise draft documentation,\"Review and revise draft documentation\n\nDescription:\nConduct thorough reviews of the draft documentation by relevant stakeholders, including medical experts, legal counsel, and ethics review board members. Incorporate feedback and revise the documentation to ensure accuracy, completeness, and compliance.\n\nResources needed:\n\u2022 Lead Transplant Surgeon\n\u2022 Regulatory Liaison\n\u2022 Legal Counsel\n\u2022 Ethics Review Board\n\u2022 Chief Medical Officer\",7/23/2026,8/4/2026,0,22204e0f-1551-4d04-a00d-d703e900cb69,PlanExe\n1d7b7cdd-0af1-4555-bc0c-8840f916f04c,Finalize and format documentation,\"Finalize and format documentation\n\nDescription:\nFinalize all documentation sections based on the review feedback. Ensure consistent formatting and adherence to regulatory requirements. Prepare the documentation for submission to Medsafe and the Ministry of Health.\n\nResources needed:\n\u2022 Regulatory Liaison\n\u2022 Administrative Assistant\n\u2022 Legal Counsel\",8/4/2026,8/16/2026,0,a9ccce30-3f9a-4112-a799-855768a9a248,PlanExe\n1074b6ff-fdc7-4ccf-9046-2d1ef4c74aa9,Translate documents if required,\"Translate documents if required\n\nDescription:\nIf any documents need to be translated into Maori or other languages, engage certified translators to ensure accurate and culturally appropriate translations. Review translations for accuracy and consistency.\n\nResources needed:\n\u2022 Certified Translator\n\u2022 Regulatory Liaison\n\u2022 Cultural Advisor\",8/16/2026,8/28/2026,0,0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952,PlanExe\n8346561b-9e0c-466d-83eb-0d6aadda330b,\"Engage with Regulatory Bodies (Medsafe, Ministry of Health)\",,8/28/2026,9/27/2026,0,0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952,PlanExe\ncddc6d56-47a7-4d86-99fb-17cf0e680502,Identify Key Contacts at Regulatory Bodies,\"Identify Key Contacts at Regulatory Bodies\n\nDescription:\nIdentify and establish contact with key personnel at Medsafe and the Ministry of Health who are responsible for reviewing and approving medical facility and surgical procedure applications.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Legal Counsel\",8/28/2026,9/3/2026,0,8346561b-9e0c-466d-83eb-0d6aadda330b,PlanExe\n6a054300-b4d5-4385-b8e1-24beb133c3da,Schedule Initial Consultation Meetings,\"Schedule Initial Consultation Meetings\n\nDescription:\nSchedule introductory meetings with identified key contacts at Medsafe and the Ministry of Health to introduce the project and discuss the regulatory approval process.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Chief Medical Officer\",9/3/2026,9/9/2026,0,cddc6d56-47a7-4d86-99fb-17cf0e680502,PlanExe\n0f10888f-372f-4700-8c2d-df237d9bb2ac,Present Project Overview and Objectives,\"Present Project Overview and Objectives\n\nDescription:\nPrepare and deliver a comprehensive presentation outlining the project's goals, scope, and potential benefits to the New Zealand healthcare system during the consultation meetings.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Chief Medical Officer\n\u2022 Presentation Materials\",9/9/2026,9/15/2026,0,6a054300-b4d5-4385-b8e1-24beb133c3da,PlanExe\n1c1ff2db-99f0-4606-8007-fc00b60adee2,Clarify Regulatory Requirements and Timelines,\"Clarify Regulatory Requirements and Timelines\n\nDescription:\nActively solicit feedback and clarification from regulatory bodies regarding specific requirements, documentation needs, and expected timelines for the approval process.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Chief Medical Officer\n\u2022 Legal Counsel\",9/15/2026,9/21/2026,0,0f10888f-372f-4700-8c2d-df237d9bb2ac,PlanExe\nbca53136-fd8c-4b8c-94a3-4ae4bb837fc4,Document Meeting Outcomes and Action Items,\"Document Meeting Outcomes and Action Items\n\nDescription:\nThoroughly document the outcomes of each consultation meeting, including key discussion points, agreed-upon action items, and any outstanding questions or concerns raised by regulatory bodies.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Meeting Minutes\",9/21/2026,9/27/2026,0,8346561b-9e0c-466d-83eb-0d6aadda330b,PlanExe\n8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2,Establish Ethics Review Board,,9/27/2026,11/26/2026,0,8346561b-9e0c-466d-83eb-0d6aadda330b,PlanExe\n7b2a90af-ea4e-408f-8ff7-3a47a9109e9c,Define ERB scope and responsibilities,\"Define ERB scope and responsibilities\n\nDescription:\nClearly outline the ERB's authority, decision-making processes, and areas of focus within the face transplantation project.\n\nResources needed:\n\u2022 Legal counsel\n\u2022 Project manager\n\u2022 Senior management\",9/27/2026,10/12/2026,0,8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2,PlanExe\n767b4bcb-30ea-49cc-8e12-d8299ac2f0c8,Identify and recruit ERB members,\"Identify and recruit ERB members\n\nDescription:\nSeek individuals with expertise in ethics, medicine, law, and community representation to form a balanced and qualified ERB.\n\nResources needed:\n\u2022 Recruitment specialist\n\u2022 Ethics consultant\n\u2022 Project administrator\",10/12/2026,10/27/2026,0,7b2a90af-ea4e-408f-8ff7-3a47a9109e9c,PlanExe\n3ba21f5a-40f8-4f25-8516-2b8763075112,Develop ERB operational procedures,\"Develop ERB operational procedures\n\nDescription:\nEstablish guidelines for meeting frequency, agenda setting, document review, conflict of interest management, and decision recording.\n\nResources needed:\n\u2022 Ethics consultant\n\u2022 Project manager\n\u2022 Legal counsel\",10/27/2026,11/11/2026,0,767b4bcb-30ea-49cc-8e12-d8299ac2f0c8,PlanExe\nf2010f0e-b89d-41ee-a8d9-44eddfbbbc8e,Secure institutional support for ERB,\"Secure institutional support for ERB\n\nDescription:\nEnsure the ERB has adequate resources, administrative support, and independence to effectively fulfill its ethical oversight role.\n\nResources needed:\n\u2022 Senior management\n\u2022 Finance department\n\u2022 Legal counsel\",11/11/2026,11/26/2026,0,8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2,PlanExe\n57831a79-0296-4839-9152-097c08f2596f,Develop Ethical Guidelines and Protocols,,11/26/2026,2/9/2027,0,8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2,PlanExe\n0dc3543e-c84f-4914-9ca7-fd90435ed6ad,Research existing ethical guidelines for transplants,\"Research existing ethical guidelines for transplants\n\nDescription:\nObjective: Gather comprehensive data on existing ethical guidelines related to organ and face transplantation from various international and national organizations.\nScope: Review guidelines from organizations like the World Health Organization (WHO), national transplant societies, and relevant medical ethics journals.\nSteps:\n1. Identify key organizations and publications.\n2. Conduct a literature review.\n3. Summarize key ethical principles and recommendations.\nDeliverables: A detailed report summarizing existing ethical guidelines.\n\nResources needed:\n\u2022 Medical ethicist\n\u2022 Research assistant\n\u2022 Access to medical databases\",11/26/2026,12/11/2026,0,57831a79-0296-4839-9152-097c08f2596f,PlanExe\n2db1a1af-3883-43b5-8968-9061eee85941,Identify key ethical considerations for face transplants,\"Identify key ethical considerations for face transplants\n\nDescription:\nObjective: Identify and analyze the unique ethical considerations specific to face transplantation, including identity, consent, and psychological impact.\nScope: Focus on ethical issues related to recipient and donor families, as well as the broader societal implications.\nSteps:\n1. Conduct expert interviews with ethicists and transplant surgeons.\n2. Analyze case studies of face transplantation.\n3. Identify potential ethical dilemmas.\nDeliverables: A comprehensive list of key ethical considerations.\n\nResources needed:\n\u2022 Medical ethicist\n\u2022 Transplant surgeon\n\u2022 Psychologist\",12/11/2026,12/26/2026,0,0dc3543e-c84f-4914-9ca7-fd90435ed6ad,PlanExe\ncca1b359-29a6-495b-b6f4-b861f9679ff5,Draft preliminary ethical guidelines for the facility,\"Draft preliminary ethical guidelines for the facility\n\nDescription:\nObjective: Develop a preliminary set of ethical guidelines tailored to the specific context of the face transplantation facility in New Zealand.\nScope: Cover all aspects of the transplantation process, from donor selection to post-transplant care.\nSteps:\n1. Synthesize research findings and expert opinions.\n2. Draft preliminary guidelines.\n3. Circulate draft for internal review.\nDeliverables: A draft document outlining the facility's ethical guidelines.\n\nResources needed:\n\u2022 Medical ethicist\n\u2022 Legal counsel\n\u2022 Transplant surgeon\",12/26/2026,1/10/2027,0,2db1a1af-3883-43b5-8968-9061eee85941,PlanExe\ndc0d3df3-d0c9-4699-9310-5e0ef605a756,Obtain feedback from stakeholders on draft guidelines,\"Obtain feedback from stakeholders on draft guidelines\n\nDescription:\nObjective: Gather feedback from key stakeholders, including patients, donor families, medical professionals, and the public, on the draft ethical guidelines.\nScope: Conduct focus groups, surveys, and individual interviews to collect diverse perspectives.\nSteps:\n1. Identify key stakeholder groups.\n2. Develop feedback collection methods.\n3. Analyze feedback and identify areas for improvement.\nDeliverables: A report summarizing stakeholder feedback and recommendations.\n\nResources needed:\n\u2022 Medical ethicist\n\u2022 Patient liaison\n\u2022 Public relations specialist\",1/10/2027,1/25/2027,0,cca1b359-29a6-495b-b6f4-b861f9679ff5,PlanExe\n19bec1c3-8e14-46bf-ba18-3878fbff3565,Finalize ethical guidelines and protocols,\"Finalize ethical guidelines and protocols\n\nDescription:\nObjective: Revise and finalize the ethical guidelines based on stakeholder feedback and expert review.\nScope: Ensure the guidelines are comprehensive, practical, and aligned with relevant regulations and ethical principles.\nSteps:\n1. Incorporate stakeholder feedback.\n2. Obtain final approval from the Ethics Review Board.\n3. Disseminate the finalized guidelines to all relevant personnel.\nDeliverables: A finalized document outlining the facility's ethical guidelines and protocols.\n\nResources needed:\n\u2022 Medical ethicist\n\u2022 Legal counsel\n\u2022 Ethics Review Board\",1/25/2027,2/9/2027,0,57831a79-0296-4839-9152-097c08f2596f,PlanExe\n8a12f9b1-21eb-466a-bb85-60afa33725c8,Obtain Necessary Permits and Licenses,,2/9/2027,6/9/2027,0,bead144a-37b0-4c63-ac6d-a0a19d9c2a33,PlanExe\n40d47d6d-7c40-4678-a775-0f7da8fbc4eb,Identify required permits and licenses,\"Identify required permits and licenses\n\nDescription:\nObjective: Determine all necessary permits and licenses for the face transplantation facility and subscription service in New Zealand.\nScope: Research and document all relevant permits and licenses at the national, regional, and local levels.\nSteps: Consult with regulatory experts, review relevant legislation, and create a comprehensive list of required permits and licenses.\nDeliverables: A detailed list of all required permits and licenses.\n\nResources needed:\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Project manager\",2/9/2027,3/5/2027,0,8a12f9b1-21eb-466a-bb85-60afa33725c8,PlanExe\ne0c241ec-776e-4488-b204-4efe721c3c73,Prepare permit and license applications,\"Prepare permit and license applications\n\nDescription:\nObjective: Prepare all necessary documentation for permit and license applications.\nScope: Gather and compile all required information, complete application forms, and ensure accuracy and completeness.\nSteps: Collect data, fill out application forms, review and verify information, and submit applications.\nDeliverables: Completed permit and license applications.\n\nResources needed:\n\u2022 Administrative staff\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\",3/5/2027,3/29/2027,0,40d47d6d-7c40-4678-a775-0f7da8fbc4eb,PlanExe\n7b8f61a3-8cb3-456b-868b-ff3d8d424e7a,Submit applications and track progress,\"Submit applications and track progress\n\nDescription:\nObjective: Submit permit and license applications to the relevant regulatory bodies and track their progress.\nScope: Submit applications, monitor their status, respond to inquiries, and address any issues that arise.\nSteps: Submit applications, track progress online or through direct contact, respond to requests for information, and resolve any problems.\nDeliverables: Confirmation of application submission and regular progress updates.\n\nResources needed:\n\u2022 Administrative staff\n\u2022 Regulatory affairs consultant\n\u2022 Project manager\",3/29/2027,4/22/2027,0,e0c241ec-776e-4488-b204-4efe721c3c73,PlanExe\n00256dc9-49c9-49ee-ac1b-8b3ce6b252b1,Address regulatory body inquiries,\"Address regulatory body inquiries\n\nDescription:\nObjective: Respond to inquiries and requests for additional information from regulatory bodies.\nScope: Gather and provide requested information, address concerns, and ensure compliance with regulatory requirements.\nSteps: Review inquiries, gather information, prepare responses, and submit responses to regulatory bodies.\nDeliverables: Timely and accurate responses to regulatory inquiries.\n\nResources needed:\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Medical personnel\",4/22/2027,5/16/2027,0,7b8f61a3-8cb3-456b-868b-ff3d8d424e7a,PlanExe\n69c8900b-dab7-46e1-ba71-dcd7d276be9f,Secure final permits and licenses,\"Secure final permits and licenses\n\nDescription:\nObjective: Obtain all necessary permits and licenses for the face transplantation facility and subscription service.\nScope: Monitor application status, address any outstanding issues, and secure final approval.\nSteps: Track application progress, resolve any remaining issues, and obtain final permits and licenses.\nDeliverables: All required permits and licenses.\n\nResources needed:\n\u2022 Administrative staff\n\u2022 Regulatory affairs consultant\n\u2022 Legal counsel\n\u2022 Project manager\",5/16/2027,6/9/2027,0,8a12f9b1-21eb-466a-bb85-60afa33725c8,PlanExe\nc3905530-1d89-4610-bc35-a66b4597170d,Facility Development & Infrastructure,,6/9/2027,10/31/2028,0,bead144a-37b0-4c63-ac6d-a0a19d9c2a33,PlanExe\nc2656566-0c94-40b2-a22e-0955e9216f46,Select Facility Location,,6/9/2027,8/8/2027,0,c3905530-1d89-4610-bc35-a66b4597170d,PlanExe\n237024a5-b5b4-4851-aca8-df98563e2edd,Define Facility Requirements and Criteria,\"Define Facility Requirements and Criteria\n\nDescription:\nEstablish detailed requirements for the facility, including size, location, accessibility, zoning regulations, and proximity to hospitals and transportation hubs. Define selection criteria based on these requirements.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Medical Consultants\n\u2022 Facility Planner\",6/9/2027,6/21/2027,0,c2656566-0c94-40b2-a22e-0955e9216f46,PlanExe\n0c68c563-330b-4258-a61d-5cd55597a7d5,Conduct Market Research and Site Analysis,\"Conduct Market Research and Site Analysis\n\nDescription:\nResearch potential locations in New Zealand, considering factors such as demographics, competition, regulatory environment, and cost of real estate. Analyze potential sites based on the defined requirements and selection criteria.\n\nResources needed:\n\u2022 Market Research Analyst\n\u2022 Real Estate Agent\n\u2022 Data Analyst\",6/21/2027,7/3/2027,0,237024a5-b5b4-4851-aca8-df98563e2edd,PlanExe\nf2fab493-d73f-42dd-bb07-c9306a9618fb,Evaluate Potential Locations and Shortlist,\"Evaluate Potential Locations and Shortlist\n\nDescription:\nEvaluate potential locations based on market research, site analysis, and defined criteria. Create a shortlist of the most promising locations for further investigation.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Medical Consultants\n\u2022 Real Estate Agent\",7/3/2027,7/15/2027,0,0c68c563-330b-4258-a61d-5cd55597a7d5,PlanExe\n5b6d72f6-7f4d-442c-93b1-918c7380da49,Negotiate Lease or Purchase Agreement,\"Negotiate Lease or Purchase Agreement\n\nDescription:\nNegotiate lease or purchase agreements with property owners for the shortlisted locations. Secure favorable terms and conditions that align with the project's budget and timeline.\n\nResources needed:\n\u2022 Legal Counsel\n\u2022 Real Estate Agent\n\u2022 Project Manager\",7/15/2027,7/27/2027,0,f2fab493-d73f-42dd-bb07-c9306a9618fb,PlanExe\nb26eeadc-c132-4b6c-8bfd-8fbb67120d3d,Conduct Due Diligence and Finalize Selection,\"Conduct Due Diligence and Finalize Selection\n\nDescription:\nConduct thorough due diligence on the selected location, including environmental assessments, zoning verification, and structural inspections. Finalize the location selection based on the due diligence findings.\n\nResources needed:\n\u2022 Environmental Consultant\n\u2022 Legal Counsel\n\u2022 Structural Engineer\n\u2022 Project Manager\",7/27/2027,8/8/2027,0,c2656566-0c94-40b2-a22e-0955e9216f46,PlanExe\nd1da9237-e263-4c03-a503-590d6eeea3f3,Design Facility Layout,,8/8/2027,10/7/2027,0,c2656566-0c94-40b2-a22e-0955e9216f46,PlanExe\n5440543e-8c9b-4f92-b57e-1d092448873d,Define Facility Requirements and Specifications,\"Define Facility Requirements and Specifications\n\nDescription:\nDetermine specific requirements for the facility layout, including surgical suites, patient rooms, recovery areas, laboratory space, and administrative offices. Define technical specifications for HVAC, electrical, plumbing, and medical gas systems.\n\nResources needed:\n\u2022 Architect\n\u2022 Medical consultants\n\u2022 Facility manager\",8/8/2027,8/20/2027,0,d1da9237-e263-4c03-a503-590d6eeea3f3,PlanExe\nb2af5698-ffd5-4944-91ce-381c09a294a4,Develop Preliminary Facility Layout Designs,\"Develop Preliminary Facility Layout Designs\n\nDescription:\nCreate initial layout designs based on the defined requirements and specifications. Explore different layout options to optimize workflow, patient safety, and operational efficiency. Consider factors such as infection control, accessibility, and privacy.\n\nResources needed:\n\u2022 Architect\n\u2022 CAD software\n\u2022 Medical consultants\",8/20/2027,9/1/2027,0,5440543e-8c9b-4f92-b57e-1d092448873d,PlanExe\n8c1e864a-bafa-4fff-be04-33d6daad4b50,Review and Refine Layout Designs,\"Review and Refine Layout Designs\n\nDescription:\nPresent the preliminary layout designs to stakeholders, including surgeons, nurses, administrators, and facility managers. Gather feedback and incorporate revisions to improve the design. Conduct simulations to evaluate workflow and identify potential bottlenecks.\n\nResources needed:\n\u2022 Architect\n\u2022 Stakeholders\n\u2022 Simulation software\",9/1/2027,9/13/2027,0,b2af5698-ffd5-4944-91ce-381c09a294a4,PlanExe\na10513ec-dbe5-41fd-8218-4e5349fa869a,Create Detailed Architectural Drawings,\"Create Detailed Architectural Drawings\n\nDescription:\nDevelop detailed architectural drawings based on the refined layout designs. Include all necessary details for construction, including dimensions, materials, finishes, and equipment locations. Ensure compliance with building codes and regulations.\n\nResources needed:\n\u2022 Architect\n\u2022 Engineers\n\u2022 CAD software\",9/13/2027,9/25/2027,0,8c1e864a-bafa-4fff-be04-33d6daad4b50,PlanExe\n304396a5-e27e-425f-b381-7c60115860eb,Obtain Design Approvals,\"Obtain Design Approvals\n\nDescription:\nSubmit the detailed architectural drawings to relevant authorities for review and approval. Address any comments or concerns raised by the authorities and make necessary revisions to the drawings. Obtain all required permits and approvals before proceeding with construction.\n\nResources needed:\n\u2022 Architect\n\u2022 Permitting specialists\n\u2022 Legal counsel\",9/25/2027,10/7/2027,0,d1da9237-e263-4c03-a503-590d6eeea3f3,PlanExe\n664a3180-076a-435e-b8bd-5c2d7be3a5e1,Procure Surgical Equipment and Medical Supplies,,10/7/2027,2/4/2028,0,d1da9237-e263-4c03-a503-590d6eeea3f3,PlanExe\n73a1139e-8e53-47f7-b2e2-a709fc200b1b,Define Equipment Specifications and Requirements,\"Define Equipment Specifications and Requirements\n\nDescription:\nEstablish detailed specifications for all surgical equipment and medical supplies needed, including technical requirements, performance criteria, and regulatory compliance standards. This involves consulting with surgeons, nurses, and technicians to identify their specific needs and preferences.\n\nResources needed:\n\u2022 Surgeons\n\u2022 Nurses\n\u2022 Technicians\n\u2022 Biomedical Engineer\",10/7/2027,10/31/2027,0,664a3180-076a-435e-b8bd-5c2d7be3a5e1,PlanExe\n81e6bdef-caf9-42c4-b685-3860865a1a54,Identify Potential Vendors and Suppliers,\"Identify Potential Vendors and Suppliers\n\nDescription:\nResearch and identify potential vendors and suppliers for surgical equipment and medical supplies, considering factors such as product quality, pricing, delivery timelines, and reputation. This includes conducting market research, attending industry trade shows, and soliciting recommendations from other medical facilities.\n\nResources needed:\n\u2022 Procurement Specialist\n\u2022 Market Research Analyst\",10/31/2027,11/24/2027,0,73a1139e-8e53-47f7-b2e2-a709fc200b1b,PlanExe\nfb659d35-bf51-44d0-a402-2ad890eee55b,Evaluate Vendor Proposals and Negotiate Contracts,\"Evaluate Vendor Proposals and Negotiate Contracts\n\nDescription:\nEvaluate vendor proposals based on predefined criteria, including product specifications, pricing, warranty terms, and service agreements. Negotiate contracts with selected vendors to secure favorable terms and conditions, ensuring compliance with legal and ethical standards.\n\nResources needed:\n\u2022 Procurement Specialist\n\u2022 Legal Counsel\n\u2022 Financial Analyst\",11/24/2027,12/18/2027,0,81e6bdef-caf9-42c4-b685-3860865a1a54,PlanExe\nfa0db33f-7f9f-4e2e-9757-2efe6e1081d1,Manage Purchase Orders and Track Deliveries,\"Manage Purchase Orders and Track Deliveries\n\nDescription:\nGenerate purchase orders for approved equipment and supplies, track deliveries to ensure timely arrival, and verify that all items meet specified requirements. This includes coordinating with vendors, logistics providers, and internal stakeholders to resolve any issues or discrepancies.\n\nResources needed:\n\u2022 Procurement Specialist\n\u2022 Logistics Coordinator\n\u2022 Inventory Manager\",12/18/2027,1/11/2028,0,fb659d35-bf51-44d0-a402-2ad890eee55b,PlanExe\n68921308-13ba-4fac-bb46-70b802f93b68,Conduct Equipment Testing and Acceptance,\"Conduct Equipment Testing and Acceptance\n\nDescription:\nConduct thorough testing and acceptance procedures for all delivered equipment and supplies to ensure they meet performance standards and regulatory requirements. This includes verifying functionality, calibrating instruments, and providing training to medical personnel on proper usage and maintenance.\n\nResources needed:\n\u2022 Biomedical Engineer\n\u2022 Surgeons\n\u2022 Nurses\n\u2022 Technicians\",1/11/2028,2/4/2028,0,664a3180-076a-435e-b8bd-5c2d7be3a5e1,PlanExe\nb3eeffe0-96c3-4758-896e-c87fe1de4a7b,Construct/Renovate Facility,,2/4/2028,10/1/2028,0,664a3180-076a-435e-b8bd-5c2d7be3a5e1,PlanExe\ne02895ff-d980-4bbc-b950-8f681cac6a23,Prepare site for construction/renovation,\"Prepare site for construction/renovation\n\nDescription:\nClear the site, prepare the foundation, and ensure compliance with safety regulations.\n\nResources needed:\n\u2022 Construction crew\n\u2022 Heavy machinery\n\u2022 Site supervisor\",2/4/2028,3/23/2028,0,b3eeffe0-96c3-4758-896e-c87fe1de4a7b,PlanExe\n011f9618-dcf2-4bd1-b8ee-2c6505951766,Execute structural construction/renovation,\"Execute structural construction/renovation\n\nDescription:\nBuild or renovate the facility's structural components, including walls, floors, and roof.\n\nResources needed:\n\u2022 Construction crew\n\u2022 Architect\n\u2022 Structural engineer\n\u2022 Building materials\",3/23/2028,5/10/2028,0,e02895ff-d980-4bbc-b950-8f681cac6a23,PlanExe\nff893814-759b-44cc-8ffa-0be1aa266165,Install electrical and plumbing systems,\"Install electrical and plumbing systems\n\nDescription:\nInstall electrical wiring, plumbing pipes, and HVAC systems according to building codes and specifications.\n\nResources needed:\n\u2022 Electricians\n\u2022 Plumbers\n\u2022 HVAC technicians\n\u2022 Inspectors\",5/10/2028,6/27/2028,0,011f9618-dcf2-4bd1-b8ee-2c6505951766,PlanExe\n0c48a713-4bd4-4cd0-8ddc-17c4b06b16f8,Install specialized medical infrastructure,\"Install specialized medical infrastructure\n\nDescription:\nInstall specialized medical infrastructure, such as operating rooms, recovery rooms, and laboratory facilities.\n\nResources needed:\n\u2022 Specialized contractors\n\u2022 Medical equipment suppliers\n\u2022 Medical consultants\",6/27/2028,8/14/2028,0,ff893814-759b-44cc-8ffa-0be1aa266165,PlanExe\nc5e28806-e26d-4473-9097-e23ddfb6e539,Complete interior finishing and fixtures,\"Complete interior finishing and fixtures\n\nDescription:\nInstall interior finishes, such as flooring, walls, ceilings, and fixtures, to create a functional and aesthetically pleasing environment.\n\nResources needed:\n\u2022 Interior designers\n\u2022 Carpenters\n\u2022 Painters\n\u2022 Electricians\",8/14/2028,10/1/2028,0,b3eeffe0-96c3-4758-896e-c87fe1de4a7b,PlanExe\nbf1f1646-5331-4128-843a-94182f9e72a2,Install Data Privacy and Security Systems,,10/1/2028,10/31/2028,0,c3905530-1d89-4610-bc35-a66b4597170d,PlanExe\n43b25536-52e8-4246-bedd-84ee796f803e,Assess data privacy regulatory requirements,\"Assess data privacy regulatory requirements\n\nDescription:\nIdentify and document all applicable data privacy regulations in New Zealand, including the Health Information Privacy Code 2020 and any relevant international standards like GDPR if applicable to data transfer or storage.\n\nResources needed:\n\u2022 Data privacy lawyer\n\u2022 Regulatory compliance officer\",10/1/2028,10/7/2028,0,bf1f1646-5331-4128-843a-94182f9e72a2,PlanExe\nb1293df1-628c-41a4-8aab-bfef544fb03b,Select and procure security hardware/software,\"Select and procure security hardware/software\n\nDescription:\nChoose appropriate data encryption software, firewalls, intrusion detection systems, and access control mechanisms based on the assessed regulatory requirements and the sensitivity of patient data. Procure the selected solutions.\n\nResources needed:\n\u2022 Cybersecurity expert\n\u2022 IT procurement specialist\n\u2022 Budget\",10/7/2028,10/13/2028,0,43b25536-52e8-4246-bedd-84ee796f803e,PlanExe\ncbc59d5f-755c-4d82-b8d9-660a92518932,Configure and integrate security systems,\"Configure and integrate security systems\n\nDescription:\nInstall and configure the selected security hardware and software, ensuring seamless integration with existing hospital IT infrastructure and electronic health record (EHR) systems. Implement access control protocols and data encryption.\n\nResources needed:\n\u2022 IT technicians\n\u2022 Cybersecurity engineer\n\u2022 Systems administrator\",10/13/2028,10/19/2028,0,b1293df1-628c-41a4-8aab-bfef544fb03b,PlanExe\nabfb3dbe-3b60-4462-b2b3-978d3e49db9c,Test and validate security system effectiveness,\"Test and validate security system effectiveness\n\nDescription:\nConduct penetration testing and vulnerability assessments to identify and address any weaknesses in the implemented security systems. Validate that the systems effectively protect patient data and comply with regulatory requirements.\n\nResources needed:\n\u2022 Penetration testers\n\u2022 Security auditors\n\u2022 IT security team\",10/19/2028,10/25/2028,0,cbc59d5f-755c-4d82-b8d9-660a92518932,PlanExe\nb9314417-b01e-492f-a16b-ea1d4ed12b44,Develop data breach response plan,\"Develop data breach response plan\n\nDescription:\nCreate a comprehensive plan outlining the steps to be taken in the event of a data breach, including incident reporting, containment, investigation, notification, and remediation. Ensure the plan complies with regulatory requirements.\n\nResources needed:\n\u2022 Data privacy lawyer\n\u2022 Cybersecurity expert\n\u2022 Legal counsel\n\u2022 Public relations team\",10/25/2028,10/31/2028,0,bf1f1646-5331-4128-843a-94182f9e72a2,PlanExe\nedea1841-d86e-4d1b-9704-04d6abb593c2,Donor Face Acquisition & Preservation,,10/31/2028,4/16/2029,0,c3905530-1d89-4610-bc35-a66b4597170d,PlanExe\n22ffa70e-b917-4918-9074-e917a9890156,Establish Partnerships with Organ Donation Organizations,,10/31/2028,12/30/2028,0,edea1841-d86e-4d1b-9704-04d6abb593c2,PlanExe\n907727c7-1fb8-46b6-9da0-4396387846fb,Identify potential organ donation partners,\"Identify potential organ donation partners\n\nDescription:\nResearch and identify organ donation organizations in New Zealand that align with the project's goals and ethical standards. This includes reviewing their mission statements, donation policies, and geographical coverage.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Research Assistant\n\u2022 Legal Counsel\",10/31/2028,11/15/2028,0,22ffa70e-b917-4918-9074-e917a9890156,PlanExe\n8ebe4ef9-feb1-4d3f-99f6-33245a10cae3,Initial contact and introductory meetings,\"Initial contact and introductory meetings\n\nDescription:\nReach out to identified organ donation organizations to schedule introductory meetings. The objective is to present the project, explain the need for donor faces, and gauge their interest in potential collaboration.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Donor Relations Specialist\",11/15/2028,11/30/2028,0,907727c7-1fb8-46b6-9da0-4396387846fb,PlanExe\ncb406d06-ae90-4da8-81d1-c352984cacac,Negotiate partnership agreements,\"Negotiate partnership agreements\n\nDescription:\nWork with interested organ donation organizations to negotiate the terms of partnership agreements. This includes defining roles and responsibilities, establishing protocols for donor face acquisition, and addressing ethical considerations.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Legal Counsel\n\u2022 Ethics Review Board Coordinator\",11/30/2028,12/15/2028,0,8ebe4ef9-feb1-4d3f-99f6-33245a10cae3,PlanExe\n1da9645e-89a2-4e93-8b0e-a0f23aca4102,Formalize partnership agreements,\"Formalize partnership agreements\n\nDescription:\nFinalize and execute partnership agreements with selected organ donation organizations. This involves obtaining necessary approvals from both parties and ensuring that all agreements comply with relevant regulations and ethical guidelines.\n\nResources needed:\n\u2022 Project Manager\n\u2022 Legal Counsel\n\u2022 Executive Leadership\",12/15/2028,12/30/2028,0,22ffa70e-b917-4918-9074-e917a9890156,PlanExe\n406b6dd6-7b44-4d60-a2e1-f31668252d62,Develop Donor Face Acquisition Protocols,,12/30/2028,2/28/2029,0,22ffa70e-b917-4918-9074-e917a9890156,PlanExe\n85546c83-65bb-4baf-b100-9ce5e8fcde72,Research current face acquisition protocols,\"Research current face acquisition protocols\n\nDescription:\nObjective: Understand existing protocols for face acquisition from organ donation organizations.\nScope: Review literature, guidelines, and best practices.\nSteps: Search databases, contact experts, analyze findings.\nDeliverables: Summary report of current protocols.\n\nResources needed:\n\u2022 Research assistant\n\u2022 Medical librarian\n\u2022 Transplant surgeon\",12/30/2028,1/14/2029,0,406b6dd6-7b44-4d60-a2e1-f31668252d62,PlanExe\n2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4,Draft initial face acquisition protocol,\"Draft initial face acquisition protocol\n\nDescription:\nObjective: Create a draft protocol tailored to the facility's needs.\nScope: Define eligibility criteria, consent process, and documentation.\nSteps: Consult with legal and ethical experts, draft protocol, review internally.\nDeliverables: Draft face acquisition protocol document.\n\nResources needed:\n\u2022 Transplant surgeon\n\u2022 Legal counsel\n\u2022 Ethicist\n\u2022 Protocol writer\",1/14/2029,1/29/2029,0,85546c83-65bb-4baf-b100-9ce5e8fcde72,PlanExe\n2ecb2eed-47f8-4efc-9936-7ea541193511,Review protocol with organ donation organizations,\"Review protocol with organ donation organizations\n\nDescription:\nObjective: Obtain feedback and ensure compatibility with organ donation organizations.\nScope: Share draft protocol, solicit feedback, revise based on input.\nSteps: Schedule meetings, present protocol, document feedback, revise.\nDeliverables: Revised face acquisition protocol document.\n\nResources needed:\n\u2022 Transplant surgeon\n\u2022 Donor relations specialist\n\u2022 Organ donation organization representatives\",1/29/2029,2/13/2029,0,2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4,PlanExe\n179b4feb-8bb6-4d4c-9601-cb9b543e99d5,Finalize and approve acquisition protocol,\"Finalize and approve acquisition protocol\n\nDescription:\nObjective: Obtain final approval from the ethics review board and facility leadership.\nScope: Address any remaining concerns, finalize protocol, obtain signatures.\nSteps: Present to ethics review board, address concerns, obtain approval, finalize document.\nDeliverables: Approved face acquisition protocol document.\n\nResources needed:\n\u2022 Ethics review board\n\u2022 Facility leadership\n\u2022 Legal counsel\",2/13/2029,2/28/2029,0,406b6dd6-7b44-4d60-a2e1-f31668252d62,PlanExe\n6184d74a-ca1e-44d1-b5b8-445aadb63208,Establish Face Transportation and Preservation Logistics,,2/28/2029,4/1/2029,0,406b6dd6-7b44-4d60-a2e1-f31668252d62,PlanExe\n0c5b34e2-b12c-410e-992a-f4bba6326ebf,Map transportation routes and identify providers,\"Map transportation routes and identify providers\n\nDescription:\nObjective: Determine optimal transportation routes for donor faces across New Zealand. Scope: Identify potential transportation providers (air, land) and map out routes considering distance, time, and cost. Steps: Use mapping software, contact transportation companies, and analyze route options. Deliverables: Route maps and provider list.\n\nResources needed:\n\u2022 Logistics coordinator\n\u2022 Mapping software\n\u2022 Transportation company contacts\",2/28/2029,3/8/2029,0,6184d74a-ca1e-44d1-b5b8-445aadb63208,PlanExe\nd46b6612-cd0a-4ae8-bf54-a74fd1ed9003,Establish preservation solution procurement process,\"Establish preservation solution procurement process\n\nDescription:\nObjective: Ensure a reliable supply of preservation solutions. Scope: Identify suppliers, negotiate contracts, and establish a procurement process. Steps: Research suppliers, obtain quotes, and create a purchase order system. Deliverables: Supplier contracts and procurement process documentation.\n\nResources needed:\n\u2022 Procurement specialist\n\u2022 Legal counsel\n\u2022 Medical supply vendors\",3/8/2029,3/16/2029,0,0c5b34e2-b12c-410e-992a-f4bba6326ebf,PlanExe\nd73df452-bb1b-46f6-aaa8-c2a91243ecba,Develop packaging and handling procedures,\"Develop packaging and handling procedures\n\nDescription:\nObjective: Minimize damage to donor faces during transportation. Scope: Create detailed packaging and handling procedures. Steps: Research best practices, design packaging, and document procedures. Deliverables: Packaging and handling procedure manual.\n\nResources needed:\n\u2022 Medical technician\n\u2022 Packaging engineer\n\u2022 Transportation specialist\",3/16/2029,3/24/2029,0,d46b6612-cd0a-4ae8-bf54-a74fd1ed9003,PlanExe\n36f291b9-ce07-4078-a331-08b7c984d520,Create temperature monitoring and tracking system,\"Create temperature monitoring and tracking system\n\nDescription:\nObjective: Maintain optimal temperature during transportation. Scope: Implement a temperature monitoring and tracking system. Steps: Select monitoring devices, integrate with transportation system, and establish alert protocols. Deliverables: Temperature monitoring system and alert protocols.\n\nResources needed:\n\u2022 IT specialist\n\u2022 Logistics coordinator\n\u2022 Temperature monitoring equipment\",3/24/2029,4/1/2029,0,6184d74a-ca1e-44d1-b5b8-445aadb63208,PlanExe\nf2158970-6c48-4dfa-97e5-6620da550d37,Implement Inventory Management System,,4/1/2029,4/16/2029,0,edea1841-d86e-4d1b-9704-04d6abb593c2,PlanExe\n1e85e3e9-276d-4f0a-a9c1-3887d39771c1,Define Inventory System Requirements,\"Define Inventory System Requirements\n\nDescription:\nClearly define the requirements for the inventory management system, including tracking parameters, user roles, and reporting needs.\n\nResources needed:\n\u2022 Inventory Manager\n\u2022 IT Specialist\n\u2022 Surgeons\n\u2022 Nurses\",4/1/2029,4/4/2029,0,f2158970-6c48-4dfa-97e5-6620da550d37,PlanExe\nd0af366a-186a-4e6b-ae0f-4a0f2fefa5b1,Select Inventory Management Software,\"Select Inventory Management Software\n\nDescription:\nEvaluate and select appropriate inventory management software that meets the defined requirements and integrates with existing hospital systems.\n\nResources needed:\n\u2022 IT Specialist\n\u2022 Inventory Manager\n\u2022 Procurement Officer\",4/4/2029,4/7/2029,0,1e85e3e9-276d-4f0a-a9c1-3887d39771c1,PlanExe\n09075e8b-5ccd-462a-96e9-b22d33b7e037,Configure and Customize Software,\"Configure and Customize Software\n\nDescription:\nConfigure and customize the selected inventory management software to track donor faces, preservation solutions, and related data.\n\nResources needed:\n\u2022 IT Specialist\n\u2022 Software Vendor Support\",4/7/2029,4/10/2029,0,d0af366a-186a-4e6b-ae0f-4a0f2fefa5b1,PlanExe\nc7be9ecc-472a-4a49-8280-d31b1a1d1c00,Train Staff on System Usage,\"Train Staff on System Usage\n\nDescription:\nProvide comprehensive training to all relevant staff members on how to use the inventory management system effectively.\n\nResources needed:\n\u2022 Training Coordinator\n\u2022 IT Specialist\n\u2022 Inventory Manager\",4/10/2029,4/13/2029,0,09075e8b-5ccd-462a-96e9-b22d33b7e037,PlanExe\na99f4878-fb70-4658-820d-e104fcca0688,Test and Validate System Functionality,\"Test and Validate System Functionality\n\nDescription:\nThoroughly test and validate the functionality of the inventory management system to ensure accuracy and reliability.\n\nResources needed:\n\u2022 IT Specialist\n\u2022 Inventory Manager\n\u2022 Quality Assurance Team\",4/13/2029,4/16/2029,0,f2158970-6c48-4dfa-97e5-6620da550d37,PlanExe\n07f8df70-3b93-46d1-9571-5f7823a7865e,Medical Team Recruitment & Training,,4/16/2029,8/29/2029,0,edea1841-d86e-4d1b-9704-04d6abb593c2,PlanExe\na6dfbdbf-d854-44fa-aaea-71b6dfc22891,\"Recruit Transplant Surgeons, Nurses, and Technicians\",,4/16/2029,5/31/2029,0,07f8df70-3b93-46d1-9571-5f7823a7865e,PlanExe\n603662c9-344a-4f04-9c30-891acb6d9c8e,\"Define Surgeon, Nurse, Technician Job Descriptions\",\"Define Surgeon, Nurse, Technician Job Descriptions\n\nDescription:\nCreate detailed job descriptions outlining responsibilities, qualifications, and experience required for each role (Transplant Surgeons, Nurses, and Technicians).\n\nResources needed:\n\u2022 HR Specialist\n\u2022 Medical Director\n\u2022 Senior Surgeons\n\u2022 Nursing Manager\n\u2022 Technical Lead\",4/16/2029,4/25/2029,0,a6dfbdbf-d854-44fa-aaea-71b6dfc22891,PlanExe\n42ec1737-196e-4c88-bfdd-8e1a359cc439,Advertise Open Positions on Relevant Platforms,\"Advertise Open Positions on Relevant Platforms\n\nDescription:\nPost job openings on medical job boards, professional networks, and university career pages to attract qualified candidates.\n\nResources needed:\n\u2022 HR Specialist\n\u2022 Marketing Team\n\u2022 Online Job Boards\n\u2022 Professional Networks\",4/25/2029,5/4/2029,0,603662c9-344a-4f04-9c30-891acb6d9c8e,PlanExe\n135fc0e9-438a-4721-b996-f43881f0fc16,Screen Applications and Conduct Initial Interviews,\"Screen Applications and Conduct Initial Interviews\n\nDescription:\nReview applications, conduct phone screenings, and schedule initial interviews with promising candidates to assess their qualifications and fit for the roles.\n\nResources needed:\n\u2022 HR Specialist\n\u2022 Recruiting Team\n\u2022 Interview Panel\",5/4/2029,5/13/2029,0,42ec1737-196e-4c88-bfdd-8e1a359cc439,PlanExe\nfc6093c8-b948-46c1-9d82-fd919b41657b,Conduct Technical and Practical Skills Assessments,\"Conduct Technical and Practical Skills Assessments\n\nDescription:\nEvaluate candidates' technical skills and practical abilities through simulations, case studies, and hands-on assessments to ensure they possess the necessary expertise.\n\nResources needed:\n\u2022 Senior Surgeons\n\u2022 Nursing Manager\n\u2022 Technical Lead\n\u2022 Simulation Equipment\",5/13/2029,5/22/2029,0,135fc0e9-438a-4721-b996-f43881f0fc16,PlanExe\nfb0389ed-03b4-4bd5-b726-119c8f3b7ba3,Perform Background Checks and Credential Verification,\"Perform Background Checks and Credential Verification\n\nDescription:\nConduct thorough background checks and verify credentials, licenses, and certifications to ensure candidates meet all legal and regulatory requirements.\n\nResources needed:\n\u2022 HR Specialist\n\u2022 Legal Counsel\n\u2022 Credentialing Agency\",5/22/2029,5/31/2029,0,a6dfbdbf-d854-44fa-aaea-71b6dfc22891,PlanExe\n7018d1da-7992-42c1-bec3-176474ec2378,Develop Training Programs for Medical Personnel,,5/31/2029,7/30/2029,0,a6dfbdbf-d854-44fa-aaea-71b6dfc22891,PlanExe\n80e6de91-5f68-4d73-9a76-851da609fa65,Curriculum Design for Face Transplant Training,\"Curriculum Design for Face Transplant Training\n\nDescription:\nDevelop a comprehensive curriculum covering surgical techniques, immunosuppression protocols, ethical considerations, and psychological support for face transplantation.\n\nResources needed:\n\u2022 Experienced transplant surgeons\n\u2022 Medical educators\n\u2022 Ethicists\n\u2022 Psychologists\n\u2022 Curriculum development specialists\",5/31/2029,6/12/2029,0,7018d1da-7992-42c1-bec3-176474ec2378,PlanExe\n08d7cf07-78da-4107-8db6-279c1946f7fe,Develop Surgical Simulation Modules,\"Develop Surgical Simulation Modules\n\nDescription:\nCreate realistic surgical simulation modules using cadaveric models or virtual reality to provide hands-on training for surgeons and surgical teams.\n\nResources needed:\n\u2022 Surgical simulation experts\n\u2022 Anatomists\n\u2022 Medical engineers\n\u2022 Cadaveric models or VR equipment\n\u2022 Funding for simulation equipment\",6/12/2029,6/24/2029,0,80e6de91-5f68-4d73-9a76-851da609fa65,PlanExe\n38a84ba4-234b-4161-883f-f301d060cc1f,Establish Mentorship Program with Experts,\"Establish Mentorship Program with Experts\n\nDescription:\nPartner with experienced face transplant centers globally to establish a mentorship program for surgeons, nurses, and technicians to gain practical experience and knowledge.\n\nResources needed:\n\u2022 Experienced face transplant surgeons\n\u2022 International transplant centers\n\u2022 Travel funding\n\u2022 Communication platform\n\u2022 Mentorship program coordinator\",6/24/2029,7/6/2029,0,08d7cf07-78da-4107-8db6-279c1946f7fe,PlanExe\nf95038eb-bebf-48da-8c5e-f6e7071c4757,Create Standardized Post-Operative Care Protocols,\"Create Standardized Post-Operative Care Protocols\n\nDescription:\nDevelop standardized post-operative care protocols for managing immunosuppression, monitoring for rejection, and providing psychological support to face transplant recipients.\n\nResources needed:\n\u2022 Transplant nurses\n\u2022 Immunologists\n\u2022 Psychologists\n\u2022 Pharmacists\n\u2022 Post-operative care specialists\",7/6/2029,7/18/2029,0,38a84ba4-234b-4161-883f-f301d060cc1f,PlanExe\n83bd2c85-436e-45c2-b215-fe9917d4962c,Develop Training Evaluation and Certification,\"Develop Training Evaluation and Certification\n\nDescription:\nEstablish a system for evaluating the effectiveness of the training program and certifying medical personnel who have successfully completed the training.\n\nResources needed:\n\u2022 Medical educators\n\u2022 Assessment specialists\n\u2022 Certification board\n\u2022 Evaluation tools\n\u2022 Administrative support\",7/18/2029,7/30/2029,0,7018d1da-7992-42c1-bec3-176474ec2378,PlanExe\na3434b32-c11f-4b3e-b010-1e564ed21e55,Conduct Simulation Training Exercises,,7/30/2029,8/29/2029,0,07f8df70-3b93-46d1-9571-5f7823a7865e,PlanExe\n1a3a2127-0354-4eca-9056-427371200c79,Develop Simulation Scenarios and Protocols,\"Develop Simulation Scenarios and Protocols\n\nDescription:\nCreate realistic scenarios that mimic face transplantation procedures, including pre-operative planning, surgical techniques, and post-operative care. Develop detailed protocols for each scenario, outlining the roles and responsibilities of each team member.\n\nResources needed:\n\u2022 Experienced transplant surgeons\n\u2022 Simulation specialists\n\u2022 Medical educators\n\u2022 Nurses\n\u2022 Technicians\",7/30/2029,8/5/2029,0,a3434b32-c11f-4b3e-b010-1e564ed21e55,PlanExe\nd21b27d7-b51a-41f9-a22a-2c7e89a6ed58,Acquire and Configure Simulation Equipment,\"Acquire and Configure Simulation Equipment\n\nDescription:\nProcure necessary simulation equipment, such as mannequins, surgical instruments, and software. Configure the equipment to accurately replicate the conditions of a real face transplantation procedure.\n\nResources needed:\n\u2022 Procurement specialists\n\u2022 Biomedical engineers\n\u2022 IT technicians\n\u2022 Simulation technicians\",8/5/2029,8/11/2029,0,1a3a2127-0354-4eca-9056-427371200c79,PlanExe\n37f79344-021f-4563-b48d-d570bf04dbf9,Train Simulation Facilitators and Observers,\"Train Simulation Facilitators and Observers\n\nDescription:\nTrain facilitators to guide the simulation exercises and observers to evaluate the performance of the medical personnel. Provide them with the necessary knowledge and skills to effectively conduct and assess the simulations.\n\nResources needed:\n\u2022 Experienced simulation specialists\n\u2022 Medical educators\n\u2022 Assessment experts\",8/11/2029,8/17/2029,0,d21b27d7-b51a-41f9-a22a-2c7e89a6ed58,PlanExe\nf4577276-a266-4bc8-a82d-2141e7fbd99c,Conduct Simulation Exercises and Gather Data,\"Conduct Simulation Exercises and Gather Data\n\nDescription:\nConduct the simulation exercises with the medical personnel, following the established protocols. Gather data on their performance, including surgical techniques, decision-making, communication, and teamwork.\n\nResources needed:\n\u2022 Transplant surgeons\n\u2022 Nurses\n\u2022 Technicians\n\u2022 Simulation facilitators\n\u2022 Observers\",8/17/2029,8/23/2029,0,37f79344-021f-4563-b48d-d570bf04dbf9,PlanExe\n1036ce4c-4986-4b0c-9ca2-aaa3e71d7dc3,Analyze Simulation Data and Provide Feedback,\"Analyze Simulation Data and Provide Feedback\n\nDescription:\nAnalyze the data gathered from the simulation exercises to identify areas for improvement. Provide constructive feedback to the medical personnel, highlighting their strengths and weaknesses.\n\nResources needed:\n\u2022 Data analysts\n\u2022 Experienced transplant surgeons\n\u2022 Medical educators\",8/23/2029,8/29/2029,0,a3434b32-c11f-4b3e-b010-1e564ed21e55,PlanExe\n96817a78-23cf-4f51-b115-c0a63c20a419,Subscription Model Development & Marketing,,8/29/2029,12/15/2029,0,07f8df70-3b93-46d1-9571-5f7823a7865e,PlanExe\nec842223-c669-493e-b08c-ecd6501b2647,Design Subscription Model Tiers and Pricing,,8/29/2029,9/14/2029,0,96817a78-23cf-4f51-b115-c0a63c20a419,PlanExe\nb723be5f-9208-453e-af6b-e20e7c2b0935,Research competitor subscription models,\"Research competitor subscription models\n\nDescription:\nAnalyze existing subscription models in related industries (e.g., cosmetic surgery, high-end fashion) to identify best practices and potential pitfalls.  Objective: Understand market trends and pricing strategies. Scope: Review competitor offerings, pricing structures, and customer feedback. Steps: Identify relevant competitors, gather data on their subscription models, analyze pricing and features, and document findings. Deliverables: Competitor analysis report.\n\nResources needed:\n\u2022 Market research analyst\n\u2022 Financial analyst\n\u2022 Industry reports\",8/29/2029,9/2/2029,0,ec842223-c669-493e-b08c-ecd6501b2647,PlanExe\n5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c,Define core service offerings,\"Define core service offerings\n\nDescription:\nDetermine the specific services to be included in each subscription tier (e.g., number of face swaps per month, access to premium features). Objective: Define the value proposition for each tier. Scope: Identify potential service offerings, evaluate their cost and feasibility, and allocate them to different tiers. Steps: Brainstorm potential service offerings, assess their cost and feasibility, prioritize offerings based on customer demand, and allocate them to different tiers. Deliverables: Service offering matrix.\n\nResources needed:\n\u2022 Product manager\n\u2022 Medical director\n\u2022 Marketing team\",9/2/2029,9/6/2029,0,b723be5f-9208-453e-af6b-e20e7c2b0935,PlanExe\n2a86897a-4999-4dde-a5f1-d0dc8ed738f1,Develop pricing models and financial projections,\"Develop pricing models and financial projections\n\nDescription:\nCreate detailed financial projections for each subscription tier, taking into account costs, revenue, and profitability. Objective: Ensure financial sustainability. Scope: Develop pricing models, forecast revenue, and project profitability. Steps: Estimate costs for each service offering, determine optimal pricing for each tier, forecast subscription uptake, and project revenue and profitability. Deliverables: Financial projections report.\n\nResources needed:\n\u2022 Financial analyst\n\u2022 Accountant\n\u2022 Business development manager\",9/6/2029,9/10/2029,0,5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c,PlanExe\nfd0ea2d9-788d-4e1c-b312-1fadfb8de5f2,Assess legal and ethical considerations,\"Assess legal and ethical considerations\n\nDescription:\nConsult with legal and ethical experts to ensure that the subscription model complies with all applicable laws and regulations and addresses potential ethical concerns. Objective: Mitigate legal and ethical risks. Scope: Review legal and ethical implications of the subscription model. Steps: Consult with legal counsel, consult with ethicists, identify potential legal and ethical risks, and develop mitigation strategies. Deliverables: Legal and ethical risk assessment report.\n\nResources needed:\n\u2022 Legal counsel\n\u2022 Ethicist\n\u2022 Compliance officer\",9/10/2029,9/14/2029,0,ec842223-c669-493e-b08c-ecd6501b2647,PlanExe\n7f9f308e-365f-46e0-ad45-31a9dc51fa8b,Develop Marketing and Advertising Strategy,,9/14/2029,11/13/2029,0,ec842223-c669-493e-b08c-ecd6501b2647,PlanExe\n3e63ebd3-2fe0-4e58-b1f0-4e8b4d98e90d,Define Target Audience and Market Segments,\"Define Target Audience and Market Segments\n\nDescription:\nIdentify specific demographics, psychographics, and needs of potential subscribers. Segment the market based on factors such as age, income, lifestyle, and interest in face transplantation.\n\nResources needed:\n\u2022 Market research analyst\n\u2022 Marketing manager\",9/14/2029,9/26/2029,0,7f9f308e-365f-46e0-ad45-31a9dc51fa8b,PlanExe\nba2348a4-afa6-475e-9a0e-8bca32eb17b4,Develop Key Messaging and Value Proposition,\"Develop Key Messaging and Value Proposition\n\nDescription:\nCraft compelling messaging that highlights the benefits of the subscription service and addresses potential ethical concerns. Define the unique value proposition for each target market segment.\n\nResources needed:\n\u2022 Copywriter\n\u2022 Marketing strategist\n\u2022 Ethicist\",9/26/2029,10/8/2029,0,3e63ebd3-2fe0-4e58-b1f0-4e8b4d98e90d,PlanExe\nedb1c4da-05e4-4c54-a328-dbe7c6828042,Select Marketing Channels and Platforms,\"Select Marketing Channels and Platforms\n\nDescription:\nDetermine the most effective channels for reaching the target audience, such as online advertising, social media, public relations, and partnerships with relevant organizations. Evaluate the suitability of different platforms for delivering the marketing message.\n\nResources needed:\n\u2022 Marketing manager\n\u2022 Digital marketing specialist\",10/8/2029,10/20/2029,0,ba2348a4-afa6-475e-9a0e-8bca32eb17b4,PlanExe\n702c7a45-d903-47be-b61d-960415c32bdf,Create Marketing Materials and Content,\"Create Marketing Materials and Content\n\nDescription:\nDevelop engaging marketing materials, including website content, brochures, videos, and social media posts. Ensure that all materials are consistent with the key messaging and value proposition.\n\nResources needed:\n\u2022 Graphic designer\n\u2022 Video editor\n\u2022 Content writer\",10/20/2029,11/1/2029,0,edb1c4da-05e4-4c54-a328-dbe7c6828042,PlanExe\nfccdd8e1-1a49-4b15-9724-d488b31c7026,Establish Public Relations and Media Outreach,\"Establish Public Relations and Media Outreach\n\nDescription:\nDevelop a public relations strategy to generate positive media coverage and build awareness of the subscription service. Engage with journalists, bloggers, and influencers to promote the service and address potential ethical concerns.\n\nResources needed:\n\u2022 Public relations specialist\n\u2022 Media relations manager\",11/1/2029,11/13/2029,0,7f9f308e-365f-46e0-ad45-31a9dc51fa8b,PlanExe\nbcbecda8-592b-4c76-911b-8fdbf3848488,Establish Customer Service and Support Protocols,,11/13/2029,12/15/2029,0,96817a78-23cf-4f51-b115-c0a63c20a419,PlanExe\n307fc299-ac88-4477-9b8c-b59b39705cb5,Develop Customer Service Training Materials,\"Develop Customer Service Training Materials\n\nDescription:\nCreate comprehensive training materials covering product knowledge, customer interaction skills, and problem-solving techniques.\n\nResources needed:\n\u2022 Training Specialist\n\u2022 Subject Matter Experts\n\u2022 Instructional Designer\",11/13/2029,11/21/2029,0,bcbecda8-592b-4c76-911b-8fdbf3848488,PlanExe\nfb381bef-9642-442b-a7bd-f9813836b69f,Establish Customer Service Channels,\"Establish Customer Service Channels\n\nDescription:\nSet up communication channels such as phone, email, and online chat to handle customer inquiries and support requests.\n\nResources needed:\n\u2022 IT Support\n\u2022 Telecommunications Specialist\n\u2022 Customer Service Manager\",11/21/2029,11/29/2029,0,307fc299-ac88-4477-9b8c-b59b39705cb5,PlanExe\nd5bc63d8-55c9-4f01-bc6f-a2a34337745d,Define Service Level Agreements (SLAs),\"Define Service Level Agreements (SLAs)\n\nDescription:\nEstablish clear SLAs for response times, resolution times, and customer satisfaction targets.\n\nResources needed:\n\u2022 Customer Service Manager\n\u2022 Operations Manager\n\u2022 Legal Counsel\",11/29/2029,12/7/2029,0,fb381bef-9642-442b-a7bd-f9813836b69f,PlanExe\n80f6dc05-65c9-43a1-81c5-d1a95d8ac6ce,Implement CRM System for Customer Data,\"Implement CRM System for Customer Data\n\nDescription:\nConfigure a CRM system to manage customer data, track interactions, and personalize support.\n\nResources needed:\n\u2022 CRM Specialist\n\u2022 IT Support\n\u2022 Data Analyst\",12/7/2029,12/15/2029,0,bcbecda8-592b-4c76-911b-8fdbf3848488,PlanExe\n881ece3f-9348-4d69-93f2-2803c75dd85c,Surgical Procedures & Patient Care,,12/15/2029,6/13/2030,0,96817a78-23cf-4f51-b115-c0a63c20a419,PlanExe\nce5e2e90-d960-4aa6-9268-cf34537813aa,Develop Pre-Transplant Assessment Protocols,,12/15/2029,12/25/2029,0,881ece3f-9348-4d69-93f2-2803c75dd85c,PlanExe\n59642d8b-cfa6-4f76-8a05-a624ca6c29a1,Gather Patient Medical History and Records,\"Gather Patient Medical History and Records\n\nDescription:\nCollect comprehensive medical history, including past illnesses, surgeries, medications, allergies, and family history. Obtain relevant medical records from previous healthcare providers.\n\nResources needed:\n\u2022 Medical Records Specialist\n\u2022 Patient Liaison\n\u2022 Electronic Health Record System\",12/15/2029,12/17/2029,0,ce5e2e90-d960-4aa6-9268-cf34537813aa,PlanExe\n0740ebfc-401c-4ae2-9111-2e108ed92750,Conduct Physical and Neurological Examination,\"Conduct Physical and Neurological Examination\n\nDescription:\nPerform a thorough physical examination to assess the patient's overall health status. Conduct a detailed neurological examination to evaluate nerve function and sensory perception.\n\nResources needed:\n\u2022 Transplant Surgeon\n\u2022 Neurologist\n\u2022 Examination Room\n\u2022 Diagnostic Equipment\",12/17/2029,12/19/2029,0,59642d8b-cfa6-4f76-8a05-a624ca6c29a1,PlanExe\nfa4f0b8a-fe8c-44f4-a0d3-114016cc67e4,Psychological Evaluation and Counseling,\"Psychological Evaluation and Counseling\n\nDescription:\nAssess the patient's psychological readiness for face transplantation. Provide counseling to address potential emotional and psychological challenges associated with the procedure.\n\nResources needed:\n\u2022 Psychologist\n\u2022 Psychiatrist\n\u2022 Counseling Room\n\u2022 Psychological Assessment Tools\",12/19/2029,12/21/2029,0,0740ebfc-401c-4ae2-9111-2e108ed92750,PlanExe\n5c2a916d-27d6-4cc2-8c2b-525402e8431d,Immunological Compatibility Testing,\"Immunological Compatibility Testing\n\nDescription:\nPerform comprehensive immunological testing to determine the patient's compatibility with potential donor faces. Assess the risk of rejection and identify appropriate immunosuppression strategies.\n\nResources needed:\n\u2022 Immunologist\n\u2022 Laboratory Technician\n\u2022 Laboratory Equipment\n\u2022 Reagents\",12/21/2029,12/23/2029,0,fa4f0b8a-fe8c-44f4-a0d3-114016cc67e4,PlanExe\nc954c1d8-3b97-4648-9c90-a48d923e6577,Financial and Insurance Assessment,\"Financial and Insurance Assessment\n\nDescription:\nEvaluate the patient's financial resources and insurance coverage to determine their ability to afford the procedure and associated costs. Provide assistance with navigating insurance claims and financial aid options.\n\nResources needed:\n\u2022 Financial Counselor\n\u2022 Insurance Specialist\n\u2022 Billing Department\n\u2022 Financial Aid Resources\",12/23/2029,12/25/2029,0,ce5e2e90-d960-4aa6-9268-cf34537813aa,PlanExe\nb239ca08-0717-4219-b325-beaacb14e951,Conduct Face Transplantation Procedures,,12/25/2029,1/14/2030,0,ce5e2e90-d960-4aa6-9268-cf34537813aa,PlanExe\n4b5491cf-aa89-40b1-87c3-04da0c26bf55,Pre-operative planning and simulations,\"Pre-operative planning and simulations\n\nDescription:\nThorough planning and simulations to anticipate potential challenges and optimize surgical approach.\n\nResources needed:\n\u2022 Surgeons\n\u2022 Anesthesiologists\n\u2022 Simulation equipment\n\u2022 Imaging data\",12/25/2029,12/29/2029,0,b239ca08-0717-4219-b325-beaacb14e951,PlanExe\nc8ec5412-99e1-45dc-b7e7-7f5a6aee9579,Ensure backup equipment and supplies,\"Ensure backup equipment and supplies\n\nDescription:\nVerify availability of backup surgical instruments, medical supplies, and emergency equipment.\n\nResources needed:\n\u2022 Operating room staff\n\u2022 Supply chain manager\n\u2022 Biomedical engineers\",12/29/2029,1/2/2030,0,4b5491cf-aa89-40b1-87c3-04da0c26bf55,PlanExe\n5ea620b1-5c65-43f9-9a73-1c1881b561b1,Experienced surgical team presence,\"Experienced surgical team presence\n\nDescription:\nConfirm the presence of experienced surgeons, nurses, and technicians during the procedure.\n\nResources needed:\n\u2022 Surgeons\n\u2022 Nurses\n\u2022 Technicians\n\u2022 Anesthesiologists\",1/2/2030,1/6/2030,0,c8ec5412-99e1-45dc-b7e7-7f5a6aee9579,PlanExe\na9703b20-d188-4b03-9664-7ff66bde33e2,Implement strict infection control protocols,\"Implement strict infection control protocols\n\nDescription:\nAdhere to rigorous infection control measures to minimize the risk of post-operative infections.\n\nResources needed:\n\u2022 Infection control specialists\n\u2022 Operating room staff\n\u2022 Sterilization equipment\",1/6/2030,1/10/2030,0,5ea620b1-5c65-43f9-9a73-1c1881b561b1,PlanExe\n20502188-d36c-45dd-9bf2-a8bc6ed0048e,Develop contingency plans for complications,\"Develop contingency plans for complications\n\nDescription:\nEstablish protocols for managing potential surgical complications, such as bleeding or nerve damage.\n\nResources needed:\n\u2022 Surgeons\n\u2022 Anesthesiologists\n\u2022 Critical care specialists\",1/10/2030,1/14/2030,0,b239ca08-0717-4219-b325-beaacb14e951,PlanExe\nc404f9dc-7a1c-4039-9c84-d6f44a6aa0a6,Implement Post-Transplant Care and Monitoring Protocols,,1/14/2030,3/15/2030,0,b239ca08-0717-4219-b325-beaacb14e951,PlanExe\nf610d7ac-9e6d-459c-8f77-d4c384a4cc73,Monitor for rejection signs and symptoms,\"Monitor for rejection signs and symptoms\n\nDescription:\nClosely observe the patient for any signs of acute or chronic rejection, such as skin changes, swelling, or decreased blood flow to the transplanted face. Regularly assess immune function through blood tests and biopsies.\n\nResources needed:\n\u2022 Transplant surgeon\n\u2022 Nurses\n\u2022 Pathologist\n\u2022 Immunologist\",1/14/2030,1/26/2030,0,c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6,PlanExe\n3f756606-3068-4ede-87bb-f4ef7811519f,Manage immunosuppression medication regimen,\"Manage immunosuppression medication regimen\n\nDescription:\nAdminister immunosuppressant medications as prescribed to prevent rejection. Monitor drug levels and adjust dosages as needed to maintain therapeutic levels while minimizing side effects. Educate the patient on the importance of medication adherence and potential side effects.\n\nResources needed:\n\u2022 Pharmacist\n\u2022 Nurses\n\u2022 Transplant physician\",1/26/2030,2/7/2030,0,f610d7ac-9e6d-459c-8f77-d4c384a4cc73,PlanExe\n27d8c508-3cb0-449e-8744-26bde56fb0cc,Provide wound care and infection control,\"Provide wound care and infection control\n\nDescription:\nEnsure proper wound healing by providing meticulous wound care, including regular cleaning and dressing changes. Monitor for signs of infection and administer antibiotics as needed. Implement strict infection control protocols to prevent hospital-acquired infections.\n\nResources needed:\n\u2022 Nurses\n\u2022 Infection control specialist\n\u2022 Surgeons\",2/7/2030,2/19/2030,0,3f756606-3068-4ede-87bb-f4ef7811519f,PlanExe\nd1789094-0d0f-4e26-b283-84c4ae73fe45,Offer physical and occupational therapy,\"Offer physical and occupational therapy\n\nDescription:\nProvide physical and occupational therapy to help the patient regain motor function and sensation in the transplanted face. Develop a customized rehabilitation plan to address specific needs and goals. Monitor progress and adjust therapy as needed.\n\nResources needed:\n\u2022 Physical therapist\n\u2022 Occupational therapist\",2/19/2030,3/3/2030,0,27d8c508-3cb0-449e-8744-26bde56fb0cc,PlanExe\n53128582-e4e8-49c1-821c-89b833908400,Address psychological and emotional needs,\"Address psychological and emotional needs\n\nDescription:\nProvide ongoing psychological support and counseling to help the patient cope with the emotional challenges of face transplantation. Address issues such as body image, identity, and social adjustment. Offer support groups and peer mentoring opportunities.\n\nResources needed:\n\u2022 Psychologist\n\u2022 Psychiatrist\n\u2022 Social worker\n\u2022 Support group facilitator\",3/3/2030,3/15/2030,0,c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6,PlanExe\n742e9056-0c0f-4c78-bec1-00825bc6dfa1,Establish Psychological Support Program,,3/15/2030,6/13/2030,0,881ece3f-9348-4d69-93f2-2803c75dd85c,PlanExe\n9bfd6658-f8e9-43bd-baa4-6a626dcf1ab0,Recruit qualified therapists and counselors,\"Recruit qualified therapists and counselors\n\nDescription:\nIdentify and recruit experienced therapists and counselors specializing in transplantation and identity issues.\n\nResources needed:\n\u2022 HR department\n\u2022 Psychiatrists\n\u2022 Psychologists\",3/15/2030,4/2/2030,0,742e9056-0c0f-4c78-bec1-00825bc6dfa1,PlanExe\n71b12a59-061d-4e45-89a0-51509d3a9ad5,Develop counseling protocols and materials,\"Develop counseling protocols and materials\n\nDescription:\nCreate standardized counseling protocols and educational materials for recipients and donor families.\n\nResources needed:\n\u2022 Psychologists\n\u2022 Medical ethicists\n\u2022 Patient support groups\",4/2/2030,4/20/2030,0,9bfd6658-f8e9-43bd-baa4-6a626dcf1ab0,PlanExe\n70e0a488-b358-4e8e-9056-592d8de91ff3,Establish support group infrastructure,\"Establish support group infrastructure\n\nDescription:\nCreate a physical or virtual space for support groups to meet and share experiences.\n\nResources needed:\n\u2022 Facility manager\n\u2022 IT support\n\u2022 Support group facilitators\",4/20/2030,5/8/2030,0,71b12a59-061d-4e45-89a0-51509d3a9ad5,PlanExe\n4f4f3167-98ea-47ee-9e04-c332daa74fec,Implement patient referral system,\"Implement patient referral system\n\nDescription:\nDevelop a system for referring patients to the psychological support program.\n\nResources needed:\n\u2022 Medical staff\n\u2022 Patient liaison\n\u2022 Psychologists\",5/8/2030,5/26/2030,0,70e0a488-b358-4e8e-9056-592d8de91ff3,PlanExe\ne54814fc-de88-4e29-bfc0-aa7ee072f345,Monitor and evaluate program effectiveness,\"Monitor and evaluate program effectiveness\n\nDescription:\nTrack patient outcomes and satisfaction to assess the effectiveness of the psychological support program.\n\nResources needed:\n\u2022 Data analysts\n\u2022 Psychologists\n\u2022 Patient feedback surveys\",5/26/2030,6/13/2030,0,742e9056-0c0f-4c78-bec1-00825bc6dfa1,PlanExe\n991ae3aa-a394-4134-a5a8-540b61b454b5,Ongoing Operations & Maintenance,,6/13/2030,7/23/2030,0,60c6b7a8-2145-4e79-a407-31d257bd7417,PlanExe\n036d3f1f-d298-4895-bd33-6009f5bf182f,Manage Facility Operations and Maintenance,,6/13/2030,6/17/2030,0,991ae3aa-a394-4134-a5a8-540b61b454b5,PlanExe\n99b05c9b-3da6-4549-ba9e-6f683164e368,Schedule routine equipment maintenance,\"Schedule routine equipment maintenance\n\nDescription:\nEstablish a schedule for routine maintenance of all medical and facility equipment to prevent unexpected failures and ensure optimal performance. This includes scheduling inspections, repairs, and replacements as needed.\n\nResources needed:\n\u2022 Maintenance technicians\n\u2022 Equipment manuals\n\u2022 Maintenance schedule software\",6/13/2030,6/14/2030,0,036d3f1f-d298-4895-bd33-6009f5bf182f,PlanExe\n24a1355a-be32-4f64-b6d7-d13216f50e26,Manage medical supply inventory,\"Manage medical supply inventory\n\nDescription:\nMaintain an adequate inventory of medical supplies, including surgical instruments, medications, and consumables, to ensure uninterrupted operations. This involves tracking inventory levels, placing orders, and managing storage.\n\nResources needed:\n\u2022 Inventory management software\n\u2022 Supply chain manager\n\u2022 Storage space\",6/14/2030,6/15/2030,0,99b05c9b-3da6-4549-ba9e-6f683164e368,PlanExe\n4ff300b0-b124-407b-b161-051804def801,Address facility maintenance requests,\"Address facility maintenance requests\n\nDescription:\nRespond to and resolve facility maintenance requests promptly and efficiently to maintain a safe and comfortable environment for patients and staff. This includes addressing issues such as plumbing problems, electrical repairs, and HVAC malfunctions.\n\nResources needed:\n\u2022 Maintenance staff\n\u2022 Repair tools\n\u2022 Facility management system\",6/15/2030,6/16/2030,0,24a1355a-be32-4f64-b6d7-d13216f50e26,PlanExe\ncf21067b-023f-478e-9348-fceb3b17fd69,Ensure compliance with safety regulations,\"Ensure compliance with safety regulations\n\nDescription:\nEnsure that the facility complies with all relevant safety regulations and standards to protect patients, staff, and visitors. This includes conducting regular safety inspections, implementing safety protocols, and providing safety training.\n\nResources needed:\n\u2022 Safety officer\n\u2022 Safety checklists\n\u2022 Regulatory guidelines\",6/16/2030,6/17/2030,0,036d3f1f-d298-4895-bd33-6009f5bf182f,PlanExe\n9ad0a546-40bb-4563-adc1-099850a36f92,Monitor and Evaluate Subscription Service Performance,,6/17/2030,6/27/2030,0,036d3f1f-d298-4895-bd33-6009f5bf182f,PlanExe\n4a247e67-a282-43d8-80c1-e1b23ec05ca9,Implement Data Collection Methods,\"Implement Data Collection Methods\n\nDescription:\nDevelop and establish robust methods for collecting data on subscription service performance, ensuring accuracy and reliability of metrics.\n\nResources needed:\n\u2022 Data analyst\n\u2022 CRM system\n\u2022 Survey tools\",6/17/2030,6/19/2030,0,9ad0a546-40bb-4563-adc1-099850a36f92,PlanExe\nc7f4ebe1-e39a-480b-a27c-2e54e214df2f,Analyze Subscription Metrics,\"Analyze Subscription Metrics\n\nDescription:\nRegularly analyze collected data to evaluate key performance indicators (KPIs) related to subscription uptake, user engagement, and retention rates.\n\nResources needed:\n\u2022 Data analyst\n\u2022 Reporting software\n\u2022 Market research tools\",6/19/2030,6/21/2030,0,4a247e67-a282-43d8-80c1-e1b23ec05ca9,PlanExe\nd1ac5d53-91d3-4dee-848f-2cf200244eca,Conduct User Feedback Surveys,\"Conduct User Feedback Surveys\n\nDescription:\nDesign and distribute surveys to current subscribers to gather feedback on their experiences and suggestions for improvement.\n\nResources needed:\n\u2022 Survey platform\n\u2022 Marketing team\n\u2022 Data analyst\",6/21/2030,6/23/2030,0,c7f4ebe1-e39a-480b-a27c-2e54e214df2f,PlanExe\n73068e2d-0133-48b5-9059-f8cf9838a9cc,Adjust Marketing Strategies,\"Adjust Marketing Strategies\n\nDescription:\nBased on performance analysis and user feedback, refine marketing strategies to enhance subscription service appeal and reach.\n\nResources needed:\n\u2022 Marketing team\n\u2022 Advertising budget\n\u2022 Market research data\",6/23/2030,6/25/2030,0,d1ac5d53-91d3-4dee-848f-2cf200244eca,PlanExe\ne5dd9714-c2a0-42ce-90b3-3a5e6b7521ab,Report Performance Findings,\"Report Performance Findings\n\nDescription:\nCompile and present findings on subscription service performance to stakeholders, highlighting successes and areas for improvement.\n\nResources needed:\n\u2022 Data analyst\n\u2022 Presentation software\n\u2022 Stakeholder engagement team\",6/25/2030,6/27/2030,0,9ad0a546-40bb-4563-adc1-099850a36f92,PlanExe\nfefe05de-7920-4c46-aad2-22acfc31ad4e,Conduct Ongoing Regulatory Compliance Audits,,6/27/2030,7/7/2030,0,9ad0a546-40bb-4563-adc1-099850a36f92,PlanExe\ne066ece9-f4fc-44da-ac21-c7b4e1227405,Identify applicable regulatory compliance standards,\"Identify applicable regulatory compliance standards\n\nDescription:\nDetermine the specific regulatory compliance standards relevant to the face transplantation facility and subscription service, including data privacy, patient safety, and ethical guidelines.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Legal Counsel\",6/27/2030,6/29/2030,0,fefe05de-7920-4c46-aad2-22acfc31ad4e,PlanExe\nbf6ab506-27ef-49cc-8f69-9cab73f21113,Schedule internal compliance audits,\"Schedule internal compliance audits\n\nDescription:\nEstablish a schedule for conducting internal compliance audits to assess adherence to regulatory standards and identify areas for improvement.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Compliance Auditor\",6/29/2030,7/1/2030,0,e066ece9-f4fc-44da-ac21-c7b4e1227405,PlanExe\n0030f8d5-5257-4b6e-9246-9bce57ff7458,Prepare audit documentation and checklists,\"Prepare audit documentation and checklists\n\nDescription:\nDevelop comprehensive audit documentation and checklists to ensure thorough and consistent evaluation of compliance with regulatory requirements.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Compliance Auditor\",7/1/2030,7/3/2030,0,bf6ab506-27ef-49cc-8f69-9cab73f21113,PlanExe\n53859978-b189-4292-bdd2-ee08e3816a82,Conduct external regulatory compliance audits,\"Conduct external regulatory compliance audits\n\nDescription:\nEngage external auditors to conduct independent assessments of compliance with regulatory standards and identify potential gaps or areas of non-compliance.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 External Auditors\",7/3/2030,7/5/2030,0,0030f8d5-5257-4b6e-9246-9bce57ff7458,PlanExe\n23e9b77b-b49f-4b95-862e-bbc0950caa82,Address audit findings and implement corrective actions,\"Address audit findings and implement corrective actions\n\nDescription:\nDevelop and implement corrective action plans to address any findings from internal or external audits and ensure ongoing compliance with regulatory requirements.\n\nResources needed:\n\u2022 Regulatory Liaison & Compliance Officer\n\u2022 Department Heads\",7/5/2030,7/7/2030,0,fefe05de-7920-4c46-aad2-22acfc31ad4e,PlanExe\nae90a39b-29b6-460d-a270-7d8989677943,Continuously Improve Processes and Technologies,,7/7/2030,7/23/2030,0,991ae3aa-a394-4134-a5a8-540b61b454b5,PlanExe\n15d712d2-0f26-4294-97cd-66a0d12f7b66,Identify areas for process improvement,\"Identify areas for process improvement\n\nDescription:\nObjective: Pinpoint specific processes within the facility that can be optimized for efficiency, cost-effectiveness, or patient outcomes.\nScope: Review existing workflows, gather feedback from staff, and analyze performance data to identify areas for improvement.\nSteps: Conduct staff surveys, analyze operational data, hold brainstorming sessions, and document findings.\nDeliverables: A report outlining identified areas for process improvement with specific recommendations.\n\nResources needed:\n\u2022 Process Improvement Specialist\n\u2022 Data Analyst\n\u2022 Medical Staff\n\u2022 Project Manager\",7/7/2030,7/11/2030,0,ae90a39b-29b6-460d-a270-7d8989677943,PlanExe\nc93808d4-549d-424b-be34-27ebc96f2ab4,Evaluate emerging medical technologies,\"Evaluate emerging medical technologies\n\nDescription:\nObjective: Assess the potential of new medical technologies to enhance face transplantation procedures and patient care.\nScope: Research and evaluate emerging technologies such as advanced imaging techniques, robotic surgery, and regenerative medicine.\nSteps: Conduct literature reviews, attend industry conferences, consult with technology vendors, and evaluate potential benefits and risks.\nDeliverables: A report summarizing the evaluation of emerging medical technologies with recommendations for potential adoption.\n\nResources needed:\n\u2022 Medical Technology Researcher\n\u2022 Transplant Surgeon\n\u2022 Biomedical Engineer\n\u2022 Research Budget\",7/11/2030,7/15/2030,0,15d712d2-0f26-4294-97cd-66a0d12f7b66,PlanExe\nd6127fca-e8dc-4737-8977-db75c7f8a284,Pilot test new processes and technologies,\"Pilot test new processes and technologies\n\nDescription:\nObjective: Implement pilot programs to test the feasibility and effectiveness of new processes and technologies in a controlled environment.\nScope: Select specific areas for pilot testing, develop testing protocols, and monitor results.\nSteps: Develop pilot program plans, train staff, implement new processes or technologies, collect data, and analyze results.\nDeliverables: Pilot program reports with recommendations for full-scale implementation or modifications.\n\nResources needed:\n\u2022 Medical Staff\n\u2022 IT Support\n\u2022 Project Manager\n\u2022 Training Materials\n\u2022 Pilot Test Budget\",7/15/2030,7/19/2030,0,c93808d4-549d-424b-be34-27ebc96f2ab4,PlanExe\na74fb24b-025c-44f1-abf3-f20f9c8c5540,Implement approved improvements facility-wide,\"Implement approved improvements facility-wide\n\nDescription:\nObjective: Roll out approved process improvements and new technologies across the entire facility.\nScope: Develop implementation plans, train staff, and monitor performance to ensure successful adoption.\nSteps: Develop implementation plans, train staff, communicate changes, monitor performance, and provide ongoing support.\nDeliverables: Updated operational procedures, trained staff, and improved facility performance metrics.\n\nResources needed:\n\u2022 Training Staff\n\u2022 Project Manager\n\u2022 Communication Team\n\u2022 Medical Staff\n\u2022 IT Support\",7/19/2030,7/23/2030,0,ae90a39b-29b6-460d-a270-7d8989677943,PlanExe\n";

    // This must be a string, eg: `"planexe_export.csv"`
    const GANTT_FILENAME_CSV = "PlanExe_Export_Face_Facility.csv";

    // This must be json. It's not a string.
    const GANTT_DATA_DHTMLX = {
  "tasks": [
    {
      "id": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "text": "Face Facility",
      "custom_tooltip": "<b>Face Facility</b><br><b>Final deliverable:</b><br>Transplant Service",
      "progress": 0,
      "open": true,
      "meta": "",
      "type": "project"
    },
    {
      "id": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "text": "Project Initiation & Planning",
      "custom_tooltip": "<b>Project Initiation &amp; Planning</b>",
      "progress": 0,
      "open": true,
      "meta": "60c6b7a8-2145-4e79-a407-31d257bd7417 SS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "5c4161cf-b3a4-42b6-914a-8b051aac2a55",
      "text": "Define Project Scope and Objectives",
      "custom_tooltip": "<b>Define Project Scope and Objectives</b>",
      "progress": 0,
      "open": true,
      "meta": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3 SS",
      "parent": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "type": "project"
    },
    {
      "id": "11fd4b20-8174-4ab9-b5c6-a231920b89f5",
      "text": "Gather Stakeholder Requirements",
      "custom_tooltip": "<b>Gather Stakeholder Requirements</b><br>Conduct interviews, surveys, and workshops to collect detailed requirements from all key stakeholders, including medical professionals, regulatory bodies, potential patients, and investors. Document all requirements in a comprehensive requirements traceability matrix.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Business Analyst</li><li>Stakeholder Representatives</li></ul>",
      "start_date": "2026-02-18",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "5c4161cf-b3a4-42b6-914a-8b051aac2a55 SS",
      "parent": "5c4161cf-b3a4-42b6-914a-8b051aac2a55"
    },
    {
      "id": "0a8f360c-e8eb-4c92-8665-721ddb344b6c",
      "text": "Analyze Requirements and Define Scope",
      "custom_tooltip": "<b>Analyze Requirements and Define Scope</b><br>Analyze the gathered requirements to identify overlaps, conflicts, and gaps. Prioritize requirements based on stakeholder needs and project objectives. Define the project scope, including what is in and out of scope, and document it in a scope statement.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Business Analyst</li><li>Subject Matter Experts</li></ul>",
      "start_date": "2026-02-20",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "11fd4b20-8174-4ab9-b5c6-a231920b89f5 FS",
      "parent": "5c4161cf-b3a4-42b6-914a-8b051aac2a55"
    },
    {
      "id": "c90639eb-9941-418a-8607-a206001be1a3",
      "text": "Establish Measurable Project Objectives",
      "custom_tooltip": "<b>Establish Measurable Project Objectives</b><br>Define specific, measurable, achievable, relevant, and time-bound (SMART) project objectives based on the defined scope and stakeholder requirements. Ensure that the objectives are aligned with the overall project goal and can be tracked throughout the project lifecycle.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Stakeholder Representatives</li><li>Subject Matter Experts</li></ul>",
      "start_date": "2026-02-22",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "0a8f360c-e8eb-4c92-8665-721ddb344b6c FS",
      "parent": "5c4161cf-b3a4-42b6-914a-8b051aac2a55"
    },
    {
      "id": "19ff72cd-a65d-4dbd-88c0-2600863b590e",
      "text": "Document Assumptions and Constraints",
      "custom_tooltip": "<b>Document Assumptions and Constraints</b><br>Identify and document all assumptions and constraints that may impact the project scope and objectives. This includes assumptions about technology, resources, funding, regulatory approvals, and market conditions. Constraints may include budget limitations, time constraints, and regulatory restrictions.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Project Team</li><li>Stakeholder Representatives</li></ul>",
      "start_date": "2026-02-24",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "5c4161cf-b3a4-42b6-914a-8b051aac2a55 FF, c90639eb-9941-418a-8607-a206001be1a3 FS",
      "parent": "5c4161cf-b3a4-42b6-914a-8b051aac2a55"
    },
    {
      "id": "e4020cc5-dc9d-4100-a124-c51bcd7091e8",
      "text": "Identify Key Stakeholders",
      "custom_tooltip": "<b>Identify Key Stakeholders</b>",
      "progress": 0,
      "open": true,
      "meta": "5c4161cf-b3a4-42b6-914a-8b051aac2a55 FS",
      "parent": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "type": "project"
    },
    {
      "id": "d974662c-4ac6-4877-9f9f-3451721ceb51",
      "text": "Identify internal project stakeholders",
      "custom_tooltip": "<b>Identify internal project stakeholders</b><br>Identify all internal individuals or groups who have an interest in the project&#x27;s success or who will be affected by its outcome. This includes surgeons, nurses, technicians, ethicists, and facility management.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Department Heads</li></ul>",
      "start_date": "2026-02-26",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "e4020cc5-dc9d-4100-a124-c51bcd7091e8 SS",
      "parent": "e4020cc5-dc9d-4100-a124-c51bcd7091e8"
    },
    {
      "id": "0a6adf98-e625-44ce-b125-e37ba651afcc",
      "text": "Identify external project stakeholders",
      "custom_tooltip": "<b>Identify external project stakeholders</b><br>Identify all external individuals or groups who have an interest in the project&#x27;s success or who will be affected by its outcome. This includes the Ministry of Health, Medsafe, organ donation organizations, patients, donor families, and investors.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Legal Counsel</li></ul>",
      "start_date": "2026-02-27",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "d974662c-4ac6-4877-9f9f-3451721ceb51 FS",
      "parent": "e4020cc5-dc9d-4100-a124-c51bcd7091e8"
    },
    {
      "id": "c7803bcd-3bfa-4478-9579-15a8dbebe8d5",
      "text": "Analyze stakeholder influence and interests",
      "custom_tooltip": "<b>Analyze stakeholder influence and interests</b><br>Assess the level of influence and the specific interests of each stakeholder to prioritize engagement efforts. Determine their potential impact on the project.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Stakeholder Analysis Template</li></ul>",
      "start_date": "2026-02-28",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "0a6adf98-e625-44ce-b125-e37ba651afcc FS",
      "parent": "e4020cc5-dc9d-4100-a124-c51bcd7091e8"
    },
    {
      "id": "5cb56967-fd56-43ed-a8e7-36b37da2c20b",
      "text": "Develop stakeholder communication plan",
      "custom_tooltip": "<b>Develop stakeholder communication plan</b><br>Create a detailed plan outlining how each stakeholder group will be engaged, including the frequency, method, and content of communication. Tailor the communication to each group&#x27;s needs and interests.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Communication Specialist</li></ul>",
      "start_date": "2026-03-01",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "e4020cc5-dc9d-4100-a124-c51bcd7091e8 FF, c7803bcd-3bfa-4478-9579-15a8dbebe8d5 FS",
      "parent": "e4020cc5-dc9d-4100-a124-c51bcd7091e8"
    },
    {
      "id": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2",
      "text": "Develop Project Management Plan",
      "custom_tooltip": "<b>Develop Project Management Plan</b>",
      "progress": 0,
      "open": true,
      "meta": "e4020cc5-dc9d-4100-a124-c51bcd7091e8 FS",
      "parent": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "type": "project"
    },
    {
      "id": "262adc91-09cc-4dc8-bff1-c413f12b0cfc",
      "text": "Define Project Scope Statement",
      "custom_tooltip": "<b>Define Project Scope Statement</b><br>Clearly articulate the project&#x27;s boundaries, deliverables, and objectives. This involves detailing what is included and excluded from the project, ensuring all stakeholders have a shared understanding of the project&#x27;s goals.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Stakeholders</li><li>Business Analyst</li></ul>",
      "start_date": "2026-03-02",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2 SS",
      "parent": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2"
    },
    {
      "id": "05562c59-0a6e-436b-ac7a-0ab3f4f34939",
      "text": "Develop Project Schedule",
      "custom_tooltip": "<b>Develop Project Schedule</b><br>Create a detailed timeline outlining all project activities, their dependencies, and estimated durations. This includes identifying critical path activities and establishing milestones to track progress.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Project Scheduling Software</li><li>Team Leads</li></ul>",
      "start_date": "2026-03-05",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "262adc91-09cc-4dc8-bff1-c413f12b0cfc FS",
      "parent": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2"
    },
    {
      "id": "fd9e4821-d042-4b82-b752-629ea9870972",
      "text": "Create Project Budget",
      "custom_tooltip": "<b>Create Project Budget</b><br>Establish a comprehensive budget that includes all project costs, such as labor, materials, equipment, and overhead. This involves estimating costs for each activity and allocating resources accordingly.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Finance Department</li><li>Cost Estimator</li></ul>",
      "start_date": "2026-03-08",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "05562c59-0a6e-436b-ac7a-0ab3f4f34939 FS",
      "parent": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2"
    },
    {
      "id": "15167f12-0777-4a68-a0ca-8a739a5a524f",
      "text": "Establish Risk Management Plan",
      "custom_tooltip": "<b>Establish Risk Management Plan</b><br>Identify potential risks that could impact the project&#x27;s success and develop mitigation strategies to minimize their impact. This includes assessing the likelihood and impact of each risk and creating contingency plans.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Risk Management Expert</li><li>Team Members</li></ul>",
      "start_date": "2026-03-11",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "fd9e4821-d042-4b82-b752-629ea9870972 FS",
      "parent": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2"
    },
    {
      "id": "0ae012b1-c327-4792-955b-aa83c3b98959",
      "text": "Define Communication Management Plan",
      "custom_tooltip": "<b>Define Communication Management Plan</b><br>Outline how project information will be communicated to stakeholders, including the frequency, format, and channels of communication. This ensures that all stakeholders are kept informed of project progress and any issues that arise.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Stakeholders</li><li>Communication Specialist</li></ul>",
      "start_date": "2026-03-14",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2 FF, 15167f12-0777-4a68-a0ca-8a739a5a524f FS",
      "parent": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2"
    },
    {
      "id": "f87a83eb-17cf-48d1-92d5-2c669cb3525d",
      "text": "Secure Initial Funding",
      "custom_tooltip": "<b>Secure Initial Funding</b>",
      "progress": 0,
      "open": true,
      "meta": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2 FS",
      "parent": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "type": "project"
    },
    {
      "id": "a7c6c689-4b9a-44d6-b200-538f71c485ce",
      "text": "Develop detailed financial projections",
      "custom_tooltip": "<b>Develop detailed financial projections</b><br>Create comprehensive financial models including revenue forecasts, cost estimates, and profitability analysis to demonstrate the financial viability of the project.<br><b>Resources needed:</b><br><ul><li>Financial analyst</li><li>Market research data</li><li>Project manager</li></ul>",
      "start_date": "2026-03-17",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "f87a83eb-17cf-48d1-92d5-2c669cb3525d SS",
      "parent": "f87a83eb-17cf-48d1-92d5-2c669cb3525d"
    },
    {
      "id": "f96dd3ac-7e5f-469a-b952-d570299a57b8",
      "text": "Prepare investor pitch deck and materials",
      "custom_tooltip": "<b>Prepare investor pitch deck and materials</b><br>Craft a compelling presentation and supporting documents highlighting the project&#x27;s vision, market opportunity, competitive advantages, and financial projections to attract potential investors.<br><b>Resources needed:</b><br><ul><li>Marketing specialist</li><li>Financial analyst</li><li>Project manager</li><li>Graphic designer</li></ul>",
      "start_date": "2026-03-29",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "a7c6c689-4b9a-44d6-b200-538f71c485ce FS",
      "parent": "f87a83eb-17cf-48d1-92d5-2c669cb3525d"
    },
    {
      "id": "1ca5a048-7c4e-41bd-b562-a6332d3bbf9d",
      "text": "Identify and engage potential investors",
      "custom_tooltip": "<b>Identify and engage potential investors</b><br>Research and identify suitable investors (venture capitalists, angel investors, private equity firms) who align with the project&#x27;s goals and values. Initiate contact and schedule meetings to present the investment opportunity.<br><b>Resources needed:</b><br><ul><li>Business development manager</li><li>Networking contacts</li><li>Investor database</li></ul>",
      "start_date": "2026-04-10",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "f96dd3ac-7e5f-469a-b952-d570299a57b8 FS",
      "parent": "f87a83eb-17cf-48d1-92d5-2c669cb3525d"
    },
    {
      "id": "5a4ed5e1-b547-49a2-97ad-275d8769e10c",
      "text": "Negotiate investment terms and agreements",
      "custom_tooltip": "<b>Negotiate investment terms and agreements</b><br>Conduct negotiations with interested investors to finalize the terms of the investment, including equity stake, valuation, and governance rights. Draft and review legal agreements to ensure compliance and protect the project&#x27;s interests.<br><b>Resources needed:</b><br><ul><li>Legal counsel</li><li>Financial advisor</li><li>Project manager</li></ul>",
      "start_date": "2026-04-22",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "1ca5a048-7c4e-41bd-b562-a6332d3bbf9d FS",
      "parent": "f87a83eb-17cf-48d1-92d5-2c669cb3525d"
    },
    {
      "id": "e240650c-02bc-4d98-bb59-2cf31e05bc42",
      "text": "Secure funding commitments and finalize agreements",
      "custom_tooltip": "<b>Secure funding commitments and finalize agreements</b><br>Obtain formal funding commitments from investors and execute legally binding agreements to secure the necessary capital for the project. Establish a clear disbursement schedule and reporting requirements.<br><b>Resources needed:</b><br><ul><li>Legal counsel</li><li>Financial advisor</li><li>Project manager</li></ul>",
      "start_date": "2026-05-04",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "f87a83eb-17cf-48d1-92d5-2c669cb3525d FF, 5a4ed5e1-b547-49a2-97ad-275d8769e10c FS",
      "parent": "f87a83eb-17cf-48d1-92d5-2c669cb3525d"
    },
    {
      "id": "0dbbdc0b-a0b3-4769-9627-5be7653573cf",
      "text": "Establish Project Governance Structure",
      "custom_tooltip": "<b>Establish Project Governance Structure</b>",
      "progress": 0,
      "open": true,
      "meta": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3 FF, f87a83eb-17cf-48d1-92d5-2c669cb3525d FS",
      "parent": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "type": "project"
    },
    {
      "id": "9d49a664-2412-4f08-9573-2c92aeb8087b",
      "text": "Define Governance Roles and Responsibilities",
      "custom_tooltip": "<b>Define Governance Roles and Responsibilities</b><br>Clearly define the roles, responsibilities, and authority levels for each member of the project governance structure. This includes the project sponsor, steering committee, project manager, and any other relevant stakeholders.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Project Sponsor</li><li>Legal Counsel</li></ul>",
      "start_date": "2026-05-16",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "0dbbdc0b-a0b3-4769-9627-5be7653573cf SS",
      "parent": "0dbbdc0b-a0b3-4769-9627-5be7653573cf"
    },
    {
      "id": "fba35e93-7777-4863-b64b-9c315894b0c0",
      "text": "Establish Decision-Making Processes",
      "custom_tooltip": "<b>Establish Decision-Making Processes</b><br>Develop a documented process for making key decisions related to the project. This includes identifying decision-making criteria, establishing escalation paths, and defining approval workflows.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Steering Committee</li><li>Subject Matter Experts</li></ul>",
      "start_date": "2026-05-19",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "9d49a664-2412-4f08-9573-2c92aeb8087b FS",
      "parent": "0dbbdc0b-a0b3-4769-9627-5be7653573cf"
    },
    {
      "id": "825fd9a0-71f0-4142-9b65-43c461cbd52b",
      "text": "Create Communication Plan for Governance",
      "custom_tooltip": "<b>Create Communication Plan for Governance</b><br>Develop a communication plan that outlines how information will be shared among members of the governance structure. This includes the frequency, format, and channels of communication.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Communication Specialist</li></ul>",
      "start_date": "2026-05-22",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "fba35e93-7777-4863-b64b-9c315894b0c0 FS",
      "parent": "0dbbdc0b-a0b3-4769-9627-5be7653573cf"
    },
    {
      "id": "95a2ae41-3554-4bfc-8e87-67212c9828cf",
      "text": "Document Governance Structure and Processes",
      "custom_tooltip": "<b>Document Governance Structure and Processes</b><br>Create a formal document that outlines the project governance structure, roles, responsibilities, decision-making processes, and communication plan. This document should be readily accessible to all stakeholders.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Document Control Specialist</li></ul>",
      "start_date": "2026-05-25",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "0dbbdc0b-a0b3-4769-9627-5be7653573cf FF, 825fd9a0-71f0-4142-9b65-43c461cbd52b FS",
      "parent": "0dbbdc0b-a0b3-4769-9627-5be7653573cf"
    },
    {
      "id": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "text": "Regulatory & Ethical Approval",
      "custom_tooltip": "<b>Regulatory &amp; Ethical Approval</b>",
      "progress": 0,
      "open": true,
      "meta": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3 FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "88873351-fe17-4656-97d3-6d6ff1defee4",
      "text": "Conduct Regulatory Landscape Assessment",
      "custom_tooltip": "<b>Conduct Regulatory Landscape Assessment</b>",
      "progress": 0,
      "open": true,
      "meta": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33 SS",
      "parent": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "project"
    },
    {
      "id": "84b8d532-072a-41dc-912b-9f423974b5e9",
      "text": "Identify relevant regulatory bodies",
      "custom_tooltip": "<b>Identify relevant regulatory bodies</b><br>Determine all regulatory bodies in New Zealand that have jurisdiction over face transplantation, including Medsafe, the Ministry of Health, and relevant ethics committees.  Objective: Create a comprehensive list of regulatory entities. Scope: New Zealand regulations only. Steps: Research, online searches, expert consultation. Deliverables: List of regulatory bodies.<br><b>Resources needed:</b><br><ul><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Research assistant</li></ul>",
      "start_date": "2026-05-28",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "88873351-fe17-4656-97d3-6d6ff1defee4 SS",
      "parent": "88873351-fe17-4656-97d3-6d6ff1defee4"
    },
    {
      "id": "e7a1fee8-b1aa-494c-98fd-76b0cf7f8a21",
      "text": "Gather face transplantation regulations",
      "custom_tooltip": "<b>Gather face transplantation regulations</b><br>Collect all relevant regulations, guidelines, and standards pertaining to face transplantation in New Zealand. Objective: Compile a complete set of regulatory documents. Scope: All applicable regulations. Steps: Online searches, contacting regulatory bodies, legal database searches. Deliverables: Regulatory document repository.<br><b>Resources needed:</b><br><ul><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Research assistant</li></ul>",
      "start_date": "2026-06-05",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "84b8d532-072a-41dc-912b-9f423974b5e9 FS",
      "parent": "88873351-fe17-4656-97d3-6d6ff1defee4"
    },
    {
      "id": "b70ffbed-ee29-4848-9f34-7d44b728b70a",
      "text": "Analyze regulatory requirements",
      "custom_tooltip": "<b>Analyze regulatory requirements</b><br>Thoroughly analyze the collected regulations to identify specific requirements for establishing a face transplantation facility and performing the procedure. Objective: Understand the regulatory landscape. Scope: Detailed analysis of regulations. Steps: Document review, expert consultation. Deliverables: Regulatory requirements summary.<br><b>Resources needed:</b><br><ul><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Medical ethicist</li></ul>",
      "start_date": "2026-06-13",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "e7a1fee8-b1aa-494c-98fd-76b0cf7f8a21 FS",
      "parent": "88873351-fe17-4656-97d3-6d6ff1defee4"
    },
    {
      "id": "54488382-a7f1-4558-91a7-1c28f78f09af",
      "text": "Document regulatory gaps and uncertainties",
      "custom_tooltip": "<b>Document regulatory gaps and uncertainties</b><br>Identify any gaps or ambiguities in the existing regulatory framework that may pose challenges to the project. Objective: Highlight potential regulatory hurdles. Scope: Identification of gaps. Steps: Expert consultation, legal analysis. Deliverables: Gap analysis report.<br><b>Resources needed:</b><br><ul><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Medical ethicist</li></ul>",
      "start_date": "2026-06-21",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "88873351-fe17-4656-97d3-6d6ff1defee4 FF, b70ffbed-ee29-4848-9f34-7d44b728b70a FS",
      "parent": "88873351-fe17-4656-97d3-6d6ff1defee4"
    },
    {
      "id": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952",
      "text": "Prepare Regulatory Approval Documentation",
      "custom_tooltip": "<b>Prepare Regulatory Approval Documentation</b>",
      "progress": 0,
      "open": true,
      "meta": "88873351-fe17-4656-97d3-6d6ff1defee4 FS",
      "parent": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "project"
    },
    {
      "id": "0998bc6f-a029-476a-aa33-0ae1695e93c1",
      "text": "Gather required documentation templates",
      "custom_tooltip": "<b>Gather required documentation templates</b><br>Identify and collect all necessary templates and forms required by Medsafe and the Ministry of Health for face transplantation approval. This includes application forms, consent forms, surgical protocols, and data privacy policies.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison</li><li>Legal Counsel</li><li>Administrative Assistant</li></ul>",
      "start_date": "2026-06-29",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952 SS",
      "parent": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952"
    },
    {
      "id": "22204e0f-1551-4d04-a00d-d703e900cb69",
      "text": "Draft initial documentation sections",
      "custom_tooltip": "<b>Draft initial documentation sections</b><br>Complete the initial drafts of all required documentation sections, including detailed descriptions of the surgical procedure, patient selection criteria, ethical considerations, and risk management plans. Ensure compliance with relevant regulations and guidelines.<br><b>Resources needed:</b><br><ul><li>Lead Transplant Surgeon</li><li>Regulatory Liaison</li><li>Ethics Review Board Coordinator</li></ul>",
      "start_date": "2026-07-11",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "0998bc6f-a029-476a-aa33-0ae1695e93c1 FS",
      "parent": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952"
    },
    {
      "id": "a9ccce30-3f9a-4112-a799-855768a9a248",
      "text": "Review and revise draft documentation",
      "custom_tooltip": "<b>Review and revise draft documentation</b><br>Conduct thorough reviews of the draft documentation by relevant stakeholders, including medical experts, legal counsel, and ethics review board members. Incorporate feedback and revise the documentation to ensure accuracy, completeness, and compliance.<br><b>Resources needed:</b><br><ul><li>Lead Transplant Surgeon</li><li>Regulatory Liaison</li><li>Legal Counsel</li><li>Ethics Review Board</li><li>Chief Medical Officer</li></ul>",
      "start_date": "2026-07-23",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "22204e0f-1551-4d04-a00d-d703e900cb69 FS",
      "parent": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952"
    },
    {
      "id": "1d7b7cdd-0af1-4555-bc0c-8840f916f04c",
      "text": "Finalize and format documentation",
      "custom_tooltip": "<b>Finalize and format documentation</b><br>Finalize all documentation sections based on the review feedback. Ensure consistent formatting and adherence to regulatory requirements. Prepare the documentation for submission to Medsafe and the Ministry of Health.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison</li><li>Administrative Assistant</li><li>Legal Counsel</li></ul>",
      "start_date": "2026-08-04",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "a9ccce30-3f9a-4112-a799-855768a9a248 FS",
      "parent": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952"
    },
    {
      "id": "1074b6ff-fdc7-4ccf-9046-2d1ef4c74aa9",
      "text": "Translate documents if required",
      "custom_tooltip": "<b>Translate documents if required</b><br>If any documents need to be translated into Maori or other languages, engage certified translators to ensure accurate and culturally appropriate translations. Review translations for accuracy and consistency.<br><b>Resources needed:</b><br><ul><li>Certified Translator</li><li>Regulatory Liaison</li><li>Cultural Advisor</li></ul>",
      "start_date": "2026-08-16",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952 FF, 1d7b7cdd-0af1-4555-bc0c-8840f916f04c FS",
      "parent": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952"
    },
    {
      "id": "8346561b-9e0c-466d-83eb-0d6aadda330b",
      "text": "Engage with Regulatory Bodies (Medsafe, Ministry of Health)",
      "custom_tooltip": "<b>Engage with Regulatory Bodies (Medsafe, Ministry of Health)</b>",
      "progress": 0,
      "open": true,
      "meta": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952 FS",
      "parent": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "project"
    },
    {
      "id": "cddc6d56-47a7-4d86-99fb-17cf0e680502",
      "text": "Identify Key Contacts at Regulatory Bodies",
      "custom_tooltip": "<b>Identify Key Contacts at Regulatory Bodies</b><br>Identify and establish contact with key personnel at Medsafe and the Ministry of Health who are responsible for reviewing and approving medical facility and surgical procedure applications.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Legal Counsel</li></ul>",
      "start_date": "2026-08-28",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "8346561b-9e0c-466d-83eb-0d6aadda330b SS",
      "parent": "8346561b-9e0c-466d-83eb-0d6aadda330b"
    },
    {
      "id": "6a054300-b4d5-4385-b8e1-24beb133c3da",
      "text": "Schedule Initial Consultation Meetings",
      "custom_tooltip": "<b>Schedule Initial Consultation Meetings</b><br>Schedule introductory meetings with identified key contacts at Medsafe and the Ministry of Health to introduce the project and discuss the regulatory approval process.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Chief Medical Officer</li></ul>",
      "start_date": "2026-09-03",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "cddc6d56-47a7-4d86-99fb-17cf0e680502 FS",
      "parent": "8346561b-9e0c-466d-83eb-0d6aadda330b"
    },
    {
      "id": "0f10888f-372f-4700-8c2d-df237d9bb2ac",
      "text": "Present Project Overview and Objectives",
      "custom_tooltip": "<b>Present Project Overview and Objectives</b><br>Prepare and deliver a comprehensive presentation outlining the project&#x27;s goals, scope, and potential benefits to the New Zealand healthcare system during the consultation meetings.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Chief Medical Officer</li><li>Presentation Materials</li></ul>",
      "start_date": "2026-09-09",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "6a054300-b4d5-4385-b8e1-24beb133c3da FS",
      "parent": "8346561b-9e0c-466d-83eb-0d6aadda330b"
    },
    {
      "id": "1c1ff2db-99f0-4606-8007-fc00b60adee2",
      "text": "Clarify Regulatory Requirements and Timelines",
      "custom_tooltip": "<b>Clarify Regulatory Requirements and Timelines</b><br>Actively solicit feedback and clarification from regulatory bodies regarding specific requirements, documentation needs, and expected timelines for the approval process.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Chief Medical Officer</li><li>Legal Counsel</li></ul>",
      "start_date": "2026-09-15",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "0f10888f-372f-4700-8c2d-df237d9bb2ac FS",
      "parent": "8346561b-9e0c-466d-83eb-0d6aadda330b"
    },
    {
      "id": "bca53136-fd8c-4b8c-94a3-4ae4bb837fc4",
      "text": "Document Meeting Outcomes and Action Items",
      "custom_tooltip": "<b>Document Meeting Outcomes and Action Items</b><br>Thoroughly document the outcomes of each consultation meeting, including key discussion points, agreed-upon action items, and any outstanding questions or concerns raised by regulatory bodies.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Meeting Minutes</li></ul>",
      "start_date": "2026-09-21",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "8346561b-9e0c-466d-83eb-0d6aadda330b FF, 1c1ff2db-99f0-4606-8007-fc00b60adee2 FS",
      "parent": "8346561b-9e0c-466d-83eb-0d6aadda330b"
    },
    {
      "id": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2",
      "text": "Establish Ethics Review Board",
      "custom_tooltip": "<b>Establish Ethics Review Board</b>",
      "progress": 0,
      "open": true,
      "meta": "8346561b-9e0c-466d-83eb-0d6aadda330b FS",
      "parent": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "project"
    },
    {
      "id": "7b2a90af-ea4e-408f-8ff7-3a47a9109e9c",
      "text": "Define ERB scope and responsibilities",
      "custom_tooltip": "<b>Define ERB scope and responsibilities</b><br>Clearly outline the ERB&#x27;s authority, decision-making processes, and areas of focus within the face transplantation project.<br><b>Resources needed:</b><br><ul><li>Legal counsel</li><li>Project manager</li><li>Senior management</li></ul>",
      "start_date": "2026-09-27",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2 SS",
      "parent": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2"
    },
    {
      "id": "767b4bcb-30ea-49cc-8e12-d8299ac2f0c8",
      "text": "Identify and recruit ERB members",
      "custom_tooltip": "<b>Identify and recruit ERB members</b><br>Seek individuals with expertise in ethics, medicine, law, and community representation to form a balanced and qualified ERB.<br><b>Resources needed:</b><br><ul><li>Recruitment specialist</li><li>Ethics consultant</li><li>Project administrator</li></ul>",
      "start_date": "2026-10-12",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "7b2a90af-ea4e-408f-8ff7-3a47a9109e9c FS",
      "parent": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2"
    },
    {
      "id": "3ba21f5a-40f8-4f25-8516-2b8763075112",
      "text": "Develop ERB operational procedures",
      "custom_tooltip": "<b>Develop ERB operational procedures</b><br>Establish guidelines for meeting frequency, agenda setting, document review, conflict of interest management, and decision recording.<br><b>Resources needed:</b><br><ul><li>Ethics consultant</li><li>Project manager</li><li>Legal counsel</li></ul>",
      "start_date": "2026-10-27",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "767b4bcb-30ea-49cc-8e12-d8299ac2f0c8 FS",
      "parent": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2"
    },
    {
      "id": "f2010f0e-b89d-41ee-a8d9-44eddfbbbc8e",
      "text": "Secure institutional support for ERB",
      "custom_tooltip": "<b>Secure institutional support for ERB</b><br>Ensure the ERB has adequate resources, administrative support, and independence to effectively fulfill its ethical oversight role.<br><b>Resources needed:</b><br><ul><li>Senior management</li><li>Finance department</li><li>Legal counsel</li></ul>",
      "start_date": "2026-11-11",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2 FF, 3ba21f5a-40f8-4f25-8516-2b8763075112 FS",
      "parent": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2"
    },
    {
      "id": "57831a79-0296-4839-9152-097c08f2596f",
      "text": "Develop Ethical Guidelines and Protocols",
      "custom_tooltip": "<b>Develop Ethical Guidelines and Protocols</b>",
      "progress": 0,
      "open": true,
      "meta": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2 FS",
      "parent": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "project"
    },
    {
      "id": "0dc3543e-c84f-4914-9ca7-fd90435ed6ad",
      "text": "Research existing ethical guidelines for transplants",
      "custom_tooltip": "<b>Research existing ethical guidelines for transplants</b><br>Objective: Gather comprehensive data on existing ethical guidelines related to organ and face transplantation from various international and national organizations.\nScope: Review guidelines from organizations like the World Health Organization (WHO), national transplant societies, and relevant medical ethics journals.\nSteps:\n1. Identify key organizations and publications.\n2. Conduct a literature review.\n3. Summarize key ethical principles and recommendations.\nDeliverables: A detailed report summarizing existing ethical guidelines.<br><b>Resources needed:</b><br><ul><li>Medical ethicist</li><li>Research assistant</li><li>Access to medical databases</li></ul>",
      "start_date": "2026-11-26",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "57831a79-0296-4839-9152-097c08f2596f SS",
      "parent": "57831a79-0296-4839-9152-097c08f2596f"
    },
    {
      "id": "2db1a1af-3883-43b5-8968-9061eee85941",
      "text": "Identify key ethical considerations for face transplants",
      "custom_tooltip": "<b>Identify key ethical considerations for face transplants</b><br>Objective: Identify and analyze the unique ethical considerations specific to face transplantation, including identity, consent, and psychological impact.\nScope: Focus on ethical issues related to recipient and donor families, as well as the broader societal implications.\nSteps:\n1. Conduct expert interviews with ethicists and transplant surgeons.\n2. Analyze case studies of face transplantation.\n3. Identify potential ethical dilemmas.\nDeliverables: A comprehensive list of key ethical considerations.<br><b>Resources needed:</b><br><ul><li>Medical ethicist</li><li>Transplant surgeon</li><li>Psychologist</li></ul>",
      "start_date": "2026-12-11",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "0dc3543e-c84f-4914-9ca7-fd90435ed6ad FS",
      "parent": "57831a79-0296-4839-9152-097c08f2596f"
    },
    {
      "id": "cca1b359-29a6-495b-b6f4-b861f9679ff5",
      "text": "Draft preliminary ethical guidelines for the facility",
      "custom_tooltip": "<b>Draft preliminary ethical guidelines for the facility</b><br>Objective: Develop a preliminary set of ethical guidelines tailored to the specific context of the face transplantation facility in New Zealand.\nScope: Cover all aspects of the transplantation process, from donor selection to post-transplant care.\nSteps:\n1. Synthesize research findings and expert opinions.\n2. Draft preliminary guidelines.\n3. Circulate draft for internal review.\nDeliverables: A draft document outlining the facility&#x27;s ethical guidelines.<br><b>Resources needed:</b><br><ul><li>Medical ethicist</li><li>Legal counsel</li><li>Transplant surgeon</li></ul>",
      "start_date": "2026-12-26",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "2db1a1af-3883-43b5-8968-9061eee85941 FS",
      "parent": "57831a79-0296-4839-9152-097c08f2596f"
    },
    {
      "id": "dc0d3df3-d0c9-4699-9310-5e0ef605a756",
      "text": "Obtain feedback from stakeholders on draft guidelines",
      "custom_tooltip": "<b>Obtain feedback from stakeholders on draft guidelines</b><br>Objective: Gather feedback from key stakeholders, including patients, donor families, medical professionals, and the public, on the draft ethical guidelines.\nScope: Conduct focus groups, surveys, and individual interviews to collect diverse perspectives.\nSteps:\n1. Identify key stakeholder groups.\n2. Develop feedback collection methods.\n3. Analyze feedback and identify areas for improvement.\nDeliverables: A report summarizing stakeholder feedback and recommendations.<br><b>Resources needed:</b><br><ul><li>Medical ethicist</li><li>Patient liaison</li><li>Public relations specialist</li></ul>",
      "start_date": "2027-01-10",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "cca1b359-29a6-495b-b6f4-b861f9679ff5 FS",
      "parent": "57831a79-0296-4839-9152-097c08f2596f"
    },
    {
      "id": "19bec1c3-8e14-46bf-ba18-3878fbff3565",
      "text": "Finalize ethical guidelines and protocols",
      "custom_tooltip": "<b>Finalize ethical guidelines and protocols</b><br>Objective: Revise and finalize the ethical guidelines based on stakeholder feedback and expert review.\nScope: Ensure the guidelines are comprehensive, practical, and aligned with relevant regulations and ethical principles.\nSteps:\n1. Incorporate stakeholder feedback.\n2. Obtain final approval from the Ethics Review Board.\n3. Disseminate the finalized guidelines to all relevant personnel.\nDeliverables: A finalized document outlining the facility&#x27;s ethical guidelines and protocols.<br><b>Resources needed:</b><br><ul><li>Medical ethicist</li><li>Legal counsel</li><li>Ethics Review Board</li></ul>",
      "start_date": "2027-01-25",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "57831a79-0296-4839-9152-097c08f2596f FF, dc0d3df3-d0c9-4699-9310-5e0ef605a756 FS",
      "parent": "57831a79-0296-4839-9152-097c08f2596f"
    },
    {
      "id": "8a12f9b1-21eb-466a-bb85-60afa33725c8",
      "text": "Obtain Necessary Permits and Licenses",
      "custom_tooltip": "<b>Obtain Necessary Permits and Licenses</b>",
      "progress": 0,
      "open": true,
      "meta": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33 FF, 57831a79-0296-4839-9152-097c08f2596f FS",
      "parent": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "project"
    },
    {
      "id": "40d47d6d-7c40-4678-a775-0f7da8fbc4eb",
      "text": "Identify required permits and licenses",
      "custom_tooltip": "<b>Identify required permits and licenses</b><br>Objective: Determine all necessary permits and licenses for the face transplantation facility and subscription service in New Zealand.\nScope: Research and document all relevant permits and licenses at the national, regional, and local levels.\nSteps: Consult with regulatory experts, review relevant legislation, and create a comprehensive list of required permits and licenses.\nDeliverables: A detailed list of all required permits and licenses.<br><b>Resources needed:</b><br><ul><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Project manager</li></ul>",
      "start_date": "2027-02-09",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "8a12f9b1-21eb-466a-bb85-60afa33725c8 SS",
      "parent": "8a12f9b1-21eb-466a-bb85-60afa33725c8"
    },
    {
      "id": "e0c241ec-776e-4488-b204-4efe721c3c73",
      "text": "Prepare permit and license applications",
      "custom_tooltip": "<b>Prepare permit and license applications</b><br>Objective: Prepare all necessary documentation for permit and license applications.\nScope: Gather and compile all required information, complete application forms, and ensure accuracy and completeness.\nSteps: Collect data, fill out application forms, review and verify information, and submit applications.\nDeliverables: Completed permit and license applications.<br><b>Resources needed:</b><br><ul><li>Administrative staff</li><li>Regulatory affairs consultant</li><li>Legal counsel</li></ul>",
      "start_date": "2027-03-05",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "40d47d6d-7c40-4678-a775-0f7da8fbc4eb FS",
      "parent": "8a12f9b1-21eb-466a-bb85-60afa33725c8"
    },
    {
      "id": "7b8f61a3-8cb3-456b-868b-ff3d8d424e7a",
      "text": "Submit applications and track progress",
      "custom_tooltip": "<b>Submit applications and track progress</b><br>Objective: Submit permit and license applications to the relevant regulatory bodies and track their progress.\nScope: Submit applications, monitor their status, respond to inquiries, and address any issues that arise.\nSteps: Submit applications, track progress online or through direct contact, respond to requests for information, and resolve any problems.\nDeliverables: Confirmation of application submission and regular progress updates.<br><b>Resources needed:</b><br><ul><li>Administrative staff</li><li>Regulatory affairs consultant</li><li>Project manager</li></ul>",
      "start_date": "2027-03-29",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "e0c241ec-776e-4488-b204-4efe721c3c73 FS",
      "parent": "8a12f9b1-21eb-466a-bb85-60afa33725c8"
    },
    {
      "id": "00256dc9-49c9-49ee-ac1b-8b3ce6b252b1",
      "text": "Address regulatory body inquiries",
      "custom_tooltip": "<b>Address regulatory body inquiries</b><br>Objective: Respond to inquiries and requests for additional information from regulatory bodies.\nScope: Gather and provide requested information, address concerns, and ensure compliance with regulatory requirements.\nSteps: Review inquiries, gather information, prepare responses, and submit responses to regulatory bodies.\nDeliverables: Timely and accurate responses to regulatory inquiries.<br><b>Resources needed:</b><br><ul><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Medical personnel</li></ul>",
      "start_date": "2027-04-22",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "7b8f61a3-8cb3-456b-868b-ff3d8d424e7a FS",
      "parent": "8a12f9b1-21eb-466a-bb85-60afa33725c8"
    },
    {
      "id": "69c8900b-dab7-46e1-ba71-dcd7d276be9f",
      "text": "Secure final permits and licenses",
      "custom_tooltip": "<b>Secure final permits and licenses</b><br>Objective: Obtain all necessary permits and licenses for the face transplantation facility and subscription service.\nScope: Monitor application status, address any outstanding issues, and secure final approval.\nSteps: Track application progress, resolve any remaining issues, and obtain final permits and licenses.\nDeliverables: All required permits and licenses.<br><b>Resources needed:</b><br><ul><li>Administrative staff</li><li>Regulatory affairs consultant</li><li>Legal counsel</li><li>Project manager</li></ul>",
      "start_date": "2027-05-16",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "8a12f9b1-21eb-466a-bb85-60afa33725c8 FF, 00256dc9-49c9-49ee-ac1b-8b3ce6b252b1 FS",
      "parent": "8a12f9b1-21eb-466a-bb85-60afa33725c8"
    },
    {
      "id": "c3905530-1d89-4610-bc35-a66b4597170d",
      "text": "Facility Development & Infrastructure",
      "custom_tooltip": "<b>Facility Development &amp; Infrastructure</b>",
      "progress": 0,
      "open": true,
      "meta": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33 FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "c2656566-0c94-40b2-a22e-0955e9216f46",
      "text": "Select Facility Location",
      "custom_tooltip": "<b>Select Facility Location</b>",
      "progress": 0,
      "open": true,
      "meta": "c3905530-1d89-4610-bc35-a66b4597170d SS",
      "parent": "c3905530-1d89-4610-bc35-a66b4597170d",
      "type": "project"
    },
    {
      "id": "237024a5-b5b4-4851-aca8-df98563e2edd",
      "text": "Define Facility Requirements and Criteria",
      "custom_tooltip": "<b>Define Facility Requirements and Criteria</b><br>Establish detailed requirements for the facility, including size, location, accessibility, zoning regulations, and proximity to hospitals and transportation hubs. Define selection criteria based on these requirements.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Medical Consultants</li><li>Facility Planner</li></ul>",
      "start_date": "2027-06-09",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "c2656566-0c94-40b2-a22e-0955e9216f46 SS",
      "parent": "c2656566-0c94-40b2-a22e-0955e9216f46"
    },
    {
      "id": "0c68c563-330b-4258-a61d-5cd55597a7d5",
      "text": "Conduct Market Research and Site Analysis",
      "custom_tooltip": "<b>Conduct Market Research and Site Analysis</b><br>Research potential locations in New Zealand, considering factors such as demographics, competition, regulatory environment, and cost of real estate. Analyze potential sites based on the defined requirements and selection criteria.<br><b>Resources needed:</b><br><ul><li>Market Research Analyst</li><li>Real Estate Agent</li><li>Data Analyst</li></ul>",
      "start_date": "2027-06-21",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "237024a5-b5b4-4851-aca8-df98563e2edd FS",
      "parent": "c2656566-0c94-40b2-a22e-0955e9216f46"
    },
    {
      "id": "f2fab493-d73f-42dd-bb07-c9306a9618fb",
      "text": "Evaluate Potential Locations and Shortlist",
      "custom_tooltip": "<b>Evaluate Potential Locations and Shortlist</b><br>Evaluate potential locations based on market research, site analysis, and defined criteria. Create a shortlist of the most promising locations for further investigation.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Medical Consultants</li><li>Real Estate Agent</li></ul>",
      "start_date": "2027-07-03",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "0c68c563-330b-4258-a61d-5cd55597a7d5 FS",
      "parent": "c2656566-0c94-40b2-a22e-0955e9216f46"
    },
    {
      "id": "5b6d72f6-7f4d-442c-93b1-918c7380da49",
      "text": "Negotiate Lease or Purchase Agreement",
      "custom_tooltip": "<b>Negotiate Lease or Purchase Agreement</b><br>Negotiate lease or purchase agreements with property owners for the shortlisted locations. Secure favorable terms and conditions that align with the project&#x27;s budget and timeline.<br><b>Resources needed:</b><br><ul><li>Legal Counsel</li><li>Real Estate Agent</li><li>Project Manager</li></ul>",
      "start_date": "2027-07-15",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "f2fab493-d73f-42dd-bb07-c9306a9618fb FS",
      "parent": "c2656566-0c94-40b2-a22e-0955e9216f46"
    },
    {
      "id": "b26eeadc-c132-4b6c-8bfd-8fbb67120d3d",
      "text": "Conduct Due Diligence and Finalize Selection",
      "custom_tooltip": "<b>Conduct Due Diligence and Finalize Selection</b><br>Conduct thorough due diligence on the selected location, including environmental assessments, zoning verification, and structural inspections. Finalize the location selection based on the due diligence findings.<br><b>Resources needed:</b><br><ul><li>Environmental Consultant</li><li>Legal Counsel</li><li>Structural Engineer</li><li>Project Manager</li></ul>",
      "start_date": "2027-07-27",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "c2656566-0c94-40b2-a22e-0955e9216f46 FF, 5b6d72f6-7f4d-442c-93b1-918c7380da49 FS",
      "parent": "c2656566-0c94-40b2-a22e-0955e9216f46"
    },
    {
      "id": "d1da9237-e263-4c03-a503-590d6eeea3f3",
      "text": "Design Facility Layout",
      "custom_tooltip": "<b>Design Facility Layout</b>",
      "progress": 0,
      "open": true,
      "meta": "c2656566-0c94-40b2-a22e-0955e9216f46 FS",
      "parent": "c3905530-1d89-4610-bc35-a66b4597170d",
      "type": "project"
    },
    {
      "id": "5440543e-8c9b-4f92-b57e-1d092448873d",
      "text": "Define Facility Requirements and Specifications",
      "custom_tooltip": "<b>Define Facility Requirements and Specifications</b><br>Determine specific requirements for the facility layout, including surgical suites, patient rooms, recovery areas, laboratory space, and administrative offices. Define technical specifications for HVAC, electrical, plumbing, and medical gas systems.<br><b>Resources needed:</b><br><ul><li>Architect</li><li>Medical consultants</li><li>Facility manager</li></ul>",
      "start_date": "2027-08-08",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "d1da9237-e263-4c03-a503-590d6eeea3f3 SS",
      "parent": "d1da9237-e263-4c03-a503-590d6eeea3f3"
    },
    {
      "id": "b2af5698-ffd5-4944-91ce-381c09a294a4",
      "text": "Develop Preliminary Facility Layout Designs",
      "custom_tooltip": "<b>Develop Preliminary Facility Layout Designs</b><br>Create initial layout designs based on the defined requirements and specifications. Explore different layout options to optimize workflow, patient safety, and operational efficiency. Consider factors such as infection control, accessibility, and privacy.<br><b>Resources needed:</b><br><ul><li>Architect</li><li>CAD software</li><li>Medical consultants</li></ul>",
      "start_date": "2027-08-20",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "5440543e-8c9b-4f92-b57e-1d092448873d FS",
      "parent": "d1da9237-e263-4c03-a503-590d6eeea3f3"
    },
    {
      "id": "8c1e864a-bafa-4fff-be04-33d6daad4b50",
      "text": "Review and Refine Layout Designs",
      "custom_tooltip": "<b>Review and Refine Layout Designs</b><br>Present the preliminary layout designs to stakeholders, including surgeons, nurses, administrators, and facility managers. Gather feedback and incorporate revisions to improve the design. Conduct simulations to evaluate workflow and identify potential bottlenecks.<br><b>Resources needed:</b><br><ul><li>Architect</li><li>Stakeholders</li><li>Simulation software</li></ul>",
      "start_date": "2027-09-01",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "b2af5698-ffd5-4944-91ce-381c09a294a4 FS",
      "parent": "d1da9237-e263-4c03-a503-590d6eeea3f3"
    },
    {
      "id": "a10513ec-dbe5-41fd-8218-4e5349fa869a",
      "text": "Create Detailed Architectural Drawings",
      "custom_tooltip": "<b>Create Detailed Architectural Drawings</b><br>Develop detailed architectural drawings based on the refined layout designs. Include all necessary details for construction, including dimensions, materials, finishes, and equipment locations. Ensure compliance with building codes and regulations.<br><b>Resources needed:</b><br><ul><li>Architect</li><li>Engineers</li><li>CAD software</li></ul>",
      "start_date": "2027-09-13",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "8c1e864a-bafa-4fff-be04-33d6daad4b50 FS",
      "parent": "d1da9237-e263-4c03-a503-590d6eeea3f3"
    },
    {
      "id": "304396a5-e27e-425f-b381-7c60115860eb",
      "text": "Obtain Design Approvals",
      "custom_tooltip": "<b>Obtain Design Approvals</b><br>Submit the detailed architectural drawings to relevant authorities for review and approval. Address any comments or concerns raised by the authorities and make necessary revisions to the drawings. Obtain all required permits and approvals before proceeding with construction.<br><b>Resources needed:</b><br><ul><li>Architect</li><li>Permitting specialists</li><li>Legal counsel</li></ul>",
      "start_date": "2027-09-25",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "d1da9237-e263-4c03-a503-590d6eeea3f3 FF, a10513ec-dbe5-41fd-8218-4e5349fa869a FS",
      "parent": "d1da9237-e263-4c03-a503-590d6eeea3f3"
    },
    {
      "id": "664a3180-076a-435e-b8bd-5c2d7be3a5e1",
      "text": "Procure Surgical Equipment and Medical Supplies",
      "custom_tooltip": "<b>Procure Surgical Equipment and Medical Supplies</b>",
      "progress": 0,
      "open": true,
      "meta": "d1da9237-e263-4c03-a503-590d6eeea3f3 FS",
      "parent": "c3905530-1d89-4610-bc35-a66b4597170d",
      "type": "project"
    },
    {
      "id": "73a1139e-8e53-47f7-b2e2-a709fc200b1b",
      "text": "Define Equipment Specifications and Requirements",
      "custom_tooltip": "<b>Define Equipment Specifications and Requirements</b><br>Establish detailed specifications for all surgical equipment and medical supplies needed, including technical requirements, performance criteria, and regulatory compliance standards. This involves consulting with surgeons, nurses, and technicians to identify their specific needs and preferences.<br><b>Resources needed:</b><br><ul><li>Surgeons</li><li>Nurses</li><li>Technicians</li><li>Biomedical Engineer</li></ul>",
      "start_date": "2027-10-07",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "664a3180-076a-435e-b8bd-5c2d7be3a5e1 SS",
      "parent": "664a3180-076a-435e-b8bd-5c2d7be3a5e1"
    },
    {
      "id": "81e6bdef-caf9-42c4-b685-3860865a1a54",
      "text": "Identify Potential Vendors and Suppliers",
      "custom_tooltip": "<b>Identify Potential Vendors and Suppliers</b><br>Research and identify potential vendors and suppliers for surgical equipment and medical supplies, considering factors such as product quality, pricing, delivery timelines, and reputation. This includes conducting market research, attending industry trade shows, and soliciting recommendations from other medical facilities.<br><b>Resources needed:</b><br><ul><li>Procurement Specialist</li><li>Market Research Analyst</li></ul>",
      "start_date": "2027-10-31",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "73a1139e-8e53-47f7-b2e2-a709fc200b1b FS",
      "parent": "664a3180-076a-435e-b8bd-5c2d7be3a5e1"
    },
    {
      "id": "fb659d35-bf51-44d0-a402-2ad890eee55b",
      "text": "Evaluate Vendor Proposals and Negotiate Contracts",
      "custom_tooltip": "<b>Evaluate Vendor Proposals and Negotiate Contracts</b><br>Evaluate vendor proposals based on predefined criteria, including product specifications, pricing, warranty terms, and service agreements. Negotiate contracts with selected vendors to secure favorable terms and conditions, ensuring compliance with legal and ethical standards.<br><b>Resources needed:</b><br><ul><li>Procurement Specialist</li><li>Legal Counsel</li><li>Financial Analyst</li></ul>",
      "start_date": "2027-11-24",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "81e6bdef-caf9-42c4-b685-3860865a1a54 FS",
      "parent": "664a3180-076a-435e-b8bd-5c2d7be3a5e1"
    },
    {
      "id": "fa0db33f-7f9f-4e2e-9757-2efe6e1081d1",
      "text": "Manage Purchase Orders and Track Deliveries",
      "custom_tooltip": "<b>Manage Purchase Orders and Track Deliveries</b><br>Generate purchase orders for approved equipment and supplies, track deliveries to ensure timely arrival, and verify that all items meet specified requirements. This includes coordinating with vendors, logistics providers, and internal stakeholders to resolve any issues or discrepancies.<br><b>Resources needed:</b><br><ul><li>Procurement Specialist</li><li>Logistics Coordinator</li><li>Inventory Manager</li></ul>",
      "start_date": "2027-12-18",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "fb659d35-bf51-44d0-a402-2ad890eee55b FS",
      "parent": "664a3180-076a-435e-b8bd-5c2d7be3a5e1"
    },
    {
      "id": "68921308-13ba-4fac-bb46-70b802f93b68",
      "text": "Conduct Equipment Testing and Acceptance",
      "custom_tooltip": "<b>Conduct Equipment Testing and Acceptance</b><br>Conduct thorough testing and acceptance procedures for all delivered equipment and supplies to ensure they meet performance standards and regulatory requirements. This includes verifying functionality, calibrating instruments, and providing training to medical personnel on proper usage and maintenance.<br><b>Resources needed:</b><br><ul><li>Biomedical Engineer</li><li>Surgeons</li><li>Nurses</li><li>Technicians</li></ul>",
      "start_date": "2028-01-11",
      "duration": 24.0,
      "progress": 0,
      "open": true,
      "meta": "664a3180-076a-435e-b8bd-5c2d7be3a5e1 FF, fa0db33f-7f9f-4e2e-9757-2efe6e1081d1 FS",
      "parent": "664a3180-076a-435e-b8bd-5c2d7be3a5e1"
    },
    {
      "id": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b",
      "text": "Construct/Renovate Facility",
      "custom_tooltip": "<b>Construct/Renovate Facility</b>",
      "progress": 0,
      "open": true,
      "meta": "664a3180-076a-435e-b8bd-5c2d7be3a5e1 FS",
      "parent": "c3905530-1d89-4610-bc35-a66b4597170d",
      "type": "project"
    },
    {
      "id": "e02895ff-d980-4bbc-b950-8f681cac6a23",
      "text": "Prepare site for construction/renovation",
      "custom_tooltip": "<b>Prepare site for construction/renovation</b><br>Clear the site, prepare the foundation, and ensure compliance with safety regulations.<br><b>Resources needed:</b><br><ul><li>Construction crew</li><li>Heavy machinery</li><li>Site supervisor</li></ul>",
      "start_date": "2028-02-04",
      "duration": 48.0,
      "progress": 0,
      "open": true,
      "meta": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b SS",
      "parent": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b"
    },
    {
      "id": "011f9618-dcf2-4bd1-b8ee-2c6505951766",
      "text": "Execute structural construction/renovation",
      "custom_tooltip": "<b>Execute structural construction/renovation</b><br>Build or renovate the facility&#x27;s structural components, including walls, floors, and roof.<br><b>Resources needed:</b><br><ul><li>Construction crew</li><li>Architect</li><li>Structural engineer</li><li>Building materials</li></ul>",
      "start_date": "2028-03-23",
      "duration": 48.0,
      "progress": 0,
      "open": true,
      "meta": "e02895ff-d980-4bbc-b950-8f681cac6a23 FS",
      "parent": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b"
    },
    {
      "id": "ff893814-759b-44cc-8ffa-0be1aa266165",
      "text": "Install electrical and plumbing systems",
      "custom_tooltip": "<b>Install electrical and plumbing systems</b><br>Install electrical wiring, plumbing pipes, and HVAC systems according to building codes and specifications.<br><b>Resources needed:</b><br><ul><li>Electricians</li><li>Plumbers</li><li>HVAC technicians</li><li>Inspectors</li></ul>",
      "start_date": "2028-05-10",
      "duration": 48.0,
      "progress": 0,
      "open": true,
      "meta": "011f9618-dcf2-4bd1-b8ee-2c6505951766 FS",
      "parent": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b"
    },
    {
      "id": "0c48a713-4bd4-4cd0-8ddc-17c4b06b16f8",
      "text": "Install specialized medical infrastructure",
      "custom_tooltip": "<b>Install specialized medical infrastructure</b><br>Install specialized medical infrastructure, such as operating rooms, recovery rooms, and laboratory facilities.<br><b>Resources needed:</b><br><ul><li>Specialized contractors</li><li>Medical equipment suppliers</li><li>Medical consultants</li></ul>",
      "start_date": "2028-06-27",
      "duration": 48.0,
      "progress": 0,
      "open": true,
      "meta": "ff893814-759b-44cc-8ffa-0be1aa266165 FS",
      "parent": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b"
    },
    {
      "id": "c5e28806-e26d-4473-9097-e23ddfb6e539",
      "text": "Complete interior finishing and fixtures",
      "custom_tooltip": "<b>Complete interior finishing and fixtures</b><br>Install interior finishes, such as flooring, walls, ceilings, and fixtures, to create a functional and aesthetically pleasing environment.<br><b>Resources needed:</b><br><ul><li>Interior designers</li><li>Carpenters</li><li>Painters</li><li>Electricians</li></ul>",
      "start_date": "2028-08-14",
      "duration": 48.0,
      "progress": 0,
      "open": true,
      "meta": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b FF, 0c48a713-4bd4-4cd0-8ddc-17c4b06b16f8 FS",
      "parent": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b"
    },
    {
      "id": "bf1f1646-5331-4128-843a-94182f9e72a2",
      "text": "Install Data Privacy and Security Systems",
      "custom_tooltip": "<b>Install Data Privacy and Security Systems</b>",
      "progress": 0,
      "open": true,
      "meta": "c3905530-1d89-4610-bc35-a66b4597170d FF, b3eeffe0-96c3-4758-896e-c87fe1de4a7b FS",
      "parent": "c3905530-1d89-4610-bc35-a66b4597170d",
      "type": "project"
    },
    {
      "id": "43b25536-52e8-4246-bedd-84ee796f803e",
      "text": "Assess data privacy regulatory requirements",
      "custom_tooltip": "<b>Assess data privacy regulatory requirements</b><br>Identify and document all applicable data privacy regulations in New Zealand, including the Health Information Privacy Code 2020 and any relevant international standards like GDPR if applicable to data transfer or storage.<br><b>Resources needed:</b><br><ul><li>Data privacy lawyer</li><li>Regulatory compliance officer</li></ul>",
      "start_date": "2028-10-01",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "bf1f1646-5331-4128-843a-94182f9e72a2 SS",
      "parent": "bf1f1646-5331-4128-843a-94182f9e72a2"
    },
    {
      "id": "b1293df1-628c-41a4-8aab-bfef544fb03b",
      "text": "Select and procure security hardware/software",
      "custom_tooltip": "<b>Select and procure security hardware/software</b><br>Choose appropriate data encryption software, firewalls, intrusion detection systems, and access control mechanisms based on the assessed regulatory requirements and the sensitivity of patient data. Procure the selected solutions.<br><b>Resources needed:</b><br><ul><li>Cybersecurity expert</li><li>IT procurement specialist</li><li>Budget</li></ul>",
      "start_date": "2028-10-07",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "43b25536-52e8-4246-bedd-84ee796f803e FS",
      "parent": "bf1f1646-5331-4128-843a-94182f9e72a2"
    },
    {
      "id": "cbc59d5f-755c-4d82-b8d9-660a92518932",
      "text": "Configure and integrate security systems",
      "custom_tooltip": "<b>Configure and integrate security systems</b><br>Install and configure the selected security hardware and software, ensuring seamless integration with existing hospital IT infrastructure and electronic health record (EHR) systems. Implement access control protocols and data encryption.<br><b>Resources needed:</b><br><ul><li>IT technicians</li><li>Cybersecurity engineer</li><li>Systems administrator</li></ul>",
      "start_date": "2028-10-13",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "b1293df1-628c-41a4-8aab-bfef544fb03b FS",
      "parent": "bf1f1646-5331-4128-843a-94182f9e72a2"
    },
    {
      "id": "abfb3dbe-3b60-4462-b2b3-978d3e49db9c",
      "text": "Test and validate security system effectiveness",
      "custom_tooltip": "<b>Test and validate security system effectiveness</b><br>Conduct penetration testing and vulnerability assessments to identify and address any weaknesses in the implemented security systems. Validate that the systems effectively protect patient data and comply with regulatory requirements.<br><b>Resources needed:</b><br><ul><li>Penetration testers</li><li>Security auditors</li><li>IT security team</li></ul>",
      "start_date": "2028-10-19",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "cbc59d5f-755c-4d82-b8d9-660a92518932 FS",
      "parent": "bf1f1646-5331-4128-843a-94182f9e72a2"
    },
    {
      "id": "b9314417-b01e-492f-a16b-ea1d4ed12b44",
      "text": "Develop data breach response plan",
      "custom_tooltip": "<b>Develop data breach response plan</b><br>Create a comprehensive plan outlining the steps to be taken in the event of a data breach, including incident reporting, containment, investigation, notification, and remediation. Ensure the plan complies with regulatory requirements.<br><b>Resources needed:</b><br><ul><li>Data privacy lawyer</li><li>Cybersecurity expert</li><li>Legal counsel</li><li>Public relations team</li></ul>",
      "start_date": "2028-10-25",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "bf1f1646-5331-4128-843a-94182f9e72a2 FF, abfb3dbe-3b60-4462-b2b3-978d3e49db9c FS",
      "parent": "bf1f1646-5331-4128-843a-94182f9e72a2"
    },
    {
      "id": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "text": "Donor Face Acquisition & Preservation",
      "custom_tooltip": "<b>Donor Face Acquisition &amp; Preservation</b>",
      "progress": 0,
      "open": true,
      "meta": "c3905530-1d89-4610-bc35-a66b4597170d FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "22ffa70e-b917-4918-9074-e917a9890156",
      "text": "Establish Partnerships with Organ Donation Organizations",
      "custom_tooltip": "<b>Establish Partnerships with Organ Donation Organizations</b>",
      "progress": 0,
      "open": true,
      "meta": "edea1841-d86e-4d1b-9704-04d6abb593c2 SS",
      "parent": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "type": "project"
    },
    {
      "id": "907727c7-1fb8-46b6-9da0-4396387846fb",
      "text": "Identify potential organ donation partners",
      "custom_tooltip": "<b>Identify potential organ donation partners</b><br>Research and identify organ donation organizations in New Zealand that align with the project&#x27;s goals and ethical standards. This includes reviewing their mission statements, donation policies, and geographical coverage.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Research Assistant</li><li>Legal Counsel</li></ul>",
      "start_date": "2028-10-31",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "22ffa70e-b917-4918-9074-e917a9890156 SS",
      "parent": "22ffa70e-b917-4918-9074-e917a9890156"
    },
    {
      "id": "8ebe4ef9-feb1-4d3f-99f6-33245a10cae3",
      "text": "Initial contact and introductory meetings",
      "custom_tooltip": "<b>Initial contact and introductory meetings</b><br>Reach out to identified organ donation organizations to schedule introductory meetings. The objective is to present the project, explain the need for donor faces, and gauge their interest in potential collaboration.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Donor Relations Specialist</li></ul>",
      "start_date": "2028-11-15",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "907727c7-1fb8-46b6-9da0-4396387846fb FS",
      "parent": "22ffa70e-b917-4918-9074-e917a9890156"
    },
    {
      "id": "cb406d06-ae90-4da8-81d1-c352984cacac",
      "text": "Negotiate partnership agreements",
      "custom_tooltip": "<b>Negotiate partnership agreements</b><br>Work with interested organ donation organizations to negotiate the terms of partnership agreements. This includes defining roles and responsibilities, establishing protocols for donor face acquisition, and addressing ethical considerations.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Legal Counsel</li><li>Ethics Review Board Coordinator</li></ul>",
      "start_date": "2028-11-30",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "8ebe4ef9-feb1-4d3f-99f6-33245a10cae3 FS",
      "parent": "22ffa70e-b917-4918-9074-e917a9890156"
    },
    {
      "id": "1da9645e-89a2-4e93-8b0e-a0f23aca4102",
      "text": "Formalize partnership agreements",
      "custom_tooltip": "<b>Formalize partnership agreements</b><br>Finalize and execute partnership agreements with selected organ donation organizations. This involves obtaining necessary approvals from both parties and ensuring that all agreements comply with relevant regulations and ethical guidelines.<br><b>Resources needed:</b><br><ul><li>Project Manager</li><li>Legal Counsel</li><li>Executive Leadership</li></ul>",
      "start_date": "2028-12-15",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "22ffa70e-b917-4918-9074-e917a9890156 FF, cb406d06-ae90-4da8-81d1-c352984cacac FS",
      "parent": "22ffa70e-b917-4918-9074-e917a9890156"
    },
    {
      "id": "406b6dd6-7b44-4d60-a2e1-f31668252d62",
      "text": "Develop Donor Face Acquisition Protocols",
      "custom_tooltip": "<b>Develop Donor Face Acquisition Protocols</b>",
      "progress": 0,
      "open": true,
      "meta": "22ffa70e-b917-4918-9074-e917a9890156 FS",
      "parent": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "type": "project"
    },
    {
      "id": "85546c83-65bb-4baf-b100-9ce5e8fcde72",
      "text": "Research current face acquisition protocols",
      "custom_tooltip": "<b>Research current face acquisition protocols</b><br>Objective: Understand existing protocols for face acquisition from organ donation organizations.\nScope: Review literature, guidelines, and best practices.\nSteps: Search databases, contact experts, analyze findings.\nDeliverables: Summary report of current protocols.<br><b>Resources needed:</b><br><ul><li>Research assistant</li><li>Medical librarian</li><li>Transplant surgeon</li></ul>",
      "start_date": "2028-12-30",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "406b6dd6-7b44-4d60-a2e1-f31668252d62 SS",
      "parent": "406b6dd6-7b44-4d60-a2e1-f31668252d62"
    },
    {
      "id": "2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4",
      "text": "Draft initial face acquisition protocol",
      "custom_tooltip": "<b>Draft initial face acquisition protocol</b><br>Objective: Create a draft protocol tailored to the facility&#x27;s needs.\nScope: Define eligibility criteria, consent process, and documentation.\nSteps: Consult with legal and ethical experts, draft protocol, review internally.\nDeliverables: Draft face acquisition protocol document.<br><b>Resources needed:</b><br><ul><li>Transplant surgeon</li><li>Legal counsel</li><li>Ethicist</li><li>Protocol writer</li></ul>",
      "start_date": "2029-01-14",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "85546c83-65bb-4baf-b100-9ce5e8fcde72 FS",
      "parent": "406b6dd6-7b44-4d60-a2e1-f31668252d62"
    },
    {
      "id": "2ecb2eed-47f8-4efc-9936-7ea541193511",
      "text": "Review protocol with organ donation organizations",
      "custom_tooltip": "<b>Review protocol with organ donation organizations</b><br>Objective: Obtain feedback and ensure compatibility with organ donation organizations.\nScope: Share draft protocol, solicit feedback, revise based on input.\nSteps: Schedule meetings, present protocol, document feedback, revise.\nDeliverables: Revised face acquisition protocol document.<br><b>Resources needed:</b><br><ul><li>Transplant surgeon</li><li>Donor relations specialist</li><li>Organ donation organization representatives</li></ul>",
      "start_date": "2029-01-29",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4 FS",
      "parent": "406b6dd6-7b44-4d60-a2e1-f31668252d62"
    },
    {
      "id": "179b4feb-8bb6-4d4c-9601-cb9b543e99d5",
      "text": "Finalize and approve acquisition protocol",
      "custom_tooltip": "<b>Finalize and approve acquisition protocol</b><br>Objective: Obtain final approval from the ethics review board and facility leadership.\nScope: Address any remaining concerns, finalize protocol, obtain signatures.\nSteps: Present to ethics review board, address concerns, obtain approval, finalize document.\nDeliverables: Approved face acquisition protocol document.<br><b>Resources needed:</b><br><ul><li>Ethics review board</li><li>Facility leadership</li><li>Legal counsel</li></ul>",
      "start_date": "2029-02-13",
      "duration": 15.0,
      "progress": 0,
      "open": true,
      "meta": "406b6dd6-7b44-4d60-a2e1-f31668252d62 FF, 2ecb2eed-47f8-4efc-9936-7ea541193511 FS",
      "parent": "406b6dd6-7b44-4d60-a2e1-f31668252d62"
    },
    {
      "id": "6184d74a-ca1e-44d1-b5b8-445aadb63208",
      "text": "Establish Face Transportation and Preservation Logistics",
      "custom_tooltip": "<b>Establish Face Transportation and Preservation Logistics</b>",
      "progress": 0,
      "open": true,
      "meta": "406b6dd6-7b44-4d60-a2e1-f31668252d62 FS",
      "parent": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "type": "project"
    },
    {
      "id": "0c5b34e2-b12c-410e-992a-f4bba6326ebf",
      "text": "Map transportation routes and identify providers",
      "custom_tooltip": "<b>Map transportation routes and identify providers</b><br>Objective: Determine optimal transportation routes for donor faces across New Zealand. Scope: Identify potential transportation providers (air, land) and map out routes considering distance, time, and cost. Steps: Use mapping software, contact transportation companies, and analyze route options. Deliverables: Route maps and provider list.<br><b>Resources needed:</b><br><ul><li>Logistics coordinator</li><li>Mapping software</li><li>Transportation company contacts</li></ul>",
      "start_date": "2029-02-28",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "6184d74a-ca1e-44d1-b5b8-445aadb63208 SS",
      "parent": "6184d74a-ca1e-44d1-b5b8-445aadb63208"
    },
    {
      "id": "d46b6612-cd0a-4ae8-bf54-a74fd1ed9003",
      "text": "Establish preservation solution procurement process",
      "custom_tooltip": "<b>Establish preservation solution procurement process</b><br>Objective: Ensure a reliable supply of preservation solutions. Scope: Identify suppliers, negotiate contracts, and establish a procurement process. Steps: Research suppliers, obtain quotes, and create a purchase order system. Deliverables: Supplier contracts and procurement process documentation.<br><b>Resources needed:</b><br><ul><li>Procurement specialist</li><li>Legal counsel</li><li>Medical supply vendors</li></ul>",
      "start_date": "2029-03-08",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "0c5b34e2-b12c-410e-992a-f4bba6326ebf FS",
      "parent": "6184d74a-ca1e-44d1-b5b8-445aadb63208"
    },
    {
      "id": "d73df452-bb1b-46f6-aaa8-c2a91243ecba",
      "text": "Develop packaging and handling procedures",
      "custom_tooltip": "<b>Develop packaging and handling procedures</b><br>Objective: Minimize damage to donor faces during transportation. Scope: Create detailed packaging and handling procedures. Steps: Research best practices, design packaging, and document procedures. Deliverables: Packaging and handling procedure manual.<br><b>Resources needed:</b><br><ul><li>Medical technician</li><li>Packaging engineer</li><li>Transportation specialist</li></ul>",
      "start_date": "2029-03-16",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "d46b6612-cd0a-4ae8-bf54-a74fd1ed9003 FS",
      "parent": "6184d74a-ca1e-44d1-b5b8-445aadb63208"
    },
    {
      "id": "36f291b9-ce07-4078-a331-08b7c984d520",
      "text": "Create temperature monitoring and tracking system",
      "custom_tooltip": "<b>Create temperature monitoring and tracking system</b><br>Objective: Maintain optimal temperature during transportation. Scope: Implement a temperature monitoring and tracking system. Steps: Select monitoring devices, integrate with transportation system, and establish alert protocols. Deliverables: Temperature monitoring system and alert protocols.<br><b>Resources needed:</b><br><ul><li>IT specialist</li><li>Logistics coordinator</li><li>Temperature monitoring equipment</li></ul>",
      "start_date": "2029-03-24",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "6184d74a-ca1e-44d1-b5b8-445aadb63208 FF, d73df452-bb1b-46f6-aaa8-c2a91243ecba FS",
      "parent": "6184d74a-ca1e-44d1-b5b8-445aadb63208"
    },
    {
      "id": "f2158970-6c48-4dfa-97e5-6620da550d37",
      "text": "Implement Inventory Management System",
      "custom_tooltip": "<b>Implement Inventory Management System</b>",
      "progress": 0,
      "open": true,
      "meta": "edea1841-d86e-4d1b-9704-04d6abb593c2 FF, 6184d74a-ca1e-44d1-b5b8-445aadb63208 FS",
      "parent": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "type": "project"
    },
    {
      "id": "1e85e3e9-276d-4f0a-a9c1-3887d39771c1",
      "text": "Define Inventory System Requirements",
      "custom_tooltip": "<b>Define Inventory System Requirements</b><br>Clearly define the requirements for the inventory management system, including tracking parameters, user roles, and reporting needs.<br><b>Resources needed:</b><br><ul><li>Inventory Manager</li><li>IT Specialist</li><li>Surgeons</li><li>Nurses</li></ul>",
      "start_date": "2029-04-01",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "f2158970-6c48-4dfa-97e5-6620da550d37 SS",
      "parent": "f2158970-6c48-4dfa-97e5-6620da550d37"
    },
    {
      "id": "d0af366a-186a-4e6b-ae0f-4a0f2fefa5b1",
      "text": "Select Inventory Management Software",
      "custom_tooltip": "<b>Select Inventory Management Software</b><br>Evaluate and select appropriate inventory management software that meets the defined requirements and integrates with existing hospital systems.<br><b>Resources needed:</b><br><ul><li>IT Specialist</li><li>Inventory Manager</li><li>Procurement Officer</li></ul>",
      "start_date": "2029-04-04",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "1e85e3e9-276d-4f0a-a9c1-3887d39771c1 FS",
      "parent": "f2158970-6c48-4dfa-97e5-6620da550d37"
    },
    {
      "id": "09075e8b-5ccd-462a-96e9-b22d33b7e037",
      "text": "Configure and Customize Software",
      "custom_tooltip": "<b>Configure and Customize Software</b><br>Configure and customize the selected inventory management software to track donor faces, preservation solutions, and related data.<br><b>Resources needed:</b><br><ul><li>IT Specialist</li><li>Software Vendor Support</li></ul>",
      "start_date": "2029-04-07",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "d0af366a-186a-4e6b-ae0f-4a0f2fefa5b1 FS",
      "parent": "f2158970-6c48-4dfa-97e5-6620da550d37"
    },
    {
      "id": "c7be9ecc-472a-4a49-8280-d31b1a1d1c00",
      "text": "Train Staff on System Usage",
      "custom_tooltip": "<b>Train Staff on System Usage</b><br>Provide comprehensive training to all relevant staff members on how to use the inventory management system effectively.<br><b>Resources needed:</b><br><ul><li>Training Coordinator</li><li>IT Specialist</li><li>Inventory Manager</li></ul>",
      "start_date": "2029-04-10",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "09075e8b-5ccd-462a-96e9-b22d33b7e037 FS",
      "parent": "f2158970-6c48-4dfa-97e5-6620da550d37"
    },
    {
      "id": "a99f4878-fb70-4658-820d-e104fcca0688",
      "text": "Test and Validate System Functionality",
      "custom_tooltip": "<b>Test and Validate System Functionality</b><br>Thoroughly test and validate the functionality of the inventory management system to ensure accuracy and reliability.<br><b>Resources needed:</b><br><ul><li>IT Specialist</li><li>Inventory Manager</li><li>Quality Assurance Team</li></ul>",
      "start_date": "2029-04-13",
      "duration": 3.0,
      "progress": 0,
      "open": true,
      "meta": "f2158970-6c48-4dfa-97e5-6620da550d37 FF, c7be9ecc-472a-4a49-8280-d31b1a1d1c00 FS",
      "parent": "f2158970-6c48-4dfa-97e5-6620da550d37"
    },
    {
      "id": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "text": "Medical Team Recruitment & Training",
      "custom_tooltip": "<b>Medical Team Recruitment &amp; Training</b>",
      "progress": 0,
      "open": true,
      "meta": "edea1841-d86e-4d1b-9704-04d6abb593c2 FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891",
      "text": "Recruit Transplant Surgeons, Nurses, and Technicians",
      "custom_tooltip": "<b>Recruit Transplant Surgeons, Nurses, and Technicians</b>",
      "progress": 0,
      "open": true,
      "meta": "07f8df70-3b93-46d1-9571-5f7823a7865e SS",
      "parent": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "type": "project"
    },
    {
      "id": "603662c9-344a-4f04-9c30-891acb6d9c8e",
      "text": "Define Surgeon, Nurse, Technician Job Descriptions",
      "custom_tooltip": "<b>Define Surgeon, Nurse, Technician Job Descriptions</b><br>Create detailed job descriptions outlining responsibilities, qualifications, and experience required for each role (Transplant Surgeons, Nurses, and Technicians).<br><b>Resources needed:</b><br><ul><li>HR Specialist</li><li>Medical Director</li><li>Senior Surgeons</li><li>Nursing Manager</li><li>Technical Lead</li></ul>",
      "start_date": "2029-04-16",
      "duration": 9.0,
      "progress": 0,
      "open": true,
      "meta": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891 SS",
      "parent": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891"
    },
    {
      "id": "42ec1737-196e-4c88-bfdd-8e1a359cc439",
      "text": "Advertise Open Positions on Relevant Platforms",
      "custom_tooltip": "<b>Advertise Open Positions on Relevant Platforms</b><br>Post job openings on medical job boards, professional networks, and university career pages to attract qualified candidates.<br><b>Resources needed:</b><br><ul><li>HR Specialist</li><li>Marketing Team</li><li>Online Job Boards</li><li>Professional Networks</li></ul>",
      "start_date": "2029-04-25",
      "duration": 9.0,
      "progress": 0,
      "open": true,
      "meta": "603662c9-344a-4f04-9c30-891acb6d9c8e FS",
      "parent": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891"
    },
    {
      "id": "135fc0e9-438a-4721-b996-f43881f0fc16",
      "text": "Screen Applications and Conduct Initial Interviews",
      "custom_tooltip": "<b>Screen Applications and Conduct Initial Interviews</b><br>Review applications, conduct phone screenings, and schedule initial interviews with promising candidates to assess their qualifications and fit for the roles.<br><b>Resources needed:</b><br><ul><li>HR Specialist</li><li>Recruiting Team</li><li>Interview Panel</li></ul>",
      "start_date": "2029-05-04",
      "duration": 9.0,
      "progress": 0,
      "open": true,
      "meta": "42ec1737-196e-4c88-bfdd-8e1a359cc439 FS",
      "parent": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891"
    },
    {
      "id": "fc6093c8-b948-46c1-9d82-fd919b41657b",
      "text": "Conduct Technical and Practical Skills Assessments",
      "custom_tooltip": "<b>Conduct Technical and Practical Skills Assessments</b><br>Evaluate candidates&#x27; technical skills and practical abilities through simulations, case studies, and hands-on assessments to ensure they possess the necessary expertise.<br><b>Resources needed:</b><br><ul><li>Senior Surgeons</li><li>Nursing Manager</li><li>Technical Lead</li><li>Simulation Equipment</li></ul>",
      "start_date": "2029-05-13",
      "duration": 9.0,
      "progress": 0,
      "open": true,
      "meta": "135fc0e9-438a-4721-b996-f43881f0fc16 FS",
      "parent": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891"
    },
    {
      "id": "fb0389ed-03b4-4bd5-b726-119c8f3b7ba3",
      "text": "Perform Background Checks and Credential Verification",
      "custom_tooltip": "<b>Perform Background Checks and Credential Verification</b><br>Conduct thorough background checks and verify credentials, licenses, and certifications to ensure candidates meet all legal and regulatory requirements.<br><b>Resources needed:</b><br><ul><li>HR Specialist</li><li>Legal Counsel</li><li>Credentialing Agency</li></ul>",
      "start_date": "2029-05-22",
      "duration": 9.0,
      "progress": 0,
      "open": true,
      "meta": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891 FF, fc6093c8-b948-46c1-9d82-fd919b41657b FS",
      "parent": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891"
    },
    {
      "id": "7018d1da-7992-42c1-bec3-176474ec2378",
      "text": "Develop Training Programs for Medical Personnel",
      "custom_tooltip": "<b>Develop Training Programs for Medical Personnel</b>",
      "progress": 0,
      "open": true,
      "meta": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891 FS",
      "parent": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "type": "project"
    },
    {
      "id": "80e6de91-5f68-4d73-9a76-851da609fa65",
      "text": "Curriculum Design for Face Transplant Training",
      "custom_tooltip": "<b>Curriculum Design for Face Transplant Training</b><br>Develop a comprehensive curriculum covering surgical techniques, immunosuppression protocols, ethical considerations, and psychological support for face transplantation.<br><b>Resources needed:</b><br><ul><li>Experienced transplant surgeons</li><li>Medical educators</li><li>Ethicists</li><li>Psychologists</li><li>Curriculum development specialists</li></ul>",
      "start_date": "2029-05-31",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "7018d1da-7992-42c1-bec3-176474ec2378 SS",
      "parent": "7018d1da-7992-42c1-bec3-176474ec2378"
    },
    {
      "id": "08d7cf07-78da-4107-8db6-279c1946f7fe",
      "text": "Develop Surgical Simulation Modules",
      "custom_tooltip": "<b>Develop Surgical Simulation Modules</b><br>Create realistic surgical simulation modules using cadaveric models or virtual reality to provide hands-on training for surgeons and surgical teams.<br><b>Resources needed:</b><br><ul><li>Surgical simulation experts</li><li>Anatomists</li><li>Medical engineers</li><li>Cadaveric models or VR equipment</li><li>Funding for simulation equipment</li></ul>",
      "start_date": "2029-06-12",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "80e6de91-5f68-4d73-9a76-851da609fa65 FS",
      "parent": "7018d1da-7992-42c1-bec3-176474ec2378"
    },
    {
      "id": "38a84ba4-234b-4161-883f-f301d060cc1f",
      "text": "Establish Mentorship Program with Experts",
      "custom_tooltip": "<b>Establish Mentorship Program with Experts</b><br>Partner with experienced face transplant centers globally to establish a mentorship program for surgeons, nurses, and technicians to gain practical experience and knowledge.<br><b>Resources needed:</b><br><ul><li>Experienced face transplant surgeons</li><li>International transplant centers</li><li>Travel funding</li><li>Communication platform</li><li>Mentorship program coordinator</li></ul>",
      "start_date": "2029-06-24",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "08d7cf07-78da-4107-8db6-279c1946f7fe FS",
      "parent": "7018d1da-7992-42c1-bec3-176474ec2378"
    },
    {
      "id": "f95038eb-bebf-48da-8c5e-f6e7071c4757",
      "text": "Create Standardized Post-Operative Care Protocols",
      "custom_tooltip": "<b>Create Standardized Post-Operative Care Protocols</b><br>Develop standardized post-operative care protocols for managing immunosuppression, monitoring for rejection, and providing psychological support to face transplant recipients.<br><b>Resources needed:</b><br><ul><li>Transplant nurses</li><li>Immunologists</li><li>Psychologists</li><li>Pharmacists</li><li>Post-operative care specialists</li></ul>",
      "start_date": "2029-07-06",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "38a84ba4-234b-4161-883f-f301d060cc1f FS",
      "parent": "7018d1da-7992-42c1-bec3-176474ec2378"
    },
    {
      "id": "83bd2c85-436e-45c2-b215-fe9917d4962c",
      "text": "Develop Training Evaluation and Certification",
      "custom_tooltip": "<b>Develop Training Evaluation and Certification</b><br>Establish a system for evaluating the effectiveness of the training program and certifying medical personnel who have successfully completed the training.<br><b>Resources needed:</b><br><ul><li>Medical educators</li><li>Assessment specialists</li><li>Certification board</li><li>Evaluation tools</li><li>Administrative support</li></ul>",
      "start_date": "2029-07-18",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "7018d1da-7992-42c1-bec3-176474ec2378 FF, f95038eb-bebf-48da-8c5e-f6e7071c4757 FS",
      "parent": "7018d1da-7992-42c1-bec3-176474ec2378"
    },
    {
      "id": "a3434b32-c11f-4b3e-b010-1e564ed21e55",
      "text": "Conduct Simulation Training Exercises",
      "custom_tooltip": "<b>Conduct Simulation Training Exercises</b>",
      "progress": 0,
      "open": true,
      "meta": "07f8df70-3b93-46d1-9571-5f7823a7865e FF, 7018d1da-7992-42c1-bec3-176474ec2378 FS",
      "parent": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "type": "project"
    },
    {
      "id": "1a3a2127-0354-4eca-9056-427371200c79",
      "text": "Develop Simulation Scenarios and Protocols",
      "custom_tooltip": "<b>Develop Simulation Scenarios and Protocols</b><br>Create realistic scenarios that mimic face transplantation procedures, including pre-operative planning, surgical techniques, and post-operative care. Develop detailed protocols for each scenario, outlining the roles and responsibilities of each team member.<br><b>Resources needed:</b><br><ul><li>Experienced transplant surgeons</li><li>Simulation specialists</li><li>Medical educators</li><li>Nurses</li><li>Technicians</li></ul>",
      "start_date": "2029-07-30",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "a3434b32-c11f-4b3e-b010-1e564ed21e55 SS",
      "parent": "a3434b32-c11f-4b3e-b010-1e564ed21e55"
    },
    {
      "id": "d21b27d7-b51a-41f9-a22a-2c7e89a6ed58",
      "text": "Acquire and Configure Simulation Equipment",
      "custom_tooltip": "<b>Acquire and Configure Simulation Equipment</b><br>Procure necessary simulation equipment, such as mannequins, surgical instruments, and software. Configure the equipment to accurately replicate the conditions of a real face transplantation procedure.<br><b>Resources needed:</b><br><ul><li>Procurement specialists</li><li>Biomedical engineers</li><li>IT technicians</li><li>Simulation technicians</li></ul>",
      "start_date": "2029-08-05",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "1a3a2127-0354-4eca-9056-427371200c79 FS",
      "parent": "a3434b32-c11f-4b3e-b010-1e564ed21e55"
    },
    {
      "id": "37f79344-021f-4563-b48d-d570bf04dbf9",
      "text": "Train Simulation Facilitators and Observers",
      "custom_tooltip": "<b>Train Simulation Facilitators and Observers</b><br>Train facilitators to guide the simulation exercises and observers to evaluate the performance of the medical personnel. Provide them with the necessary knowledge and skills to effectively conduct and assess the simulations.<br><b>Resources needed:</b><br><ul><li>Experienced simulation specialists</li><li>Medical educators</li><li>Assessment experts</li></ul>",
      "start_date": "2029-08-11",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "d21b27d7-b51a-41f9-a22a-2c7e89a6ed58 FS",
      "parent": "a3434b32-c11f-4b3e-b010-1e564ed21e55"
    },
    {
      "id": "f4577276-a266-4bc8-a82d-2141e7fbd99c",
      "text": "Conduct Simulation Exercises and Gather Data",
      "custom_tooltip": "<b>Conduct Simulation Exercises and Gather Data</b><br>Conduct the simulation exercises with the medical personnel, following the established protocols. Gather data on their performance, including surgical techniques, decision-making, communication, and teamwork.<br><b>Resources needed:</b><br><ul><li>Transplant surgeons</li><li>Nurses</li><li>Technicians</li><li>Simulation facilitators</li><li>Observers</li></ul>",
      "start_date": "2029-08-17",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "37f79344-021f-4563-b48d-d570bf04dbf9 FS",
      "parent": "a3434b32-c11f-4b3e-b010-1e564ed21e55"
    },
    {
      "id": "1036ce4c-4986-4b0c-9ca2-aaa3e71d7dc3",
      "text": "Analyze Simulation Data and Provide Feedback",
      "custom_tooltip": "<b>Analyze Simulation Data and Provide Feedback</b><br>Analyze the data gathered from the simulation exercises to identify areas for improvement. Provide constructive feedback to the medical personnel, highlighting their strengths and weaknesses.<br><b>Resources needed:</b><br><ul><li>Data analysts</li><li>Experienced transplant surgeons</li><li>Medical educators</li></ul>",
      "start_date": "2029-08-23",
      "duration": 6.0,
      "progress": 0,
      "open": true,
      "meta": "a3434b32-c11f-4b3e-b010-1e564ed21e55 FF, f4577276-a266-4bc8-a82d-2141e7fbd99c FS",
      "parent": "a3434b32-c11f-4b3e-b010-1e564ed21e55"
    },
    {
      "id": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "text": "Subscription Model Development & Marketing",
      "custom_tooltip": "<b>Subscription Model Development &amp; Marketing</b>",
      "progress": 0,
      "open": true,
      "meta": "07f8df70-3b93-46d1-9571-5f7823a7865e FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "ec842223-c669-493e-b08c-ecd6501b2647",
      "text": "Design Subscription Model Tiers and Pricing",
      "custom_tooltip": "<b>Design Subscription Model Tiers and Pricing</b>",
      "progress": 0,
      "open": true,
      "meta": "96817a78-23cf-4f51-b115-c0a63c20a419 SS",
      "parent": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "type": "project"
    },
    {
      "id": "b723be5f-9208-453e-af6b-e20e7c2b0935",
      "text": "Research competitor subscription models",
      "custom_tooltip": "<b>Research competitor subscription models</b><br>Analyze existing subscription models in related industries (e.g., cosmetic surgery, high-end fashion) to identify best practices and potential pitfalls.  Objective: Understand market trends and pricing strategies. Scope: Review competitor offerings, pricing structures, and customer feedback. Steps: Identify relevant competitors, gather data on their subscription models, analyze pricing and features, and document findings. Deliverables: Competitor analysis report.<br><b>Resources needed:</b><br><ul><li>Market research analyst</li><li>Financial analyst</li><li>Industry reports</li></ul>",
      "start_date": "2029-08-29",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "ec842223-c669-493e-b08c-ecd6501b2647 SS",
      "parent": "ec842223-c669-493e-b08c-ecd6501b2647"
    },
    {
      "id": "5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c",
      "text": "Define core service offerings",
      "custom_tooltip": "<b>Define core service offerings</b><br>Determine the specific services to be included in each subscription tier (e.g., number of face swaps per month, access to premium features). Objective: Define the value proposition for each tier. Scope: Identify potential service offerings, evaluate their cost and feasibility, and allocate them to different tiers. Steps: Brainstorm potential service offerings, assess their cost and feasibility, prioritize offerings based on customer demand, and allocate them to different tiers. Deliverables: Service offering matrix.<br><b>Resources needed:</b><br><ul><li>Product manager</li><li>Medical director</li><li>Marketing team</li></ul>",
      "start_date": "2029-09-02",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "b723be5f-9208-453e-af6b-e20e7c2b0935 FS",
      "parent": "ec842223-c669-493e-b08c-ecd6501b2647"
    },
    {
      "id": "2a86897a-4999-4dde-a5f1-d0dc8ed738f1",
      "text": "Develop pricing models and financial projections",
      "custom_tooltip": "<b>Develop pricing models and financial projections</b><br>Create detailed financial projections for each subscription tier, taking into account costs, revenue, and profitability. Objective: Ensure financial sustainability. Scope: Develop pricing models, forecast revenue, and project profitability. Steps: Estimate costs for each service offering, determine optimal pricing for each tier, forecast subscription uptake, and project revenue and profitability. Deliverables: Financial projections report.<br><b>Resources needed:</b><br><ul><li>Financial analyst</li><li>Accountant</li><li>Business development manager</li></ul>",
      "start_date": "2029-09-06",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c FS",
      "parent": "ec842223-c669-493e-b08c-ecd6501b2647"
    },
    {
      "id": "fd0ea2d9-788d-4e1c-b312-1fadfb8de5f2",
      "text": "Assess legal and ethical considerations",
      "custom_tooltip": "<b>Assess legal and ethical considerations</b><br>Consult with legal and ethical experts to ensure that the subscription model complies with all applicable laws and regulations and addresses potential ethical concerns. Objective: Mitigate legal and ethical risks. Scope: Review legal and ethical implications of the subscription model. Steps: Consult with legal counsel, consult with ethicists, identify potential legal and ethical risks, and develop mitigation strategies. Deliverables: Legal and ethical risk assessment report.<br><b>Resources needed:</b><br><ul><li>Legal counsel</li><li>Ethicist</li><li>Compliance officer</li></ul>",
      "start_date": "2029-09-10",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "ec842223-c669-493e-b08c-ecd6501b2647 FF, 2a86897a-4999-4dde-a5f1-d0dc8ed738f1 FS",
      "parent": "ec842223-c669-493e-b08c-ecd6501b2647"
    },
    {
      "id": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b",
      "text": "Develop Marketing and Advertising Strategy",
      "custom_tooltip": "<b>Develop Marketing and Advertising Strategy</b>",
      "progress": 0,
      "open": true,
      "meta": "ec842223-c669-493e-b08c-ecd6501b2647 FS",
      "parent": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "type": "project"
    },
    {
      "id": "3e63ebd3-2fe0-4e58-b1f0-4e8b4d98e90d",
      "text": "Define Target Audience and Market Segments",
      "custom_tooltip": "<b>Define Target Audience and Market Segments</b><br>Identify specific demographics, psychographics, and needs of potential subscribers. Segment the market based on factors such as age, income, lifestyle, and interest in face transplantation.<br><b>Resources needed:</b><br><ul><li>Market research analyst</li><li>Marketing manager</li></ul>",
      "start_date": "2029-09-14",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b SS",
      "parent": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b"
    },
    {
      "id": "ba2348a4-afa6-475e-9a0e-8bca32eb17b4",
      "text": "Develop Key Messaging and Value Proposition",
      "custom_tooltip": "<b>Develop Key Messaging and Value Proposition</b><br>Craft compelling messaging that highlights the benefits of the subscription service and addresses potential ethical concerns. Define the unique value proposition for each target market segment.<br><b>Resources needed:</b><br><ul><li>Copywriter</li><li>Marketing strategist</li><li>Ethicist</li></ul>",
      "start_date": "2029-09-26",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "3e63ebd3-2fe0-4e58-b1f0-4e8b4d98e90d FS",
      "parent": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b"
    },
    {
      "id": "edb1c4da-05e4-4c54-a328-dbe7c6828042",
      "text": "Select Marketing Channels and Platforms",
      "custom_tooltip": "<b>Select Marketing Channels and Platforms</b><br>Determine the most effective channels for reaching the target audience, such as online advertising, social media, public relations, and partnerships with relevant organizations. Evaluate the suitability of different platforms for delivering the marketing message.<br><b>Resources needed:</b><br><ul><li>Marketing manager</li><li>Digital marketing specialist</li></ul>",
      "start_date": "2029-10-08",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "ba2348a4-afa6-475e-9a0e-8bca32eb17b4 FS",
      "parent": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b"
    },
    {
      "id": "702c7a45-d903-47be-b61d-960415c32bdf",
      "text": "Create Marketing Materials and Content",
      "custom_tooltip": "<b>Create Marketing Materials and Content</b><br>Develop engaging marketing materials, including website content, brochures, videos, and social media posts. Ensure that all materials are consistent with the key messaging and value proposition.<br><b>Resources needed:</b><br><ul><li>Graphic designer</li><li>Video editor</li><li>Content writer</li></ul>",
      "start_date": "2029-10-20",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "edb1c4da-05e4-4c54-a328-dbe7c6828042 FS",
      "parent": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b"
    },
    {
      "id": "fccdd8e1-1a49-4b15-9724-d488b31c7026",
      "text": "Establish Public Relations and Media Outreach",
      "custom_tooltip": "<b>Establish Public Relations and Media Outreach</b><br>Develop a public relations strategy to generate positive media coverage and build awareness of the subscription service. Engage with journalists, bloggers, and influencers to promote the service and address potential ethical concerns.<br><b>Resources needed:</b><br><ul><li>Public relations specialist</li><li>Media relations manager</li></ul>",
      "start_date": "2029-11-01",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b FF, 702c7a45-d903-47be-b61d-960415c32bdf FS",
      "parent": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b"
    },
    {
      "id": "bcbecda8-592b-4c76-911b-8fdbf3848488",
      "text": "Establish Customer Service and Support Protocols",
      "custom_tooltip": "<b>Establish Customer Service and Support Protocols</b>",
      "progress": 0,
      "open": true,
      "meta": "96817a78-23cf-4f51-b115-c0a63c20a419 FF, 7f9f308e-365f-46e0-ad45-31a9dc51fa8b FS",
      "parent": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "type": "project"
    },
    {
      "id": "307fc299-ac88-4477-9b8c-b59b39705cb5",
      "text": "Develop Customer Service Training Materials",
      "custom_tooltip": "<b>Develop Customer Service Training Materials</b><br>Create comprehensive training materials covering product knowledge, customer interaction skills, and problem-solving techniques.<br><b>Resources needed:</b><br><ul><li>Training Specialist</li><li>Subject Matter Experts</li><li>Instructional Designer</li></ul>",
      "start_date": "2029-11-13",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "bcbecda8-592b-4c76-911b-8fdbf3848488 SS",
      "parent": "bcbecda8-592b-4c76-911b-8fdbf3848488"
    },
    {
      "id": "fb381bef-9642-442b-a7bd-f9813836b69f",
      "text": "Establish Customer Service Channels",
      "custom_tooltip": "<b>Establish Customer Service Channels</b><br>Set up communication channels such as phone, email, and online chat to handle customer inquiries and support requests.<br><b>Resources needed:</b><br><ul><li>IT Support</li><li>Telecommunications Specialist</li><li>Customer Service Manager</li></ul>",
      "start_date": "2029-11-21",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "307fc299-ac88-4477-9b8c-b59b39705cb5 FS",
      "parent": "bcbecda8-592b-4c76-911b-8fdbf3848488"
    },
    {
      "id": "d5bc63d8-55c9-4f01-bc6f-a2a34337745d",
      "text": "Define Service Level Agreements (SLAs)",
      "custom_tooltip": "<b>Define Service Level Agreements (SLAs)</b><br>Establish clear SLAs for response times, resolution times, and customer satisfaction targets.<br><b>Resources needed:</b><br><ul><li>Customer Service Manager</li><li>Operations Manager</li><li>Legal Counsel</li></ul>",
      "start_date": "2029-11-29",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "fb381bef-9642-442b-a7bd-f9813836b69f FS",
      "parent": "bcbecda8-592b-4c76-911b-8fdbf3848488"
    },
    {
      "id": "80f6dc05-65c9-43a1-81c5-d1a95d8ac6ce",
      "text": "Implement CRM System for Customer Data",
      "custom_tooltip": "<b>Implement CRM System for Customer Data</b><br>Configure a CRM system to manage customer data, track interactions, and personalize support.<br><b>Resources needed:</b><br><ul><li>CRM Specialist</li><li>IT Support</li><li>Data Analyst</li></ul>",
      "start_date": "2029-12-07",
      "duration": 8.0,
      "progress": 0,
      "open": true,
      "meta": "bcbecda8-592b-4c76-911b-8fdbf3848488 FF, d5bc63d8-55c9-4f01-bc6f-a2a34337745d FS",
      "parent": "bcbecda8-592b-4c76-911b-8fdbf3848488"
    },
    {
      "id": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "text": "Surgical Procedures & Patient Care",
      "custom_tooltip": "<b>Surgical Procedures &amp; Patient Care</b>",
      "progress": 0,
      "open": true,
      "meta": "96817a78-23cf-4f51-b115-c0a63c20a419 FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "ce5e2e90-d960-4aa6-9268-cf34537813aa",
      "text": "Develop Pre-Transplant Assessment Protocols",
      "custom_tooltip": "<b>Develop Pre-Transplant Assessment Protocols</b>",
      "progress": 0,
      "open": true,
      "meta": "881ece3f-9348-4d69-93f2-2803c75dd85c SS",
      "parent": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "type": "project"
    },
    {
      "id": "59642d8b-cfa6-4f76-8a05-a624ca6c29a1",
      "text": "Gather Patient Medical History and Records",
      "custom_tooltip": "<b>Gather Patient Medical History and Records</b><br>Collect comprehensive medical history, including past illnesses, surgeries, medications, allergies, and family history. Obtain relevant medical records from previous healthcare providers.<br><b>Resources needed:</b><br><ul><li>Medical Records Specialist</li><li>Patient Liaison</li><li>Electronic Health Record System</li></ul>",
      "start_date": "2029-12-15",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "ce5e2e90-d960-4aa6-9268-cf34537813aa SS",
      "parent": "ce5e2e90-d960-4aa6-9268-cf34537813aa"
    },
    {
      "id": "0740ebfc-401c-4ae2-9111-2e108ed92750",
      "text": "Conduct Physical and Neurological Examination",
      "custom_tooltip": "<b>Conduct Physical and Neurological Examination</b><br>Perform a thorough physical examination to assess the patient&#x27;s overall health status. Conduct a detailed neurological examination to evaluate nerve function and sensory perception.<br><b>Resources needed:</b><br><ul><li>Transplant Surgeon</li><li>Neurologist</li><li>Examination Room</li><li>Diagnostic Equipment</li></ul>",
      "start_date": "2029-12-17",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "59642d8b-cfa6-4f76-8a05-a624ca6c29a1 FS",
      "parent": "ce5e2e90-d960-4aa6-9268-cf34537813aa"
    },
    {
      "id": "fa4f0b8a-fe8c-44f4-a0d3-114016cc67e4",
      "text": "Psychological Evaluation and Counseling",
      "custom_tooltip": "<b>Psychological Evaluation and Counseling</b><br>Assess the patient&#x27;s psychological readiness for face transplantation. Provide counseling to address potential emotional and psychological challenges associated with the procedure.<br><b>Resources needed:</b><br><ul><li>Psychologist</li><li>Psychiatrist</li><li>Counseling Room</li><li>Psychological Assessment Tools</li></ul>",
      "start_date": "2029-12-19",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "0740ebfc-401c-4ae2-9111-2e108ed92750 FS",
      "parent": "ce5e2e90-d960-4aa6-9268-cf34537813aa"
    },
    {
      "id": "5c2a916d-27d6-4cc2-8c2b-525402e8431d",
      "text": "Immunological Compatibility Testing",
      "custom_tooltip": "<b>Immunological Compatibility Testing</b><br>Perform comprehensive immunological testing to determine the patient&#x27;s compatibility with potential donor faces. Assess the risk of rejection and identify appropriate immunosuppression strategies.<br><b>Resources needed:</b><br><ul><li>Immunologist</li><li>Laboratory Technician</li><li>Laboratory Equipment</li><li>Reagents</li></ul>",
      "start_date": "2029-12-21",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "fa4f0b8a-fe8c-44f4-a0d3-114016cc67e4 FS",
      "parent": "ce5e2e90-d960-4aa6-9268-cf34537813aa"
    },
    {
      "id": "c954c1d8-3b97-4648-9c90-a48d923e6577",
      "text": "Financial and Insurance Assessment",
      "custom_tooltip": "<b>Financial and Insurance Assessment</b><br>Evaluate the patient&#x27;s financial resources and insurance coverage to determine their ability to afford the procedure and associated costs. Provide assistance with navigating insurance claims and financial aid options.<br><b>Resources needed:</b><br><ul><li>Financial Counselor</li><li>Insurance Specialist</li><li>Billing Department</li><li>Financial Aid Resources</li></ul>",
      "start_date": "2029-12-23",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "ce5e2e90-d960-4aa6-9268-cf34537813aa FF, 5c2a916d-27d6-4cc2-8c2b-525402e8431d FS",
      "parent": "ce5e2e90-d960-4aa6-9268-cf34537813aa"
    },
    {
      "id": "b239ca08-0717-4219-b325-beaacb14e951",
      "text": "Conduct Face Transplantation Procedures",
      "custom_tooltip": "<b>Conduct Face Transplantation Procedures</b>",
      "progress": 0,
      "open": true,
      "meta": "ce5e2e90-d960-4aa6-9268-cf34537813aa FS",
      "parent": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "type": "project"
    },
    {
      "id": "4b5491cf-aa89-40b1-87c3-04da0c26bf55",
      "text": "Pre-operative planning and simulations",
      "custom_tooltip": "<b>Pre-operative planning and simulations</b><br>Thorough planning and simulations to anticipate potential challenges and optimize surgical approach.<br><b>Resources needed:</b><br><ul><li>Surgeons</li><li>Anesthesiologists</li><li>Simulation equipment</li><li>Imaging data</li></ul>",
      "start_date": "2029-12-25",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "b239ca08-0717-4219-b325-beaacb14e951 SS",
      "parent": "b239ca08-0717-4219-b325-beaacb14e951"
    },
    {
      "id": "c8ec5412-99e1-45dc-b7e7-7f5a6aee9579",
      "text": "Ensure backup equipment and supplies",
      "custom_tooltip": "<b>Ensure backup equipment and supplies</b><br>Verify availability of backup surgical instruments, medical supplies, and emergency equipment.<br><b>Resources needed:</b><br><ul><li>Operating room staff</li><li>Supply chain manager</li><li>Biomedical engineers</li></ul>",
      "start_date": "2029-12-29",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "4b5491cf-aa89-40b1-87c3-04da0c26bf55 FS",
      "parent": "b239ca08-0717-4219-b325-beaacb14e951"
    },
    {
      "id": "5ea620b1-5c65-43f9-9a73-1c1881b561b1",
      "text": "Experienced surgical team presence",
      "custom_tooltip": "<b>Experienced surgical team presence</b><br>Confirm the presence of experienced surgeons, nurses, and technicians during the procedure.<br><b>Resources needed:</b><br><ul><li>Surgeons</li><li>Nurses</li><li>Technicians</li><li>Anesthesiologists</li></ul>",
      "start_date": "2030-01-02",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "c8ec5412-99e1-45dc-b7e7-7f5a6aee9579 FS",
      "parent": "b239ca08-0717-4219-b325-beaacb14e951"
    },
    {
      "id": "a9703b20-d188-4b03-9664-7ff66bde33e2",
      "text": "Implement strict infection control protocols",
      "custom_tooltip": "<b>Implement strict infection control protocols</b><br>Adhere to rigorous infection control measures to minimize the risk of post-operative infections.<br><b>Resources needed:</b><br><ul><li>Infection control specialists</li><li>Operating room staff</li><li>Sterilization equipment</li></ul>",
      "start_date": "2030-01-06",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "5ea620b1-5c65-43f9-9a73-1c1881b561b1 FS",
      "parent": "b239ca08-0717-4219-b325-beaacb14e951"
    },
    {
      "id": "20502188-d36c-45dd-9bf2-a8bc6ed0048e",
      "text": "Develop contingency plans for complications",
      "custom_tooltip": "<b>Develop contingency plans for complications</b><br>Establish protocols for managing potential surgical complications, such as bleeding or nerve damage.<br><b>Resources needed:</b><br><ul><li>Surgeons</li><li>Anesthesiologists</li><li>Critical care specialists</li></ul>",
      "start_date": "2030-01-10",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "b239ca08-0717-4219-b325-beaacb14e951 FF, a9703b20-d188-4b03-9664-7ff66bde33e2 FS",
      "parent": "b239ca08-0717-4219-b325-beaacb14e951"
    },
    {
      "id": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6",
      "text": "Implement Post-Transplant Care and Monitoring Protocols",
      "custom_tooltip": "<b>Implement Post-Transplant Care and Monitoring Protocols</b>",
      "progress": 0,
      "open": true,
      "meta": "b239ca08-0717-4219-b325-beaacb14e951 FS",
      "parent": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "type": "project"
    },
    {
      "id": "f610d7ac-9e6d-459c-8f77-d4c384a4cc73",
      "text": "Monitor for rejection signs and symptoms",
      "custom_tooltip": "<b>Monitor for rejection signs and symptoms</b><br>Closely observe the patient for any signs of acute or chronic rejection, such as skin changes, swelling, or decreased blood flow to the transplanted face. Regularly assess immune function through blood tests and biopsies.<br><b>Resources needed:</b><br><ul><li>Transplant surgeon</li><li>Nurses</li><li>Pathologist</li><li>Immunologist</li></ul>",
      "start_date": "2030-01-14",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6 SS",
      "parent": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6"
    },
    {
      "id": "3f756606-3068-4ede-87bb-f4ef7811519f",
      "text": "Manage immunosuppression medication regimen",
      "custom_tooltip": "<b>Manage immunosuppression medication regimen</b><br>Administer immunosuppressant medications as prescribed to prevent rejection. Monitor drug levels and adjust dosages as needed to maintain therapeutic levels while minimizing side effects. Educate the patient on the importance of medication adherence and potential side effects.<br><b>Resources needed:</b><br><ul><li>Pharmacist</li><li>Nurses</li><li>Transplant physician</li></ul>",
      "start_date": "2030-01-26",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "f610d7ac-9e6d-459c-8f77-d4c384a4cc73 FS",
      "parent": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6"
    },
    {
      "id": "27d8c508-3cb0-449e-8744-26bde56fb0cc",
      "text": "Provide wound care and infection control",
      "custom_tooltip": "<b>Provide wound care and infection control</b><br>Ensure proper wound healing by providing meticulous wound care, including regular cleaning and dressing changes. Monitor for signs of infection and administer antibiotics as needed. Implement strict infection control protocols to prevent hospital-acquired infections.<br><b>Resources needed:</b><br><ul><li>Nurses</li><li>Infection control specialist</li><li>Surgeons</li></ul>",
      "start_date": "2030-02-07",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "3f756606-3068-4ede-87bb-f4ef7811519f FS",
      "parent": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6"
    },
    {
      "id": "d1789094-0d0f-4e26-b283-84c4ae73fe45",
      "text": "Offer physical and occupational therapy",
      "custom_tooltip": "<b>Offer physical and occupational therapy</b><br>Provide physical and occupational therapy to help the patient regain motor function and sensation in the transplanted face. Develop a customized rehabilitation plan to address specific needs and goals. Monitor progress and adjust therapy as needed.<br><b>Resources needed:</b><br><ul><li>Physical therapist</li><li>Occupational therapist</li></ul>",
      "start_date": "2030-02-19",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "27d8c508-3cb0-449e-8744-26bde56fb0cc FS",
      "parent": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6"
    },
    {
      "id": "53128582-e4e8-49c1-821c-89b833908400",
      "text": "Address psychological and emotional needs",
      "custom_tooltip": "<b>Address psychological and emotional needs</b><br>Provide ongoing psychological support and counseling to help the patient cope with the emotional challenges of face transplantation. Address issues such as body image, identity, and social adjustment. Offer support groups and peer mentoring opportunities.<br><b>Resources needed:</b><br><ul><li>Psychologist</li><li>Psychiatrist</li><li>Social worker</li><li>Support group facilitator</li></ul>",
      "start_date": "2030-03-03",
      "duration": 12.0,
      "progress": 0,
      "open": true,
      "meta": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6 FF, d1789094-0d0f-4e26-b283-84c4ae73fe45 FS",
      "parent": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6"
    },
    {
      "id": "742e9056-0c0f-4c78-bec1-00825bc6dfa1",
      "text": "Establish Psychological Support Program",
      "custom_tooltip": "<b>Establish Psychological Support Program</b>",
      "progress": 0,
      "open": true,
      "meta": "881ece3f-9348-4d69-93f2-2803c75dd85c FF, c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6 FS",
      "parent": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "type": "project"
    },
    {
      "id": "9bfd6658-f8e9-43bd-baa4-6a626dcf1ab0",
      "text": "Recruit qualified therapists and counselors",
      "custom_tooltip": "<b>Recruit qualified therapists and counselors</b><br>Identify and recruit experienced therapists and counselors specializing in transplantation and identity issues.<br><b>Resources needed:</b><br><ul><li>HR department</li><li>Psychiatrists</li><li>Psychologists</li></ul>",
      "start_date": "2030-03-15",
      "duration": 18.0,
      "progress": 0,
      "open": true,
      "meta": "742e9056-0c0f-4c78-bec1-00825bc6dfa1 SS",
      "parent": "742e9056-0c0f-4c78-bec1-00825bc6dfa1"
    },
    {
      "id": "71b12a59-061d-4e45-89a0-51509d3a9ad5",
      "text": "Develop counseling protocols and materials",
      "custom_tooltip": "<b>Develop counseling protocols and materials</b><br>Create standardized counseling protocols and educational materials for recipients and donor families.<br><b>Resources needed:</b><br><ul><li>Psychologists</li><li>Medical ethicists</li><li>Patient support groups</li></ul>",
      "start_date": "2030-04-02",
      "duration": 18.0,
      "progress": 0,
      "open": true,
      "meta": "9bfd6658-f8e9-43bd-baa4-6a626dcf1ab0 FS",
      "parent": "742e9056-0c0f-4c78-bec1-00825bc6dfa1"
    },
    {
      "id": "70e0a488-b358-4e8e-9056-592d8de91ff3",
      "text": "Establish support group infrastructure",
      "custom_tooltip": "<b>Establish support group infrastructure</b><br>Create a physical or virtual space for support groups to meet and share experiences.<br><b>Resources needed:</b><br><ul><li>Facility manager</li><li>IT support</li><li>Support group facilitators</li></ul>",
      "start_date": "2030-04-20",
      "duration": 18.0,
      "progress": 0,
      "open": true,
      "meta": "71b12a59-061d-4e45-89a0-51509d3a9ad5 FS",
      "parent": "742e9056-0c0f-4c78-bec1-00825bc6dfa1"
    },
    {
      "id": "4f4f3167-98ea-47ee-9e04-c332daa74fec",
      "text": "Implement patient referral system",
      "custom_tooltip": "<b>Implement patient referral system</b><br>Develop a system for referring patients to the psychological support program.<br><b>Resources needed:</b><br><ul><li>Medical staff</li><li>Patient liaison</li><li>Psychologists</li></ul>",
      "start_date": "2030-05-08",
      "duration": 18.0,
      "progress": 0,
      "open": true,
      "meta": "70e0a488-b358-4e8e-9056-592d8de91ff3 FS",
      "parent": "742e9056-0c0f-4c78-bec1-00825bc6dfa1"
    },
    {
      "id": "e54814fc-de88-4e29-bfc0-aa7ee072f345",
      "text": "Monitor and evaluate program effectiveness",
      "custom_tooltip": "<b>Monitor and evaluate program effectiveness</b><br>Track patient outcomes and satisfaction to assess the effectiveness of the psychological support program.<br><b>Resources needed:</b><br><ul><li>Data analysts</li><li>Psychologists</li><li>Patient feedback surveys</li></ul>",
      "start_date": "2030-05-26",
      "duration": 18.0,
      "progress": 0,
      "open": true,
      "meta": "742e9056-0c0f-4c78-bec1-00825bc6dfa1 FF, 4f4f3167-98ea-47ee-9e04-c332daa74fec FS",
      "parent": "742e9056-0c0f-4c78-bec1-00825bc6dfa1"
    },
    {
      "id": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "text": "Ongoing Operations & Maintenance",
      "custom_tooltip": "<b>Ongoing Operations &amp; Maintenance</b>",
      "progress": 0,
      "open": true,
      "meta": "60c6b7a8-2145-4e79-a407-31d257bd7417 FF, 881ece3f-9348-4d69-93f2-2803c75dd85c FS",
      "parent": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "type": "project"
    },
    {
      "id": "036d3f1f-d298-4895-bd33-6009f5bf182f",
      "text": "Manage Facility Operations and Maintenance",
      "custom_tooltip": "<b>Manage Facility Operations and Maintenance</b>",
      "progress": 0,
      "open": true,
      "meta": "991ae3aa-a394-4134-a5a8-540b61b454b5 SS",
      "parent": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "type": "project"
    },
    {
      "id": "99b05c9b-3da6-4549-ba9e-6f683164e368",
      "text": "Schedule routine equipment maintenance",
      "custom_tooltip": "<b>Schedule routine equipment maintenance</b><br>Establish a schedule for routine maintenance of all medical and facility equipment to prevent unexpected failures and ensure optimal performance. This includes scheduling inspections, repairs, and replacements as needed.<br><b>Resources needed:</b><br><ul><li>Maintenance technicians</li><li>Equipment manuals</li><li>Maintenance schedule software</li></ul>",
      "start_date": "2030-06-13",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "036d3f1f-d298-4895-bd33-6009f5bf182f SS",
      "parent": "036d3f1f-d298-4895-bd33-6009f5bf182f"
    },
    {
      "id": "24a1355a-be32-4f64-b6d7-d13216f50e26",
      "text": "Manage medical supply inventory",
      "custom_tooltip": "<b>Manage medical supply inventory</b><br>Maintain an adequate inventory of medical supplies, including surgical instruments, medications, and consumables, to ensure uninterrupted operations. This involves tracking inventory levels, placing orders, and managing storage.<br><b>Resources needed:</b><br><ul><li>Inventory management software</li><li>Supply chain manager</li><li>Storage space</li></ul>",
      "start_date": "2030-06-14",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "99b05c9b-3da6-4549-ba9e-6f683164e368 FS",
      "parent": "036d3f1f-d298-4895-bd33-6009f5bf182f"
    },
    {
      "id": "4ff300b0-b124-407b-b161-051804def801",
      "text": "Address facility maintenance requests",
      "custom_tooltip": "<b>Address facility maintenance requests</b><br>Respond to and resolve facility maintenance requests promptly and efficiently to maintain a safe and comfortable environment for patients and staff. This includes addressing issues such as plumbing problems, electrical repairs, and HVAC malfunctions.<br><b>Resources needed:</b><br><ul><li>Maintenance staff</li><li>Repair tools</li><li>Facility management system</li></ul>",
      "start_date": "2030-06-15",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "24a1355a-be32-4f64-b6d7-d13216f50e26 FS",
      "parent": "036d3f1f-d298-4895-bd33-6009f5bf182f"
    },
    {
      "id": "cf21067b-023f-478e-9348-fceb3b17fd69",
      "text": "Ensure compliance with safety regulations",
      "custom_tooltip": "<b>Ensure compliance with safety regulations</b><br>Ensure that the facility complies with all relevant safety regulations and standards to protect patients, staff, and visitors. This includes conducting regular safety inspections, implementing safety protocols, and providing safety training.<br><b>Resources needed:</b><br><ul><li>Safety officer</li><li>Safety checklists</li><li>Regulatory guidelines</li></ul>",
      "start_date": "2030-06-16",
      "duration": 1.0,
      "progress": 0,
      "open": true,
      "meta": "036d3f1f-d298-4895-bd33-6009f5bf182f FF, 4ff300b0-b124-407b-b161-051804def801 FS",
      "parent": "036d3f1f-d298-4895-bd33-6009f5bf182f"
    },
    {
      "id": "9ad0a546-40bb-4563-adc1-099850a36f92",
      "text": "Monitor and Evaluate Subscription Service Performance",
      "custom_tooltip": "<b>Monitor and Evaluate Subscription Service Performance</b>",
      "progress": 0,
      "open": true,
      "meta": "036d3f1f-d298-4895-bd33-6009f5bf182f FS",
      "parent": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "type": "project"
    },
    {
      "id": "4a247e67-a282-43d8-80c1-e1b23ec05ca9",
      "text": "Implement Data Collection Methods",
      "custom_tooltip": "<b>Implement Data Collection Methods</b><br>Develop and establish robust methods for collecting data on subscription service performance, ensuring accuracy and reliability of metrics.<br><b>Resources needed:</b><br><ul><li>Data analyst</li><li>CRM system</li><li>Survey tools</li></ul>",
      "start_date": "2030-06-17",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "9ad0a546-40bb-4563-adc1-099850a36f92 SS",
      "parent": "9ad0a546-40bb-4563-adc1-099850a36f92"
    },
    {
      "id": "c7f4ebe1-e39a-480b-a27c-2e54e214df2f",
      "text": "Analyze Subscription Metrics",
      "custom_tooltip": "<b>Analyze Subscription Metrics</b><br>Regularly analyze collected data to evaluate key performance indicators (KPIs) related to subscription uptake, user engagement, and retention rates.<br><b>Resources needed:</b><br><ul><li>Data analyst</li><li>Reporting software</li><li>Market research tools</li></ul>",
      "start_date": "2030-06-19",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "4a247e67-a282-43d8-80c1-e1b23ec05ca9 FS",
      "parent": "9ad0a546-40bb-4563-adc1-099850a36f92"
    },
    {
      "id": "d1ac5d53-91d3-4dee-848f-2cf200244eca",
      "text": "Conduct User Feedback Surveys",
      "custom_tooltip": "<b>Conduct User Feedback Surveys</b><br>Design and distribute surveys to current subscribers to gather feedback on their experiences and suggestions for improvement.<br><b>Resources needed:</b><br><ul><li>Survey platform</li><li>Marketing team</li><li>Data analyst</li></ul>",
      "start_date": "2030-06-21",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "c7f4ebe1-e39a-480b-a27c-2e54e214df2f FS",
      "parent": "9ad0a546-40bb-4563-adc1-099850a36f92"
    },
    {
      "id": "73068e2d-0133-48b5-9059-f8cf9838a9cc",
      "text": "Adjust Marketing Strategies",
      "custom_tooltip": "<b>Adjust Marketing Strategies</b><br>Based on performance analysis and user feedback, refine marketing strategies to enhance subscription service appeal and reach.<br><b>Resources needed:</b><br><ul><li>Marketing team</li><li>Advertising budget</li><li>Market research data</li></ul>",
      "start_date": "2030-06-23",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "d1ac5d53-91d3-4dee-848f-2cf200244eca FS",
      "parent": "9ad0a546-40bb-4563-adc1-099850a36f92"
    },
    {
      "id": "e5dd9714-c2a0-42ce-90b3-3a5e6b7521ab",
      "text": "Report Performance Findings",
      "custom_tooltip": "<b>Report Performance Findings</b><br>Compile and present findings on subscription service performance to stakeholders, highlighting successes and areas for improvement.<br><b>Resources needed:</b><br><ul><li>Data analyst</li><li>Presentation software</li><li>Stakeholder engagement team</li></ul>",
      "start_date": "2030-06-25",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "9ad0a546-40bb-4563-adc1-099850a36f92 FF, 73068e2d-0133-48b5-9059-f8cf9838a9cc FS",
      "parent": "9ad0a546-40bb-4563-adc1-099850a36f92"
    },
    {
      "id": "fefe05de-7920-4c46-aad2-22acfc31ad4e",
      "text": "Conduct Ongoing Regulatory Compliance Audits",
      "custom_tooltip": "<b>Conduct Ongoing Regulatory Compliance Audits</b>",
      "progress": 0,
      "open": true,
      "meta": "9ad0a546-40bb-4563-adc1-099850a36f92 FS",
      "parent": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "type": "project"
    },
    {
      "id": "e066ece9-f4fc-44da-ac21-c7b4e1227405",
      "text": "Identify applicable regulatory compliance standards",
      "custom_tooltip": "<b>Identify applicable regulatory compliance standards</b><br>Determine the specific regulatory compliance standards relevant to the face transplantation facility and subscription service, including data privacy, patient safety, and ethical guidelines.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Legal Counsel</li></ul>",
      "start_date": "2030-06-27",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "fefe05de-7920-4c46-aad2-22acfc31ad4e SS",
      "parent": "fefe05de-7920-4c46-aad2-22acfc31ad4e"
    },
    {
      "id": "bf6ab506-27ef-49cc-8f69-9cab73f21113",
      "text": "Schedule internal compliance audits",
      "custom_tooltip": "<b>Schedule internal compliance audits</b><br>Establish a schedule for conducting internal compliance audits to assess adherence to regulatory standards and identify areas for improvement.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Compliance Auditor</li></ul>",
      "start_date": "2030-06-29",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "e066ece9-f4fc-44da-ac21-c7b4e1227405 FS",
      "parent": "fefe05de-7920-4c46-aad2-22acfc31ad4e"
    },
    {
      "id": "0030f8d5-5257-4b6e-9246-9bce57ff7458",
      "text": "Prepare audit documentation and checklists",
      "custom_tooltip": "<b>Prepare audit documentation and checklists</b><br>Develop comprehensive audit documentation and checklists to ensure thorough and consistent evaluation of compliance with regulatory requirements.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Compliance Auditor</li></ul>",
      "start_date": "2030-07-01",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "bf6ab506-27ef-49cc-8f69-9cab73f21113 FS",
      "parent": "fefe05de-7920-4c46-aad2-22acfc31ad4e"
    },
    {
      "id": "53859978-b189-4292-bdd2-ee08e3816a82",
      "text": "Conduct external regulatory compliance audits",
      "custom_tooltip": "<b>Conduct external regulatory compliance audits</b><br>Engage external auditors to conduct independent assessments of compliance with regulatory standards and identify potential gaps or areas of non-compliance.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>External Auditors</li></ul>",
      "start_date": "2030-07-03",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "0030f8d5-5257-4b6e-9246-9bce57ff7458 FS",
      "parent": "fefe05de-7920-4c46-aad2-22acfc31ad4e"
    },
    {
      "id": "23e9b77b-b49f-4b95-862e-bbc0950caa82",
      "text": "Address audit findings and implement corrective actions",
      "custom_tooltip": "<b>Address audit findings and implement corrective actions</b><br>Develop and implement corrective action plans to address any findings from internal or external audits and ensure ongoing compliance with regulatory requirements.<br><b>Resources needed:</b><br><ul><li>Regulatory Liaison &amp; Compliance Officer</li><li>Department Heads</li></ul>",
      "start_date": "2030-07-05",
      "duration": 2.0,
      "progress": 0,
      "open": true,
      "meta": "fefe05de-7920-4c46-aad2-22acfc31ad4e FF, 53859978-b189-4292-bdd2-ee08e3816a82 FS",
      "parent": "fefe05de-7920-4c46-aad2-22acfc31ad4e"
    },
    {
      "id": "ae90a39b-29b6-460d-a270-7d8989677943",
      "text": "Continuously Improve Processes and Technologies",
      "custom_tooltip": "<b>Continuously Improve Processes and Technologies</b>",
      "progress": 0,
      "open": true,
      "meta": "991ae3aa-a394-4134-a5a8-540b61b454b5 FF, fefe05de-7920-4c46-aad2-22acfc31ad4e FS",
      "parent": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "type": "project"
    },
    {
      "id": "15d712d2-0f26-4294-97cd-66a0d12f7b66",
      "text": "Identify areas for process improvement",
      "custom_tooltip": "<b>Identify areas for process improvement</b><br>Objective: Pinpoint specific processes within the facility that can be optimized for efficiency, cost-effectiveness, or patient outcomes.\nScope: Review existing workflows, gather feedback from staff, and analyze performance data to identify areas for improvement.\nSteps: Conduct staff surveys, analyze operational data, hold brainstorming sessions, and document findings.\nDeliverables: A report outlining identified areas for process improvement with specific recommendations.<br><b>Resources needed:</b><br><ul><li>Process Improvement Specialist</li><li>Data Analyst</li><li>Medical Staff</li><li>Project Manager</li></ul>",
      "start_date": "2030-07-07",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "ae90a39b-29b6-460d-a270-7d8989677943 SS",
      "parent": "ae90a39b-29b6-460d-a270-7d8989677943"
    },
    {
      "id": "c93808d4-549d-424b-be34-27ebc96f2ab4",
      "text": "Evaluate emerging medical technologies",
      "custom_tooltip": "<b>Evaluate emerging medical technologies</b><br>Objective: Assess the potential of new medical technologies to enhance face transplantation procedures and patient care.\nScope: Research and evaluate emerging technologies such as advanced imaging techniques, robotic surgery, and regenerative medicine.\nSteps: Conduct literature reviews, attend industry conferences, consult with technology vendors, and evaluate potential benefits and risks.\nDeliverables: A report summarizing the evaluation of emerging medical technologies with recommendations for potential adoption.<br><b>Resources needed:</b><br><ul><li>Medical Technology Researcher</li><li>Transplant Surgeon</li><li>Biomedical Engineer</li><li>Research Budget</li></ul>",
      "start_date": "2030-07-11",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "15d712d2-0f26-4294-97cd-66a0d12f7b66 FS",
      "parent": "ae90a39b-29b6-460d-a270-7d8989677943"
    },
    {
      "id": "d6127fca-e8dc-4737-8977-db75c7f8a284",
      "text": "Pilot test new processes and technologies",
      "custom_tooltip": "<b>Pilot test new processes and technologies</b><br>Objective: Implement pilot programs to test the feasibility and effectiveness of new processes and technologies in a controlled environment.\nScope: Select specific areas for pilot testing, develop testing protocols, and monitor results.\nSteps: Develop pilot program plans, train staff, implement new processes or technologies, collect data, and analyze results.\nDeliverables: Pilot program reports with recommendations for full-scale implementation or modifications.<br><b>Resources needed:</b><br><ul><li>Medical Staff</li><li>IT Support</li><li>Project Manager</li><li>Training Materials</li><li>Pilot Test Budget</li></ul>",
      "start_date": "2030-07-15",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "c93808d4-549d-424b-be34-27ebc96f2ab4 FS",
      "parent": "ae90a39b-29b6-460d-a270-7d8989677943"
    },
    {
      "id": "a74fb24b-025c-44f1-abf3-f20f9c8c5540",
      "text": "Implement approved improvements facility-wide",
      "custom_tooltip": "<b>Implement approved improvements facility-wide</b><br>Objective: Roll out approved process improvements and new technologies across the entire facility.\nScope: Develop implementation plans, train staff, and monitor performance to ensure successful adoption.\nSteps: Develop implementation plans, train staff, communicate changes, monitor performance, and provide ongoing support.\nDeliverables: Updated operational procedures, trained staff, and improved facility performance metrics.<br><b>Resources needed:</b><br><ul><li>Training Staff</li><li>Project Manager</li><li>Communication Team</li><li>Medical Staff</li><li>IT Support</li></ul>",
      "start_date": "2030-07-19",
      "duration": 4.0,
      "progress": 0,
      "open": true,
      "meta": "ae90a39b-29b6-460d-a270-7d8989677943 FF, d6127fca-e8dc-4737-8977-db75c7f8a284 FS",
      "parent": "ae90a39b-29b6-460d-a270-7d8989677943"
    }
  ],
  "links": [
    {
      "id": "link_1",
      "source": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "target": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_2",
      "source": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "target": "5c4161cf-b3a4-42b6-914a-8b051aac2a55",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_3",
      "source": "11fd4b20-8174-4ab9-b5c6-a231920b89f5",
      "target": "0a8f360c-e8eb-4c92-8665-721ddb344b6c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_4",
      "source": "0a8f360c-e8eb-4c92-8665-721ddb344b6c",
      "target": "c90639eb-9941-418a-8607-a206001be1a3",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_5",
      "source": "c90639eb-9941-418a-8607-a206001be1a3",
      "target": "19ff72cd-a65d-4dbd-88c0-2600863b590e",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_6",
      "source": "5c4161cf-b3a4-42b6-914a-8b051aac2a55",
      "target": "e4020cc5-dc9d-4100-a124-c51bcd7091e8",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_7",
      "source": "d974662c-4ac6-4877-9f9f-3451721ceb51",
      "target": "0a6adf98-e625-44ce-b125-e37ba651afcc",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_8",
      "source": "0a6adf98-e625-44ce-b125-e37ba651afcc",
      "target": "c7803bcd-3bfa-4478-9579-15a8dbebe8d5",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_9",
      "source": "c7803bcd-3bfa-4478-9579-15a8dbebe8d5",
      "target": "5cb56967-fd56-43ed-a8e7-36b37da2c20b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_10",
      "source": "e4020cc5-dc9d-4100-a124-c51bcd7091e8",
      "target": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_11",
      "source": "262adc91-09cc-4dc8-bff1-c413f12b0cfc",
      "target": "05562c59-0a6e-436b-ac7a-0ab3f4f34939",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_12",
      "source": "05562c59-0a6e-436b-ac7a-0ab3f4f34939",
      "target": "fd9e4821-d042-4b82-b752-629ea9870972",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_13",
      "source": "fd9e4821-d042-4b82-b752-629ea9870972",
      "target": "15167f12-0777-4a68-a0ca-8a739a5a524f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_14",
      "source": "15167f12-0777-4a68-a0ca-8a739a5a524f",
      "target": "0ae012b1-c327-4792-955b-aa83c3b98959",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_15",
      "source": "482de1c5-eb8f-41bc-a073-6b3c2a12b7d2",
      "target": "f87a83eb-17cf-48d1-92d5-2c669cb3525d",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_16",
      "source": "a7c6c689-4b9a-44d6-b200-538f71c485ce",
      "target": "f96dd3ac-7e5f-469a-b952-d570299a57b8",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_17",
      "source": "f96dd3ac-7e5f-469a-b952-d570299a57b8",
      "target": "1ca5a048-7c4e-41bd-b562-a6332d3bbf9d",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_18",
      "source": "1ca5a048-7c4e-41bd-b562-a6332d3bbf9d",
      "target": "5a4ed5e1-b547-49a2-97ad-275d8769e10c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_19",
      "source": "5a4ed5e1-b547-49a2-97ad-275d8769e10c",
      "target": "e240650c-02bc-4d98-bb59-2cf31e05bc42",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_20",
      "source": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "target": "0dbbdc0b-a0b3-4769-9627-5be7653573cf",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_21",
      "source": "f87a83eb-17cf-48d1-92d5-2c669cb3525d",
      "target": "0dbbdc0b-a0b3-4769-9627-5be7653573cf",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_22",
      "source": "9d49a664-2412-4f08-9573-2c92aeb8087b",
      "target": "fba35e93-7777-4863-b64b-9c315894b0c0",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_23",
      "source": "fba35e93-7777-4863-b64b-9c315894b0c0",
      "target": "825fd9a0-71f0-4142-9b65-43c461cbd52b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_24",
      "source": "825fd9a0-71f0-4142-9b65-43c461cbd52b",
      "target": "95a2ae41-3554-4bfc-8e87-67212c9828cf",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_25",
      "source": "44c372a4-1064-45ef-b1d2-9bbfe3b9ffe3",
      "target": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_26",
      "source": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "target": "88873351-fe17-4656-97d3-6d6ff1defee4",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_27",
      "source": "84b8d532-072a-41dc-912b-9f423974b5e9",
      "target": "e7a1fee8-b1aa-494c-98fd-76b0cf7f8a21",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_28",
      "source": "e7a1fee8-b1aa-494c-98fd-76b0cf7f8a21",
      "target": "b70ffbed-ee29-4848-9f34-7d44b728b70a",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_29",
      "source": "b70ffbed-ee29-4848-9f34-7d44b728b70a",
      "target": "54488382-a7f1-4558-91a7-1c28f78f09af",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_30",
      "source": "88873351-fe17-4656-97d3-6d6ff1defee4",
      "target": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_31",
      "source": "0998bc6f-a029-476a-aa33-0ae1695e93c1",
      "target": "22204e0f-1551-4d04-a00d-d703e900cb69",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_32",
      "source": "22204e0f-1551-4d04-a00d-d703e900cb69",
      "target": "a9ccce30-3f9a-4112-a799-855768a9a248",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_33",
      "source": "a9ccce30-3f9a-4112-a799-855768a9a248",
      "target": "1d7b7cdd-0af1-4555-bc0c-8840f916f04c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_34",
      "source": "1d7b7cdd-0af1-4555-bc0c-8840f916f04c",
      "target": "1074b6ff-fdc7-4ccf-9046-2d1ef4c74aa9",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_35",
      "source": "0f4de4aa-ecf2-4c36-baa6-7d4e3f7dc952",
      "target": "8346561b-9e0c-466d-83eb-0d6aadda330b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_36",
      "source": "cddc6d56-47a7-4d86-99fb-17cf0e680502",
      "target": "6a054300-b4d5-4385-b8e1-24beb133c3da",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_37",
      "source": "6a054300-b4d5-4385-b8e1-24beb133c3da",
      "target": "0f10888f-372f-4700-8c2d-df237d9bb2ac",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_38",
      "source": "0f10888f-372f-4700-8c2d-df237d9bb2ac",
      "target": "1c1ff2db-99f0-4606-8007-fc00b60adee2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_39",
      "source": "1c1ff2db-99f0-4606-8007-fc00b60adee2",
      "target": "bca53136-fd8c-4b8c-94a3-4ae4bb837fc4",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_40",
      "source": "8346561b-9e0c-466d-83eb-0d6aadda330b",
      "target": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_41",
      "source": "7b2a90af-ea4e-408f-8ff7-3a47a9109e9c",
      "target": "767b4bcb-30ea-49cc-8e12-d8299ac2f0c8",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_42",
      "source": "767b4bcb-30ea-49cc-8e12-d8299ac2f0c8",
      "target": "3ba21f5a-40f8-4f25-8516-2b8763075112",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_43",
      "source": "3ba21f5a-40f8-4f25-8516-2b8763075112",
      "target": "f2010f0e-b89d-41ee-a8d9-44eddfbbbc8e",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_44",
      "source": "8b7c3d53-570e-4aab-9aa0-0b52f10dc6f2",
      "target": "57831a79-0296-4839-9152-097c08f2596f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_45",
      "source": "0dc3543e-c84f-4914-9ca7-fd90435ed6ad",
      "target": "2db1a1af-3883-43b5-8968-9061eee85941",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_46",
      "source": "2db1a1af-3883-43b5-8968-9061eee85941",
      "target": "cca1b359-29a6-495b-b6f4-b861f9679ff5",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_47",
      "source": "cca1b359-29a6-495b-b6f4-b861f9679ff5",
      "target": "dc0d3df3-d0c9-4699-9310-5e0ef605a756",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_48",
      "source": "dc0d3df3-d0c9-4699-9310-5e0ef605a756",
      "target": "19bec1c3-8e14-46bf-ba18-3878fbff3565",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_49",
      "source": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "target": "8a12f9b1-21eb-466a-bb85-60afa33725c8",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_50",
      "source": "57831a79-0296-4839-9152-097c08f2596f",
      "target": "8a12f9b1-21eb-466a-bb85-60afa33725c8",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_51",
      "source": "40d47d6d-7c40-4678-a775-0f7da8fbc4eb",
      "target": "e0c241ec-776e-4488-b204-4efe721c3c73",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_52",
      "source": "e0c241ec-776e-4488-b204-4efe721c3c73",
      "target": "7b8f61a3-8cb3-456b-868b-ff3d8d424e7a",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_53",
      "source": "7b8f61a3-8cb3-456b-868b-ff3d8d424e7a",
      "target": "00256dc9-49c9-49ee-ac1b-8b3ce6b252b1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_54",
      "source": "00256dc9-49c9-49ee-ac1b-8b3ce6b252b1",
      "target": "69c8900b-dab7-46e1-ba71-dcd7d276be9f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_55",
      "source": "bead144a-37b0-4c63-ac6d-a0a19d9c2a33",
      "target": "c3905530-1d89-4610-bc35-a66b4597170d",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_56",
      "source": "c3905530-1d89-4610-bc35-a66b4597170d",
      "target": "c2656566-0c94-40b2-a22e-0955e9216f46",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_57",
      "source": "237024a5-b5b4-4851-aca8-df98563e2edd",
      "target": "0c68c563-330b-4258-a61d-5cd55597a7d5",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_58",
      "source": "0c68c563-330b-4258-a61d-5cd55597a7d5",
      "target": "f2fab493-d73f-42dd-bb07-c9306a9618fb",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_59",
      "source": "f2fab493-d73f-42dd-bb07-c9306a9618fb",
      "target": "5b6d72f6-7f4d-442c-93b1-918c7380da49",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_60",
      "source": "5b6d72f6-7f4d-442c-93b1-918c7380da49",
      "target": "b26eeadc-c132-4b6c-8bfd-8fbb67120d3d",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_61",
      "source": "c2656566-0c94-40b2-a22e-0955e9216f46",
      "target": "d1da9237-e263-4c03-a503-590d6eeea3f3",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_62",
      "source": "5440543e-8c9b-4f92-b57e-1d092448873d",
      "target": "b2af5698-ffd5-4944-91ce-381c09a294a4",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_63",
      "source": "b2af5698-ffd5-4944-91ce-381c09a294a4",
      "target": "8c1e864a-bafa-4fff-be04-33d6daad4b50",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_64",
      "source": "8c1e864a-bafa-4fff-be04-33d6daad4b50",
      "target": "a10513ec-dbe5-41fd-8218-4e5349fa869a",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_65",
      "source": "a10513ec-dbe5-41fd-8218-4e5349fa869a",
      "target": "304396a5-e27e-425f-b381-7c60115860eb",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_66",
      "source": "d1da9237-e263-4c03-a503-590d6eeea3f3",
      "target": "664a3180-076a-435e-b8bd-5c2d7be3a5e1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_67",
      "source": "73a1139e-8e53-47f7-b2e2-a709fc200b1b",
      "target": "81e6bdef-caf9-42c4-b685-3860865a1a54",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_68",
      "source": "81e6bdef-caf9-42c4-b685-3860865a1a54",
      "target": "fb659d35-bf51-44d0-a402-2ad890eee55b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_69",
      "source": "fb659d35-bf51-44d0-a402-2ad890eee55b",
      "target": "fa0db33f-7f9f-4e2e-9757-2efe6e1081d1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_70",
      "source": "fa0db33f-7f9f-4e2e-9757-2efe6e1081d1",
      "target": "68921308-13ba-4fac-bb46-70b802f93b68",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_71",
      "source": "664a3180-076a-435e-b8bd-5c2d7be3a5e1",
      "target": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_72",
      "source": "e02895ff-d980-4bbc-b950-8f681cac6a23",
      "target": "011f9618-dcf2-4bd1-b8ee-2c6505951766",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_73",
      "source": "011f9618-dcf2-4bd1-b8ee-2c6505951766",
      "target": "ff893814-759b-44cc-8ffa-0be1aa266165",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_74",
      "source": "ff893814-759b-44cc-8ffa-0be1aa266165",
      "target": "0c48a713-4bd4-4cd0-8ddc-17c4b06b16f8",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_75",
      "source": "0c48a713-4bd4-4cd0-8ddc-17c4b06b16f8",
      "target": "c5e28806-e26d-4473-9097-e23ddfb6e539",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_76",
      "source": "c3905530-1d89-4610-bc35-a66b4597170d",
      "target": "bf1f1646-5331-4128-843a-94182f9e72a2",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_77",
      "source": "b3eeffe0-96c3-4758-896e-c87fe1de4a7b",
      "target": "bf1f1646-5331-4128-843a-94182f9e72a2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_78",
      "source": "43b25536-52e8-4246-bedd-84ee796f803e",
      "target": "b1293df1-628c-41a4-8aab-bfef544fb03b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_79",
      "source": "b1293df1-628c-41a4-8aab-bfef544fb03b",
      "target": "cbc59d5f-755c-4d82-b8d9-660a92518932",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_80",
      "source": "cbc59d5f-755c-4d82-b8d9-660a92518932",
      "target": "abfb3dbe-3b60-4462-b2b3-978d3e49db9c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_81",
      "source": "abfb3dbe-3b60-4462-b2b3-978d3e49db9c",
      "target": "b9314417-b01e-492f-a16b-ea1d4ed12b44",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_82",
      "source": "c3905530-1d89-4610-bc35-a66b4597170d",
      "target": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_83",
      "source": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "target": "22ffa70e-b917-4918-9074-e917a9890156",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_84",
      "source": "907727c7-1fb8-46b6-9da0-4396387846fb",
      "target": "8ebe4ef9-feb1-4d3f-99f6-33245a10cae3",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_85",
      "source": "8ebe4ef9-feb1-4d3f-99f6-33245a10cae3",
      "target": "cb406d06-ae90-4da8-81d1-c352984cacac",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_86",
      "source": "cb406d06-ae90-4da8-81d1-c352984cacac",
      "target": "1da9645e-89a2-4e93-8b0e-a0f23aca4102",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_87",
      "source": "22ffa70e-b917-4918-9074-e917a9890156",
      "target": "406b6dd6-7b44-4d60-a2e1-f31668252d62",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_88",
      "source": "85546c83-65bb-4baf-b100-9ce5e8fcde72",
      "target": "2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_89",
      "source": "2f990dbd-b61f-40a0-afaa-d3c2a2f4d0b4",
      "target": "2ecb2eed-47f8-4efc-9936-7ea541193511",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_90",
      "source": "2ecb2eed-47f8-4efc-9936-7ea541193511",
      "target": "179b4feb-8bb6-4d4c-9601-cb9b543e99d5",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_91",
      "source": "406b6dd6-7b44-4d60-a2e1-f31668252d62",
      "target": "6184d74a-ca1e-44d1-b5b8-445aadb63208",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_92",
      "source": "0c5b34e2-b12c-410e-992a-f4bba6326ebf",
      "target": "d46b6612-cd0a-4ae8-bf54-a74fd1ed9003",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_93",
      "source": "d46b6612-cd0a-4ae8-bf54-a74fd1ed9003",
      "target": "d73df452-bb1b-46f6-aaa8-c2a91243ecba",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_94",
      "source": "d73df452-bb1b-46f6-aaa8-c2a91243ecba",
      "target": "36f291b9-ce07-4078-a331-08b7c984d520",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_95",
      "source": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "target": "f2158970-6c48-4dfa-97e5-6620da550d37",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_96",
      "source": "6184d74a-ca1e-44d1-b5b8-445aadb63208",
      "target": "f2158970-6c48-4dfa-97e5-6620da550d37",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_97",
      "source": "1e85e3e9-276d-4f0a-a9c1-3887d39771c1",
      "target": "d0af366a-186a-4e6b-ae0f-4a0f2fefa5b1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_98",
      "source": "d0af366a-186a-4e6b-ae0f-4a0f2fefa5b1",
      "target": "09075e8b-5ccd-462a-96e9-b22d33b7e037",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_99",
      "source": "09075e8b-5ccd-462a-96e9-b22d33b7e037",
      "target": "c7be9ecc-472a-4a49-8280-d31b1a1d1c00",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_100",
      "source": "c7be9ecc-472a-4a49-8280-d31b1a1d1c00",
      "target": "a99f4878-fb70-4658-820d-e104fcca0688",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_101",
      "source": "edea1841-d86e-4d1b-9704-04d6abb593c2",
      "target": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_102",
      "source": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "target": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_103",
      "source": "603662c9-344a-4f04-9c30-891acb6d9c8e",
      "target": "42ec1737-196e-4c88-bfdd-8e1a359cc439",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_104",
      "source": "42ec1737-196e-4c88-bfdd-8e1a359cc439",
      "target": "135fc0e9-438a-4721-b996-f43881f0fc16",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_105",
      "source": "135fc0e9-438a-4721-b996-f43881f0fc16",
      "target": "fc6093c8-b948-46c1-9d82-fd919b41657b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_106",
      "source": "fc6093c8-b948-46c1-9d82-fd919b41657b",
      "target": "fb0389ed-03b4-4bd5-b726-119c8f3b7ba3",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_107",
      "source": "a6dfbdbf-d854-44fa-aaea-71b6dfc22891",
      "target": "7018d1da-7992-42c1-bec3-176474ec2378",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_108",
      "source": "80e6de91-5f68-4d73-9a76-851da609fa65",
      "target": "08d7cf07-78da-4107-8db6-279c1946f7fe",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_109",
      "source": "08d7cf07-78da-4107-8db6-279c1946f7fe",
      "target": "38a84ba4-234b-4161-883f-f301d060cc1f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_110",
      "source": "38a84ba4-234b-4161-883f-f301d060cc1f",
      "target": "f95038eb-bebf-48da-8c5e-f6e7071c4757",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_111",
      "source": "f95038eb-bebf-48da-8c5e-f6e7071c4757",
      "target": "83bd2c85-436e-45c2-b215-fe9917d4962c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_112",
      "source": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "target": "a3434b32-c11f-4b3e-b010-1e564ed21e55",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_113",
      "source": "7018d1da-7992-42c1-bec3-176474ec2378",
      "target": "a3434b32-c11f-4b3e-b010-1e564ed21e55",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_114",
      "source": "1a3a2127-0354-4eca-9056-427371200c79",
      "target": "d21b27d7-b51a-41f9-a22a-2c7e89a6ed58",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_115",
      "source": "d21b27d7-b51a-41f9-a22a-2c7e89a6ed58",
      "target": "37f79344-021f-4563-b48d-d570bf04dbf9",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_116",
      "source": "37f79344-021f-4563-b48d-d570bf04dbf9",
      "target": "f4577276-a266-4bc8-a82d-2141e7fbd99c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_117",
      "source": "f4577276-a266-4bc8-a82d-2141e7fbd99c",
      "target": "1036ce4c-4986-4b0c-9ca2-aaa3e71d7dc3",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_118",
      "source": "07f8df70-3b93-46d1-9571-5f7823a7865e",
      "target": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_119",
      "source": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "target": "ec842223-c669-493e-b08c-ecd6501b2647",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_120",
      "source": "b723be5f-9208-453e-af6b-e20e7c2b0935",
      "target": "5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_121",
      "source": "5734b2c4-e02d-4dc0-8845-56c3f4fb3d0c",
      "target": "2a86897a-4999-4dde-a5f1-d0dc8ed738f1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_122",
      "source": "2a86897a-4999-4dde-a5f1-d0dc8ed738f1",
      "target": "fd0ea2d9-788d-4e1c-b312-1fadfb8de5f2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_123",
      "source": "ec842223-c669-493e-b08c-ecd6501b2647",
      "target": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_124",
      "source": "3e63ebd3-2fe0-4e58-b1f0-4e8b4d98e90d",
      "target": "ba2348a4-afa6-475e-9a0e-8bca32eb17b4",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_125",
      "source": "ba2348a4-afa6-475e-9a0e-8bca32eb17b4",
      "target": "edb1c4da-05e4-4c54-a328-dbe7c6828042",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_126",
      "source": "edb1c4da-05e4-4c54-a328-dbe7c6828042",
      "target": "702c7a45-d903-47be-b61d-960415c32bdf",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_127",
      "source": "702c7a45-d903-47be-b61d-960415c32bdf",
      "target": "fccdd8e1-1a49-4b15-9724-d488b31c7026",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_128",
      "source": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "target": "bcbecda8-592b-4c76-911b-8fdbf3848488",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_129",
      "source": "7f9f308e-365f-46e0-ad45-31a9dc51fa8b",
      "target": "bcbecda8-592b-4c76-911b-8fdbf3848488",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_130",
      "source": "307fc299-ac88-4477-9b8c-b59b39705cb5",
      "target": "fb381bef-9642-442b-a7bd-f9813836b69f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_131",
      "source": "fb381bef-9642-442b-a7bd-f9813836b69f",
      "target": "d5bc63d8-55c9-4f01-bc6f-a2a34337745d",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_132",
      "source": "d5bc63d8-55c9-4f01-bc6f-a2a34337745d",
      "target": "80f6dc05-65c9-43a1-81c5-d1a95d8ac6ce",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_133",
      "source": "96817a78-23cf-4f51-b115-c0a63c20a419",
      "target": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_134",
      "source": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "target": "ce5e2e90-d960-4aa6-9268-cf34537813aa",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_135",
      "source": "59642d8b-cfa6-4f76-8a05-a624ca6c29a1",
      "target": "0740ebfc-401c-4ae2-9111-2e108ed92750",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_136",
      "source": "0740ebfc-401c-4ae2-9111-2e108ed92750",
      "target": "fa4f0b8a-fe8c-44f4-a0d3-114016cc67e4",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_137",
      "source": "fa4f0b8a-fe8c-44f4-a0d3-114016cc67e4",
      "target": "5c2a916d-27d6-4cc2-8c2b-525402e8431d",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_138",
      "source": "5c2a916d-27d6-4cc2-8c2b-525402e8431d",
      "target": "c954c1d8-3b97-4648-9c90-a48d923e6577",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_139",
      "source": "ce5e2e90-d960-4aa6-9268-cf34537813aa",
      "target": "b239ca08-0717-4219-b325-beaacb14e951",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_140",
      "source": "4b5491cf-aa89-40b1-87c3-04da0c26bf55",
      "target": "c8ec5412-99e1-45dc-b7e7-7f5a6aee9579",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_141",
      "source": "c8ec5412-99e1-45dc-b7e7-7f5a6aee9579",
      "target": "5ea620b1-5c65-43f9-9a73-1c1881b561b1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_142",
      "source": "5ea620b1-5c65-43f9-9a73-1c1881b561b1",
      "target": "a9703b20-d188-4b03-9664-7ff66bde33e2",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_143",
      "source": "a9703b20-d188-4b03-9664-7ff66bde33e2",
      "target": "20502188-d36c-45dd-9bf2-a8bc6ed0048e",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_144",
      "source": "b239ca08-0717-4219-b325-beaacb14e951",
      "target": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_145",
      "source": "f610d7ac-9e6d-459c-8f77-d4c384a4cc73",
      "target": "3f756606-3068-4ede-87bb-f4ef7811519f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_146",
      "source": "3f756606-3068-4ede-87bb-f4ef7811519f",
      "target": "27d8c508-3cb0-449e-8744-26bde56fb0cc",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_147",
      "source": "27d8c508-3cb0-449e-8744-26bde56fb0cc",
      "target": "d1789094-0d0f-4e26-b283-84c4ae73fe45",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_148",
      "source": "d1789094-0d0f-4e26-b283-84c4ae73fe45",
      "target": "53128582-e4e8-49c1-821c-89b833908400",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_149",
      "source": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "target": "742e9056-0c0f-4c78-bec1-00825bc6dfa1",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_150",
      "source": "c404f9dc-7a1c-4039-9c84-d6f44a6aa0a6",
      "target": "742e9056-0c0f-4c78-bec1-00825bc6dfa1",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_151",
      "source": "9bfd6658-f8e9-43bd-baa4-6a626dcf1ab0",
      "target": "71b12a59-061d-4e45-89a0-51509d3a9ad5",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_152",
      "source": "71b12a59-061d-4e45-89a0-51509d3a9ad5",
      "target": "70e0a488-b358-4e8e-9056-592d8de91ff3",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_153",
      "source": "70e0a488-b358-4e8e-9056-592d8de91ff3",
      "target": "4f4f3167-98ea-47ee-9e04-c332daa74fec",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_154",
      "source": "4f4f3167-98ea-47ee-9e04-c332daa74fec",
      "target": "e54814fc-de88-4e29-bfc0-aa7ee072f345",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_155",
      "source": "60c6b7a8-2145-4e79-a407-31d257bd7417",
      "target": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_156",
      "source": "881ece3f-9348-4d69-93f2-2803c75dd85c",
      "target": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_157",
      "source": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "target": "036d3f1f-d298-4895-bd33-6009f5bf182f",
      "type": "1",
      "lag": 0.0
    },
    {
      "id": "link_158",
      "source": "99b05c9b-3da6-4549-ba9e-6f683164e368",
      "target": "24a1355a-be32-4f64-b6d7-d13216f50e26",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_159",
      "source": "24a1355a-be32-4f64-b6d7-d13216f50e26",
      "target": "4ff300b0-b124-407b-b161-051804def801",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_160",
      "source": "4ff300b0-b124-407b-b161-051804def801",
      "target": "cf21067b-023f-478e-9348-fceb3b17fd69",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_161",
      "source": "036d3f1f-d298-4895-bd33-6009f5bf182f",
      "target": "9ad0a546-40bb-4563-adc1-099850a36f92",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_162",
      "source": "4a247e67-a282-43d8-80c1-e1b23ec05ca9",
      "target": "c7f4ebe1-e39a-480b-a27c-2e54e214df2f",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_163",
      "source": "c7f4ebe1-e39a-480b-a27c-2e54e214df2f",
      "target": "d1ac5d53-91d3-4dee-848f-2cf200244eca",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_164",
      "source": "d1ac5d53-91d3-4dee-848f-2cf200244eca",
      "target": "73068e2d-0133-48b5-9059-f8cf9838a9cc",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_165",
      "source": "73068e2d-0133-48b5-9059-f8cf9838a9cc",
      "target": "e5dd9714-c2a0-42ce-90b3-3a5e6b7521ab",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_166",
      "source": "9ad0a546-40bb-4563-adc1-099850a36f92",
      "target": "fefe05de-7920-4c46-aad2-22acfc31ad4e",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_167",
      "source": "e066ece9-f4fc-44da-ac21-c7b4e1227405",
      "target": "bf6ab506-27ef-49cc-8f69-9cab73f21113",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_168",
      "source": "bf6ab506-27ef-49cc-8f69-9cab73f21113",
      "target": "0030f8d5-5257-4b6e-9246-9bce57ff7458",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_169",
      "source": "0030f8d5-5257-4b6e-9246-9bce57ff7458",
      "target": "53859978-b189-4292-bdd2-ee08e3816a82",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_170",
      "source": "53859978-b189-4292-bdd2-ee08e3816a82",
      "target": "23e9b77b-b49f-4b95-862e-bbc0950caa82",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_171",
      "source": "991ae3aa-a394-4134-a5a8-540b61b454b5",
      "target": "ae90a39b-29b6-460d-a270-7d8989677943",
      "type": "2",
      "lag": 0.0
    },
    {
      "id": "link_172",
      "source": "fefe05de-7920-4c46-aad2-22acfc31ad4e",
      "target": "ae90a39b-29b6-460d-a270-7d8989677943",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_173",
      "source": "15d712d2-0f26-4294-97cd-66a0d12f7b66",
      "target": "c93808d4-549d-424b-be34-27ebc96f2ab4",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_174",
      "source": "c93808d4-549d-424b-be34-27ebc96f2ab4",
      "target": "d6127fca-e8dc-4737-8977-db75c7f8a284",
      "type": "0",
      "lag": 0.0
    },
    {
      "id": "link_175",
      "source": "d6127fca-e8dc-4737-8977-db75c7f8a284",
      "target": "a74fb24b-025c-44f1-abf3-f20f9c8c5540",
      "type": "0",
      "lag": 0.0
    }
  ]
};

    function zoomFit() {
        const tasks = gantt.getTaskByTime();
        if (tasks.length > 0) {
            const firstTask = tasks[0];
            const lastTask = tasks[tasks.length - 1];
            gantt.showDate(firstTask.start_date);
            
            // Calculate total duration in days
            const startDate = new Date(firstTask.start_date);
            const endDate = new Date(lastTask.end_date);
            const durationDays = (endDate - startDate) / (1000 * 60 * 60 * 24);
            
            // Choose appropriate scale based on duration
            if (durationDays > 3650) { // More than 10 years
                gantt.config.scale_unit = "year";
                gantt.config.step = 10;
                gantt.config.subscales = [
                    {unit: "year", step: 1, date: "%Y"}
                ];
            } else if (durationDays > 365) { // More than 1 year
                gantt.config.scale_unit = "year";
                gantt.config.step = 1;
                gantt.config.subscales = [
                    {unit: "month", step: 1, date: "%M"}
                ];
            } else if (durationDays > 30) { // More than 1 month
                gantt.config.scale_unit = "month";
                gantt.config.step = 1;
                gantt.config.subscales = [
                    {unit: "day", step: 1, date: "%d"}
                ];
            } else if (durationDays > 7) { // More than 1 week
                gantt.config.scale_unit = "week";
                gantt.config.step = 1;
                gantt.config.subscales = [
                    {unit: "day", step: 1, date: "%d"}
                ];
            } else {
                gantt.config.scale_unit = "day";
                gantt.config.step = 1;
                gantt.config.subscales = [];
            }
            gantt.render();
        }
    }

    function zoomIn() {
        const currentUnit = gantt.config.scale_unit;
        const currentStep = gantt.config.step;
        
        if (currentUnit === "year" && currentStep === 10) {
            gantt.config.scale_unit = "year";
            gantt.config.step = 1;
            gantt.config.subscales = [
                {unit: "month", step: 1, date: "%M"}
            ];
        } else if (currentUnit === "year") {
            gantt.config.scale_unit = "month";
            gantt.config.step = 1;
            gantt.config.subscales = [
                {unit: "day", step: 1, date: "%d"}
            ];
        } else if (currentUnit === "month") {
            gantt.config.scale_unit = "week";
            gantt.config.step = 1;
            gantt.config.subscales = [
                {unit: "day", step: 1, date: "%d"}
            ];
        } else if (currentUnit === "week") {
            gantt.config.scale_unit = "day";
            gantt.config.step = 1;
            gantt.config.subscales = [];
        }
        gantt.render();
    }

    function zoomOut() {
        const currentUnit = gantt.config.scale_unit;
        const currentStep = gantt.config.step;
        
        if (currentUnit === "day") {
            gantt.config.scale_unit = "week";
            gantt.config.step = 1;
            gantt.config.subscales = [
                {unit: "day", step: 1, date: "%d"}
            ];
        } else if (currentUnit === "week") {
            gantt.config.scale_unit = "month";
            gantt.config.step = 1;
            gantt.config.subscales = [
                {unit: "day", step: 1, date: "%d"}
            ];
        } else if (currentUnit === "month") {
            gantt.config.scale_unit = "year";
            gantt.config.step = 1;
            gantt.config.subscales = [
                {unit: "month", step: 1, date: "%M"}
            ];
        } else if (currentUnit === "year") {
            gantt.config.scale_unit = "year";
            gantt.config.step = 10;
            gantt.config.subscales = [
                {unit: "year", step: 1, date: "%Y"}
            ];
        }
        gantt.render();
    }

    function downloadCSV() {
        if (GANTT_DATA_CSV === null) {
            return;
        }
        const blob = new Blob([GANTT_DATA_CSV], { type: 'text/csv;charset=utf-8;' });
        const link = document.createElement('a');
        const url = URL.createObjectURL(blob);
        link.setAttribute('href', url);
        link.setAttribute('download', GANTT_FILENAME_CSV);
        link.style.visibility = 'hidden';
        document.body.appendChild(link);
        link.click();
        document.body.removeChild(link);
    }

    // Gantt Initialization
    gantt.config.readonly = true;
    gantt.config.date_format = "%Y-%m-%d";
    gantt.config.scale_unit = "month";
    gantt.config.step = 1;
    gantt.config.subscales = [
        {unit: "day", step: 1, date: "%d"}
    ];

    gantt.config.columns = [
        {name:"text", label:"Task name", width:"*", tree:true},
        // {name:"start_date", label:"Start time", align: "center"},
        // {name:"duration", label:"Duration", align: "center"}
    ];

    gantt.templates.task_class = function(start, end, task) {
        if (task.type === "project") {
            return "project-task";
        }
        return "";
    };

    gantt.templates.tooltip_text = function(start, end, task) {
        return task.custom_tooltip || "No tooltip";
    };
    
	gantt.plugins({
		tooltip: true
	});
	gantt.attachEvent("onGanttReady", function(){
		var tooltips = gantt.ext.tooltips;
		tooltips.tooltip.setViewport(gantt.$task_data);
	});
    gantt.init("gantt_container");
    gantt.parse(GANTT_DATA_DHTMLX);

    // Hide the export to CSV button if there is no CSV data
    if (GANTT_DATA_CSV === null) {
        document.getElementById('exportToCSVButton').style.display = 'none';
    }

    document.getElementById('zoomFitButton').addEventListener('click', zoomFit);
    document.getElementById('zoomInButton').addEventListener('click', zoomIn);
    document.getElementById('zoomOutButton').addEventListener('click', zoomOut);
    document.getElementById('exportToCSVButton').addEventListener('click', downloadCSV);
</script>

    <script>
        var coll = document.getElementsByClassName("collapsible");
        var i;

        for (i = 0; i < coll.length; i++) {
            coll[i].addEventListener("click", function() {
                this.classList.toggle("active");
                var content = this.nextElementSibling;
                if (content.style.maxHeight){
                    content.style.maxHeight = null;
                } else {
                    content.style.maxHeight = content.scrollHeight + "px";
                }
            });
        }
    </script>
    <script>
// Checkbox controls button enable/disable and button text
const checkbox = document.getElementById('planexe-execute-confirm-checkbox');
const executeBtn = document.getElementById('planexe-execute-button');
const animationMsg = document.getElementById('planexe-execute-message');

function updateExecuteBtnState() {
    if (checkbox.checked) {
        executeBtn.disabled = false;
        executeBtn.innerHTML = 'Execute';
        executeBtn.classList.add('execute-active');
        executeBtn.classList.remove('ready');
        document.getElementById('planexe-execute-button-warning').style.display = '';
    } else {
        executeBtn.disabled = true;
        executeBtn.innerHTML = 'Execute';
        executeBtn.classList.remove('execute-active', 'ready');
        document.getElementById('planexe-execute-button-warning').style.display = 'none';
    }
}

// Initial state
updateExecuteBtnState();

checkbox.addEventListener('change', updateExecuteBtnState);

// Fancy animation on Execute
executeBtn.addEventListener('click', function() {
    if (executeBtn.disabled) return;
    executeBtn.classList.remove('execute-active');
    executeBtn.classList.add('executing');
    executeBtn.innerHTML = '<span class="spinner"></span> Executing...';
    document.getElementById('planexe-execute-button-warning').style.display = 'none';
    animationMsg.innerHTML = '';
    setTimeout(() => {
        executeBtn.classList.remove('executing');
        executeBtn.classList.add('ready');
        executeBtn.innerHTML = 'Done!';
        animationMsg.innerHTML = '<span style="color: #27ae60; font-weight: bold; font-size: 1.1em;">Plan execution complete!</span>';
        
        // Redirect to execute page after 2 seconds
        setTimeout(() => {
            const pageTitle = document.title || 'PlanExe report without title';
            const encodedTitle = encodeURIComponent(pageTitle);
            window.location.href = `https://planexe.org/execute/?title=${encodedTitle}`;
        }, 2000);
    }, 2200);
});
</script>
<style>
.fancy-execute-btn {
    background: linear-gradient(90deg, #2f3833 0%, #2980b9 100%);
    color: white;
    border: none;
    border-radius: 6px;
    padding: 14px 36px;
    font-size: 1.1em;
    font-weight: normal;
    cursor: pointer;
    box-shadow: 0 2px 8px rgba(41,128,185,0.08);
    transition: box-shadow 0.3s, transform 0.2s, color 0.2s, border 0.2s;
    position: relative;
    outline: none;
}
.fancy-execute-btn.execute-active {
    background: #fff;
    color: #666;
    border: 1.5px solid #666;
    box-shadow: 0 2px 8px rgba(0,0,0,0.04);
}
.fancy-execute-btn.execute-active:hover {
    color: #333 !important;
    border: 1.5px solid #333 !important;
    animation: execute-pulse-simple 1s infinite;
}
@keyframes execute-pulse-simple {
    0% { background-color: #ccc; }
    10% { background-color: #fff; }
    20% { background-color: #ccc; }
    30% { background-color: #fff; }
    90% { background-color: #fff; }
    100% { background-color: #ccc; }
}
.fancy-execute-btn:disabled {
    background: #f8f9fa;
    color: #bbb;
    cursor: not-allowed;
    box-shadow: none;
    border: 1.5px solid #bbb;
}
.fancy-execute-btn.executing {
    background: repeating-linear-gradient(90deg, #757876 0%, #596770 50%, #4d6055 100%);
    animation: pulse 0.7s infinite alternate;
    box-shadow: 0 0 16px 2px #2980b933;
    transform: scale(1.04);
}
@keyframes pulse {
    0% { box-shadow: 0 0 16px 2px #27ae6033; }
    100% { box-shadow: 0 0 32px 6px #2980b933; }
}
.fancy-execute-btn .spinner {
    display: inline-block;
    width: 20px;
    height: 20px;
    border: 3px solid #fff;
    border-top: 3px solid #2980b9;
    border-radius: 50%;
    animation: spin 0.8s linear infinite;
    margin-right: 10px;
    vertical-align: middle;
}
@keyframes spin {
    0% { transform: rotate(0deg); }
    100% { transform: rotate(360deg); }
}
.fancy-execute-btn.ready {
    background: #bdbfbe;
    color: #333;
    box-shadow: 0 0 12px 2px #27ae6033;
    transform: scale(1.01);
}
</style>
</body>
</html>